Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution
3005785	p-ck-mbm	ug/l (ug/l)	29194	69081	0.03%
3005785	p-ck-mbm	— (—)	6508	9529	100.00%	Distribution not available
3005785	p-ck-mbm	ug/l______ (ug/l)	397	522	0.00%
3005785	p-ckmbm	ug/l (ug/l)	292	372	0.00%
3005785	p-ck-mbm	µg/L (ug/l)	153	209	0.00%
3005785	p-kreatiinikinaasi,mb-alayksikkö,massa	ug/l______ (ug/l)	51	59	0.00%
3005785	s-ck-mbm	— (—)	32	33	100.00%	Distribution not available
3005785	p-kreatiinikinaasi,mb-alayksikkö,massa	ug/l (ug/l)	28	33	0.00%
3005785	p-ck-mb	ug/l (ug/l)	26	26	0.00%
3005785	s-ck-mbm	ug/l (ug/l)	17	17	0.00%
3005785	p-kreatiinikinaasi,mb-alayksikkö,massa	— (—)	15	17	100.00%	Distribution not available
3005785	s-ck-mbm	µg/l (ug/l)	15	22	0.00%
3005785	b-cardiac,ckmb	— (—)	10	10	100.00%	Distribution not available
3005785	p-ckmbm	— (—)	9	9	100.00%	Distribution not available
3005785	b-cardiac,ckmb	ng/ml (ug/l)	6	14	0.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Implicit viral Sepsis

1922

7759

2.80

322.19

3.6

2.3

9.49

6.79

ug/l

2.75

1687

6751

Viral Sepsis

1924

7771

2.80

322.16

3.6

2.3

9.48

6.78

ug/l

2.75

1689

6762

Transient ischemic attack

4193

18116

1.99

313.99

2.8

2.3

6.40

7.43

ug/l

2.40

3738

15646

Disorders of lipoprotein metabolism and other lipidaemias

6068

19808

1.98

307.65

2.6

2.2

7.77

7.45

ug/l

0.51

5304

17425

Left ventricular outflow tract obstruction (LVOTO), broad definition

1077

2942

4.54

307.65

2.5

2.3

15.64

8.82

ug/l

11.35

1029

2681

Persons encountering health services for specific procedures and health care

7334

23325

1.95

307.65

2.6

2.2

8.20

7.28

ug/l

1.66

6493

20316

Angina pectoris

5421

10676

3.88

307.65

3.2

1.8

8.16

3.95

ug/l

35.17

4878

8847

Symptoms and signs involving the digestive system and abdomen

6377

18387

1.81

307.65

2.6

2.2

6.17

8.54

ug/l

14.12

5578

16081

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

2148

3656

3.94

307.65

2.4

1.4

8.01

3.09

ug/l

11.25

1913

3112

Renal failure

4311

18726

2.15

307.65

2.9

2.4

9.59

7.16

ug/l

5.23

3745

16165

Persons encountering health services for examination and investigation

3936

9452

2.19

307.65

2.4

2.0

7.71

8.68

ug/l

1.20

3450

8327

Cerebrovascular diseases

6072

21676

2.10

307.65

2.6

2.3

7.36

7.57

ug/l

0.29

5310

18987

Implicit bacterial Sepsis

4057

15124

2.57

307.65

3.1

2.3

8.25

7.15

ug/l

1.66

3472

13180

Condition for Implicit Sepsis (Organ dysfunction codes)

7227

21613

2.52

307.65

2.8

2.1

9.77

6.88

ug/l

9.81

6295

19037

Bacterial Sepsis

4500

16295

2.54

307.65

3.1

2.3

8.20

7.18

ug/l

1.65

3851

14250

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

7650

21315

2.44

307.65

2.7

2.1

11.19

6.07

ug/l

36.56

6832

18545

Hypertensive heart and/or renal disease

2451

6843

2.96

307.65

2.8

2.2

6.65

7.69

ug/l

1.86

2119

5874

Diseases of arteries, arterioles and capillaries

5831

21230

2.20

307.65

2.8

2.3

8.81

7.17

ug/l

5.76

5150

18431

Anaemias

1201

980

8.50

307.65

2.9

1.3

10.59

3.24

ug/l

12.94

1077

857

Heart failure, not strict

7381

17480

3.23

307.65

2.9

2.0

10.59

6.91

ug/l

16.67

6580

15410

Antihypertensive medication - note that there are other indications

2864

4625

3.40

307.65

2.4

1.6

7.39

5.10

ug/l

5.41

2565

3911

Septicaemia

3736

16199

2.31

307.65

2.9

2.3

8.08

7.37

ug/l

0.85

3225

14104

Other heart diseases, wide

8002

13633

3.95

307.65

2.6

1.8

10.59

5.53

ug/l

33.89

7235

11776

Non-rheumatic valve diseases

5497

9312

5.07

307.65

2.7

1.9

12.72

5.95

ug/l

55.91

5052

7975

Fever of other and unknown origin

4447

15790

2.64

307.65

2.9

2.0

7.51

8.24

ug/l

0.98

3855

13941

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

6949

24535

1.99

307.65

2.7

2.2

7.81

7.43

ug/l

0.61

6040

21661

Explicit Sepsis, including avohilmo

3897

16096

2.41

307.65

2.9

2.2

7.93

7.03

ug/l

1.28

3363

14059

Cerebrovascular diseases (FINNGEN)

2555

2886

7.08

307.65

2.6

1.4

8.50

3.23

ug/l

22.17

2298

2457

Medical observation and evaluation for suspected diseases and conditions

4842

9442

2.82

307.65

2.6

2.0

7.08

8.68

ug/l

3.68

4065

8322

Metabolic disorders

6842

21010

2.07

307.65

2.7

2.1

7.72

7.34

ug/l

0.64

5998

18430

Ischemic heart diseases

8895

13309

4.65

307.65

2.8

1.8

11.90

3.95

ug/l

90.68

8165

11159

Implicit viral Sepsis, including avohilmo

2734

11558

2.63

307.65

3.3

2.2

8.71

6.83

ug/l

2.36

2386

10043

Implicit Sepsis

6848

21442

2.59

307.65

2.9

2.2

8.87

7.12

ug/l

4.58

5916

18875

Hypertensive diseases (excluding secondary)

2987

3912

4.80

307.65

2.5

1.4

8.68

3.11

ug/l

24.72

2710

3339

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

6817

25925

1.87

307.65

2.7

2.2

8.43

7.08

ug/l

3.40

5880

22764

Implicit bacterial Sepsis, including avohilmo

4441

16044

2.57

307.65

3.1

2.3

8.47

7.16

ug/l

2.17

3812

14020

Major coronary heart disease event excluding revascularizations

6624

11798

4.38

307.65

3.1

1.9

11.09

4.03

ug/l

49.58

5940

9749

First line medication for Crohn's disease

6968

22467

1.74

307.65

2.5

2.2

7.81

7.47

ug/l

0.44

6082

19686

Ischaemic heart disease, wide definition

7826

15370

3.61

307.65

2.9

1.9

10.74

5.98

ug/l

29.88

7112

13196

Continuous positive airway pressure

1098

2165

4.62

307.65

2.2

1.5

10.83

4.23

ug/l

8.42

873

1819

Pneumonias (Asthma/COPD co-morbidities)

7061

24292

2.01

307.65

2.7

2.1

7.92

7.35

ug/l

1.05

6131

21450

Hypertensive Heart Disease

2250

6493

2.98

307.65

2.8

2.2

6.46

7.53

ug/l

2.11

1944

5563

Bleeding

6557

23718

2.08

307.65

2.7

2.3

7.36

7.47

ug/l

0.12

5745

20724

Hypothyroidism and >3 levothyroxin purchases

1021

1010

5.97

307.65

2.3

1.3

7.71

3.21

ug/l

5.69

909

881

Complications of surgical and medical care, not elsewhere classified

7450

26077

2.03

307.65

2.8

2.2

7.25

7.34

ug/l

0.12

6547

22747

Explicit Sepsis

3821

15863

2.41

307.65

2.9

2.2

7.98

7.00

ug/l

1.43

3296

13844

General symptoms and signs

7320

17427

2.23

307.65

2.6

2.0

6.81

8.21

ug/l

4.51

6397

15391

Condition for Implicit Sepsis (Organ dysfunction codes), including avohilmo

7141

21321

2.44

307.65

2.7

2.1

9.74

6.87

ug/l

9.60

6251

18796

Conduction disorders

2598

6739

3.49

307.65

3.2

1.9

9.00

6.13

ug/l

4.98

2263

5691

Hypertensive diseases

4842

13068

2.21

307.65

2.5

2.0

8.60

7.47

ug/l

1.94

4338

11454

General examination and investigation of persons without complaint and reported diagnosis

5050

9389

3.03

307.65

2.9

2.0

6.20

8.70

ug/l

8.34

4509

8283

Abnormalities of breathing

6933

14064

3.06

307.65

2.7

1.9

6.50

8.23

ug/l

6.43

6080

12218

Calcific aortic valvular stenosis, operated

3602

13265

3.13

307.65

2.8

2.5

9.66

6.86

ug/l

13.09

3298

11178

Implicit Sepsis, including avohilmo

7227

21833

2.59

307.65

2.8

2.1

9.28

6.96

ug/l

7.21

6258

19215

STROKE

4623

8083

4.33

307.65

2.6

1.7

7.46

3.86

ug/l

21.72

4156

6742

Cardiomyopathy

1526

4527

3.89

307.65

3.2

1.9

16.77

6.57

ug/l

11.15

1398

3851

Bacterial infection, other or unspecified, including avohilmo

4708

19595

2.12

307.65

2.8

2.3

7.20

7.40

ug/l

0.23

3990

17161

Atrial fibrillation and flutter

2981

2750

8.21

307.65

3.0

1.4

11.71

3.18

ug/l

36.26

2759

2343

Erysipelas, including avohilmo

5419

21596

1.98

307.65

2.6

2.2

6.83

7.54

ug/l

1.50

4763

18983

Coronary artery bypass grafting

3646

5659

6.31

307.65

2.9

1.9

12.71

4.03

ug/l

93.44

3429

4582

Percutaneous Coronary Intervention

9258

13036

5.16

307.65

2.8

1.8

11.86

3.96

ug/l

96.32

8537

10922

Major coronary heart disease event

9459

14272

4.67

307.65

2.8

1.8

11.88

4.01

ug/l

96.02

8701

11914

Atrial fibrillation and flutter with reimbursement

2530

2225

8.54

307.65

2.9

1.4

10.84

3.24

ug/l

26.90

2324

1879

Other CVD (FINNGEN)

1090

1139

8.77

307.65

3.3

1.5

6.69

3.38

ug/l

6.00

906

933

AV-block

1786

4526

3.92

307.65

3.4

1.9

9.78

6.49

ug/l

4.03

1585

3757

Heart failure, strict

6238

17087

2.92

307.65

3.2

2.2

10.12

7.06

ug/l

10.31

5505

14875

Myocardial infarction

5479

9781

4.70

307.65

3.1

1.9

12.28

4.00

ug/l

50.09

4915

8074

Hypertension, essential

4860

12937

2.25

307.65

2.5

2.0

7.63

7.46

ug/l

0.18

4337

11349

6176

18384

2.08

307.65

2.7

2.1

7.88

7.39

ug/l

0.77

5359

16221

Status post-ami

2583

5871

3.92

307.65

3.4

1.9

9.44

4.01

ug/l

16.51

2270

4742

Spinal stenosis

3995

15353

2.07

307.65

2.7

2.2

5.85

8.36

ug/l

11.09

3447

13374

Dyspnoea

8030

24465

2.60

307.65

2.9

2.1

6.43

7.67

ug/l

5.03

7020

21380

Heart failure,strict

5710

13663

3.41

307.65

3.2

2.1

10.45

6.98

ug/l

11.46

5082

11968

Presence of cardiac and vascular implants and grafts

5907

13416

3.98

307.65

3.1

2.3

12.91

6.54

ug/l

40.61

5386

11582

Heart failure and coronary heart disease

5087

9199

4.74

307.65

3.4

1.9

11.15

4.04

ug/l

39.83

4581

7477

Examination and observation for other reasons

5068

9278

3.39

307.65

2.8

2.0

7.01

8.72

ug/l

4.07

4481

8206

Paroxysmal tachycardia

1795

2348

7.26

307.65

3.1

1.5

11.90

3.17

ug/l

13.56

1633

1970

Cardiac arrest

669

748

9.27

307.65

3.3

1.5

19.31

3.69

ug/l

9.52

616

604

Diverticular disease of intestine

5404

18358

1.95

307.65

2.6

2.2

6.23

8.06

ug/l

7.22

4741

16122

Other special examinations and investigations of persons without complaint or reported diagnosis

4169

9451

2.36

307.65

2.5

2.0

6.94

8.68

ug/l

4.11

3676

8327

Dialysis, with operation codes

1325

4383

3.66

307.65

3.2

2.4

19.78

7.38

ug/l

11.66

1227

3902

Statin medication

3731

9188

2.40

307.65

2.5

2.0

9.10

5.83

ug/l

7.29

3299

7856

Low back pain

5482

18254

2.15

307.65

2.6

2.2

5.35

8.35

ug/l

23.51

4767

15960

Sciatica+with lumbago

3845

15813

2.32

307.65

2.7

2.2

4.98

8.48

ug/l

25.95

3485

13929

Pain in limb

5619

18997

1.98

307.65

2.7

2.2

6.16

8.04

ug/l

7.82

4935

16572

Malaise and fatigue

4479

14061

2.75

307.65

3.1

2.1

5.86

8.15

ug/l

9.14

3767

12350

All kidney diseases

6897

24321

2.01

307.65

2.6

2.2

8.56

7.15

ug/l

3.47

5983

21400

Codeine or tramadol medication

7414

23755

1.77

307.65

2.5

2.2

6.59

7.66

ug/l

3.65

6473

20761

Any gastric operation

4444

11565

2.01

307.65

2.4

2.1

7.62

7.57

ug/l

0.04

3811

10219

Pure hypercholesterolaemia

5399

19204

1.89

307.65

2.5

2.2

7.98

7.47

ug/l

0.85

4676

16891

All pneumoniae

7104

24260

2.01

307.65

2.7

2.1

7.94

7.37

ug/l

1.06

6170

21428

Other dorsopathies, not elsewhere classified

6434

18624

1.88

307.65

2.5

2.2

5.94

8.30

ug/l

14.61

5623

16253

Non-ischemic cardiomyopathy

2510

7304

3.05

307.65

2.6

1.9

9.22

5.17

ug/l

7.67

2152

6124

Valvular heart disease excluding rheumatic fever

5558

9343

5.13

307.65

2.7

1.9

12.89

5.94

ug/l

59.17

5113

8000

Dorsalgia

6722

18604

2.02

307.65

2.6

2.2

5.72

8.30

ug/l

18.13

5899

16236

Lower back pain or/and sciatica

7677

26202

1.92

307.65

2.6

2.2

5.37

7.91

ug/l

24.05

6755

22881

Other neurological diseases

5707

23711

2.00

307.65

2.7

2.3

6.48

7.40

ug/l

2.44

5047

20573

Other bacterial diseases, including avohilmo

7376

23283

2.10

307.65

2.6

2.2

7.65

7.42

ug/l

0.31

6417

20454

Other soft tissue disorders, not elsewhere classified

6078

19254

1.88

307.65

2.7

2.2

6.26

8.03

ug/l

7.31

5333

16782

Heart failure and bmi 25plus

3221

8694

2.81

307.65

2.9

2.1

10.55

7.31

ug/l

5.68

2781

7424

Renal tubulo-interstitial diseases

6544

24344

2.10

307.65

2.7

2.2

8.60

7.09

ug/l

3.76

5671

21368

Episodal and paroxysmal disorders

6813

20232

1.78

307.65

2.6

2.2

6.29

8.02

ug/l

7.70

5936

17584

All chronic kidney diseases

4442

17721

2.16

307.65

2.8

2.3

8.10

7.32

ug/l

1.07

3880

15493

Other heart diseases

4314

3938

8.19

307.65

2.7

1.4

12.67

3.15

ug/l

54.59

3991

3353

Cardiac arrhythmias

4794

5869

5.85

307.65

2.7

1.5

9.98

3.79

ug/l

33.06

4331

4945

GASTRO-related operations

4444

11565

2.01

307.65

2.4

2.1

7.62

7.57

ug/l

0.04

3811

10219

Intracranial trauma

3747

10560

2.55

307.65

2.6

2.0

5.93

8.55

ug/l

11.08

3258

9374

Hard cardiovascular diseases

8723

12398

4.84

307.65

2.7

1.8

11.65

3.98

ug/l

81.44

7996

10377

Stroke, including SAH

5083

19308

2.04

307.65

2.6

2.3

6.93

7.64

ug/l

1.49

4448

16779

Stroke, excluding SAH

4813

18763

2.00

307.65

2.6

2.3

6.96

7.55

ug/l

1.11

4206

16260

Unstable angina pectoris

3751

8841

3.91

307.65

3.5

1.9

6.84

4.02

ug/l

13.62

3357

7190

Coronary revascularization (ANGIO or CABG)

9263

13040

5.16

307.65

2.8

1.8

11.93

3.96

ug/l

97.67

8547

10926

Other bacterial diseases

7224

24014

2.13

307.65

2.7

2.2

7.69

7.43

ug/l

0.36

6266

21119

Other arrhythmias

5064

12203

3.41

307.65

2.8

1.8

7.81

5.66

ug/l

6.33

4493

10522

Myocardial infarction, strict

4995

9395

4.48

307.65

3.1

1.9

12.13

4.01

ug/l

46.51

4493

7747

Asthma, unspecified (mode), excluding more controls

3395

10688

2.42

307.65

2.7

1.9

5.86

7.45

ug/l

5.77

2971

9487

Other diseases of intestines

6515

21277

1.78

307.65

2.5

2.2

6.79

7.93

ug/l

2.85

5667

18684

Influenza and pneumonia

7361

23563

2.04

307.65

2.7

2.1

7.88

7.37

ug/l

0.91

6421

20800

Bacterial infection, other or unspecified

4318

18863

2.08

307.65

2.8

2.3

7.18

7.40

ug/l

0.28

3642

16494

Diseases of oesophagus, stomach and duodenum

7155

24500

1.81

307.65

2.6

2.2

6.47

7.67

ug/l

4.28

6223

21493

Cardiovascular diseases (excluding rheumatic etc)

3701

4618

4.93

307.65

2.4

1.4

10.04

3.02

ug/l

29.32

3342

3939

Complications of procedures, not elsewhere classified

5924

25428

1.99

307.65

2.8

2.2

7.11

7.35

ug/l

0.33

5232

22205

Myocardial infarction, without ST-elevation

4916

16297

3.25

307.65

3.2

2.3

9.18

6.99

ug/l

7.36

4333

13983

Hypothyroidism (congenital or acquired)

1029

1015

5.98

307.65

2.3

1.3

7.83

3.21

ug/l

5.94

915

884

Asthma (only as main-diagnosis), excluding more controls

4089

11055

2.15

307.65

2.6

1.9

5.81

7.41

ug/l

6.14

3600

9827

Asthma, excluding more controls

4307

11055

2.10

307.65

2.6

1.9

6.28

7.41

ug/l

3.28

3813

9827

Other septicaemia, including avohilmo

3422

15277

2.31

307.65

2.9

2.3

8.12

7.32

ug/l

0.92

2956

13269

Spondylopathies

5570

17572

1.98

307.65

2.6

2.2

6.03

8.37

ug/l

10.23

4860

15343

Syncope and collapse

3803

13363

2.60

307.65

2.9

2.1

6.68

8.25

ug/l

3.66

3281

11714

Calcific aortic valvular stenosis

3602

13265

3.13

307.65

2.8

2.5

9.66

6.86

ug/l

13.09

3298

11178

Hypothyroidism, levothyroxine purchases

1021

1010

5.97

307.65

2.3

1.3

7.71

3.21

ug/l

5.69

909

881

Pain in throat and chest

7597

13989

3.56

307.65

2.8

1.9

7.02

8.26

ug/l

3.18

6706

12153

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

1835

2973

3.25

307.65

2.3

1.8

7.20

10.70

ug/l

6.21

1643

2663

Emergency coronary revascularization (for ACS)

10114

15420

4.70

307.65

2.8

1.9

11.49

4.28

ug/l

91.01

9294

12813

Headache

4413

15688

2.31

307.65

2.9

2.0

5.50

8.19

ug/l

10.27

3841

13864

Symptoms and signs involving the circulatory and respiratory systems

6894

14073

2.62

307.65

2.6

1.9

6.99

8.23

ug/l

3.31

6039

12226

Infections, IBD-co-morbidities

1035

1825

4.36

307.65

2.5

1.9

8.78

11.18

ug/l

1.34

912

1633

Cardiovascular diseases

3194

3697

4.89

307.65

2.3

1.4

8.63

2.98

ug/l

26.44

2868

3167

All-cause Heart Failure

6070

16852

2.87

307.65

3.1

2.2

9.56

7.02

ug/l

7.73

5347

14651

Haemorrhage from respiratory passages

2764

10039

2.67

307.65

2.9

2.0

8.40

8.50

ug/l

0.06

2397

8644

Symptoms and signs involving cognition, perception, emotional state and behaviour

7290

24394

2.13

307.65

2.7

2.2

6.57

7.76

ug/l

3.81

6303

21506

Pain, not elsewhere classified

2165

8166

2.91

307.65

3.2

2.0

6.01

8.34

ug/l

3.92

1920

7173

Calcific aortic valvular stenosis, diagnosis (helper)

3593

13259

3.13

307.65

2.8

2.5

9.60

6.86

ug/l

12.65

3289

11173

Aortic valve malfunction, age under 60 years

1017

2774

4.58

307.65

2.5

2.3

15.56

9.05

ug/l

9.80

977

2531

Inflammatory bowel disease treatment related agents

7435

24570

1.75

307.65

2.6

2.2

7.94

7.28

ug/l

1.11

6530

21431

Heart failure and antihypertensive medication

2721

2597

8.32

307.65

3.3

1.7

13.80

5.97

ug/l

13.70

2481

2175

Abnormalities of heart beat

2812

9833

3.04

307.65

3.1

1.9

6.63

7.97

ug/l

1.77

2444

8466

Operations 2 for CAVS

3593

13259

3.13

307.65

2.8

2.5

9.60

6.86

ug/l

12.65

3289

11173

Calcific aortic valvular stenosis, including rheumatic fever

3599

13290

3.12

307.65

2.8

2.5

9.61

6.87

ug/l

12.67

3294

11204

ILD medications: prednisolone, methylprednisolone, prednisone

7320

23208

1.84

307.65

2.6

2.2

7.95

7.20

ug/l

1.42

6378

20326

Pneumonia, organism unspecified

6673

23090

2.11

307.65

2.8

2.1

7.70

7.41

ug/l

0.42

5791

20392

Valvular operations

2554

3833

10.10

307.65

2.6

1.9

19.38

6.64

ug/l

79.49

2472

3231

Abdominal and pelvic pain

6464

18387

1.84

307.65

2.6

2.2

5.98

8.54

ug/l

17.37

5701

16081

ILD medications

7265

23340

1.75

307.65

2.6

2.2

8.31

7.19

ug/l

2.47

6338

20441

Oxycodone

3288

12923

2.38

307.65

2.9

2.2

5.42

8.06

ug/l

11.59

2759

11406

Depression medications

1091

1057

5.43

307.65

2.1

1.2

6.00

3.17

ug/l

4.93

964

919

Concussion

3153

10519

2.46

307.65

2.7

2.0

5.80

8.56

ug/l

10.47

2729

9337

Parasetamol

4470

9188

2.60

307.65

2.5

2.0

6.72

9.17

ug/l

7.52

3913

8140

Tramadol

5940

16069

2.38

307.65

2.6

2.2

7.24

7.90

ug/l

1.14

5184

14180

Hypertension

4841

13066

2.21

307.65

2.5

2.0

8.60

7.47

ug/l

1.93

4337

11452

Coronary atherosclerosis

7002

11473

4.55

307.65

2.9

1.8

10.38

3.95

ug/l

58.13

6378

9558

Codeine

5968

16497

2.06

307.65

2.5

2.1

6.51

7.86

ug/l

4.45

5220

14555

Oral corticosteroids

7301

24323

1.85

307.65

2.7

2.2

7.80

7.28

ug/l

0.82

6427

21214

Other intervertebral disc disorders

5466

17955

1.91

307.65

2.5

2.2

5.95

8.39

ug/l

14.45

4830

15706

Dizziness and giddiness

5823

22435

2.16

307.65

2.9

2.2

5.89

7.70

ug/l

8.30

5047

19726

Other septicaemia

3345

15019

2.31

307.65

2.9

2.3

8.20

7.33

ug/l

1.01

2887

13032

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

6176

18384

2.08

307.65

2.7

2.1

7.88

7.39

ug/l

0.77

5359

16221

Pacemaker

3800

15516

2.61

307.65

3.3

2.4

10.68

6.93

ug/l

8.30

3428

13196

Asthma, unspecified (mode)

3574

12671

2.15

307.65

2.7

2.0

5.77

7.81

ug/l

9.69

3112

11241

Diseases of arteries, arterioles and capillaries (FINNGEN)

2412

2204

9.04

307.65

2.8

1.4

11.04

3.28

ug/l

37.75

2209

1864

Opioids

6017

16667

1.95

307.65

2.5

2.1

7.08

7.83

ug/l

1.44

5220

14681

Vocal cord dysfunction

756

1368

5.28

307.65

2.5

1.4

7.78

3.54

ug/l

4.91

649

1178

Complications of medical and surgical care

5110

26617

1.82

306.84

2.7

2.3

7.59

7.17

ug/l

0.56

4462

23239

Cardiomyopathies, Primary/intrinsic

1043

3094

3.91

303.93

3.4

1.8

19.09

6.69

ug/l

9.74

965

2645

Any reimbursement code in KELA

2634

5722

2.40

301.63

2.4

1.7

7.79

6.97

ug/l

0.83

2362

4977

Other disorders of skin and subcutaneous tissue

5183

25560

1.81

300.22

2.6

2.3

6.89

7.30

ug/l

0.57

4511

22285

Ischaemic Stroke, excluding all haemorrhages

4454

18315

1.92

298.67

2.7

2.3

6.88

7.50

ug/l

1.12

3884

15830

Other postsurgical states

729

1737

5.31

295.87

2.8

2.1

5.12

6.37

ug/l

1.09

671

1538

Diabetes mellitus

6267

21869

1.72

293.18

2.6

2.2

7.53

7.40

ug/l

0.16

5554

19052

Type 2 diabetes

6161

21491

1.73

292.13

2.6

2.2

7.63

7.42

ug/l

0.26

5466

18731

Type 2 diabetes, wide definition

5346

19695

1.80

292.06

2.6

2.2

7.32

7.66

ug/l

0.46

4686

17180

Diabetes, varying definitions

6241

21883

1.72

291.32

2.6

2.2

7.55

7.40

ug/l

0.17

5532

19064

Asthma (only as main-diagnosis)

4321

13095

1.93

290.00

2.7

2.0

5.78

7.81

ug/l

10.12

3798

11633

Other disorders of fluid, electrolyte and acid-base balance

2627

11944

2.27

283.74

3.3

2.3

6.35

7.05

ug/l

0.90

2217

10378

Erysipelas

4164

20093

1.90

281.98

2.7

2.3

7.06

7.64

ug/l

0.88

3622

17667

Cardiomyopathy (excluding other)

1065

3372

3.64

279.69

3.4

1.9

18.92

6.56

ug/l

10.11

987

2897

Nephropathy related operations

1226

4277

3.44

279.26

3.2

2.4

19.21

7.66

ug/l

10.28

1141

3824

Peripheral artery disease

3682

15788

2.00

277.05

3.0

2.4

6.90

7.03

ug/l

0.15

3197

13569

7221

23150

1.64

274.14

2.8

2.2

6.59

7.38

ug/l

1.83

6241

20222

Asthma

4547

13095

1.87

272.15

2.6

2.0

6.20

7.81

ug/l

6.42

4020

11633

Acute tubulo-interstitial nephritis

4272

20519

1.85

270.31

2.7

2.3

6.39

6.91

ug/l

0.85

3599

17904

Lumbar disc prolapse

4065

16782

1.89

267.58

2.5

2.2

6.14

8.52

ug/l

10.53

3608

14807

Neurological diseases

4743

13500

1.83

267.12

2.4

2.1

6.54

8.43

ug/l

6.73

4141

11951

Atherosclerosis, excluding cerebral and coronary sclerosis

3522

14999

2.01

266.43

3.0

2.4

6.88

6.97

ug/l

0.09

3049

12863

Injuries to the head

6992

26453

1.63

265.13

2.6

2.2

6.83

7.52

ug/l

1.65

6025

23237

Pain (limb, back, neck, head abdominally)

4304

11953

1.88

261.48

2.5

2.1

6.49

9.17

ug/l

10.50

3761

10405

Transplanted organ and tissue status

874

2564

4.03

260.99

3.1

2.1

29.91

6.89

ug/l

19.03

822

2293

COPD/asthma related infections

6004

18384

1.70

259.51

2.6

2.1

7.07

7.39

ug/l

0.41

5241

16221

COPD/asthma/ILD related infections

6004

18384

1.70

259.51

2.6

2.1

7.07

7.39

ug/l

0.41

5241

16221

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

5853

21360

1.69

257.81

2.5

2.2

7.07

7.44

ug/l

0.56

5183

18611

Shoulder lesions

5025

17863

1.77

256.26

2.5

2.2

6.11

8.13

ug/l

7.22

4485

15650

Dorsopathies

6007

18665

1.69

255.94

2.5

2.2

6.15

8.31

ug/l

10.31

5241

16287

Type 2 diabetes, definitions combined

5874

21144

1.68

251.97

2.6

2.2

7.71

7.39

ug/l

0.40

5203

18427

Other antidepressants

6475

20793

1.65

251.90

2.6

2.2

6.81

7.93

ug/l

2.69

5545

18455

Asthma (mode)

4419

13190

1.83

250.77

2.6

2.0

5.94

7.85

ug/l

8.87

3900

11720

Type 2 diabetes, strict (exclude DM1)

5890

21254

1.68

250.23

2.6

2.2

7.70

7.42

ug/l

0.33

5217

18523

Neurological diseases, wide definition

1348

2275

3.11

249.45

2.4

1.8

7.11

10.95

ug/l

4.54

1199

2016

Myocarditis

361

511

8.23

248.55

3.2

1.4

15.20

3.55

ug/l

4.49

324

423

Chronic kidney disease

2809

14098

2.10

247.88

3.0

2.4

8.81

7.03

ug/l

2.30

2447

12077

Other headache syndromes

2539

12651

2.12

244.82

2.8

2.1

4.83

8.01

ug/l

15.96

2217

11045

Acute renal failure

2056

9688

2.38

243.54

3.0

2.4

13.10

7.09

ug/l

8.22

1790

8389

Cervicobrachial syndrome

1565

6507

2.62

241.37

2.9

2.1

4.87

8.60

ug/l

8.81

1437

5747

Type 2 diabetes, definitions combined, including avohilmo

5807

20931

1.67

241.00

2.5

2.2

7.56

7.44

ug/l

0.12

5142

18244

Symptoms and signs involving the nervous and musculoskeletal systems

3976

23116

1.82

240.99

2.8

2.3

5.70

7.47

ug/l

6.74

3555

20118

Secondary hypertension

484

926

5.76

239.76

2.5

1.5

6.08

3.50

ug/l

2.85

418

766

Other symptoms and signs involving cognitive functions and awareness

3519

17481

1.90

239.61

2.7

2.3

5.94

7.61

ug/l

5.09

2917

15301

Factors influencing health status and contact with health services

1761

3555

2.62

238.20

2.5

1.8

7.76

8.30

ug/l

0.34

1563

3152

Left ventricular outflow tract obstruction, narrow definition

564

1314

5.56

237.27

2.4

2.2

17.44

7.88

ug/l

11.79

544

1187

Cough

2358

10800

2.15

235.51

2.8

1.9

5.84

8.15

ug/l

6.34

2031

9388

Endocrine, nutritional and metabolic diseases

4116

11743

1.83

233.62

2.5

2.0

7.39

7.72

ug/l

0.34

3659

10333

Diabetes, insulin treatment (Kela reimbursement)

6335

24267

1.61

231.84

2.5

2.3

6.92

7.63

ug/l

1.53

5604

21131

Insulin medication

4112

20071

1.79

231.41

2.7

2.3

6.68

7.85

ug/l

2.99

3621

17458

Congenital malformations of aortic and mitral valves

513

1137

6.02

230.97

2.4

2.3

17.70

7.92

ug/l

10.92

498

1021

Polyarthropathies

4176

15623

1.79

229.43

2.6

2.3

7.55

8.38

ug/l

1.02

3661

13735

Oedema, not elsewhere classified

2267

10924

2.17

228.53

2.8

2.1

6.18

8.16

ug/l

5.18

1898

9573

Spondylosis

3649

16285

1.85

225.61

2.6

2.2

5.49

8.43

ug/l

17.57

3248

14291

Caries of dentine

1681

7157

2.47

225.19

2.8

2.2

11.28

8.45

ug/l

3.03

1452

6314

Other pulmonary diagnosis

4489

13212

1.77

224.33

2.5

2.0

7.62

7.83

ug/l

0.20

3943

11738

Nausea and vomiting

1932

8845

2.29

221.97

3.2

2.2

6.00

7.72

ug/l

3.12

1643

7559

Bronchitis

6744

26688

1.57

220.41

2.8

2.2

7.01

7.28

ug/l

0.35

5858

23318

Benzodiazepine use

6264

27601

1.59

220.11

2.6

2.3

6.11

7.58

ug/l

5.16

5227

24387

Dental caries

1832

7968

2.35

219.73

2.7

2.2

11.48

8.36

ug/l

3.66

1591

7025

All influenza

1965

9374

2.27

219.47

3.3

2.2

6.96

7.53

ug/l

0.48

1696

8196

Hyperlipidaemia, other/unspecified

2976

14685

1.96

218.73

2.7

2.3

7.37

7.39

ug/l

0.02

2603

12863

Visual disturbances and blindness

3579

20756

1.82

218.55

2.7

2.3

7.14

7.11

ug/l

0.03

3046

18111

Certain infectious and parasitic diseases

5558

17430

1.65

217.96

2.5

2.1

7.47

7.49

ug/l

0.02

4826

15359

Excluding asthma or asthma-COPD overlap

4460

13212

1.75

217.73

2.5

2.0

7.59

7.83

ug/l

0.23

3923

11738

Symptoms and signs involving the skin and subcutaneous tissue

4593

26808

1.69

216.89

2.6

2.3

6.29

7.42

ug/l

2.97

4031

23475

Endocarditis

418

815

6.70

216.27

2.8

1.9

15.86

6.13

ug/l

8.80

391

690

Hernia

5821

24963

1.61

215.23

2.5

2.3

6.55

7.60

ug/l

3.58

5115

21750

Congenital malformations of heart and great arteries

977

3304

3.24

215.05

2.4

2.3

16.50

7.84

ug/l

14.87

915

2947

Congenital malformations of the circulatory system

1067

3795

3.06

213.97

2.3

16.26

7.70

ug/l

15.59

992

3391

Other/unspecified dorsalgia

2416

12370

2.04

210.66

2.7

2.2

5.29

8.09

ug/l

12.22

2109

10731

Aplastic and other anaemias

3577

19198

1.82

210.39

3.0

2.4

7.67

6.98

ug/l

0.86

3074

16536

Nerve, nerve root and plexus disorders

6636

26500

1.56

209.84

2.5

2.3

6.37

7.58

ug/l

3.66

5863

23111

Asthma-related infections

3858

22465

1.75

209.39

2.9

2.3

5.88

7.40

ug/l

6.39

3378

19465

Asthma, hospital admission 2, infections

3858

22465

1.75

209.39

2.9

2.3

5.88

7.40

ug/l

6.39

3378

19465

COPD differential diagnosis

4415

13190

1.74

209.03

2.4

2.0

7.68

7.85

ug/l

0.14

3887

11720

Familial hypercholesterolemia, with ischemic heart disease

850

2836

3.55

207.84

3.4

2.0

7.61

5.69

ug/l

2.21

729

2368

ILD differential diagnosis

4407

13190

1.73

207.21

2.4

2.0

7.69

7.85

ug/l

0.14

3881

11720

Migraine

2540

10274

2.00

206.82

2.5

2.0

5.59

8.01

ug/l

5.75

2270

9006

Cardiodefibrillation

2871

16018

1.95

205.55

2.9

2.4

12.16

7.29

ug/l

11.98

2631

13957

Bicuspidal aortic valve syndrome

466

1057

5.95

204.92

2.5

2.3

17.47

8.06

ug/l

9.22

454

961

Soft tissue disorders

5876

19417

1.60

204.15

2.5

2.2

6.76

8.02

ug/l

3.37

5137

16900

Dipeptidyl peptidase 4 (DPP-4) inhibitors

4046

19251

1.75

204.01

2.7

2.3

6.67

7.76

ug/l

2.24

3510

16801

Hypothyroidism, drug reimbursement

488

681

5.25

202.14

2.0

1.3

9.69

3.30

ug/l

3.46

434

595

Intracranial injury

3875

21770

1.74

201.77

2.7

2.3

5.86

7.52

ug/l

6.98

3305

19082

Diabetes medication

6159

23738

1.57

199.85

2.5

2.2

6.74

7.61

ug/l

2.38

5459

20682

Other functional intestinal disorders

3039

15608

1.86

199.00

3.0

2.2

5.47

7.41

ug/l

5.82

2573

13560

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

1146

4378

2.80

198.07

2.3

15.15

7.43

ug/l

15.66

1067

3911

Ulcer of lower limb, not elsewhere classified

1381

6049

2.61

196.92

2.8

2.4

6.61

7.52

ug/l

1.10

1215

5248

Rotator cuff syndrome

4073

17028

1.73

196.65

2.5

2.2

6.12

8.23

ug/l

6.01

3659

14983

Migraine with aura

1269

5223

2.57

195.74

2.7

2.0

5.20

7.79

ug/l

5.50

1143

4584

Substance abuse, excluding more controls

3439

16824

1.79

195.45

2.9

2.2

6.94

8.29

ug/l

2.70

3041

15148

Iron deficiency anaemia

3115

17622

1.84

195.40

2.9

2.4

7.90

6.76

ug/l

1.51

2611

15200

Provisional assignment of new diseases of uncertain etiology

3468

20396

1.77

194.58

3.0

2.3

7.27

7.25

ug/l

0.03

2987

17786

L04AD Calcineurin inhibitors

873

3051

3.28

194.24

3.1

2.3

29.35

7.76

ug/l

17.07

822

2765

Codes for special purposes

3469

20415

1.77

194.09

3.0

2.3

7.27

7.24

ug/l

0.03

2988

17801

Insulin, intermediate and long-acting

3809

22391

1.73

193.78

2.7

2.3

6.28

7.80

ug/l

5.41

3356

19551

Visual disturbances

3222

18787

1.81

193.68

2.7

2.3

7.09

7.20

ug/l

0.10

2799

16448

Cardiomyopathy, other and unspecified

634

1841

4.00

191.28

3.6

1.9

19.56

6.17

ug/l

6.17

580

1575

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

3993

24198

1.70

190.89

2.7

2.3

7.90

7.14

ug/l

1.05

3481

21140

Other symptoms and signs involving the nervous and musculoskeletal systems

2715

15147

1.90

189.81

2.8

2.3

5.25

7.55

ug/l

7.35

2477

13215

Disorders of thyroid, IBD co-morbidities

852

1872

3.29

189.59

2.5

1.8

9.87

11.50

ug/l

0.56

745

1669

Diarrhoea and gastroenteritis of presumed infectious origin

4341

24350

1.65

189.09

2.8

2.2

6.81

7.41

ug/l

0.79

3763

21220

Any mental disorder

6413

21484

1.54

188.82

2.6

2.2

7.02

7.61

ug/l

1.03

5504

19185

Pain in joint

3212

11223

1.83

188.26

2.3

2.1

5.87

9.33

ug/l

14.52

2739

9876

Aortic aneurysm

1968

9816

2.16

187.72

2.6

2.4

11.99

7.72

ug/l

9.04

1786

8584

Disorders of gallbladder, biliary tract and pancreas

6132

25614

1.54

187.06

2.6

2.3

5.74

7.78

ug/l

14.17

5348

22416

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly, including avohilmo

1195

4796

2.66

186.69

2.3

2.4

14.90

7.38

ug/l

16.02

1113

4259

Peripheral arterial reconstruction

1607

7666

2.38

186.59

3.2

2.5

7.84

6.75

ug/l

0.97

1409

6617

Other anaemias

3306

18421

1.79

184.87

3.0

2.4

7.47

6.99

ug/l

0.50

2839

15843

Covid-19 confirmed case

2720

15376

1.89

183.36

3.0

2.4

7.84

7.10

ug/l

0.96

2341

13349

Mood disorders, excluding more controls

5444

20953

1.58

183.11

2.5

2.2

6.68

7.63

ug/l

1.89

4618

18732

Hernia of abdominal wall, postoperative

1309

5648

2.50

182.51

2.8

2.2

5.65

8.30

ug/l

6.75

1167

5058

Other and unspecified anaemias

3274

18330

1.79

181.94

3.0

2.4

7.47

6.99

ug/l

0.50

2812

15758

Finngen Rheumatological endpoints

5391

20003

1.58

180.83

2.3

2.2

6.99

8.03

ug/l

2.10

4709

17571

Other CVD

1819

9166

2.21

180.33

3.3

2.4

6.93

6.69

ug/l

0.19

1495

7856

Nutritional anaemias

3485

20214

1.73

177.89

2.9

2.4

7.80

6.81

ug/l

1.36

2922

17468

Fitting and adjustment of other devices

2836

14369

1.86

177.74

2.6

2.3

4.69

6.96

ug/l

15.05

2378

12320

Intestinal infectious diseases

5670

28314

1.54

177.07

2.8

2.2

6.83

7.41

ug/l

0.94

4907

24773

Asthma (diagnoses ohter than nonallergic)

5267

28236

1.56

176.78

2.7

2.3

5.67

7.56

ug/l

13.72

4601

24630

Care involving use of rehabilitation procedures

3876

21703

1.67

175.86

2.9

2.2

7.86

7.37

ug/l

0.45

3562

18915

Sequelae of cerebrovascular disease

2807

13799

1.86

175.61

2.8

2.4

7.27

7.37

ug/l

0.08

2320

11880

Pain in thoracic spine

1052

4235

2.71

174.03

3.1

2.1

4.07

8.47

ug/l

17.61

949

3720

Thoracic aortic aneurysm

1274

5695

2.55

173.04

2.6

2.3

13.62

7.96

ug/l

9.91

1177

5079

Insulin, combination of fast acting with intermediate-acting or long-acting

4123

23798

1.65

172.88

2.7

2.4

6.67

7.69

ug/l

2.50

3631

20711

Symptoms and signs involving the urinary system

4941

24555

1.58

171.49

2.6

2.3

6.60

7.45

ug/l

1.91

4189

21587

Benign neoplasm of colon, rectum, anus and anal canal

4436

24320

1.62

170.84

2.6

2.4

6.29

7.51

ug/l

3.74

3865

21283

ILD medications: immunosuppressive drugs

3688

20685

1.68

170.63

2.5

2.2

12.10

7.28

ug/l

10.69

3285

18310

Depression or dysthymia

3968

13376

1.68

169.37

2.5

2.2

6.83

8.50

ug/l

3.83

3355

12074

Follow-up examination after treatment for conditions other than malignant neoplasms

2232

7836

1.97

169.02

2.4

2.0

7.34

8.59

ug/l

1.29

1916

6902

Other diseases of pericardium

421

1004

5.09

168.94

3.0

1.9

9.59

5.96

ug/l

4.12

366

860

Psychiatric diseases

5648

18867

1.55

168.64

2.5

2.2

7.35

7.87

ug/l

0.72

4897

16868

Any death

4308

19366

1.64

168.06

2.6

2.3

8.60

7.61

ug/l

1.13

3702

17357

2709

15491

1.82

167.68

3.0

2.2

5.76

7.63

ug/l

6.34

2369

13450

Amiodarone users

981

3995

2.91

166.98

3.9

2.4

15.91

7.62

ug/l

5.98

916

3516

Other (not insulin) diabetes medications

5797

23092

1.52

165.01

2.5

2.3

6.65

7.62

ug/l

2.58

5123

20133

Osteopathies and chondropathies

3647

20873

1.67

163.71

2.7

2.3

7.43

7.14

ug/l

0.24

3026

18293

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

4438

25288

1.60

163.10

2.6

2.3

6.85

7.33

ug/l

0.74

3843

22118

Operations for atrial fibrillation

278

518

10.28

162.64

2.7

2.5

28.12

8.11

ug/l

15.85

273

462

Non-invasive ventilation

864

2727

2.84

161.99

2.5

1.5

8.77

4.04

ug/l

5.43

712

2318

Chronic lower respiratory diseases

6910

25523

1.47

161.40

2.5

2.2

6.43

7.76

ug/l

5.33

6041

22358

Certain infectious and parasitic diseases, including avohilmo

4052

12710

1.65

158.97

2.5

2.1

7.34

7.62

ug/l

0.30

3542

11156

Lung transplantation

169

183

21.55

158.41

2.7

2.5

36.79

8.86

ug/l

17.70

169

162

Hypotension

1593

8046

2.21

157.39

3.4

2.4

5.98

6.69

ug/l

0.78

1285

6861

Other or ill-defined heart diseases

432

1096

4.54

157.19

3.0

1.8

10.41

6.01

ug/l

2.00

374

939

Intestinal infectious diseases, including avohilmo, including avohilmo

6800

26687

1.46

156.89

2.7

2.2

6.74

7.45

ug/l

1.45

5924

23356

Hypo-osmolality and hyponatraemia

1431

6863

2.28

156.68

3.3

2.3

6.27

7.00

ug/l

0.86

1206

5897

Gastro-oesophageal reflux disease

4148

22720

1.60

155.93

2.6

2.2

5.89

7.71

ug/l

8.45

3530

20001

Lung transplant status

167

182

21.26

155.75

2.7

2.5

36.67

8.90

ug/l

17.36

167

161

Convulsions, not elsewhere classified

1392

6507

2.24

155.53

2.6

2.0

6.81

8.67

ug/l

3.00

1208

5768

Biguanides

5702

23625

1.50

154.55

2.5

2.3

6.36

7.69

ug/l

5.17

5024

20618

Care involving dialysis

720

2591

3.26

153.98

3.0

2.2

12.01

8.21

ug/l

1.48

660

2317

Dysphagia

1759

9201

2.05

152.01

2.6

2.2

6.36

8.18

ug/l

2.77

1474

8020

Asthma-related pneumonia

2572

15066

1.80

151.12

3.1

2.3

6.00

7.11

ug/l

2.76

2234

12890

Asthma, hospital admissions 3, pneumonia

2573

15087

1.80

150.59

3.1

2.3

6.00

7.11

ug/l

2.76

2235

12909

Asthma-related pneumonia or sepsis

2573

15087

1.80

150.59

3.1

2.3

6.00

7.11

ug/l

2.76

2235

12909

Other and unspecified iron deficiency

2393

13787

1.84

150.28

2.9

2.4

7.86

6.71

ug/l

1.33

1984

11889

Asthma/COPD (KELA code 203)

5540

25498

1.49

149.41

2.6

2.2

5.58

7.75

ug/l

17.21

4868

22338

Persons encountering health services in other circumstances, wide

6775

24688

1.45

148.79

2.6

2.2

7.73

7.32

ug/l

0.62

5967

21506

Nonischemic cardiomyopathy

727

2670

3.05

146.15

2.9

2.0

15.42

5.71

ug/l

5.29

653

2277

Asthma, hospital admissions , main diagnosis only

4725

27846

1.52

144.95

2.7

2.3

5.69

7.52

ug/l

10.82

4142

24274

Gastrointestinal diseases

2792

8138

1.77

143.27

2.5

2.0

7.36

8.22

ug/l

0.87

2458

7140

Disorders of lens

4113

16676

1.59

143.06

2.6

2.2

7.90

8.23

ug/l

0.33

3638

14905

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

3617

23360

1.61

142.57

2.7

2.3

7.67

7.08

ug/l

0.70

3139

20410

Disorders of choroid and retina

5166

24929

1.50

142.01

2.6

2.3

6.77

7.60

ug/l

1.95

4431

21867

Other specific joint derangements/joint disorders

3913

15735

1.60

141.72

2.4

2.2

5.91

8.44

ug/l

10.69

3368

13907

Oxicams

1649

4704

2.12

141.29

2.6

2.4

5.90

9.99

ug/l

8.44

1439

4118

Benign neoplasm: Colon

3771

23198

1.60

141.11

2.6

2.4

6.43

7.47

ug/l

2.44

3297

20323

COPD (mode)

2125

9300

1.90

140.91

2.8

2.1

6.86

8.01

ug/l

1.71

1817

8237

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

636

1457

3.32

140.53

2.7

2.0

12.37

11.88

ug/l

0.14

565

1308

Diseases of the respiratory system

3465

10789

1.66

140.21

2.4

2.0

6.91

7.77

ug/l

1.31

3041

9540

Personality disorders, excluding more controls

1239

5809

2.24

140.06

2.5

2.0

6.12

8.59

ug/l

2.52

1068

5234

Diseases of the skin and subcutaneous tissue

5604

19506

1.48

137.31

2.5

2.2

7.07

7.75

ug/l

1.26

4860

17079

Gout

2125

10402

1.88

137.22

3.0

2.4

7.92

8.56

ug/l

0.39

1858

9117

Volume depletion

847

3498

2.74

136.15

3.5

2.3

5.40

7.23

ug/l

3.16

706

2983

Mental and behavioural disorders due to psychoactive substance use

3551

21122

1.60

135.24

2.8

2.3

6.99

8.11

ug/l

2.04

3146

18757

Chronic ulcer of skin, not elsewhere classified

661

2444

3.19

135.18

3.4

2.4

6.10

7.58

ug/l

0.72

577

2130

Constipation

5392

25571

1.47

134.86

2.7

2.3

5.87

7.65

ug/l

9.24

4496

22606

Fall on same level

6308

23971

1.44

134.71

2.4

2.2

7.21

7.66

ug/l

0.74

5405

21340

Subjective visual disturbances

1643

8784

2.00

132.67

2.8

2.3

7.28

7.03

ug/l

0.14

1424

7703

Dermatitis

3792

24615

1.56

131.93

2.6

2.3

6.04

7.55

ug/l

5.19

3325

21543

Disturbances of skin sensation

1565

8220

2.01

131.76

2.6

2.2

5.37

7.53

ug/l

5.11

1360

7262

Diseases of the digestive system

3102

19630

1.65

131.63

2.9

2.4

6.51

7.36

ug/l

1.41

2707

16931

Other acute lower respiratory infections

3343

20585

1.61

130.87

2.9

2.3

7.01

7.43

ug/l

0.40

2864

17805

Other retinal disorders

4258

21931

1.54

130.05

2.7

2.3

6.47

7.42

ug/l

2.59

3619

19145

Gonarthrosis [arthrosis of knee](FG)

4603

18034

1.52

129.35

2.4

2.3

6.14

8.14

ug/l

6.13

4042

15866

Injuries to the thorax

3089

19748

1.64

129.20

2.6

2.4

6.97

7.70

ug/l

1.06

2628

17265

Anxiety disorders, excluding more controls

4398

19002

1.52

128.89

2.6

2.2

7.05

7.61

ug/l

0.58

3749

17020

Substance abuse

3439

20839

1.59

128.75

2.9

2.3

6.94

8.17

ug/l

2.38

3041

18514

Diseases of the musculoskeletal system and connective tissue

2583

7615

1.75

127.73

2.3

2.1

6.89

9.63

ug/l

6.33

2272

6730

Insulin, fast-acting

2286

13607

1.77

127.57

2.8

2.3

6.79

7.83

ug/l

1.57

2024

11901

3619

20776

1.57

127.15

2.7

2.3

7.04

8.22

ug/l

2.02

3212

18414

Other disorders of urethra and urinary system

4055

18918

1.54

126.59

2.6

2.2

5.54

7.27

ug/l

7.61

3467

16580

Epilepsy

1855

10408

1.87

125.38

2.6

2.2

5.94

8.23

ug/l

6.27

1585

9039

Gonarthrosis

3930

14719

1.56

125.30

2.4

2.3

6.02

8.44

ug/l

8.39

3445

12961

Unknown and unspecified causes of morbidity

526

1759

3.36

125.29

2.8

2.1

4.16

8.20

ug/l

10.39

500

1551

Infections of the skin and subcutaneous tissue

3369

21693

1.58

124.86

2.7

2.3

7.29

7.84

ug/l

0.64

2925

19152

Injuries to the abdomen, lower back, lumbar spine and pelvis

2669

16392

1.68

124.21

2.6

2.4

6.35

7.19

ug/l

1.16

2216

14185

L04AA Selective immunosuppressants

1358

6978

2.08

123.41

2.8

2.3

19.21

7.21

ug/l

13.95

1243

6193

Asthma, including avohilmo

6691

26972

1.40

123.09

2.6

2.2

5.90

7.76

ug/l

12.86

5872

23547

3474

20462

1.57

123.08

2.7

2.3

6.82

8.23

ug/l

3.28

3082

18138

Alcohol use disorder, Swedish definition

3319

19764

1.59

121.89

2.7

2.3

7.02

8.26

ug/l

2.01

2947

17557

Other disorders of ear

5400

24845

1.45

121.63

2.5

2.3

6.42

7.74

ug/l

4.35

4642

21854

GI-bleeding

2363

14441

1.74

121.05

3.0

2.4

6.63

7.31

ug/l

0.77

2085

12399

Myocardial infarction, with ST-elevation

1444

7705

2.06

120.94

3.1

2.4

15.26

7.21

ug/l

10.01

1300

6662

Diaphragmatic hernia

2401

14723

1.73

120.83

2.6

2.4

5.92

7.26

ug/l

3.70

2074

12780

Heartburn

777

3232

2.63

120.47

3.0

2.2

5.00

8.53

ug/l

6.47

656

2877

Mood disorders

5691

26152

1.43

120.44

2.5

2.3

6.72

7.49

ug/l

1.38

4835

23073

Other diseases of pleura

3186

18081

1.61

120.41

2.9

2.4

7.62

7.38

ug/l

0.24

2755

15686

Implicit fungal Sepsis, including avohilmo

608

2272

3.08

120.36

3.3

2.2

9.02

6.91

ug/l

0.78

514

2015

Mood [affective] disorders

5673

26126

1.43

119.79

2.5

2.3

6.67

7.50

ug/l

1.58

4821

23050

Poisoning by drugs, medicaments and biological substances

1242

6234

2.10

118.88

2.7

2.2

6.12

7.74

ug/l

1.44

1064

5551

Amputation

896

4049

2.51

118.51

3.0

2.4

7.61

7.55

ug/l

0.03

788

3491

Cervical disc disorders

2131

12708

1.76

117.68

2.5

2.2

6.14

8.73

ug/l

6.38

1850

11244

Persons encountering health services in other circumstances

2376

14388

1.70

117.54

3.4

2.2

5.76

7.26

ug/l

3.03

2153

12589

Arthrosis

4111

15239

1.52

117.47

2.4

2.2

6.19

8.43

ug/l

8.47

3605

13423

Obesity related asthma

2082

12360

1.77

117.26

2.9

2.2

5.70

8.07

ug/l

8.02

1813

10973

Senile cataract

3812

15572

1.55

116.67

2.6

2.2

7.91

8.18

ug/l

0.24

3347

13904

Other diseases of the digestive system

2337

14379

1.73

116.63

3.0

2.4

6.67

7.33

ug/l

0.74

2045

12365

Peripheral artery operations in Hilmo

1059

5126

2.29

116.51

3.0

2.4

6.87

7.14

ug/l

0.21

939

4412

Use of hypnotics and sedatives

6026

25072

1.41

115.98

2.5

2.3

6.87

7.70

ug/l

1.76

5237

22153

Depression

5188

24739

1.44

115.62

2.5

2.3

6.64

7.60

ug/l

1.78

4418

21897

Other medical care

3111

17045

1.60

115.38

2.6

2.3

6.27

7.21

ug/l

1.63

2707

14751

Acute bronchitis

2616

16199

1.66

114.79

2.9

2.4

6.88

7.00

ug/l

0.09

2219

13921

Other and unspecified dermatitis

3113

20446

1.58

114.42

2.6

2.3

5.78

7.48

ug/l

5.83

2726

17897

Extracorporeal dialysis

547

2003

3.23

114.26

3.2

2.4

13.84

8.12

ug/l

1.91

503

1807

Mental and behavioural disorders due to alcohol

3045

18949

1.59

113.89

2.8

2.3

6.94

8.27

ug/l

2.54

2711

16835

Poisoning by medicine

1127

5558

2.14

113.38

2.7

2.2

6.23

7.88

ug/l

1.29

972

4958

Cholelithiasis, broad definition with cholecystitis

5099

24253

1.44

113.20

2.6

2.3

5.70

7.65

ug/l

10.84

4419

21158

Adjustment and management of implanted device

1463

8004

1.99

112.81

3.1

2.4

14.25

7.02

ug/l

7.77

1337

6845

Early onset COPD, excluding more controls

1268

6574

2.06

111.77

2.9

2.1

7.87

8.72

ug/l

0.60

1114

5924

Disorders of eyelid, lacrimal system and orbit

5080

26719

1.43

111.58

2.6

2.3

6.02

7.49

ug/l

5.92

4330

23427

Familial hypercholesterolemia

1169

5962

2.15

111.29

3.2

2.3

6.69

7.42

ug/l

0.66

1007

5200

Missing teeth due to accident, extraction or parodontitis

3901

24063

1.51

111.14

2.6

2.3

6.80

7.44

ug/l

0.99

3366

21248

Migraine without aura

806

3497

2.41

109.99

2.1

1.9

5.56

7.20

ug/l

1.11

704

3082

Diarrhoea and gastroenteritis of presumed infectious origin, including avohilmo

5734

26870

1.40

109.91

2.6

2.2

6.32

7.50

ug/l

3.55

4983

23512

All influenza (not pneumonia)

952

4481

2.29

109.85

3.5

2.2

7.55

7.81

ug/l

0.10

845

3952

Acute upper respiratory infections of multiple and unspecified sites

4220

21409

1.48

109.84

2.8

2.2

7.30

7.43

ug/l

0.11

3684

18754

Osteoporosis

1895

10288

1.81

109.39

2.8

2.4

6.47

6.34

ug/l

0.09

1513

8768

Abnormal findings on diagnostic imaging of lung

3270

20802

1.56

109.22

2.6

2.4

7.05

7.38

ug/l

0.34

2825

18183

Cervicalgia

1264

6608

2.03

108.69

2.6

2.2

5.82

8.20

ug/l

2.80

1099

5759

Viral pneumonia

922

4326

2.32

108.34

3.1

2.2

8.72

7.66

ug/l

0.55

793

3798

Other joint disorders

4509

16397

1.47

107.94

2.3

2.2

6.02

8.37

ug/l

10.03

3897

14412

Insulin, fast-acting or short human

2291

14243

1.69

107.86

2.8

2.3

6.78

7.69

ug/l

1.29

2029

12432

Conductive and sensorineural hearing loss

4850

23035

1.44

107.68

2.6

2.3

6.22

7.79

ug/l

5.74

4130

20249

Presence of other devices

1684

9519

1.85

107.67

2.6

2.3

4.52

6.24

ug/l

6.17

1500

8088

Chronic periodontitis, including avohilmo

5675

26523

1.40

107.64

2.3

7.72

7.32

ug/l

0.54

5011

23308

Other gastritis (incl. Duodenitis)

1522

8508

1.91

107.48

2.9

2.3

6.08

7.71

ug/l

2.91

1325

7417

Anxiety (asthma-related co-morbidities)

2877

14123

1.59

107.40

2.6

2.1

6.47

7.92

ug/l

1.74

2440

12573

Periodontitis

5678

26520

1.40

107.33

2.3

7.70

7.32

ug/l

0.51

5017

23298

Autoimmune diseases excluding thyroid diseases

5755

22782

1.40

106.99

2.4

2.3

7.07

7.67

ug/l

1.08

5054

19982

Acute upper respiratory infections

5935

26243

1.39

105.88

2.7

2.2

6.71

7.27

ug/l

0.90

5135

22906

Pericarditis

290

740

4.61

105.72

3.1

1.9

9.42

5.89

ug/l

1.57

246

638

Autoimmune diseases excluding thyroid diseases, strict definition

5596

22185

1.40

105.47

2.4

2.3

6.98

7.66

ug/l

1.34

4905

19470

Mental and behavioural disorders due to alcohol, excluding acute intoxication

2672

17150

1.61

105.24

2.8

2.3

6.84

8.46

ug/l

3.13

2379

15296

Carpal tunnel syndrome

3545

20992

1.51

105.09

2.5

2.3

6.15

7.57

ug/l

2.91

3162

18332

Gastroduodenal ulcer

1864

11080

1.78

104.93

2.8

2.3

6.95

7.70

ug/l

0.64

1650

9582

Any operation in hilmo

161

11.96

104.76

2.2

1.3

9.90

3.15

ug/l

2.29

149

Sleep apnoea

5355

24604

1.41

104.57

2.5

2.3

6.52

7.75

ug/l

3.92

4666

21762

Sensorineural hearing loss

4698

22418

1.44

104.32

2.6

2.3

6.13

7.78

ug/l

6.25

3997

19703

Congenital malformations, deformations and chromosomal abnormalities

2849

17673

1.57

104.09

2.3

2.2

10.18

7.30

ug/l

6.89

2548

15576

Benign neoplasms

5302

20893

1.41

103.84

2.4

2.3

6.94

7.83

ug/l

2.00

4601

18395

Artrosis, including avohilmo

4572

17688

1.45

103.76

2.4

2.3

6.17

8.54

ug/l

11.34

4000

15575

Autoimmune diseases

6094

22864

1.38

103.64

2.4

2.3

7.29

7.66

ug/l

0.52

5334

20052

Gonarthrosis,primary

5490

24278

1.41

103.44

2.4

5.87

7.86

ug/l

8.44

4799

21282

Mycoses

1739

10197

1.80

103.11

2.8

2.3

6.87

7.45

ug/l

0.46

1511

8963

Presence of other functional implants

3501

16292

1.52

103.01

2.6

2.2

6.06

6.24

ug/l

0.21

2942

14102

Other reaction to severe stress, and adjustment disorders

1667

9614

1.80

101.70

2.8

2.1

8.47

7.70

ug/l

0.43

1451

8532

Acute sinusitis

2670

15730

1.59

101.54

2.6

2.2

7.28

7.66

ug/l

0.30

2323

13870

Other cataract

2739

13245

1.60

101.28

2.7

2.2

7.31

8.02

ug/l

0.79

2414

11776

Aneurysms, operations, SAH

1117

5777

2.09

100.98

2.8

2.3

5.71

7.42

ug/l

1.96

992

5024

Other mental disorders due to brain damage and dysfunction and to physical disease

977

4858

2.24

100.83

3.4

2.4

4.75

7.01

ug/l

6.63

807

4251

Used for control exclusion in common control thyroid runs

5755

21349

1.39

100.73

2.4

2.3

7.43

7.76

ug/l

0.43

5017

18756

Other degenerative diseases of the nervous system

1645

6842

1.84

100.53

2.5

2.2

6.29

8.08

ug/l

3.08

1310

6044

Injuries to the shoulder and upper arm

4998

28135

1.41

100.27

2.5

2.3

6.93

7.47

ug/l

0.84

4356

24662

Traumatic subdural haemorrhage

971

4460

2.21

99.93

2.5

2.3

6.32

8.41

ug/l

3.31

831

3920

Other anxiety disorders

2139

11223

1.67

98.88

2.7

2.1

6.35

7.76

ug/l

1.40

1799

9952

Cholelithiasis

4831

23912

1.42

98.82

2.6

2.3

5.72

7.64

ug/l

9.84

4182

20835

Sleep disorders (combined)

6124

23874

1.37

98.73

2.6

2.3

6.42

7.72

ug/l

4.32

5285

20915

Persons encountering health services for other counselling and medical advice, not elsewhere classified

6144

24410

1.37

98.09

2.4

2.2

7.57

7.34

ug/l

0.29

5389

21318

Fracture of rib(s), sternum and thoracic spine

2120

13311

1.68

97.27

2.7

2.4

6.96

7.72

ug/l

0.88

1770

11623

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

1221

6418

1.95

96.96

2.5

2.0

6.65

8.25

ug/l

1.34

1041

5749

Other disorders of skin and subcutaneous tissue, not elsewhere classified

1009

5115

2.14

96.86

3.0

2.4

5.99

7.55

ug/l

1.20

836

4456

Other diseases of urinary system

5413

22367

1.39

96.79

2.6

2.2

6.63

7.80

ug/l

3.26

4650

19775

Coxarthrosis

3152

13689

1.54

96.68

2.5

2.3

6.26

8.46

ug/l

8.28

2753

12037

Injury, poisoning and certain other consequences of external causes

2639

8423

1.61

96.30

2.4

2.1

6.69

7.95

ug/l

2.38

2316

7434

Dental operations

3748

13313

1.49

95.80

2.4

2.3

6.85

7.68

ug/l

1.55

3240

11439

Venous thromboembolism

3431

22970

1.49

95.56

2.5

2.4

6.81

7.20

ug/l

0.39

2933

19950

Sleep apnoea, including avohilmo

5512

24728

1.38

95.30

2.5

2.3

6.43

7.72

ug/l

4.39

4808

21845

Alcohol use disorder, ICD-based

2450

15923

1.60

95.24

2.8

2.3

6.76

8.53

ug/l

3.34

2178

14213

Allergic asthma (mode), excluding more controls

972

4708

2.09

94.07

2.6

1.9

5.81

6.98

ug/l

1.33

868

4169

Localized swelling, mass and lump of skin and subcutaneous tissue

1913

11807

1.70

92.92

2.7

2.3

6.46

7.57

ug/l

1.22

1698

10368

Paralytic ileus and intestinal obstruction

1692

10130

1.76

92.75

2.7

2.3

5.23

7.75

ug/l

10.01

1457

8812

Personality disorders

1239

6744

1.92

92.61

2.5

2.2

6.12

7.99

ug/l

1.64

1068

6050

Coxarthrosis [arthrosis of hip](FG)

3428

16321

1.50

92.49

2.5

2.3

6.11

8.18

ug/l

8.53

2994

14327

Diseases of the eye and adnexa

3707

12858

1.48

91.15

2.5

2.1

7.60

8.43

ug/l

1.02

3277

11495

Specific personality disorders

1083

5675

2.00

91.13

2.6

2.2

6.40

7.89

ug/l

0.96

927

5083

Pulmonary heart disease, diseases of pulmonary circulation

2173

13948

1.64

90.79

2.7

2.4

8.44

7.16

ug/l

1.03

1865

12028

Kidney transplant status

409

1441

3.28

90.52

2.3

11.46

8.15

ug/l

0.73

383

1309

Unspecified haematuria

2808

15397

1.55

90.45

2.7

2.4

7.20

7.81

ug/l

0.75

2437

13589

All anxiety disorders

2906

15162

1.53

90.33

2.6

2.1

6.46

7.77

ug/l

1.50

2467

13487

Open wound of head

3295

21554

1.48

89.63

2.7

2.3

7.36

7.79

ug/l

0.47

2785

18942

Obesity and other hyperalimentation

3275

21384

1.48

89.46

2.4

2.2

6.27

7.77

ug/l

3.37

2802

18979

Nontraumatic intracranial haemmorrhage

1413

8179

1.85

88.99

2.5

2.4

5.96

6.97

ug/l

1.67

1225

6998

Other nutritional deficiencies

3451

22126

1.46

88.58

2.6

2.2

6.26

7.76

ug/l

3.61

2947

19635

Disorders of adult personality and behaviour

1274

7088

1.87

88.55

2.5

2.2

6.34

8.03

ug/l

1.43

1091

6345

Obesity

3253

21289

1.48

88.49

2.4

2.2

6.19

7.78

ug/l

3.73

2786

18897

Other diseases of anus and rectum

1879

11645

1.68

88.31

2.7

2.2

6.56

7.57

ug/l

0.99

1598

10133

Falls/tendency to fall

5552

20773

1.37

87.87

2.4

2.2

7.53

7.69

ug/l

0.18

4777

18549

Selective serotonin reuptake inhibitors

5381

20837

1.37

87.66

2.4

2.2

6.86

7.93

ug/l

2.22

4579

18488

Soft tissue disorders related to use, overuse and pressure

1642

9908

1.74

87.11

2.4

2.2

6.99

8.20

ug/l

0.97

1423

8709

Neurotic, stress-related and somatoform disorders

4525

22803

1.40

87.01

2.6

2.2

7.07

7.60

ug/l

0.55

3861

20185

Anxiety disorders

4583

23048

1.40

86.94

2.6

2.2

7.06

7.60

ug/l

0.56

3913

20388

Dental caries, including avohilmo

4361

16123

1.42

86.88

2.4

2.3

6.65

7.34

ug/l

1.43

3786

13912

Arthropathies

4491

16416

1.41

86.87

2.3

2.2

6.98

8.38

ug/l

2.75

3907

14427

Vascular disorders of the intestines

595

2580

2.61

86.66

3.4

2.3

7.53

7.64

ug/l

0.04

539

2241

Dilated cardiomyopathy

908

4649

2.17

86.55

3.4

2.4

19.02

7.96

ug/l

6.76

841

4109

Caries of dentine, including avohilmo

4591

17099

1.41

86.48

2.4

2.3

6.76

7.41

ug/l

1.27

3982

14802

Non-allergic asthma (mode), excluding more controls

983

5037

2.03

86.21

2.7

2.0

6.22

7.17

ug/l

1.14

888

4412

Cardiac murmurs and other cardiac sounds

480

1825

2.78

86.04

2.3

1.9

6.99

7.53

ug/l

0.24

424

1575

Gout, FINNGEN

2125

13681

1.63

85.83

3.0

2.4

7.92

7.62

ug/l

0.16

1858

11932

Diabetic nephropathy, excluding more controls

1086

4755

2.03

85.66

3.1

2.4

6.45

8.03

ug/l

1.88

984

4152

Gastric ulcer

1270

7225

1.89

85.18

3.0

2.3

7.45

7.63

ug/l

0.08

1129

6236

Other arthrosis

3070

14140

1.50

84.91

2.5

2.3

6.79

8.50

ug/l

2.71

2673

12510

Amputation of toe

624

2806

2.55

84.44

3.1

2.4

6.76

7.42

ug/l

0.49

554

2457

Disorder of lipoprotein metabolism, unspecified

955

4996

2.08

84.26

2.9

2.3

8.50

7.39

ug/l

0.81

827

4364

Organic, including symptomatic, mental disorders

3474

17317

1.47

84.12

2.7

2.4

5.68

7.15

ug/l

5.48

2793

15214

DVT of lower extremities and pulmonary embolism

2706

18404

1.53

83.68

2.6

2.4

6.70

7.24

ug/l

0.49

2307

15919

Misadventures to patients during surgical and medical care

956

5001

2.06

83.54

3.0

2.4

6.47

7.20

ug/l

0.63

853

4377

Type 1 diabetes, wide definition, subgroup 1

1073

5776

1.95

83.46

2.7

2.1

7.68

8.07

ug/l

0.22

953

5065

Other systemic involvement of connective tissue (FG)

1525

8960

1.75

83.20

2.5

2.3

6.59

6.97

ug/l

0.22

1287

7732

Diseases of pulp and periapical tissues and dental caries

3927

14396

1.44

83.04

2.5

2.3

6.98

7.33

ug/l

0.46

3419

12347

Myalgia

1245

7047

1.85

82.35

2.6

2.2

6.36

7.81

ug/l

1.56

1057

6179

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

5406

25871

1.35

82.28

2.5

2.3

7.15

7.53

ug/l

0.44

4690

22738

Injuries to the hip and thigh

3110

19542

1.48

82.02

2.6

2.4

6.68

7.16

ug/l

0.51

2619

16905

Candidiasis, including avohilmo

1631

9963

1.71

82.00

2.7

2.3

6.02

7.09

ug/l

1.04

1382

8681

Chronic gastritis

1767

11077

1.68

81.58

2.6

2.3

6.53

7.22

ug/l

0.61

1469

9565

Left bundle-branch block

474

1883

2.77

81.40

2.5

1.9

9.10

5.74

ug/l

1.51

396

1589

Congenital malformations, deformations and chromosomal abnormalities, including avohilmo

3083

19617

1.47

80.94

2.4

2.2

9.95

7.23

ug/l

6.96

2746

17292

Symptoms and signs concerning food and fluid intake

679

3154

2.32

80.89

2.9

2.1

6.47

8.21

ug/l

0.91

581

2772

Alcohol abuse, main dg, excluding more controls

853

4318

2.10

80.67

3.2

2.2

6.19

8.95

ug/l

4.10

763

3929

Diseases of oral cavity, salivary glands and jaws

3448

12476

1.47

80.61

2.5

2.3

7.21

7.57

ug/l

0.39

2994

10698

Recurrent or chronic depression

1857

8019

1.65

80.04

2.4

2.1

6.55

8.91

ug/l

3.11

1573

7283

Fungal Sepsis

364

1296

3.28

79.56

3.5

2.2

10.12

7.76

ug/l

0.64

315

1167

Iron deficiency anaemia secondary to blood loss (chronic)

1132

6355

1.91

79.55

3.0

2.4

8.03

6.65

ug/l

0.81

978

5458

Sequelae of external causes of morbidity and mortality

1621

10016

1.71

79.26

2.7

2.4

7.10

7.38

ug/l

0.20

1464

8727

Alzheimer’s disease (Atypical or mixed), excluding more controls

707

2477

2.33

79.11

2.7

2.3

5.23

7.37

ug/l

3.12

541

2162

Glomerular disorders in diseases classified elsewhere

827

4215

2.15

78.95

2.9

2.4

6.32

8.04

ug/l

2.14

735

3732

Obesity due to excess calories

2365

15845

1.54

78.69

2.5

2.2

5.97

7.91

ug/l

5.96

2030

14106

Retention of urine

2348

12695

1.57

78.67

2.9

2.4

7.20

7.66

ug/l

0.41

1974

11163

Deforming dorsopathies

1453

8708

1.74

78.25

2.4

2.2

8.20

8.25

ug/l

0.02

1274

7617

Pulmonary embolism

1945

12619

1.62

77.52

2.7

2.4

7.27

7.16

ug/l

0.06

1666

10891

Undetermined asthma, excluding more controls

704

3363

2.22

77.27

2.6

2.0

5.84

6.79

ug/l

0.93

618

2966

COPD

2919

16595

1.49

77.20

2.9

2.4

6.72

7.97

ug/l

2.76

2483

14529

Pulmonary heart disease

1945

12660

1.62

76.42

2.7

2.4

7.27

7.21

ug/l

0.03

1666

10933

Systemic connective tissue disorders

2056

13515

1.59

76.34

2.6

2.4

6.56

6.68

ug/l

0.08

1738

11653

Focal epilepsy

1277

7485

1.80

75.99

2.7

2.3

5.72

7.53

ug/l

4.26

1103

6544

Glomerular diseases

1150

6567

1.87

75.97

2.8

2.4

6.71

7.83

ug/l

1.06

1026

5775

Hyperkalaemia

500

2129

2.66

75.95

3.5

2.3

6.00

7.34

ug/l

0.56

438

1841

Unspecified kidney failure

833

4325

2.12

75.91

3.0

2.4

7.45

6.78

ug/l

0.52

721

3696

Type 1 diabetes

1294

7576

1.78

75.71

2.6

2.2

7.40

8.00

ug/l

0.45

1145

6612

Urinary track infection

2396

7895

1.56

75.67

2.5

2.0

5.96

6.11

ug/l

0.11

2052

6838

Hernia of abdominal wall

2709

18861

1.49

75.41

2.7

2.3

5.72

7.98

ug/l

12.20

2406

16602

Other chronic obstructive pulmonary disease

2819

16125

1.49

75.36

2.9

2.4

6.67

7.93

ug/l

2.80

2388

14103

Endovascular or surgical operations to intracerebral aneurysms

454

1853

2.77

75.17

2.7

2.3

5.44

7.26

ug/l

1.27

416

1658

Migraine with aura and triptan purchases

652

3044

2.24

75.11

2.4

2.1

4.88

6.67

ug/l

2.28

578

2692

Cystitis

4466

19779

1.37

75.08

2.7

2.2

6.29

7.43

ug/l

2.91

3825

17378

Nonorganic sleeping disorders, excluding more controls

965

5190

1.94

75.02

3.0

2.1

5.46

7.60

ug/l

3.49

816

4652

Diseases of the ear and mastoid process

5921

22886

1.32

74.87

2.4

2.2

6.87

7.83

ug/l

2.21

5130

20207

Paracetamol or NSAID medication

761

1787

2.22

74.73

2.5

2.1

6.94

10.73

ug/l

3.48

662

1558

Implicit fungal Sepsis

337

1192

3.30

74.66

3.6

2.2

10.46

7.85

ug/l

0.66

291

1072

COPD related to multimorbidity

2686

15798

1.50

74.46

2.9

2.4

6.81

7.48

ug/l

1.01

2268

13789

Other external causes of accidental injury

4158

15270

1.39

74.41

2.5

2.2

6.93

7.57

ug/l

1.17

3573

13648

Focal epilepsy, mode (most common among epilepsy diagnosis)

1148

6578

1.85

74.30

2.7

2.3

5.75

7.50

ug/l

3.53

991

5754

Allergic asthma (mode)

972

5115

1.92

73.93

2.6

2.0

5.81

7.61

ug/l

2.49

868

4531

Mycoses, including avohilmo

4909

28447

1.34

73.87

2.6

2.3

7.35

7.37

ug/l

0.02

4245

25051

Focal epilepsy, strict definition

1209

7044

1.82

73.79

2.7

2.4

5.81

7.55

ug/l

3.72

1044

6157

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

766

3840

2.10

73.71

2.7

2.3

6.27

7.84

ug/l

1.14

660

3457

Obesity, other/unspecified

1639

10284

1.65

73.36

2.4

2.2

5.89

7.69

ug/l

2.10

1396

9120

Oter anti-inflammatory and antirheumatic agents, non-steroids

1410

4564

1.78

73.24

2.5

2.4

6.36

9.84

ug/l

7.49

1192

3992

Cardiomyopathy, Hypertrophic obstructive

170

387

5.43

73.00

5.5

1.9

29.97

5.87

ug/l

5.21

159

334

Preparatory care for dialysis

378

1446

3.08

72.96

2.7

2.4

6.82

7.75

ug/l

0.43

342

1311

Dialysis

327

1154

3.31

72.74

3.1

2.4

8.27

7.58

ug/l

0.21

309

1053

Other diseases of hard tissues of teeth

3308

12178

1.45

72.63

2.5

2.3

6.78

7.59

ug/l

1.45

2883

10506

Accidents

4143

15270

1.39

72.49

2.5

2.2

6.97

7.57

ug/l

0.91

3570

13648

Cellulitis

1329

7974

1.76

72.49

2.6

2.3

8.25

7.85

ug/l

0.18

1167

7039

Explicit bacterial Sepsis, including avohilmo

726

3639

2.15

71.67

2.9

2.2

8.29

7.42

ug/l

0.40

634

3206

External causes of morbidity and mortality

3230

11444

1.45

71.37

2.4

2.2

7.02

7.50

ug/l

0.53

2822

10192

Diabetic retinopathy, excluding more controls

1640

5712

1.70

70.85

2.8

2.3

7.35

7.88

ug/l

0.37

1447

4977

Superficial injury of head

1447

8908

1.70

70.77

2.8

2.3

6.37

7.20

ug/l

0.63

1224

7680

Glucagon-like peptide-1 (GLP-1) analogues

1664

10631

1.63

69.88

2.5

2.2

5.91

8.88

ug/l

7.76

1499

9572

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

1664

10631

1.63

69.88

2.5

2.2

5.91

8.88

ug/l

7.76

1499

9572

Gout, idiopatic and unspecified

1780

11634

1.62

69.80

3.0

2.4

8.47

7.65

ug/l

0.45

1554

10195

Sequelae with surgical and medical care as external cause

1303

7888

1.75

69.60

2.7

2.4

7.13

7.35

ug/l

0.13

1174

6865

Fracture of lumbar spine and pelvis

1541

9711

1.67

69.33

2.7

2.5

6.25

6.79

ug/l

0.49

1238

8295

Explicit bacterial Sepsis

707

3559

2.14

68.99

2.9

2.2

8.33

7.43

ug/l

0.40

617

3134

Cervicocranial syndrome

625

3002

2.23

68.53

2.9

2.1

5.99

8.58

ug/l

1.78

572

2626

Genitourinary diseases

2864

10015

1.47

68.43

2.4

2.1

9.06

8.63

ug/l

0.27

2539

9061

Cerebral aneurysm, nonruptured

565

2629

2.35

68.38

2.8

2.3

6.44

7.10

ug/l

0.25

503

2347

Anosmia

107

153

7.32

68.23

2.6

1.4

5.11

3.94

ug/l

0.62

132

Alzheimer disease, excluding more controls

1116

4108

1.86

68.18

2.5

2.2

5.79

8.17

ug/l

4.40

868

3640

Ventral hernia

1474

9240

1.68

67.96

2.7

2.3

5.45

7.55

ug/l

6.00

1298

8041

Cutaneous abscess, furuncle and carbuncle

1409

8705

1.69

67.90

2.9

2.3

7.05

8.12

ug/l

1.11

1210

7717

Type 1 diabetes, wide definition

1101

6369

1.80

67.40

2.7

2.2

7.61

7.92

ug/l

0.18

977

5561

Other symptoms and signs involving the digestive system and abdomen

894

4880

1.93

67.10

2.5

2.1

6.11

7.68

ug/l

1.36

742

4240

Other or unspecified ileus, impaction or obstruction

1204

7200

1.77

66.89

2.7

2.3

4.95

7.79

ug/l

9.85

1043

6258

ILD medications: azathioprine

768

4001

2.03

66.67

2.5

2.1

13.24

7.30

ug/l

2.51

694

3570

Autoimmune diseases related-to ILD

4498

28731

1.33

66.29

2.5

2.3

6.38

7.39

ug/l

2.40

3925

25130

Disorders of synovium and tendon

2677

16027

1.45

66.04

2.3

2.2

5.89

8.22

ug/l

9.43

2346

14107

Dermatitis and eczema

6005

28045

1.29

65.96

2.5

2.3

6.33

7.57

ug/l

4.40

5264

24511

Substance use, excluding alcohol

982

5545

1.85

65.76

2.9

2.2

7.22

8.26

ug/l

0.53

841

4950

Benign neoplasm: Sigmoid colon

1273

7798

1.74

65.56

2.7

2.4

6.63

7.69

ug/l

1.14

1128

6832

Disorders of lacrimal system

2432

16726

1.48

65.51

2.6

2.3

5.66

6.92

ug/l

2.48

2057

14580

Diseases of the myoneural junction and muscle

844

4606

1.98

65.47

2.8

2.4

13.09

7.57

ug/l

4.13

677

4049

Schizophrenia or delusion, excluding more controls

1407

8631

1.67

65.34

2.6

2.2

6.22

7.96

ug/l

2.02

1198

7717

Other and unspecified myopathies

662

3353

2.18

64.88

2.8

2.4

14.51

7.44

ug/l

4.48

526

2943

Other chronic obstructive pulmonary disease, including avohilmo

3376

20486

1.40

64.81

2.8

2.4

6.67

7.66

ug/l

2.19

2865

17999

Diseases of pulp and periapical tissues, including avohilmo

5569

22494

1.30

64.73

2.4

2.3

7.29

7.27

ug/l

0.02

4889

19540

Special screening examination for other diseases and disorders

594

2850

2.19

64.23

2.7

2.0

4.88

8.16

ug/l

6.78

559

2510

Other disorders of lacrimal gland

2009

13625

1.53

63.85

2.7

2.3

5.45

7.04

ug/l

3.18

1699

11924

Chronic apical periodontitis

5872

25985

1.29

63.70

2.4

2.3

7.93

7.12

ug/l

1.48

5164

22740

Azathioprine

768

4064

1.99

63.67

2.5

2.1

13.24

7.41

ug/l

2.43

694

3611

Problems related to lifestyle

584

2808

2.22

63.64

3.0

2.1

7.10

8.63

ug/l

0.44

517

2515

Congenital malformations of cardiac septa

372

1428

2.75

63.58

2.2

2.3

16.72

7.43

ug/l

6.83

334

1264

Streptococcal septicaemia, including avohilmo

653

3304

2.16

63.56

2.8

2.3

8.33

7.92

ug/l

0.15

574

2918

Artificial joint operation, meniscal resection

5213

26065

1.31

63.24

2.4

6.04

7.76

ug/l

7.85

4560

22844

Viral infections characterized by skin and mucous membrane lesions, including avohilmo

4758

28737

1.31

62.41

2.4

2.3

6.63

7.48

ug/l

1.87

4164

25209

Benign neoplasm: Stomach

670

3452

2.13

62.35

2.9

2.4

5.07

6.93

ug/l

2.43

590

3017

Non-selective monoamine reuptake inhibitors

2031

13295

1.52

62.10

2.6

2.3

5.60

7.45

ug/l

3.29

1679

11760

Delirium, not induced by alcohol and other psychoactive substances

935

5343

1.89

62.07

3.0

2.4

5.40

6.85

ug/l

2.25

764

4632

Intestinal stricture

1947

13251

1.54

61.78

2.7

2.4

5.75

7.33

ug/l

3.75

1690

11500

Bacterial pneumoniae

2317

14211

1.48

61.74

2.7

2.2

7.83

7.51

ug/l

0.26

2016

12414

Other diseases of upper respiratory tract

5970

24666

1.28

61.45

2.5

2.3

6.91

7.53

ug/l

1.01

5175

21544

Impingement syndrome of shoulder

1305

8126

1.68

61.42

2.3

2.2

6.07

9.01

ug/l

5.30

1140

7244

Other bacterial intestinal infections

1141

6885

1.75

61.41

2.6

2.3

6.97

7.46

ug/l

0.29

962

5929

Hypokalaemia

773

4172

1.98

61.39

3.5

2.3

5.26

7.18

ug/l

2.76

648

3618

Streptococcal septicaemia

634

3218

2.15

61.18

2.8

2.3

8.37

7.98

ug/l

0.14

557

2842

Gout, unspecified

1452

9352

1.65

61.03

3.0

2.4

8.76

7.74

ug/l

0.53

1273

8199

Exposure to other specified factors

4111

26984

1.33

60.98

2.4

2.3

7.56

7.49

ug/l

0.05

3542

23857

Non-allergic asthma (mode)

983

5625

1.81

60.77

2.7

2.1

6.22

7.49

ug/l

1.80

888

4953

Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere

524

2495

2.32

60.29

2.9

2.4

4.98

6.99

ug/l

2.03

460

2153

Undetermined asthma

704

3688

2.01

59.95

2.6

2.1

5.84

7.47

ug/l

2.00

618

3265

Other bacterial intestinal infections, including avohilmo

1378

8748

1.65

59.89

2.6

2.3

8.43

7.22

ug/l

0.59

1162

7538

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

1221

7483

1.68

59.88

2.5

2.2

6.65

7.60

ug/l

0.64

1041

6668

Polyarthrosis

1263

7053

1.70

59.83

2.8

2.3

4.78

7.60

ug/l

6.43

1044

6107

Hypertrophic cardiomyopathy

345

1390

2.88

59.77

4.1

2.5

20.74

7.50

ug/l

5.23

324

1245

Candidiasis

798

4381

1.93

59.49

3.1

2.3

7.24

7.02

ug/l

0.08

674

3840

Maze procedure for atrial fibrillation

147

12.30

59.05

2.5

2.8

30.54

8.91

ug/l

4.65

127

Later onset COPD, excluding more controls

1385

6696

1.66

58.85

2.8

2.2

5.76

7.61

ug/l

5.20

1152

5857

Other complications of surgical and medical care, not elsewhere classified

580

2876

2.17

58.83

3.8

2.2

5.63

7.16

ug/l

1.21

529

2521

Benign neoplasm of other and ill-defined parts of digestive system

1109

6737

1.75

58.68

2.7

2.4

5.58

7.16

ug/l

2.56

979

5871

Heart failure and hypertrophic cardiomyopathy

200

613

4.20

58.45

5.2

2.6

25.35

7.73

ug/l

3.93

187

550

Cholecystectomy

3888

25277

1.34

57.74

2.6

2.3

5.47

7.31

ug/l

7.96

3388

21949

Atrial septal defect

242

807

3.35

57.63

2.2

2.3

16.80

7.05

ug/l

4.47

217

711

Spondylolisthesis/Spondylolysis

975

5722

1.79

57.57

2.4

2.2

5.52

8.61

ug/l

7.35

876

5041

Alcohol dependence

1531

10058

1.59

57.24

3.0

2.3

6.44

8.63

ug/l

3.63

1352

8993

Other diseases of intestine

969

5707

1.80

57.24

2.8

2.3

7.98

8.46

ug/l

0.26

889

5048

Acute pancreatitis

1198

7465

1.69

56.82

2.7

2.3

5.28

8.25

ug/l

11.12

1045

6557

Bacterial pneumonia, not elsewhere classified

2194

13553

1.47

56.37

2.7

2.2

7.84

7.52

ug/l

0.26

1910

11826

Emotionally unstable personality disorder

482

2244

2.25

56.18

2.4

2.1

4.98

7.22

ug/l

1.12

406

1991

Other symptoms and signs involving the circulatory and respiratory systems

367

1536

2.57

55.99

3.1

1.9

7.73

8.61

ug/l

0.21

290

1341

Fentanyl

701

3771

1.99

55.98

2.8

2.3

5.45

7.53

ug/l

1.63

577

3237

Persons encountering health services for specific procedures, not carried out

494

2347

2.25

55.88

2.4

2.2

6.15

7.63

ug/l

1.24

437

2101

Other and unspecified effects of external causes

1267

7983

1.64

55.87

2.6

2.3

5.35

7.35

ug/l

4.38

1105

7025

Gout, strict definition

1302

8356

1.66

55.86

3.1

2.4

8.57

7.73

ug/l

0.36

1139

7340

Diabetic maculopathy, excluding more controls

663

3513

2.02

55.73

3.1

2.3

7.11

7.84

ug/l

0.48

592

3067

Bipolar affective disorders

796

4431

1.87

55.52

2.3

2.2

4.81

8.14

ug/l

8.57

696

3985

Somatoform disorder

810

4554

1.87

55.32

2.7

2.2

5.54

7.25

ug/l

1.24

688

4037

Injuries to the knee and lower leg

6222

27143

1.26

55.27

2.4

2.3

7.06

7.40

ug/l

0.44

5398

23785

Radiculopathy

936

5508

1.79

55.11

2.9

2.2

5.71

8.18

ug/l

3.37

826

4767

Trochanteric bursitis

822

4662

1.86

55.01

2.5

2.2

5.67

7.58

ug/l

1.57

712

4047

Alcohol abuse, main dg

853

4891

1.84

54.96

3.2

2.3

6.19

8.76

ug/l

3.58

763

4421

Hypothyroidism, strict autoimmune

3768

18853

1.34

54.94

2.4

2.3

6.61

7.28

ug/l

0.97

3259

16458

Myocardial infarction, unclassifiable

1603

9598

1.57

54.79

3.4

2.5

9.19

6.56

ug/l

3.89

1383

8115

Subarachnoid haemorrhage

671

3602

2.01

54.68

2.7

2.3

4.90

7.04

ug/l

4.71

595

3098

Viral and other specified intestinal infections, including avohilmo

1195

7156

1.65

54.61

2.7

2.1

6.80

7.35

ug/l

0.30

1063

6213

Panic disorder

596

3035

2.04

54.51

2.6

2.1

5.03

6.85

ug/l

1.89

501

2700

Abnormal involuntary movements

799

4524

1.88

54.22

2.9

2.3

6.14

7.99

ug/l

1.77

676

3974

Enterocolitis due to Clostridium difficile

741

4119

1.94

54.19

2.7

2.4

7.64

7.00

ug/l

0.27

619

3534

Haemorrhoids and perianal venous thrombosis

1901

13076

1.49

54.02

2.3

2.2

5.69

7.65

ug/l

5.51

1648

11454

Gonarthrosis, primary, with knee surgery

3503

20785

1.35

53.93

2.4

5.39

7.76

ug/l

12.81

3045

18182

Other and unspecified injuries of head

495

2401

2.24

53.86

2.7

2.3

6.01

7.80

ug/l

1.03

432

2103

Viral hepatitis, IBD co-morbidity

213

678

3.32

53.80

2.4

1.9

10.15

12.64

ug/l

0.42

190

619

Functional dyspepsia

1390

9060

1.59

53.34

2.6

2.2

5.34

7.55

ug/l

5.33

1206

7904

Other and unspecified polyneuropathies, also in other diseases

1247

7997

1.65

53.09

2.9

2.4

6.70

7.58

ug/l

0.68

1068

7015

Bacterial intestinal infections, IBD co-morbidities

1138

7125

1.68

53.04

2.6

2.4

7.16

7.23

ug/l

0.03

961

6149

Other systemic involvement of connective tissue

1546

10372

1.55

52.35

2.5

2.4

6.54

6.63

ug/l

0.04

1305

8911

Dissection of aorta

281

1097

2.99

52.11

2.6

2.4

17.85

7.01

ug/l

3.24

264

973

Suicide or other Intentional self-harm

1098

6803

1.67

52.02

2.6

2.3

7.12

7.93

ug/l

0.45

933

6077

Meniscus derangement

2916

14373

1.38

51.41

2.4

2.3

6.69

8.55

ug/l

3.30

2559

12737

Mouth breathing

2063

14635

1.45

51.27

2.6

2.3

5.69

8.62

ug/l

9.66

1882

13103

Coxibs

1449

4906

1.60

51.22

2.3

6.28

9.86

ug/l

8.85

1194

4292

Conotruncal defects

191

6.21

51.03

1.9

2.5

25.59

8.64

ug/l

4.02

169

Vascular syndromes of brain in cerebrovascular disorders

365

1622

2.57

50.96

3.2

2.5

4.82

6.96

ug/l

1.59

332

1435

Degeneration of macula and posterior pole

3074

17911

1.37

50.95

2.7

2.4

5.87

7.03

ug/l

4.08

2572

15501

Examination and encounter for administrative purposes

475

2308

2.21

50.89

2.8

2.1

8.09

8.66

ug/l

0.15

443

2058

COPD, early/later onset

2841

17845

1.38

50.71

2.9

2.4

6.64

7.67

ug/l

2.06

2402

15625

Polyneuropathies and other disorders of the peripheral nervous system

1378

9120

1.59

50.68

2.9

2.4

7.01

7.70

ug/l

0.51

1185

8000

Polycystic ovarian syndrome, consortium definition

2962

12621

1.37

50.10

2.2

5.86

5.64

ug/l

0.21

2443

10868

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

534

2729

2.10

49.98

3.4

2.3

5.71

6.99

ug/l

0.89

480

2412

Rheumatoid arthritis

1698

10313

1.51

49.98

2.4

2.3

6.43

7.89

ug/l

1.68

1468

9024

Other congenital malformations of upper alimentary tract

100

209

7.09

49.80

3.8

2.4

2.89

7.06

ug/l

2.65

187

Hyperkinetic disorders, excluding more controls

335

1296

2.48

49.78

1.8

1.7

3.97

6.73

ug/l

3.65

289

1140

Coxarthrosis, primary

3647

23498

1.32

49.67

2.5

2.4

5.84

7.45

ug/l

7.09

3167

20457

Alzheimer’s disease (Late onset), excluding more controls

923

3547

1.78

49.54

2.5

2.2

6.30

8.04

ug/l

1.69

707

3126

Viral and other specified intestinal infections

877

5053

1.75

49.40

2.8

2.1

7.11

7.24

ug/l

0.05

779

4364

Charcot foot

113

250

5.20

49.28

2.6

1.7

5.21

4.84

ug/l

0.14

216

Superficial injury of lower leg

1335

8775

1.58

49.21

2.6

2.3

6.80

7.17

ug/l

0.18

1140

7630

Disorders of the thyroid gland

4881

25305

1.27

48.94

2.4

2.3

6.99

7.40

ug/l

0.56

4225

22150

COPD, hospital admissions

2802

17744

1.37

48.57

2.9

2.4

6.67

7.65

ug/l

1.89

2372

15531

Chronic sinusitis

2074

14842

1.43

48.46

2.4

2.3

7.51

7.81

ug/l

0.18

1835

13113

COPD, hospital admission 2, with asthma infections

2082

12882

1.45

48.39

3.1

2.4

6.88

7.52

ug/l

0.70

1746

11225

Dronedarone medication

197

658

3.43

47.90

3.4

2.0

9.38

6.18

ug/l

0.72

181

563

Inguinal hernia

3284

16675

1.34

47.88

2.4

2.3

7.60

8.36

ug/l

1.17

2950

14639

Visual impairment including blindness (binocular or monocular)

484

2441

2.16

47.75

2.6

2.5

8.70

6.61

ug/l

0.51

343

2094

Haemorrhage, not elsewhere classified

295

1219

2.72

47.74

2.8

2.2

9.36

7.89

ug/l

0.55

264

1065

Disorders of vitreous body and globe

2910

20863

1.36

47.71

2.6

2.3

5.90

7.34

ug/l

3.03

2582

18283

Migraine without aura and triptan purchases

570

2991

1.97

47.56

2.1

4.68

6.64

ug/l

1.62

497

2661

Other dialysis

243

924

3.06

47.38

2.9

2.4

7.31

7.75

ug/l

0.14

230

845

Viral infections characterized by skin and mucous membrane lesions

2186

15892

1.41

46.92

2.5

2.3

7.16

7.71

ug/l

0.50

1908

13920

Acute pancreatitis (for exclusion)

1198

7815

1.61

46.82

2.7

2.4

5.28

7.90

ug/l

9.45

1045

6859

Acute alcohol intoxication

1402

9433

1.54

46.68

3.1

2.3

6.38

8.47

ug/l

3.76

1249

8386

Intracerebral haemorrhage

845

5091

1.77

46.36

2.4

6.48

7.06

ug/l

0.47

726

4309

Pleural effusion

1041

6616

1.67

46.29

2.9

2.4

7.58

7.07

ug/l

0.26

908

5743

Other and unspecified drugs and medicaments

508

2627

2.08

46.18

3.3

2.3

5.72

7.06

ug/l

0.90

458

2324

Gingivitis and periodontal diseases

5312

22189

1.26

46.17

2.4

2.3

7.29

7.21

ug/l

0.08

4676

19342

Noninfective enteritis and colitis

2316

17035

1.39

45.85

2.7

2.3

6.39

7.58

ug/l

1.92

2011

14914

Other and unspecified visual disturbances

610

3353

1.94

45.76

2.7

2.3

7.68

6.92

ug/l

0.27

536

2957

Disorders of vitreous body

2819

20370

1.35

45.67

2.6

2.3

5.90

7.32

ug/l

2.85

2509

17871

Internal derangement of knee

1852

13020

1.45

45.58

2.3

6.58

8.58

ug/l

3.27

1608

11565

Disorders of muscles

574

3094

1.97

45.50

2.7

2.2

11.28

8.47

ug/l

1.42

522

2738

Unspecified fall

2807

20920

1.35

45.32

2.6

2.4

6.96

7.28

ug/l

0.30

2316

18241

Dermatophytosis

833

5025

1.76

45.30

2.7

2.4

6.33

7.87

ug/l

1.19

734

4457

Other shoulder lesions

506

2620

2.05

45.14

2.5

2.1

6.76

8.74

ug/l

1.09

437

2322

Hypothyroidism, strict autoimmune, 3 medication purchases required

4211

22465

1.28

45.06

2.4

2.3

6.35

7.06

ug/l

1.23

3635

19562

Benign neoplasm: Transverse colon

727

4255

1.84

45.06

2.9

2.4

6.47

7.28

ug/l

0.56

661

3777

Benign neoplasm: Ascending colon

921

5728

1.72

45.03

2.7

2.4

6.91

7.48

ug/l

0.30

830

5019

Cholecystitis

899

5552

1.71

44.61

2.8

2.4

5.14

7.37

ug/l

4.54

778

4756

Acute gastritis

480

2469

2.10

44.57

2.8

2.3

4.81

7.70

ug/l

5.02

414

2171

Nonorganic sleeping disorders

965

6028

1.66

44.30

3.0

2.2

5.46

7.40

ug/l

2.99

816

5331

Fracture of femur

1798

11544

1.46

44.20

2.5

6.22

6.61

ug/l

0.37

1476

9751

Other enthesopathies

1416

9626

1.52

44.13

2.3

2.1

6.01

8.34

ug/l

2.72

1255

8488

Early onset COPD

1268

8480

1.56

44.12

2.9

2.3

7.87

8.46

ug/l

0.37

1114

7564

Complex cardiac defects

9.64

43.88

2.3

2.7

31.45

3.99

ug/l

3.84

Zoster [herpes zoster], including avohilmo

2888

21356

1.34

43.82

2.6

2.4

6.53

7.01

ug/l

0.71

2511

18603

Other skin changes

1179

7781

1.59

43.66

2.7

2.3

6.64

7.35

ug/l

0.49

1033

6775

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

1010

6306

1.62

43.57

2.6

2.2

5.67

6.95

ug/l

1.73

859

5570

Diabetic nephropathy

1091

7049

1.63

43.26

3.1

2.6

6.45

7.49

ug/l

1.18

987

6150

Vascular diseases of the intestine

313

1395

2.54

43.19

3.3

2.4

7.00

6.71

ug/l

0.08

277

1203

Amputation of thigh

274

1160

2.74

43.08

2.9

2.6

8.30

6.30

ug/l

0.48

234

984

Injuries to the neck

1109

7214

1.59

42.95

2.4

2.3

6.73

7.48

ug/l

0.40

967

6360

Psychotic depression

313

1374

2.43

42.89

2.6

2.2

4.61

8.87

ug/l

5.21

270

1249

Complications of cardiac and vascular prosthetic devices, implants and grafts

190

672

3.38

42.87

3.2

2.4

12.98

6.37

ug/l

1.75

171

600

Congenital malformations of great arteries

124

321

4.29

42.75

2.4

2.3

18.67

7.98

ug/l

4.10

117

280

Complications of internal orthopaedic prosthetic devices, implants and grafts

1361

9298

1.53

42.69

2.6

2.4

5.91

6.86

ug/l

1.06

1168

7987

L04AX Other immunosuppressants

2744

20934

1.34

42.58

2.4

2.3

8.51

7.30

ug/l

1.09

2422

18451

Kela-code for severe mental illness

1679

11877

1.45

42.41

2.6

2.3

5.57

7.96

ug/l

5.93

1458

10467

Fracture of lower leg, including ankle

2850

21484

1.33

42.26

2.5

2.3

6.50

7.43

ug/l

1.41

2481

18860

Temporomandibular joint disorders, including avohilmo

1773

12243

1.43

42.01

2.3

2.2

5.14

7.07

ug/l

2.78

1540

10816

Acute alcohol intoxication, ICD10

1050

6796

1.61

42.00

3.1

2.3

6.54

9.01

ug/l

3.55

937

6125

Excessive, frequent and irregular menstruation

1488

5384

1.51

41.86

2.2

4.55

6.37

ug/l

4.29

1216

4618

Second line medication for Crohn's disease

2796

21452

1.33

41.44

2.3

8.49

7.31

ug/l

1.06

2465

18928

Disorders of vestibular function (Vertigo)

2595

19250

1.35

41.37

2.5

2.4

5.93

7.02

ug/l

1.70

2208

16782

Unspecified acute lower respiratory infection

853

5290

1.69

41.13

3.0

2.3

8.01

7.85

ug/l

0.05

756

4645

Gangrene, not elsewhere classified

199

6.05

41.09

3.4

1.9

3.53

8.24

ug/l

2.40

169

Other epidermal thickening

304

1359

2.47

41.03

2.9

2.3

7.25

7.58

ug/l

0.06

274

1209

Symptoms and signs involving speech and voice

1789

12909

1.43

40.91

2.6

2.4

6.14

6.94

ug/l

0.88

1518

11239

Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care

473

2494

2.05

40.90

3.1

2.4

7.09

6.90

ug/l

0.07

421

2198

Unspecified mental disorder

1814

13079

1.42

40.83

2.5

2.3

5.71

7.91

ug/l

5.51

1575

11529

Artificial opening status

343

1614

2.33

40.69

2.8

2.2

6.10

6.79

ug/l

0.32

300

1419

Other aneurysm

382

1882

2.23

40.54

3.3

2.3

8.35

7.53

ug/l

0.31

343

1646

Disorders of oesophagus in diseases classified elsewhere

184

658

3.30

40.52

3.2

2.4

4.87

7.68

ug/l

2.40

166

579

Hypothyroidism, other/unspecified

4428

23539

1.26

40.20

2.4

2.3

6.76

7.23

ug/l

0.64

3819

20557

Irritable bowel syndrome

1225

8246

1.53

40.10

2.3

2.2

5.44

7.51

ug/l

3.87

1014

7227

Supplementary factors related to causes of morbidity and mortality classified elsewhere

1604

11387

1.45

40.07

2.6

2.4

6.45

7.70

ug/l

1.83

1321

9987

Parkinson's disease, excluding more controls

733

4037

1.75

39.93

2.4

2.2

6.30

8.86

ug/l

3.92

572

3591

2011

12758

1.41

39.87

2.7

2.5

5.34

6.54

ug/l

3.46

1635

10895

Right bundle-branch block

222

866

2.81

39.87

2.4

1.9

7.70

6.15

ug/l

0.41

180

729

Corns and callosities

418

2134

2.12

39.79

3.2

2.4

6.24

7.68

ug/l

0.86

363

1898

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

2565

18869

1.34

39.70

2.4

2.3

8.28

7.98

ug/l

0.17

2231

16801

Other diseases of the respiratory system

1279

8766

1.53

39.63

2.9

2.4

8.07

7.05

ug/l

0.96

1095

7538

Other respiratory disorders and diseases

1279

8766

1.53

39.63

2.9

2.4

8.07

7.05

ug/l

0.96

1095

7538

Acetic acid derivatives and related substances

1394

4875

1.52

39.61

2.4

2.3

6.72

9.89

ug/l

5.37

1166

4265

Decubitus ulcer and pressure area

453

2392

2.07

39.53

3.0

2.4

9.79

7.13

ug/l

1.43

362

2067

Other pleural conditions

694

4171

1.78

38.93

2.9

2.4

6.11

7.02

ug/l

0.95

600

3614

Xerosis cutis

160

545

3.53

38.68

2.9

2.5

9.09

7.00

ug/l

0.26

145

481

Other diseases of arteries and capillaries

541

3027

1.91

38.60

2.8

2.3

6.91

6.96

ug/l

0.03

471

2629

Parkinson's disease, strict definition, excluding more controls

693

3853

1.76

38.55

2.3

2.2

6.34

8.92

ug/l

3.78

537

3424

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

670

3942

1.75

38.53

2.3

2.2

3.84

5.63

ug/l

2.95

577

3422

Intestinal adhesions without obstruction

533

2973

1.92

38.52

2.7

2.3

4.70

7.90

ug/l

7.72

454

2609

Neoplasms

3317

13597

1.30

38.36

2.3

7.71

8.32

ug/l

0.62

2909

12089

Hypothyreosis and Thyroxine purchase for inclusion criteria

4585

24496

1.24

38.36

2.4

2.3

6.68

7.22

ug/l

0.79

3952

21381

Diplopia

743

4543

1.72

38.27

3.0

2.3

7.03

7.45

ug/l

0.19

657

3992

Mixed hyperlipidaemia

277

1234

2.49

37.89

3.0

2.2

7.31

7.90

ug/l

0.16

247

1104

Septal defects

305

1371

2.33

37.62

2.3

15.50

7.63

ug/l

4.75

271

1219

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

583

3363

1.85

37.59

2.9

2.4

8.27

7.32

ug/l

0.39

522

2977

Ulcer of oesophagus

464

2511

2.01

37.52

3.2

2.3

5.56

7.75

ug/l

1.24

424

2212

Schizophrenia, schizotypal and delusional disorders

1418

9957

1.46

37.38

2.6

2.3

6.53

7.96

ug/l

1.25

1203

8784

Asthma and allergy, excluding more controls

408

2045

2.03

37.37

2.3

1.8

5.75

6.15

ug/l

0.17

360

1816

Hypertensive Renal Disease

262

1147

2.53

37.20

2.5

2.2

6.70

7.61

ug/l

0.30

223

965

Arterial embolism and thrombosis

398

2055

2.11

36.87

3.6

2.4

9.14

7.13

ug/l

0.83

349

1764

Disorders of skin appendages

2218

16671

1.35

36.81

2.3

7.03

7.50

ug/l

0.37

1957

14700

Dementia in Alzheimer disease

1294

7516

1.51

36.77

2.7

2.5

5.27

6.29

ug/l

1.29

890

6387

Schizophrenia or delusion

1407

9897

1.46

36.75

2.6

2.3

6.22

8.00

ug/l

2.06

1198

8735

Other arthritis (FG)

1510

10769

1.44

36.64

2.4

2.3

7.81

7.96

ug/l

0.07

1327

9483

Seborrhoeic keratosis

1438

10217

1.46

36.43

2.5

2.4

7.03

7.19

ug/l

0.09

1297

8882

Adhesive capsulitis of shoulder

863

5526

1.63

36.35

2.5

2.2

5.34

8.33

ug/l

7.18

771

4841

Diabetic retinopathy

2103

9784

1.39

36.20

2.8

2.6

6.90

7.35

ug/l

0.41

1829

8617

Diagnoses used for exclusion with ILD

1452

10354

1.45

35.95

2.8

2.4

9.05

7.30

ug/l

1.18

1260

8985

Other viral diseases

1206

8242

1.50

35.85

2.6

2.3

8.90

7.70

ug/l

0.68

1057

7288

Abnormal findings on examination of blood, without diagnosis

2684

18947

1.31

35.60

2.6

2.4

7.88

7.83

ug/l

0.04

2424

16618

Enlarged lymph nodes

721

4434

1.69

35.49

2.3

2.0

6.39

8.88

ug/l

2.06

629

3918

Exposure to unspecified factor

5130

29016

1.22

35.44

2.5

2.3

8.54

7.13

ug/l

2.80

4362

25519

Insulin, fast-acting (human)

649

3890

1.74

35.42

2.7

2.2

7.37

7.90

ug/l

0.30

575

3407

Superficial injury of hip and thigh

913

5969

1.60

35.34

2.7

2.4

6.37

7.03

ug/l

0.45

769

5095

Lesion of ulnar nerve

740

4609

1.68

35.20

2.6

2.3

7.85

8.52

ug/l

0.25

663

4129

Fibromyalgia

380

1936

2.05

35.19

2.3

2.0

4.12

6.48

ug/l

2.12

321

1687

Post-traumatic stress disorder

287

1313

2.27

34.98

2.3

1.9

5.14

6.58

ug/l

0.99

248

1171

Hydrocephalus

487

2732

1.92

34.93

2.5

2.4

4.85

7.00

ug/l

2.65

413

2335

Superficial injury of abdomen, lower back and pelvis

798

5073

1.64

34.56

2.6

2.3

5.44

7.40

ug/l

2.37

691

4458

Other noninfective gastroenteritis and colitis

1240

8633

1.48

34.49

2.7

2.3

6.08

7.23

ug/l

1.42

1057

7467

Urticaria and erythema

1586

11507

1.41

34.49

2.6

2.3

5.46

7.27

ug/l

4.34

1349

10071

Dissociative [conversion] disorders

175

647

2.90

34.46

2.9

2.1

3.73

6.33

ug/l

1.27

146

576

Other viral diseases, not elsewhere classified

828

5287

1.62

34.40

2.7

2.3

9.08

7.63

ug/l

0.66

724

4678

Viral pneumonia (unknown virus, not influenza)

385

2004

2.06

34.37

3.1

2.3

11.30

7.31

ug/l

1.54

334

1792

Propionic acid derivatives

1423

4997

1.47

34.29

2.4

2.3

5.95

9.88

ug/l

12.51

1230

4364

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

570

2860

1.77

34.25

2.0

5.56

7.66

ug/l

1.19

498

2520

COPD, hospital admissions 3, with asthma pneumonia sepsis

1741

11039

1.40

34.08

3.1

2.4

6.47

7.47

ug/l

1.55

1449

9575

Unspecified misadventure during surgical and medical care

362

1861

2.12

34.05

3.0

2.4

5.48

7.29

ug/l

2.09

326

1668

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

291

1361

2.25

34.03

2.3

2.1

6.30

8.28

ug/l

1.01

262

1228

Toxic effects of substances chiefly nonmedicinal as to source

554

3224

1.80

34.00

2.8

2.3

5.98

8.08

ug/l

2.50

498

2896

severe traumatic brain injury, does not include concussion

1380

9867

1.45

33.96

2.5

6.48

7.33

ug/l

1.14

1174

8506

Failure and rejection of transplanted organs and tissues

109

315

4.10

33.92

5.9

2.4

27.62

7.00

ug/l

2.64

101

285

Type of accident

1470

10598

1.43

33.69

2.5

2.4

6.58

7.60

ug/l

1.21

1205

9287

Diseases of inner ear

2927

22242

1.29

33.53

2.5

2.4

6.07

7.14

ug/l

1.81

2486

19440

Zoster [herpes zoster]

1073

7344

1.52

33.41

2.8

2.4

6.85

6.95

ug/l

0.06

917

6328

Inflammatory diseases of female pelvic organs

2456

12955

1.32

33.29

2.3

2.2

4.57

5.86

ug/l

3.54

2061

11153

Diseases of salivary glands

1574

11496

1.41

33.27

2.4

2.3

6.58

7.40

ug/l

0.68

1354

10084

Other viral diseases, including avohilmo

1507

10785

1.41

33.27

2.5

2.2

8.43

7.81

ug/l

0.36

1320

9528

Brachial plexus disorders

400

2118

1.98

33.25

2.4

2.1

4.52

7.64

ug/l

2.41

360

1909

Idiopathic gout

646

3985

1.74

33.13

3.0

2.4

6.67

8.05

ug/l

0.58

561

3520

1472

9975

1.44

33.08

2.7

2.5

4.84

6.43

ug/l

5.62

1194

8407

Dementia, including avohilmo

2907

15719

1.30

32.96

2.5

5.75

6.90

ug/l

3.08

2259

13801

Disorders of other endocrine glands

2126

15982

1.34

32.95

2.8

2.3

6.69

7.09

ug/l

0.33

1801

13828

Congenital aortic valve stenosis

8.72

32.90

2.5

2.4

17.06

10.17

ug/l

0.81

KRA_PSY_EATING, excluding more controls

224

937

2.44

32.71

2.1

1.8

4.96

5.93

ug/l

0.33

190

823

Generalized anxiety disorder

559

3269

1.75

32.64

2.2

2.1

8.32

7.50

ug/l

0.17

453

2920

Abdominal aortic aneurysm (AAA)

662

4071

1.71

32.62

3.0

2.4

7.44

6.77

ug/l

0.42

574

3458

Panniculitis affecting regions of neck and back

215

911

2.58

32.58

2.7

2.1

5.69

7.77

ug/l

1.02

197

820

Disorders of sclera, cornea, iris and ciliary body

2715

21447

1.29

32.55

2.5

2.3

6.41

7.51

ug/l

1.68

2402

18815

Gastrojejunal ulcer

111

335

3.97

32.53

3.0

2.4

4.44

8.93

ug/l

1.88

106

296

Other viral diseases, not elsewhere classified, including avohilmo

1092

7453

1.49

32.27

2.6

2.3

8.56

7.55

ug/l

0.54

954

6575

Bacterial pneumonia (organism specified)

2485

17600

1.31

32.14

2.7

2.3

7.66

7.30

ug/l

0.34

2155

15172

Amputation of foot

216

940

2.65

32.11

2.9

2.6

5.83

7.53

ug/l

1.20

194

849

Asthma and allergy

408

2156

1.92

32.00

2.3

1.9

5.75

6.99

ug/l

0.68

360

1918

Osteomyelitis

412

2258

1.97

31.92

2.9

2.3

7.98

8.09

ug/l

0.04

358

2020

598

3605

1.72

31.82

2.3

2.1

16.79

7.01

ug/l

4.91

532

3180

Menorrhagia

1325

5182

1.46

31.81

2.3

4.82

6.41

ug/l

3.15

1072

4447

Sub-endpoint used in defining T1D endpoints

1438

10254

1.42

31.73

2.7

2.3

7.12

7.56

ug/l

0.35

1275

8828

Acute peritonitis

401

2186

1.98

31.59

3.2

2.4

7.45

7.52

ug/l

0.02

366

1932

Other infectious diseases, including avohilmo

534

3157

1.80

31.58

3.8

2.4

6.61

7.24

ug/l

0.36

487

2755

Use of pramipexole

1224

8681

1.47

31.52

2.6

2.4

5.43

7.18

ug/l

3.13

1029

7537

Other extrapyramidal and movement disorders in other diseases

1339

9640

1.44

31.40

2.6

2.4

5.27

7.18

ug/l

5.65

1128

8433

Umbilical hernia

1404

10177

1.42

31.38

2.6

2.3

5.89

8.81

ug/l

9.54

1265

9058

Acute posthaemorrhagic anaemia

255

1192

2.38

31.29

3.3

2.5

9.63

6.94

ug/l

0.52

212

1029

Urticaria

1246

8831

1.45

31.15

2.6

2.3

5.28

7.26

ug/l

3.99

1058

7762

Coarctation of the aorta

188

4.92

31.04

2.4

2.2

15.42

9.88

ug/l

1.33

175

Benign paroxysmal vertigo

1580

11704

1.39

30.99

2.6

2.4

5.86

6.94

ug/l

0.96

1336

10159

Fracture of skull and facial bones

1045

7195

1.50

30.98

2.7

2.3

8.06

8.18

ug/l

0.05

891

6373

Any dementia, excluding more controls

2259

12013

1.33

30.96

2.6

2.4

5.97

6.94

ug/l

1.63

1726

10563

Dementia

2726

14781

1.30

30.90

2.5

5.86

6.92

ug/l

2.31

2107

12941

Ovarian cyst

1289

5174

1.45

30.89

2.3

2.2

4.39

6.42

ug/l

4.85

1078

4467

Irregular menses

1608

8863

1.38

30.85

2.1

5.48

5.99

ug/l

0.40

1374

7737

Status epilepticus

225

999

2.46

30.81

2.9

2.3

7.92

8.06

ug/l

0.02

192

890

Persistent mood disorders

889

5932

1.55

30.80

2.8

2.3

6.78

7.44

ug/l

0.27

732

5203

ICD-8 DM (Sub-endpoint used for defining DM endpoints)

196

816

2.60

30.71

2.7

2.1

11.41

8.27

ug/l

0.65

178

754

Other problems related to primary support group, including family circumstances

397

2085

1.92

30.61

2.6

2.2

4.66

6.78

ug/l

2.84

341

1842

Other symptoms and signs involving general sensations and perceptions

261

1237

2.30

30.49

2.9

2.3

6.57

7.43

ug/l

0.25

221

1068

Congenital malformations of pulmonary and tricuspid valves

100

6.60

30.31

2.0

2.8

30.76

6.97

ug/l

2.64

Extrapyramidal and movement disorders

2149

16677

1.32

30.30

2.7

2.4

5.47

7.16

ug/l

7.10

1780

14544

Diseases of peritoneum

571

3477

1.74

30.17

3.0

2.4

6.70

7.17

ug/l

0.18

505

3045

Secondary parkinsonism, excluding more controls

163

630

2.87

30.16

3.1

2.2

5.08

8.15

ug/l

2.02

132

573

Embolic stroke with flimmer

191

801

2.67

30.11

2.6

2.3

7.00

5.80

ug/l

0.42

164

666

Viral pneumonia (known virus, not influenza)

207

909

2.56

29.68

3.3

2.4

6.42

7.20

ug/l

0.30

186

799

Other disorders of eyelid

2496

18648

1.29

29.58

2.6

2.4

5.53

7.10

ug/l

4.89

2125

16232

Adverse effects, not elsewhere classified

827

5479

1.56

29.53

2.6

2.3

4.67

7.24

ug/l

6.78

714

4804

Retinal vascular occlusion

761

5000

1.61

29.49

2.8

2.4

6.61

7.00

ug/l

0.18

656

4296

Reimbursement for rheumatic diseases

2766

22016

1.27

29.44

2.3

6.85

7.08

ug/l

0.17

2415

19207

Other local infections of skin and subcutaneous tissue

554

3363

1.73

29.40

2.8

2.3

6.08

7.65

ug/l

1.53

483

2987

Other infectious diseases

457

2645

1.84

29.35

4.1

2.4

7.01

7.41

ug/l

0.18

415

2312

Mental and behavioural disorders due to sedatives or hypnotics

328

1702

2.04

29.34

2.5

2.2

6.31

8.24

ug/l

1.16

272

1538

Other pulmonary heart/vessel disease

322

1684

2.10

29.24

2.7

2.5

17.97

6.93

ug/l

3.43

283

1458

Benign neoplasm: Rectum

1057

7419

1.49

29.17

2.5

2.4

5.53

7.69

ug/l

3.96

917

6509

Retinal vascular disorders

770

5086

1.60

29.08

2.7

2.4

6.59

6.95

ug/l

0.17

665

4370

Pain and other conditions associated with female genital organs and menstrual cycle

645

3352

1.64

29.04

1.8

2.1

4.96

6.82

ug/l

1.19

529

2944

Rheumatism, unspecified

607

3773

1.67

28.95

2.4

2.2

4.61

6.99

ug/l

3.14

511

3276

Vitreous haemorrhage

584

3617

1.71

28.95

2.8

2.4

6.28

7.95

ug/l

2.08

525

3183

Speech and linguistic disorders, excluding more controls

275

1247

2.14

28.90

2.3

2.1

7.09

7.39

ug/l

0.09

239

1096

Other specified and unspecified personality disorders

381

2081

1.92

28.88

2.5

2.2

5.31

8.26

ug/l

3.54

318

1886

Focal brain injury

334

1756

2.01

28.70

2.6

2.2

6.90

8.94

ug/l

1.32

285

1579

Mental and behavioural disorders due to opioids

168

670

2.68

28.56

5.3

2.2

11.95

8.99

ug/l

0.39

149

607

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

316

1633

2.04

28.55

2.8

2.2

4.52

7.52

ug/l

4.28

269

1465

Other benign neoplasms of skin

1957

15115

1.33

28.51

2.5

2.4

6.65

7.13

ug/l

0.33

1663

13135

Disorders resulting from impaired renal tubular function

243

1158

2.32

28.45

2.3

2.5

6.06

7.68

ug/l

1.26

220

1047

Other other unspecified disorders of the circulatory system

240

1137

2.33

28.45

3.2

2.3

12.32

7.38

ug/l

2.00

221

1003

Lung diseases due to external agents

848

5731

1.55

28.43

2.9

2.4

8.63

7.19

ug/l

0.63

709

4951

Benign neoplasm: Rectum, anus and anal canal

1168

8382

1.45

28.34

2.5

2.4

5.67

7.48

ug/l

3.20

1013

7346

Trigger finger

695

4484

1.61

28.31

2.5

2.1

6.51

8.23

ug/l

1.33

616

3950

Other condition

706

4578

1.60

28.24

2.6

2.3

7.15

7.73

ug/l

0.29

623

4073

Other and unspecified tonsillitis

1181

6970

1.43

28.13

2.1

2.0

7.97

8.87

ug/l

0.41

1034

6312

2521

18106

1.29

28.09

2.6

2.5

6.18

6.92

ug/l

1.06

2178

15523

Abnormalities of gait and mobility

713

4664

1.61

28.04

2.5

2.3

6.06

7.29

ug/l

1.62

625

4063

Cerebral cysts

285

1432

2.12

28.03

2.7

2.3

13.96

7.51

ug/l

1.67

257

1274

Enthesopathies of lower limb, excluding foot

984

6820

1.48

28.00

2.3

2.1

6.36

8.89

ug/l

2.84

839

6053

Other and unspecified local infections of skin and subcutaneous tissue

520

3146

1.74

28.00

2.8

2.3

6.20

7.43

ug/l

1.06

460

2789

Chronic pancreatitis

700

4558

1.61

27.98

2.9

2.3

4.79

8.81

ug/l

12.38

615

4053

Disease of hard tissues of teeth, NOS

2761

11514

1.28

27.97

2.4

2.3

6.94

7.71

ug/l

1.17

2439

10016

Benign neoplasm: Caecum

660

4260

1.64

27.84

2.8

2.4

5.94

7.25

ug/l

1.58

586

3749

Other diseases of lip and oral mucosa

2017

15671

1.32

27.83

2.3

6.68

7.45

ug/l

0.58

1757

13805

Phobic anxiety disorders

437

2498

1.79

27.67

2.4

2.0

5.36

7.66

ug/l

1.65

381

2234

Open wound of lower leg

804

5389

1.55

27.66

2.8

2.3

6.45

7.54

ug/l

0.91

680

4711

Amputation of ankle bones

177

753

2.69

27.60

3.1

2.6

5.50

7.21

ug/l

1.19

164

667

ILD, hospital admission 2, with pulmonary infections

584

3661

1.68

27.57

2.9

2.3

11.17

7.51

ug/l

3.27

513

3203

Dislocation, sprain and strain of joints and ligaments at neck level

613

3865

1.64

27.29

2.4

2.3

5.19

7.31

ug/l

2.82

542

3458

Other disorders of glucose regulation and pancreatic internal secretion

450

2639

1.80

27.26

2.7

2.4

5.45

7.33

ug/l

2.03

396

2305

Diseases of liver

1775

13616

1.34

27.23

2.6

2.3

8.24

7.81

ug/l

0.27

1546

12044

Primary gonarthrosis, bilateral

2890

19634

1.26

27.19

2.4

5.83

7.71

ug/l

4.80

2447

17160

Chronic rhinitis, nasopharyngitis and pharyngitis

1427

10586

1.38

27.15

2.2

5.99

7.76

ug/l

3.73

1230

9373

Combinations of oral blood glucose lowering drugs

1531

11529

1.37

27.11

2.6

2.3

6.16

8.61

ug/l

6.85

1381

10232

Diseases of external ear

1804

13874

1.33

27.08

2.4

6.20

7.49

ug/l

2.36

1399

12241

Atrial septal defect, secundum type

145

554

2.85

27.07

1.8

2.4

16.15

6.84

ug/l

2.94

125

489

Dermatophytosis, including avohilmo

3171

25469

1.24

26.99

2.5

2.3

7.70

7.51

ug/l

0.13

2750

22550

Transient global amnesia

542

3363

1.71

26.99

2.5

2.4

5.66

7.05

ug/l

1.41

483

2970

Alzheimer’s disease (Atypical or mixed)

791

5280

1.56

26.94

2.7

2.6

5.08

5.91

ug/l

0.96

600

4383

Injuries to the elbow and forearm

3424

24202

1.23

26.91

2.5

2.3

6.95

7.18

ug/l

0.22

2903

21166

Other ill-defined and unspecified causes of mortality

609

3894

1.66

26.91

3.2

2.4

5.59

7.24

ug/l

1.53

529

3350

Chondrocostal junction syndrome [Tietze]

220

1025

2.34

26.87

3.4

2.4

5.59

7.07

ug/l

0.63

191

907

Coagulation defects, purpura and other haemorrhagic conditions

971

6790

1.48

26.80

2.6

2.3

8.72

7.25

ug/l

1.09

847

5934

Varicose veins

3234

20033

1.24

26.79

2.5

2.3

5.44

7.13

ug/l

6.18

2777

17461

Conjunctivitis (acute, non atopic)

1247

9043

1.41

26.73

2.6

2.3

5.54

7.43

ug/l

2.79

1084

7993

Disorders of calcium metabolism

355

1960

1.93

26.58

2.7

2.1

4.99

7.12

ug/l

2.95

304

1725

Other specified/unspecified arthritis

1260

9209

1.40

26.57

2.4

2.3

8.50

8.24

ug/l

0.10

1100

8136

Acidosis

153

616

2.81

26.56

3.6

2.3

10.73

7.32

ug/l

0.47

132

556

Voice disturbances

1305

9623

1.40

26.29

2.4

2.3

5.84

7.10

ug/l

1.50

1128

8429

Early lumbar disc prolapse, operated

324

1724

1.94

26.27

1.9

5.56

11.06

ug/l

4.00

298

1575

COPD, hospital admissions 1, only main diagnosis

2041

13758

1.31

26.25

2.9

2.4

6.91

7.46

ug/l

0.57

1719

11966

Other diseases of pancreas

492

2999

1.74

26.16

2.4

2.3

5.17

8.13

ug/l

5.87

437

2665

Osteoporosis with pathological fracture (FG)

447

2662

1.79

26.05

3.0

2.5

5.95

6.36

ug/l

0.18

352

2208

Skin changes due to chronic exposure to nonionizing radiation

2399

17421

1.28

25.80

2.6

2.5

6.06

6.87

ug/l

1.16

2077

14929

Chronic periodontitis, complicated

2919

23283

1.24

25.62

2.5

2.3

8.42

7.61

ug/l

0.86

2578

20655

Actinic keratosis

2347

17106

1.28

25.55

2.6

2.5

6.14

6.88

ug/l

0.99

2030

14646

Excessive earwax

3377

25388

1.23

25.51

2.5

2.4

5.41

7.61

ug/l

17.39

2883

22337

Lateral epicondylitis

576

3644

1.64

25.49

2.2

2.1

6.83

8.84

ug/l

0.66

511

3265

Other bursopathies

678

4469

1.58

25.36

2.6

2.2

7.68

8.15

ug/l

0.13

580

3904

Anti-inflammatory and antirheumatic products, non-steroids

1359

4997

1.40

25.30

2.5

2.3

6.17

9.88

ug/l

11.38

1186

4364

Secondary right heart disease

286

1512

2.07

25.23

2.8

2.5

18.58

6.99

ug/l

3.29

253

1307

Contact with and exposure to communicable diseases

410

6861

0.58

25.18

1.9

2.1

11.73

7.25

ug/l

1.30

344

6105

Pneumonitis due to solids and liquids

523

3270

1.69

25.16

2.9

2.4

8.59

7.27

ug/l

0.32

419

2821

Hypotension due to drugs

130

504

3.05

24.97

3.8

2.7

8.38

7.01

ug/l

0.26

110

445

Benign neoplasm: Descending colon

438

2632

1.78

24.91

3.0

2.4

6.60

7.53

ug/l

0.35

391

2342

Disturbance of activity and attention

319

1671

1.90

24.81

1.8

2.0

3.72

6.97

ug/l

5.59

275

1454

Cerebral palsy and other paralytic syndromes

557

3540

1.64

24.52

2.7

2.4

6.59

7.46

ug/l

0.60

472

3103

Moderate visual impairment, binocular

219

1064

2.28

24.48

2.4

2.6

7.28

5.85

ug/l

0.22

124

888

Fissure and fistula of anal and rectal regions

1108

8043

1.41

24.45

2.3

2.2

6.91

8.37

ug/l

1.00

928

7147

Other disorders of eye and adnexa

646

4241

1.58

24.40

2.7

2.3

5.83

7.00

ug/l

0.62

544

3741

Keratitis

1700

13147

1.32

24.38

2.6

2.3

6.99

7.62

ug/l

0.43

1492

11542

Fracture of shoulder and upper arm

1852

14470

1.31

24.35

2.4

8.27

7.31

ug/l

0.61

1531

12495

Other diseases of oesophagus

536

3390

1.66

24.35

2.6

2.3

8.67

7.79

ug/l

0.29

446

2957

Coxarthrosis, primary, with hip surgery

2693

20402

1.25

24.35

2.5

2.4

6.11

7.19

ug/l

2.50

2347

17717

Anaemia in chronic diseases classified elsewhere

179

807

2.50

24.34

2.5

2.4

9.32

7.16

ug/l

0.42

159

712

Acute suppurative otitis media

845

5424

1.48

24.26

2.3

2.2

7.43

7.86

ug/l

0.14

731

4827

Hyperkinetic disorders

338

1815

1.85

24.23

1.9

2.0

3.95

6.63

ug/l

4.27

292

1582

Transport accidents

2071

13607

1.29

24.20

2.4

2.2

7.66

7.70

ug/l

0.02

1798

12234

Hypoglycaemia, other or unspecified

363

2075

1.85

24.19

2.7

2.4

5.22

7.27

ug/l

3.01

320

1828

Seropositive rheumatoid arthritis

1218

8950

1.39

24.19

2.3

6.67

7.25

ug/l

0.33

1058

7768

Hallux rigidus

717

4833

1.54

24.18

2.4

2.3

5.97

8.22

ug/l

2.47

601

4226

Other and unspecified disorders of vitreous body

2184

17069

1.28

24.13

2.5

2.3

5.92

7.35

ug/l

2.01

1944

15017

Stomatitis and related lesions

908

6394

1.46

24.01

2.5

2.4

5.18

7.33

ug/l

4.63

774

5625

Polyuria

1245

9267

1.39

23.95

2.8

2.4

6.14

7.52

ug/l

2.04

1043

8200

Arterial embolism and thrombosis of lower extremity artery

241

1224

2.16

23.78

3.2

2.5

9.99

6.73

ug/l

1.04

209

1054

Disorders of mineral metabolism

437

2639

1.74

23.77

2.6

2.2

5.04

7.26

ug/l

3.29

370

2333

Elevated blood glucose level

449

2734

1.73

23.76

2.6

2.4

8.43

7.35

ug/l

0.33

391

2430

Sulfasalazine

1263

9399

1.37

23.74

2.4

2.2

6.88

7.33

ug/l

0.24

1133

8257

Postmenopausal bleeding

1219

4653

1.41

23.68

2.6

2.3

4.96

6.63

ug/l

2.67

1000

4007

Superficial injury of thorax

782

5384

1.51

23.60

2.8

2.3

6.85

7.67

ug/l

0.44

681

4714

Tubulo-interstitial nephritis, not specified as acute or chronic

371

2149

1.82

23.60

2.9

2.4

6.28

6.58

ug/l

0.12

319

1848

Central retinal artery occlusion

174

789

2.50

23.51

2.6

4.89

6.73

ug/l

1.13

152

682

Visual field defects

469

2904

1.71

23.38

2.5

2.4

5.59

7.18

ug/l

1.82

403

2558

Special screening examination for neoplasms

303

1651

1.92

23.32

2.4

2.1

6.53

9.65

ug/l

2.55

258

1474

Use of disulfiram, acamprosate or naltrexone

426

2569

1.74

23.29

2.8

2.3

9.93

9.50

ug/l

0.06

384

2356

Excessive attrition of teeth

2625

21210

1.24

23.26

2.3

2.2

6.61

7.75

ug/l

1.74

2334

18847

Covid-19 suspected case

844

5892

1.47

23.15

3.3

2.2

5.53

7.19

ug/l

2.40

728

5223

Disorders of parathyroid gland

1141

8331

1.40

23.05

2.7

2.4

6.20

6.41

ug/l

0.13

945

7056

Shock, not elsewhere classified

277

3.70

22.91

2.7

2.2

16.52

7.50

ug/l

1.40

243

Noninfectious colitis NAS

657

4393

1.55

22.89

2.7

2.3

5.32

7.13

ug/l

3.04

556

3853

Appendectomy

2804

21962

1.23

22.86

2.4

2.2

5.97

7.70

ug/l

3.60

2497

19380

Injuries to the wrist and hand

4893

27909

1.17

22.80

2.4

2.3

7.50

7.40

ug/l

0.09

4296

24542

Diabetic retinopathy, strict definition

957

6122

1.45

22.66

2.8

2.6

6.90

7.97

ug/l

0.90

826

5392

Polymyalgia rheumatica

827

5829

1.49

22.61

2.6

2.5

5.83

6.79

ug/l

0.99

692

4962

Monoamine oxidase A inhibitors

547

3533

1.61

22.42

2.5

2.2

5.48

8.25

ug/l

4.55

464

3185

Normal-pressure hydrocephalus

338

1959

1.88

22.38

2.6

2.5

4.60

6.44

ug/l

2.16

288

1675

Other malignant neoplasms of skin (=non-melanoma skin cancer), including Hilmo

2735

15157

1.24

22.36

2.4

7.13

7.72

ug/l

0.62

2362

13289

Injury of muscle and tendon at shoulder and upper arm level

1880

14917

1.29

22.34

2.5

2.4

6.55

8.26

ug/l

2.59

1717

13305

Certain disorders involving the immune mechanism

888

6324

1.45

22.26

2.6

2.4

8.45

7.58

ug/l

0.35

797

5604

Ill-defined and unknown causes of mortality

635

4278

1.57

22.08

3.2

2.4

5.72

7.25

ug/l

1.37

553

3685

Assault

505

3202

1.62

22.05

2.5

2.2

8.32

8.74

ug/l

0.09

440

2911

Other necrotizing vasculopathies (FG)

342

1983

1.84

21.97

2.8

2.4

4.99

7.63

ug/l

4.17

288

1742

Ascites

404

2445

1.74

21.97

2.8

2.2

7.34

8.93

ug/l

0.84

366

2171

Ocular pain

392

2346

1.75

21.94

2.9

2.3

3.32

6.99

ug/l

13.19

332

2089

Respiratory insufficiency

450

2795

1.68

21.73

2.9

2.2

9.67

7.41

ug/l

1.54

375

2450

Somnolence, stupor and coma

242

1265

2.05

21.62

3.0

2.3

9.36

7.74

ug/l

0.27

219

1117

Seborrhoeic dermatitis

530

3437

1.61

21.60

2.6

2.3

6.02

8.23

ug/l

2.15

472

3071

Abnormal results of function studies

434

2681

1.69

21.59

2.7

2.4

8.72

7.26

ug/l

0.51

379

2396

Eating disorders

325

1839

1.82

21.57

2.4

2.3

6.87

6.38

ug/l

0.07

284

1605

Wet age-related macular degeneration

1138

8206

1.39

21.54

2.7

2.5

5.59

6.27

ug/l

0.82

922

6879

Injuries to the ankle and foot

3136

22371

1.21

21.53

2.5

2.2

7.13

7.73

ug/l

0.70

2731

19818

Other congenital malformations of the digestive system

208

1023

2.15

21.40

2.9

2.4

6.23

7.51

ug/l

0.45

186

907

Cardiomyopathy in other diseases

133

5.07

21.39

3.0

2.1

5.08

5.06

ug/l

0.01

115

Amenorrhoea

188

888

2.18

21.31

2.1

2.4

4.88

6.78

ug/l

1.08

165

769

Obsessive-compulsive disorder

214

1069

2.07

20.95

1.9

2.0

5.28

7.53

ug/l

1.66

182

947

Childhood asthma (age<16), excluding more controls

268

1108

1.92

20.89

1.8

1.6

8.25

5.60

ug/l

1.05

229

971

Disorders of psychological development

360

1958

1.75

20.88

2.3

6.73

6.77

ug/l

0.01

309

1712

Use of other anti-dementia drugs

1825

11703

1.29

20.83

2.5

2.6

5.03

6.29

ug/l

3.76

1340

9935

Use of memantine

1825

11703

1.29

20.83

2.5

2.6

5.03

6.29

ug/l

3.76

1340

9935

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

1403

10812

1.33

20.80

2.4

2.3

7.20

8.16

ug/l

0.60

1244

9553

Malignant neoplasm of skin, including Hilmo

2908

16205

1.22

20.73

2.4

7.38

7.87

ug/l

0.49

2518

14247

Other abnormal uterine and vaginal bleeding

931

4811

1.42

20.66

2.4

2.3

6.05

6.40

ug/l

0.17

676

4126

Tobacco use

275

1520

1.92

20.61

2.7

2.3

6.73

8.46

ug/l

0.27

244

1381

Liquid cancers, including Hilmo

1978

14021

1.27

20.61

2.4

2.5

6.74

7.88

ug/l

1.21

1699

12254

Other/unspecified cytomegaloviral diseases

123

506

2.71

20.37

2.7

2.3

16.11

7.63

ug/l

1.18

110

458

COPD-related respiratory insufficiency

703

4904

1.50

20.36

2.7

2.4

9.51

7.29

ug/l

1.22

573

4276

Schizoaffective disorder

320

1855

1.80

20.11

2.9

2.2

5.18

7.85

ug/l

2.38

275

1683

Erythema intertrigo

169

804

2.32

20.03

2.9

2.4

6.16

7.60

ug/l

0.40

144

712

Basal cell carcinoma, including Hilmo

2647

14844

1.23

19.99

2.4

7.40

7.62

ug/l

0.17

2286

12999

Unspecific neurodegenerative disorder

2608

14791

1.23

19.98

2.4

2.5

5.76

6.57

ug/l

1.57

1998

12833

Superficial injury of wrist and hand

833

5964

1.43

19.92

2.5

2.3

6.25

7.56

ug/l

0.94

722

5263

Other embolism and thrombosis

669

4630

1.50

19.89

2.6

2.3

9.70

7.66

ug/l

0.57

579

4045

Any dementia

2451

13966

1.24

19.85

2.5

5.84

6.57

ug/l

1.18

1870

12106

Preterm labour and delivery

795

5646

1.44

19.76

2.4

2.1

4.56

6.18

ug/l

2.09

715

4937

Strabismus

1117

8372

1.36

19.76

2.4

2.3

6.56

7.34

ug/l

0.50

961

7325

Open wound of wrist and hand

2031

15888

1.25

19.66

2.4

2.3

7.94

8.25

ug/l

0.21

1798

14196

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

1394

10646

1.31

19.61

2.6

2.1

7.52

7.87

ug/l

0.17

1206

9426

Behavioural syndromes associated with physiological disturbances and physical factors

4401

25720

1.17

19.60

2.5

2.3

5.93

7.57

ug/l

6.60

3814

22619

Eating disorder

226

1178

1.97

19.42

2.1

2.2

4.93

5.64

ug/l

0.23

192

1026

Other specified/unspecified dorsopathies

180

881

2.19

19.34

2.6

2.1

4.05

7.74

ug/l

5.73

160

776

Budesonide

604

4105

1.52

19.34

2.5

2.1

6.25

7.30

ug/l

0.71

521

3622

Malignant neoplasm, including Hilmo

4079

20396

1.18

19.31

2.2

2.3

6.98

7.97

ug/l

1.95

3544

18010

Superficial injury of forearm

443

2820

1.63

19.29

2.9

2.3

7.86

7.02

ug/l

0.17

377

2507

Inflammatory bowel disease

1344

10397

1.32

19.29

2.6

2.3

6.84

8.01

ug/l

1.03

1190

9184

Rheumatoid arthritis, including avohilmo

1846

14861

1.27

19.27

2.4

6.39

7.04

ug/l

0.58

1598

12883

135

591

2.48

19.21

2.5

2.1

5.09

7.56

ug/l

0.85

130

542

Unspecified privation

523

3470

1.57

19.16

2.4

9.64

7.30

ug/l

1.29

466

3061

Duodenal ulcer

624

4299

1.51

19.16

2.7

2.3

6.24

7.48

ug/l

1.54

538

3741

Glucosamine medication

2589

17200

1.23

19.15

2.4

5.95

6.69

ug/l

1.36

2155

14866

Specific development disorders of scholastic skills

127

522

2.48

19.14

1.9

9.18

7.26

ug/l

0.39

112

456

Malignant neoplasm, wide definition

4085

20433

1.18

19.12

2.2

2.3

6.97

7.97

ug/l

1.97

3551

18042

Malignant neoplasm of skin

2780

15718

1.22

19.09

2.4

7.07

7.79

ug/l

0.87

2400

13805

Other malignant neoplasms of skin (=non-melanoma skin cancer)

2618

14774

1.23

19.01

2.4

6.93

7.62

ug/l

0.81

2250

12938

Methotrexate

628

4325

1.50

18.92

2.3

2.2

5.48

7.14

ug/l

2.34

555

3785

Other disorders starting during childhood or adolecense, excluding more controls

111

417

2.61

18.89

2.4

1.8

4.59

7.80

ug/l

1.65

101

361

Myositis

160

761

2.30

18.87

2.8

2.3

15.80

7.64

ug/l

3.21

149

683

Other specified/unspecified systemic involvement of connective tissue

274

1554

1.86

18.86

2.6

2.3

10.93

6.69

ug/l

0.73

236

1370

Other disorders of bone

826

5971

1.42

18.84

2.6

2.2

8.44

7.44

ug/l

0.36

694

5315

Diseases of tongue

309

1813

1.79

18.81

2.8

2.3

4.55

7.44

ug/l

3.13

261

1572

Other congenital malformations of the digestive system, including avohilmo

231

1232

1.96

18.78

2.8

2.4

6.59

7.51

ug/l

0.32

206

1092

Sequelae of other external causes

296

1720

1.82

18.78

2.7

2.4

7.75

7.57

ug/l

0.04

278

1535

Traumatic subarachnoid haemorrhage

206

1071

2.05

18.75

2.3

7.94

8.04

ug/l

0.02

176

963

Other hammer toe(s) (acquired)

871

5785

1.41

18.72

2.4

2.3

5.63

7.28

ug/l

1.91

696

4983

Hyperparathyroidism

996

7373

1.38

18.61

2.8

2.4

6.06

6.32

ug/l

0.16

828

6234

Unspecified visual impairment (binocular)

102

401

2.85

18.61

2.5

2.3

5.28

6.65

ug/l

0.41

356

Other and unspecified nonorganic psychotic disorders

687

4811

1.46

18.60

2.5

2.3

6.72

7.86

ug/l

0.48

577

4285

Calcific tendinitis of shoulder

268

1514

1.86

18.59

2.5

2.2

5.20

8.25

ug/l

2.54

249

1358

Embolic stroke

299

1755

1.82

18.58

2.5

6.96

7.11

ug/l

0.05

260

1518

Benign neoplasm: Skin of eyelid, including canthus

799

5786

1.43

18.49

2.6

2.4

6.90

7.42

ug/l

0.17

689

5033

ILD, hospital admissions 3, with pneumonia sepsis

494

3277

1.58

18.44

3.0

2.3

11.03

7.39

ug/l

2.68

428

2862

Pain associated with micturition

589

4035

1.51

18.41

2.9

2.3

3.74

7.07

ug/l

13.41

472

3551

conjunctival haemorrhage

429

2762

1.64

18.38

3.1

2.4

8.22

7.42

ug/l

0.23

373

2445

Other necrotizing vasculopathies

399

2527

1.67

18.37

2.9

2.4

5.35

7.11

ug/l

1.85

339

2229

Foreign body in alimentary tract

286

1659

1.83

18.35

3.1

2.4

4.79

7.48

ug/l

4.58

251

1491

Lesion of lateral popliteal nerve

268

1528

1.87

18.31

2.7

2.4

9.55

8.23

ug/l

0.24

246

1381

Speech disturbances, not elsewhere classified

516

3460

1.56

18.29

2.9

2.4

6.73

7.14

ug/l

0.15

416

3000

Pneumonia due to other infectious organisms, not elsewhere classified

190

972

2.11

18.28

2.5

2.2

7.05

7.93

ug/l

0.29

167

870

DVT of lower extremities

997

7485

1.37

18.24

2.5

2.4

6.69

7.49

ug/l

0.34

845

6507

Childhood asthma (age<16)

268

1160

1.83

18.19

1.8

1.6

8.25

6.49

ug/l

0.58

229

1021

Open wound of ankle and foot

496

3289

1.57

18.17

2.5

2.3

7.46

8.33

ug/l

0.43

446

2935

Hallux valgus (acquired)

1499

8426

1.30

18.16

2.4

2.2

5.52

7.54

ug/l

5.14

1273

7333

Other eating disorders

133

583

2.35

18.16

2.4

1.9

6.31

5.97

ug/l

0.06

110

511

Sulfonylureas

1989

12889

1.25

18.16

2.9

2.4

5.59

7.40

ug/l

5.77

1694

10994

Cytomegalovirus infection, IBD co-morbidity

136

616

2.43

18.12

2.6

2.4

15.52

7.43

ug/l

1.26

122

555

Peritonsillar abscess

793

5725

1.41

18.07

2.2

5.47

8.31

ug/l

8.01

711

5153

Olecranon bursitis

347

2131

1.72

18.05

2.6

2.2

8.40

9.80

ug/l

0.23

300

1920

Restless leg syndrome

686

4856

1.46

17.99

2.7

2.3

5.06

7.13

ug/l

4.22

586

4258

Disorders of ocular muscles, binocular movement, accommodation and refraction

1996

16143

1.24

17.99

2.3

6.97

7.40

ug/l

0.34

1738

14228

Ganglion

812

5894

1.41

17.93

2.2

2.1

5.34

8.04

ug/l

5.46

714

5204

Disorders of continuity of bone

439

2841

1.60

17.90

2.4

2.3

9.46

7.35

ug/l

0.39

375

2541

Inflammatory disease of uterus

433

2782

1.59

17.85

2.3

2.2

4.51

5.39

ug/l

0.51

365

2435

Discitis, unspecified

119

515

2.59

17.84

3.1

2.2

8.47

8.15

ug/l

0.06

104

456

Bruxism

330

2.92

17.83

2.7

2.2

3.29

6.22

ug/l

2.44

299

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

1397

9470

1.30

17.81

2.1

4.70

6.16

ug/l

2.88

1254

8253

Other metabolic disorders

518

3474

1.53

17.71

2.3

2.1

8.18

6.71

ug/l

0.67

451

3058

Hypertrophic disorders of skin

233

1279

1.90

17.64

2.4

2.2

12.14

7.14

ug/l

0.76

209

1142

Injuries to unspecified part of trunk, limb or body region

507

3403

1.55

17.63

2.9

2.4

9.44

7.37

ug/l

0.50

436

3012

Arthropod-borne viral fevers and viral haemorrhagic fevers, including avohilmo

832

6101

1.40

17.60

2.4

2.3

7.05

7.69

ug/l

0.35

770

5408

Ventricular septal defect, a heart condition

330

2.88

17.58

2.4

2.5

19.99

6.59

ug/l

3.74

288

Acute appendicitis, no complications

2309

19045

1.22

17.55

2.3

2.2

6.60

8.05

ug/l

2.06

2095

16928

Attention to artificial openings

242

1359

1.91

17.54

3.0

2.3

4.86

6.84

ug/l

1.63

206

1210

Endometriosis

1165

5141

1.34

17.53

2.1

2.2

5.47

6.36

ug/l

0.68

973

4440

Oesophagitis

300

1788

1.78

17.53

3.2

2.3

7.41

7.86

ug/l

0.13

269

1596

Alcohol-induced chronic pancreatitis

349

2167

1.71

17.48

3.2

2.3

5.32

9.49

ug/l

5.84

318

1991

Recurrent aphthous stomatitis , including avohilmo

650

4577

1.46

17.45

2.6

2.3

4.92

7.12

ug/l

4.56

562

4014

Retinal detachments and breaks

1884

15385

1.25

17.42

2.5

2.4

7.16

7.51

ug/l

0.26

1637

13477

Exclusion endpoint for clefts

310

2.94

17.42

2.3

2.4

12.90

8.41

ug/l

0.98

277

Haemorrhage in early pregnancy

802

5656

1.40

17.40

2.1

5.02

6.24

ug/l

0.89

706

4925

Other and unspecified epidermal thickening

148

703

2.28

17.39

3.0

2.4

4.87

7.76

ug/l

2.29

135

629

Cytomegaloviral disease, including avohilmo

139

646

2.35

17.37

2.6

2.4

15.18

7.41

ug/l

1.23

125

583

Acquired absence of limb

256

3.33

17.37

2.9

2.3

10.73

6.24

ug/l

0.40

219

Basal cell carcinoma

2541

14494

1.22

17.35

2.4

7.03

7.61

ug/l

0.62

2183

12673

Alcohol withdrawal state with delirium

379

2406

1.66

17.32

3.0

2.4

8.79

9.42

ug/l

0.13

331

2196

277

3.01

17.28

2.4

2.0

9.37

6.05

ug/l

0.31

250

Burns and corrosions

593

4111

1.49

17.27

2.4

2.3

5.43

8.42

ug/l

5.53

530

3696

Paralytic ileus

225

1243

1.94

17.22

3.2

2.3

5.07

7.87

ug/l

3.38

197

1113

Need for immunization against other single viral diseases

121

535

2.51

17.19

3.2

2.5

10.41

7.96

ug/l

0.29

101

488

Other disorders of patella

637

4473

1.46

17.09

2.4

2.2

7.06

8.73

ug/l

0.82

545

4020

Maltreatment syndromes

186

957

2.02

17.04

2.5

2.0

5.96

7.90

ug/l

0.68

167

863

Other/unspecified rheumatoid arthritis

637

4505

1.47

17.02

2.7

2.4

6.11

6.60

ug/l

0.31

532

3857

Otitis externa, unspecified

492

3299

1.54

17.01

2.5

2.3

6.25

7.80

ug/l

0.89

429

2964

Collagenous colitis

446

2939

1.58

16.98

2.7

2.3

6.63

6.90

ug/l

0.10

386

2599

Exclusions for E4_PCOS_CONSORTIUM

2846

14977

1.20

16.95

2.4

2.2

5.82

6.67

ug/l

1.45

2375

13034

Other sleep disorders

493

3312

1.54

16.87

2.6

2.2

5.70

8.62

ug/l

4.18

413

2947

Other disorders of kidney and ureter

689

4953

1.44

16.80

2.5

2.4

6.34

7.70

ug/l

1.51

614

4380

Cytomegaloviral disease

137

642

2.33

16.79

2.6

2.4

15.41

7.44

ug/l

1.24

123

579

Thyroiditis, ILD-related definition

458

3031

1.56

16.79

2.5

2.2

5.71

6.46

ug/l

0.35

411

2659

Other obstructive and reflux uropathy

200

1066

1.98

16.78

2.6

2.3

4.87

6.82

ug/l

2.15

169

931

Speech and linguistic disorders

278

1554

1.76

16.75

2.3

2.5

7.30

7.03

ug/l

0.08

242

1354

Pruritus

524

3573

1.52

16.71

2.8

2.3

5.22

6.89

ug/l

1.14

449

3098

Postprocedural disorders of nervous system

245

1385

1.83

16.71

2.3

2.0

3.64

7.22

ug/l

5.17

211

1237

Other specified/unspecified soft tissue disorders

254

1464

1.83

16.65

2.9

2.2

5.13

6.75

ug/l

1.08

223

1257

Malignant neoplasm

3986

20250

1.16

16.59

2.2

2.3

6.79

7.96

ug/l

2.56

3465

17882

Superficial injury of shoulder and upper arm

559

3871

1.49

16.49

2.4

2.3

5.18

7.66

ug/l

3.45

481

3408

Infarction of spleen

192

3.85

16.48

2.6

12.20

9.12

ug/l

0.37

172

Exposure to other and unspecified man-made environmental factors

107

454

2.57

16.47

2.3

5.11

7.23

ug/l

1.05

100

411

Outcome of delivery

104

1455

0.43

16.45

1.3

1.8

6.98

5.95

ug/l

0.30

1268

Malignant neoplasm

3982

20241

1.16

16.44

2.2

2.3

6.78

7.96

ug/l

2.55

3461

17876

Mixed and other personality disorders

294

1761

1.73

16.38

2.4

2.1

4.54

8.00

ug/l

4.38

246

1592

Injury of unspecified body region

387

2494

1.62

16.37

3.1

2.4

10.09

7.32

ug/l

0.53

330

2203

Tinnitus

1108

8564

1.32

16.34

2.4

2.3

5.40

7.88

ug/l

7.17

954

7583

Corneal ulcer

811

5991

1.39

16.31

2.7

2.3

5.92

7.74

ug/l

1.94

725

5307

Pregnancy hypertension

1203

8348

1.30

16.29

2.1

4.88

6.01

ug/l

1.59

1080

7291

Endometriosis of rectovaginal septum and vagina

309

1881

1.71

16.28

2.4

2.3

6.48

7.10

ug/l

0.13

261

1635

Purpura and other haemorrhagic conditions

653

4669

1.45

16.24

2.8

2.4

8.48

7.60

ug/l

0.42

578

4096

Car occupant injured in other and unspecified transport accidents

734

5336

1.41

16.19

2.6

2.3

6.95

7.31

ug/l

0.14

640

4724

Hypocalcemia

140

673

2.28

16.16

3.1

2.3

5.64

7.20

ug/l

0.67

125

603

Herpesviral [herpes simplex] infections, including avohilmo

976

7406

1.34

16.16

2.4

2.2

5.40

7.03

ug/l

1.48

840

6526

Unspecified urinary incontinence

448

2993

1.56

16.07

2.3

2.4

3.50

6.26

ug/l

8.78

292

2596

Mixed disorders of conduct and emotions, excluding more controls

142

3.72

16.06

1.9

1.5

3.74

8.28

ug/l

1.74

117

Sleep disorders

4162

25031

1.16

16.06

2.5

2.3

5.83

7.58

ug/l

7.08

3596

22006

Acute appendicitis

3048

24218

1.18

16.03

2.3

6.70

7.81

ug/l

1.86

2750

21404

Degenerative macular diseases

677

4899

1.44

15.99

2.7

2.4

5.56

6.92

ug/l

2.09

575

4180

Hyperhidrosis

125

569

2.31

15.94

2.4

1.9

4.01

7.83

ug/l

2.65

108

512

Labour and delivery complicated by umbilical cord complications

162

816

2.07

15.81

2.0

1.8

3.90

5.72

ug/l

1.51

150

720

Thyrotoxicosis, other and/or unspecified

842

6286

1.37

15.77

2.5

2.3

9.22

6.84

ug/l

1.34

713

5468

Otitis externa

1008

7726

1.33

15.74

2.4

2.3

5.88

7.53

ug/l

2.16

844

6842

Otalgia

357

2277

1.63

15.59

2.6

2.3

4.47

7.01

ug/l

3.73

306

2024

Metatarsalgia

398

2601

1.58

15.53

2.5

2.2

4.86

8.06

ug/l

4.77

357

2294

Appendicitis, broad definition

3263

25257

1.17

15.49

2.3

6.80

7.75

ug/l

1.47

2942

22300

Other and unspecified urticaria

754

5547

1.39

15.48

2.7

2.2

5.25

7.31

ug/l

2.48

636

4884

Agoraphobia

103

436

2.47

15.45

2.4

1.9

6.22

7.24

ug/l

0.14

392

Diseases of appendix

3294

25429

1.17

15.45

2.3

6.84

7.74

ug/l

1.38

2967

22446

SLE (Finngen)

164

843

2.07

15.44

2.6

2.2

6.76

6.31

ug/l

0.15

142

741

Other enthesopathy of foot (+metatarsalgia)

421

2791

1.55

15.35

2.5

2.2

4.76

8.11

ug/l

5.28

379

2461

Other specified disorders of muscle

161

827

2.09

15.35

2.8

2.3

11.52

8.18

ug/l

0.54

141

733

Viral warts, including avohilmo

856

6428

1.36

15.33

2.3

6.28

7.54

ug/l

1.03

771

5686

Solid cancers, including Hilmo

3989

20282

1.16

15.29

2.2

2.3

6.99

7.95

ug/l

1.82

3463

17917

Explicit fungal Sepsis

173

3.75

15.27

3.4

2.4

8.46

7.20

ug/l

0.14

155

Crohn disease

512

3534

1.49

15.27

2.5

2.2

6.98

8.03

ug/l

0.46

454

3183

Viral haemorrhagic fevers, not elsewhere classified/unspecified, including avohilmo

720

5286

1.40

15.20

2.4

2.3

7.01

7.45

ug/l

0.22

664

4687

Glaucoma

3069

22461

1.18

15.11

2.5

2.4

6.15

7.13

ug/l

1.73

2630

19471

Scoliosis

309

1914

1.66

15.09

2.2

2.1

12.94

7.26

ug/l

1.00

258

1658

Pre-eclampsia or eclampsia

633

4537

1.42

15.07

2.2

2.1

4.69

6.04

ug/l

1.50

564

3953

Other follicular disorders

311

1935

1.67

15.07

2.3

6.68

7.33

ug/l

0.25

270

1740

Cramp and spasm

229

1320

1.83

15.05

3.0

2.4

4.96

7.09

ug/l

1.25

193

1194

Phlebitis and thrombophlebitis (not including DVT)

1079

8406

1.31

15.04

2.5

2.4

7.83

7.49

ug/l

0.12

921

7363

Faecal incontinence

424

2837

1.55

14.99

2.2

6.16

7.17

ug/l

0.39

343

2441

Acute pharyngitis

499

3394

1.48

14.98

2.4

2.0

8.23

8.51

ug/l

0.07

424

3056

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

427

2874

1.56

14.97

3.1

2.4

6.42

6.79

ug/l

0.15

368

2467

Atrophic disorders of skin

671

4880

1.41

14.96

2.1

2.3

5.11

6.69

ug/l

1.77

591

4235

Cluster headache, strict

149

746

2.10

14.96

2.7

2.2

5.37

9.14

ug/l

1.41

127

681

Gout due to impairment of renal function

364

2.81

14.93

3.8

2.8

7.02

8.18

ug/l

0.22

325

Other diseases of biliary tract

469

3217

1.52

14.88

2.3

4.72

7.34

ug/l

4.92

404

2798

Effects of foreign body entering through natural orifice

1068

8314

1.31

14.87

2.8

2.3

6.39

8.56

ug/l

2.89

961

7447

Pre-eclampsia

576

4072

1.44

14.84

2.2

2.1

4.24

6.10

ug/l

3.10

513

3542

Benign neoplasm: Duodenum

166

880

2.07

14.83

3.1

2.6

6.08

7.13

ug/l

0.37

151

784

Acute and transient psychotic disorders

462

3146

1.51

14.83

2.5

2.3

8.83

8.11

ug/l

0.14

389

2824

Benign thyroid growths and nodules

1529

11528

1.26

14.81

2.4

2.3

5.07

6.29

ug/l

2.52

1331

9923

Other arterial embolism and thrombosis

172

919

2.02

14.77

3.9

2.4

7.88

6.74

ug/l

0.29

150

797

Vasomotor and allergic rhinitis

1387

10864

1.26

14.75

2.2

6.15

7.85

ug/l

2.78

1212

9631

Extreme obesity with alveolar hypoventilation

218

1251

1.86

14.73

3.0

2.4

4.44

7.98

ug/l

4.17

177

1128

Explicit fungal Sepsis, including avohilmo

177

3.65

14.72

3.4

2.4

8.46

7.08

ug/l

0.16

159

Fracture of neck

343

2214

1.63

14.69

2.4

8.31

7.11

ug/l

0.41

296

1943

Cluster headache, wide

159

822

2.03

14.58

2.7

2.2

5.28

9.15

ug/l

1.60

135

747

Infective dermatitis

543

3835

1.46

14.56

2.7

2.3

6.33

7.92

ug/l

1.01

490

3393

Alzheimer disease, including avohilmo

2296

13417

1.21

14.51

2.5

5.70

6.43

ug/l

1.28

1779

11473

Vitamin D deficiency

100

436

2.48

14.48

2.7

2.4

6.42

7.32

ug/l

0.23

387

Other/unspecified enthesopathies of lower limb, excluding foot

284

1744

1.69

14.47

2.3

2.1

7.41

7.99

ug/l

0.11

233

1558

Dependence on enabling machines and devices, not elsewhere classified

235

3.11

14.40

3.2

2.3

12.71

6.45

ug/l

1.24

201

Viral warts

408

2729

1.54

14.36

2.4

2.3

6.08

7.59

ug/l

0.63

373

2438

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

1455

11792

1.26

14.34

2.5

2.3

7.74

7.09

ug/l

0.40

1246

10287

Allergic bronchopulmonary aspergillosis (ABPA)

6.91

14.33

2.0

1.5

18.24

4.32

ug/l

1.32

Hypertrophic scar

205

1156

1.85

14.30

2.5

2.2

12.63

7.45

ug/l

0.67

185

1029

Any event in cancer register

4139

21240

1.15

14.29

2.2

2.3

7.05

7.88

ug/l

1.30

3592

18740

Spinal instabilities

137

683

2.14

14.15

2.4

2.1

3.56

8.05

ug/l

7.33

122

613

Arthropathies in other diseases classified elsewhere

183

1008

1.93

14.10

2.5

2.4

7.38

8.36

ug/l

0.35

158

896

Nail disorders

372

2454

1.57

14.09

2.6

2.3

6.45

7.26

ug/l

0.36

331

2191

Other (seronegative) rheumatoid arthritis, wide

906

6967

1.34

14.08

2.6

2.4

5.93

6.98

ug/l

1.11

763

6031

Small fibre neuropathy

178

979

1.97

14.06

2.8

2.4

9.80

7.52

ug/l

0.29

147

883

Hydronephrosis

567

4065

1.44

14.00

2.5

2.3

5.67

7.08

ug/l

1.80

499

3576

Assault by bodily force

283

1751

1.67

13.95

2.4

2.2

7.83

8.31

ug/l

0.08

240

1598

Exclusions for E4_PCOS_BROAD

705

5223

1.38

13.90

3.2

2.3

5.71

7.63

ug/l

2.10

598

4629

Synovial cyst of popliteal space [Baker]

361

2379

1.58

13.87

2.6

2.2

6.50

7.98

ug/l

0.71

310

2075

Background retinopathy and retinal vascular changes

131

653

2.19

13.83

2.5

2.4

5.48

7.34

ug/l

1.12

116

575

Postprocedural endocrine and metabolic disorders, not elsewhere classified

464

3204

1.49

13.82

2.3

2.1

7.41

6.43

ug/l

0.37

405

2817

Other disorders of nervous system

331

2145

1.62

13.81

2.3

7.59

7.81

ug/l

0.05

281

1912

Haemolytic anaemias

181

1002

1.93

13.80

2.3

2.5

11.24

7.31

ug/l

0.68

162

888

Insomnia

4009

24558

1.15

13.78

2.5

2.3

5.85

7.57

ug/l

6.53

3474

21612

Noninflammatory disorders of female genital tract

1350

5393

1.27

13.77

2.3

2.2

5.04

6.37

ug/l

2.18

1134

4625

Giant cell arteritis

253

1548

1.75

13.76

3.2

2.6

5.57

6.80

ug/l

0.70

213

1357

Fall involving bed

216

1268

1.83

13.74

3.1

2.6

5.04

6.45

ug/l

0.98

175

1074

Other and unspecified mood [affective] disorders

224

1306

1.76

13.73

2.7

2.1

5.61

7.90

ug/l

1.14

180

1161

Behavioural disorders, excluding more controls

232

2.93

13.73

2.6

1.8

13.85

9.87

ug/l

0.22

208

Diseases of male genital organs

2576

11042

1.19

13.65

2.4

2.3

9.13

9.27

ug/l

0.07

2289

9992

Thyrotoxicosis

1077

8486

1.29

13.65

2.5

2.3

9.00

6.72

ug/l

1.58

921

7348

Diabetic maculopathy

658

4597

1.40

13.59

3.1

2.6

7.13

7.90

ug/l

0.51

588

4049

Shoulder region

414

2.52

13.58

3.6

2.4

2.54

7.07

ug/l

5.67

371

Arthropod-borne viral fevers and viral haemorrhagic fevers

450

3116

1.50

13.57

2.6

2.3

5.76

8.33

ug/l

1.84

421

2812

Acquired haemolytic anaemia

139

712

2.12

13.56

2.4

2.6

12.40

7.61

ug/l

0.65

127

634

D07AA Corticosteroids, weak (group I)

553

3946

1.43

13.56

2.4

5.66

7.10

ug/l

1.77

493

3453

Solid cancers

3894

20061

1.15

13.55

2.2

2.3

6.79

7.93

ug/l

2.40

3379

17718

Invasive ventilation

367

2444

1.57

13.52

2.2

2.4

11.98

7.72

ug/l

1.22

326

2169

Communicating hydrocephalus

128

639

2.19

13.48

2.7

2.5

5.02

6.81

ug/l

0.49

114

561

Pre-eclampsia or poor fetal growth

795

5980

1.34

13.45

2.1

2.0

4.66

5.86

ug/l

1.45

715

5219

Anorexia (incl.atypical)

187

1043

1.85

13.36

2.6

2.1

7.09

7.12

ug/l

0.00

167

914

Fibroblastic disorders

1120

8898

1.29

13.34

2.6

2.2

6.41

8.12

ug/l

2.02

961

7790

Other respiratory diseases principally affecting the interstitium

999

7851

1.31

13.33

2.9

2.4

10.22

7.05

ug/l

3.97

884

6777

Mental and behavioural disorders due to use of other stimulants, including caffeine

429

2.37

13.30

2.1

2.0

6.72

9.24

ug/l

0.68

392

Temporal arteritis

226

1357

1.79

13.28

3.2

2.5

5.12

6.75

ug/l

1.44

189

1186

Lung cancer and mesothelioma

955

6304

1.31

13.23

2.3

2.2

6.38

7.97

ug/l

1.54

841

5574

Other orthopaedic follow-up care

269

1676

1.68

13.19

2.3

6.26

7.04

ug/l

0.16

229

1490

Spondyloarthritis

779

5909

1.35

13.19

2.8

2.3

6.45

7.61

ug/l

0.48

673

5170

Injury of other and unspecified intrathoracic organs

329

2153

1.60

13.18

2.5

2.4

9.10

8.08

ug/l

0.34

289

1936

Bronchitis, not specified as acute or chronic

408

2787

1.52

13.11

2.7

2.3

7.78

8.29

ug/l

0.11

342

2448

Early complications of trauma

230

1383

1.76

13.11

3.2

2.4

10.59

7.70

ug/l

0.94

201

1241

!Aliquae complicationes praecoces traumatis

230

1383

1.76

13.11

3.2

2.4

10.59

7.70

ug/l

0.94

201

1241

Dermatopolymyositis (FG)

339

2.63

13.02

2.8

2.5

17.34

6.88

ug/l

2.45

301

Benign neoplasm: Colon, unspecified

1350

11003

1.26

13.02

2.5

2.4

6.33

7.51

ug/l

1.92

1149

9638

Dermatographic urticaria

258

1591

1.68

13.01

2.3

2.2

3.54

6.99

ug/l

6.64

221

1432

Other and unspecified vascular occlusions

531

3828

1.44

12.99

2.7

2.4

7.31

7.21

ug/l

0.03

460

3280

Carcinoma in situ of other and unspecified genital organs

105

491

2.32

12.98

2.7

2.3

2.81

6.18

ug/l

4.75

434

Paralytic strabismus

365

2452

1.56

12.98

2.6

2.4

7.28

7.43

ug/l

0.03

316

2178

Blood alcohol or alcohol intoxication level

111

528

2.24

12.98

3.4

2.2

4.63

8.89

ug/l

4.56

485

Mental and behavioural disorders due to tobacco

390

2648

1.53

12.95

2.5

2.3

7.32

8.57

ug/l

0.33

329

2409

SLE, ICD10

156

840

1.97

12.91

2.4

2.3

6.58

6.49

ug/l

0.02

135

747

SLE, strict definition

156

840

1.97

12.91

2.4

2.3

6.58

6.49

ug/l

0.02

135

747

Giant cell arteritis with polymyalgia rheumatica

226

1369

1.77

12.87

3.2

2.6

5.12

6.84

ug/l

1.55

189

1194

Poisoning by narcotics and psychodysleptics [hallucinogens]

272

2.76

12.86

2.6

2.2

6.61

7.91

ug/l

0.36

246

Smoking dependency

390

2654

1.52

12.81

2.5

2.3

7.32

8.61

ug/l

0.34

329

2409

Cystic kidney disease

160

873

1.95

12.80

2.3

5.06

7.54

ug/l

2.41

148

784

Complications of other internal prosthetic devices, implants and grafts

224

1348

1.76

12.79

2.8

2.3

5.11

6.89

ug/l

1.34

194

1168

Early lumbar disc prolapse operation

332

2174

1.56

12.78

1.9

2.1

5.49

9.15

ug/l

2.40

306

1971

Diseases of spleen

110

530

2.28

12.77

2.8

2.4

10.67

7.25

ug/l

0.78

481

Pulmonary oedema

121

605

2.19

12.76

4.0

2.7

6.16

6.01

ug/l

0.05

112

520

Problems related to social environment

149

798

1.98

12.56

3.2

2.5

4.95

6.74

ug/l

0.85

126

693

Systemic lupus erythematosus

164

906

1.91

12.52

2.6

2.3

6.76

6.44

ug/l

0.10

142

806

Ulcerative colitis, NAS

559

4067

1.41

12.50

2.9

2.2

6.39

7.79

ug/l

0.64

502

3643

Herpesviral [herpes simplex] infections

490

3491

1.44

12.47

2.4

2.3

6.43

6.86

ug/l

0.12

421

3084

Toxic effect of ethanol

169

941

1.88

12.47

3.0

2.2

5.70

8.65

ug/l

2.34

150

848

Neuralgia and neuritis, unspecified

232

1414

1.71

12.41

2.5

2.2

7.24

8.47

ug/l

0.23

198

1261

Sequelae of injuries, of poisoning and of other consequences of external causes

1003

7932

1.29

12.39

2.2

2.3

8.60

7.99

ug/l

0.26

863

7070

Neovascular glaucoma

228

1392

1.74

12.39

2.7

2.5

6.98

7.03

ug/l

0.01

201

1215

Superficial injury of ankle and foot

446

3121

1.46

12.38

2.3

2.2

5.81

7.51

ug/l

1.48

402

2769

Other disorders of conjunctiva

716

5440

1.36

12.32

3.1

2.3

8.28

7.62

ug/l

0.24

621

4783

Abnormal blood-pressure reading, without diagnosis

170

949

1.86

12.30

2.7

1.8

3.97

7.55

ug/l

5.24

145

825

Acute laryngitis and tracheitis

342

2232

1.54

12.30

2.4

2.0

3.94

7.48

ug/l

6.49

296

1966

Degenerative diseases of the nervous system

2216

13618

1.19

12.28

2.5

5.78

6.47

ug/l

1.10

1691

11691

Hypersomnia

318

2.61

12.20

2.6

2.3

4.11

7.86

ug/l

2.34

285

Suppurative and unspecified otitis media

1208

8620

1.26

12.18

2.2

7.28

7.50

ug/l

0.09

1043

7594

Glomerulonephritis

453

3206

1.46

12.16

2.6

2.4

6.88

7.73

ug/l

0.30

409

2853

Other/unspecified synovitis and tenosynovitis

476

3389

1.44

12.14

2.5

2.1

6.64

8.20

ug/l

0.76

423

2977

Glaucoma secondary to other eye disorders

229

1408

1.72

12.11

2.7

2.5

6.98

7.24

ug/l

0.04

201

1243

Ulcerative colitis

995

7882

1.28

12.07

2.7

2.3

6.86

7.88

ug/l

0.66

883

6990

Blindness, monocular

274

2.81

12.07

2.4

2.5

15.11

7.33

ug/l

0.32

245

Open wound of forearm

444

3131

1.46

12.07

2.5

2.4

5.61

7.49

ug/l

2.13

363

2763

Hemiplegia

240

1489

1.69

12.05

2.4

6.69

7.05

ug/l

0.10

203

1315

Ingrowing nail

236

1457

1.69

12.02

2.7

2.4

6.16

7.98

ug/l

0.73

209

1300

Urolithiasis

1617

13515

1.22

11.96

2.4

6.42

7.87

ug/l

2.52

1373

11955

Bell's palsy

526

3826

1.41

11.93

2.3

7.50

8.01

ug/l

0.16

456

3373

Anankastic personality disorder

145

781

1.94

11.83

2.0

2.1

9.48

7.74

ug/l

0.21

129

707

Maternal care for other conditions predominantly related to pregnancy

457

3144

1.44

11.82

1.9

2.0

5.86

5.73

ug/l

0.04

410

2762

Sacroiliitis, not elsewhere classified

150

814

1.90

11.82

2.5

2.0

4.38

8.04

ug/l

2.46

132

728

Achilles tendinitis

429

3015

1.46

11.81

2.4

2.2

6.13

9.25

ug/l

2.89

380

2710

malignant neoplasm of female genital organs, including Hilmo

815

6030

1.32

11.77

2.4

4.38

5.92

ug/l

1.92

694

5100

Postmenopausal atrophic vaginitis

1044

4504

1.29

11.68

2.3

2.2

4.58

6.75

ug/l

2.98

912

3922

Systemic lupus erythematosus, unspecified

133

704

2.01

11.65

2.5

2.2

7.11

6.80

ug/l

0.08

117

631

Benign neoplasm: Small intestine

223

1380

1.72

11.64

2.8

2.6

5.70

7.25

ug/l

0.88

201

1223

Secondary parkinsonism+Parkinsonism in other disease

165

941

1.88

11.63

3.1

2.6

5.13

7.21

ug/l

1.23

133

830

Papulosquamous disorders

1802

15235

1.20

11.59

2.4

2.3

5.96

7.71

ug/l

5.06

1574

13461

Hypothermia

114

578

2.15

11.59

3.1

2.6

9.33

7.77

ug/l

0.27

525

Secondary parkinsonism

163

928

1.89

11.58

3.1

2.6

5.08

6.92

ug/l

1.03

132

819

Other strabismus

805

6218

1.31

11.56

2.3

6.86

7.48

ug/l

0.34

686

5463

Effects of other external causes

116

585

2.08

11.53

2.3

3.88

8.80

ug/l

3.79

104

537

Pyogenic arthritis

325

2183

1.55

11.50

2.9

2.3

4.62

8.56

ug/l

5.02

281

1936

Emotional disorders starting during childhood or adolecense, excluding more controls

351

2.34

11.49

1.6

1.7

6.78

7.99

ug/l

0.21

299

Fracture of foot, except ankle

963

7644

1.28

11.47

2.4

2.2

6.02

7.71

ug/l

2.38

833

6751

Female infertility, associated with anovulation

145

782

1.89

11.45

1.5

2.2

2.90

6.24

ug/l

3.41

126

680

Alcohol-induced acute pancreatitis

196

1178

1.77

11.39

2.7

2.4

5.87

9.20

ug/l

2.14

175

1084

Alzheimer disease

2020

12327

1.19

11.39

2.5

2.6

5.62

6.31

ug/l

1.01

1529

10507

Liquid cancers

1554

12298

1.22

11.39

2.4

2.5

6.86

7.72

ug/l

0.66

1309

10691

Burns and corrosions of external body surface, specified by site

446

3179

1.44

11.37

2.5

2.3

5.48

8.30

ug/l

3.96

396

2864

Other specified/unspecified spondylopathies

138

750

1.97

11.31

3.0

2.3

6.09

7.53

ug/l

0.23

113

655

Amyloidosis

129

687

2.02

11.29

2.5

2.3

5.62

7.55

ug/l

1.22

109

605

Postmenopausal osteoporosis with pathological fracture

369

2564

1.51

11.29

2.9

2.5

5.21

5.54

ug/l

0.17

285

2141

Pre-existing hypertension complicating pregnancy, childbirth and the puerperium

191

1127

1.74

11.27

2.2

1.8

3.57

5.70

ug/l

2.51

166

996

Squamous cell neoplasms and carcinomas of the skin, including Hilmo

779

6009

1.32

11.26

2.7

2.6

5.51

7.03

ug/l

3.10

653

5096

Cystic kidney disease, including avohilmo

168

968

1.84

11.26

2.2

2.4

4.92

7.58

ug/l

2.92

156

870

Social phobias

232

1441

1.64

11.18

2.1

1.9

5.84

7.60

ug/l

0.80

195

1278

Nummular dermatitis

419

2975

1.46

11.16

2.5

2.3

5.64

7.64

ug/l

1.98

374

2645

Complications following infusion, transfusion and therapeutic injection

390

2.38

11.14

2.9

2.3

5.05

6.70

ug/l

0.73

344

Flat foot [pes planus] (acquired)

401

2816

1.47

11.14

2.4

2.3

5.05

7.85

ug/l

2.24

340

2469

Atypical facial pain

227

1417

1.67

11.13

2.4

2.3

4.07

7.04

ug/l

5.21

196

1258

Polycystic kidney disease

135

733

1.97

11.09

2.4

2.3

5.61

7.93

ug/l

1.40

125

660

Other congenital malformations

288

1893

1.56

11.01

2.1

2.2

11.14

7.14

ug/l

1.27

268

1690

Cholangitis (primary sclerosing, PSC)

312

2100

1.55

11.01

3.7

2.3

4.86

7.57

ug/l

3.21

266

1835

Unspecified/other endometriosis

226

1371

1.65

10.98

1.9

2.3

2.12

6.55

ug/l

12.92

178

1188

Hypermobility syndrome

155

870

1.84

10.98

2.1

2.0

4.44

5.47

ug/l

0.29

132

783

Dependent personality disorder

484

2.20

10.96

3.1

2.3

4.19

7.57

ug/l

2.43

438

Dentofacial anomalies [including malocclusion]

2718

18559

1.15

10.94

2.4

2.2

5.48

7.68

ug/l

5.69

2383

16457

Periapical abscess

2033

17437

1.18

10.93

2.4

2.3

7.19

8.03

ug/l

0.91

1804

15539

Other disorders starting during childhood or adolescence

112

558

2.03

10.91

2.4

1.9

4.77

7.12

ug/l

1.29

102

481

Other coagulation defects

317

2139

1.53

10.91

2.2

2.4

9.18

6.86

ug/l

0.95

271

1882

Intestinal malabsorption

216

1341

1.69

10.89

2.7

2.4

5.35

7.76

ug/l

2.13

189

1209

Sarcoidosis

588

4420

1.37

10.89

2.6

2.3

10.39

7.79

ug/l

0.93

538

3945

False labour

646

3002

1.35

10.88

1.8

2.0

3.18

6.09

ug/l

6.30

579

2642

Viral haemorrhagic fevers, not elsewhere classified/unspecified

356

2465

1.50

10.85

2.6

2.3

5.21

8.06

ug/l

2.47

332

2232

Injury of intra-abdominal organs

118

616

2.03

10.80

2.7

2.3

16.26

8.13

ug/l

0.90

107

557

Complications peculiar to reattachment and amputation

201

3.05

10.75

2.6

4.44

7.72

ug/l

1.16

175

Hepatic failure, not elsewhere classified

202

1243

1.72

10.74

2.6

2.5

12.09

7.42

ug/l

0.93

172

1112

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

1186

9727

1.24

10.73

2.4

6.68

6.85

ug/l

0.08

1031

8424

Female genital prolapse

1097

4906

1.26

10.70

2.3

2.2

4.54

6.61

ug/l

5.16

937

4212

Retinal haemorrhage

149

846

1.89

10.69

2.9

2.5

6.69

6.31

ug/l

0.13

134

734

Gestational [pregnancy-induced] oedema and proteinuria without hypertension

288

1909

1.55

10.68

2.3

2.1

4.90

6.15

ug/l

0.71

262

1664

Fibrosis and cirrhosis of liver

394

2793

1.47

10.68

2.6

2.4

10.84

7.59

ug/l

0.95

349

2489

Superficial injuries involving multiple body regions

126

675

1.98

10.67

2.8

2.3

6.31

7.42

ug/l

0.25

111

606

Other noninfective disorders of lymphatic vessels and lymph nodes

178

1058

1.77

10.67

2.7

2.3

7.39

7.31

ug/l

0.02

158

934

Male infertility

173

1014

1.77

10.67

2.2

2.1

7.93

9.75

ug/l

0.44

156

920

Other noninflammatory disorders of uterus, except cervix

874

4592

1.29

10.65

2.5

2.3

5.44

6.61

ug/l

0.84

736

3950

Other specified and unspecified retinal disorders

192

1169

1.74

10.64

2.8

2.4

5.53

7.23

ug/l

0.91

172

1034

Allergic urticaria

307

2065

1.53

10.63

2.2

6.89

6.95

ug/l

0.02

258

1839

Anoxic brain damage

413

2.32

10.61

3.1

2.7

28.38

7.30

ug/l

2.62

366

Dermatopolymyositis

372

2.37

10.60

2.8

2.3

17.34

6.92

ug/l

2.45

328

Spondylopathies (FG)

504

3705

1.39

10.60

2.7

2.2

6.35

8.14

ug/l

0.51

439

3324

Calculus of kidney and ureter

1473

12356

1.21

10.55

2.4

6.42

7.87

ug/l

2.31

1265

10939

Infection of intervertebral disc (pyogenic)

421

2.31

10.55

2.4

2.3

6.81

8.37

ug/l

0.37

373

Event of undetermined intent

259

1687

1.59

10.51

2.7

2.3

7.84

7.83

ug/l

0.00

223

1526

Monoarthritis, not elsewhere classified

186

1122

1.73

10.45

2.7

2.3

5.04

7.86

ug/l

2.56

171

990

Disorders of breast

1787

13368

1.19

10.44

2.2

4.19

5.82

ug/l

6.01

1516

11482

Fracture of forearm

2480

19427

1.16

10.44

2.4

2.3

6.96

6.95

ug/l

0.00

2095

16913

Other and unspecified follicular disorders

188

1139

1.73

10.44

2.4

2.3

7.08

7.53

ug/l

0.11

162

1032

Squamous cell neoplasms and carcinomas of the skin

627

4802

1.35

10.43

2.5

2.6

5.56

6.95

ug/l

2.46

521

4077

Suppurative and necrotic conditions of lower respiratory tract

294

1985

1.55

10.36

2.7

2.4

7.93

7.62

ug/l

0.11

262

1770

Other noninflammatory disorders of vulva and perineum

317

2156

1.50

10.30

2.2

6.31

6.91

ug/l

0.13

259

1874

Pneumocystosis, including avohilmo

116

619

2.05

10.29

2.3

2.5

7.67

6.67

ug/l

0.24

103

556

Pneumocystosis

116

619

2.05

10.29

2.3

2.5

7.67

6.68

ug/l

0.24

103

556

Colonic or urogenital fistula

1189

9795

1.23

10.25

2.4

2.3

6.83

7.71

ug/l

0.54

989

8646

Injuries involving multiple body regions

170

1009

1.77

10.19

2.7

2.4

6.13

7.04

ug/l

0.27

151

899

Other disorders of the musculoskeletal system and connective tissue

699

5437

1.32

10.16

2.5

2.4

7.30

7.60

ug/l

0.10

615

4784

Lichen planus

603

4601

1.35

10.13

2.3

5.88

7.13

ug/l

1.09

519

4040

5-aminosalicylic acid

780

6132

1.29

10.12

2.5

2.1

6.38

7.46

ug/l

0.89

690

5426

Other/unspecified seropositive rheumatoid arthritis

1205

9960

1.23

10.11

2.4

6.66

6.89

ug/l

0.11

1047

8615

Personal history of other diseases and conditions

291

1940

1.52

10.08

2.2

1.9

10.85

5.18

ug/l

3.44

235

1695

Disorders of magnesium metabolism

213

2.87

10.07

2.2

2.4

6.40

8.72

ug/l

0.64

194

Amyloidosis, other/unspecified

108

565

2.07

10.07

2.6

2.4

6.08

7.14

ug/l

0.48

500

Seropositive rheumatoid arthritis, wide

1218

10083

1.23

10.06

2.3

2.4

6.67

6.86

ug/l

0.09

1058

8721

Rheumatic fever incl heart disease

168

1005

1.77

9.96

2.4

2.5

11.66

6.65

ug/l

1.05

149

861

Other behavioural and emotional disorders with onset usually occurring in childhood and adolescence

126

668

1.89

9.95

2.4

1.9

5.08

7.29

ug/l

1.32

115

581

Primary coxarthrosis, bilateral

1531

12969

1.20

9.94

2.5

2.4

5.62

7.07

ug/l

3.98

1295

11209

Vascular dementia

574

4211

1.36

9.92

2.5

2.6

4.40

6.02

ug/l

3.66

433

3535

Cardiomyopathies, Secondary/extrinsic

134

3.33

9.91

3.7

2.1

7.77

5.89

ug/l

0.25

119

Thiazolidinediones

582

4443

1.35

9.90

2.6

2.4

7.25

8.10

ug/l

0.42

506

3908

Schizophrenia

601

4586

1.34

9.89

2.5

2.3

6.13

8.51

ug/l

1.76

530

4135

Sacrococcygeal disorders, not elsewhere classified

116

618

1.96

9.88

2.2

2.1

3.66

7.31

ug/l

4.41

551

Other general symptoms and signs

177

1055

1.71

9.86

2.1

2.0

5.82

7.56

ug/l

0.93

150

939

Trigeminal neuralgia

262

1740

1.56

9.84

2.6

2.3

7.46

6.98

ug/l

0.09

218

1540

Kyphosis

338

2.38

9.83

2.7

2.3

5.71

7.20

ug/l

0.47

290

Clefts and syndromes for tooth agenesis exclusion, including avohilmo

102

519

2.04

9.80

2.3

11.87

8.08

ug/l

1.00

460

N06DA Anticholinesterases

2099

14041

1.17

9.78

2.4

2.5

6.06

6.37

ug/l

0.31

1595

11995

Use of anticholinesterases

2099

14041

1.17

9.78

2.4

2.5

6.06

6.37

ug/l

0.31

1595

11995

Bulimia nervosa (incl. atypical)

339

2.27

9.76

1.6

1.8

3.02

4.81

ug/l

0.74

300

Bullous disorders

296

2028

1.52

9.71

2.4

2.5

5.87

6.84

ug/l

0.57

249

1771

Dislocation of lens

482

2.14

9.68

2.7

2.3

6.40

6.84

ug/l

0.14

409

Recurrent dislocation of patella

131

726

1.85

9.67

2.1

2.0

6.57

6.83

ug/l

0.05

112

641

Inflammatory diseases of the central nervous system

356

2519

1.46

9.63

2.4

5.82

7.42

ug/l

1.40

307

2252

Vitamin deficiency, wide

225

1454

1.61

9.63

4.2

2.4

5.15

7.33

ug/l

1.99

186

1290

Vitamin deficiency

225

1454

1.61

9.63

4.2

2.4

5.15

7.33

ug/l

1.99

186

1290

Secondary malignant neoplasm of other and unspecified sites, including Hilmo

1284

10408

1.22

9.62

2.3

2.5

4.62

7.89

ug/l

11.55

1141

9157

Other and unspecified mononeuropathies, also in other diseases

151

886

1.81

9.61

2.5

2.4

4.59

7.66

ug/l

3.08

126

784

Lichen simplex chronicus and prurigo

297

2038

1.51

9.57

2.5

2.3

6.47

7.59

ug/l

0.35

267

1814

Crohn's disease NAS

251

1660

1.56

9.54

2.4

2.2

6.21

7.74

ug/l

0.41

215

1499

Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies

181

1109

1.69

9.54

2.1

4.75

8.23

ug/l

3.84

166

1002

Spontaneous rupture of synovium and tendon

380

2727

1.44

9.52

2.4

2.2

6.50

8.71

ug/l

1.48

320

2405

Other diseases of liver

784

6231

1.28

9.49

2.4

2.3

7.45

7.62

ug/l

0.08

690

5522

Tongue abnormality

287

1962

1.52

9.48

2.8

2.4

4.51

7.12

ug/l

3.03

240

1739

Late syphilis, including avohilmo

458

2.15

9.46

3.3

2.4

4.43

7.94

ug/l

3.35

419

Other disorders of optic [2nd] nerve and visual pathways

279

1894

1.53

9.46

2.4

4.99

7.23

ug/l

2.82

245

1692

Diabetes mellitus in pregnancy

641

3113

1.32

9.46

1.9

4.36

5.76

ug/l

1.31

576

2709

Pure hyperglyceridaemia

118

648

1.94

9.40

2.9

2.2

5.30

7.67

ug/l

1.29

105

583

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

735

5822

1.30

9.35

2.6

2.4

8.51

8.34

ug/l

0.06

641

5198

Manic episode

121

667

1.90

9.33

2.4

2.2

10.40

8.06

ug/l

0.25

102

589

Acne

252

1656

1.54

9.33

2.2

7.50

6.76

ug/l

0.22

226

1433

Postprocedural musculoskeletal disorders, not elsewhere classified

357

2552

1.45

9.31

2.7

2.4

4.50

7.13

ug/l

6.15

322

2268

Cirrhosis of liver, NAS

290

1999

1.52

9.31

2.8

2.4

10.44

7.82

ug/l

0.60

263

1809

Late syphilis

374

2.28

9.28

3.3

2.4

4.39

8.65

ug/l

3.64

340

Follow-up examination after treatment for malignant neoplasms

401

2910

1.41

9.27

2.3

2.1

7.36

7.74

ug/l

0.12

336

2507

Artificial joint re-operation

359

2574

1.45

9.26

2.3

2.5

5.48

7.10

ug/l

0.75

307

2259

Lesion of radial nerve

184

1147

1.68

9.26

3.0

2.3

9.31

7.90

ug/l

0.30

155

1025

Conduct disorder

297

2.35

9.25

2.6

1.9

13.48

8.98

ug/l

0.26

268

Other superficial mycoses

100

521

2.03

9.23

2.3

11.29

7.83

ug/l

0.32

474

Other and unspecified abdominal hernia

205

1314

1.64

9.22

2.4

6.32

7.14

ug/l

0.34

176

1168

Other inflammatory liver diseases

293

2020

1.50

9.21

2.6

2.4

6.54

7.43

ug/l

0.49

255

1814

Speech therapy

1202

10029

1.22

9.20

2.2

2.4

7.46

7.18

ug/l

0.12

1124

8693

Prepatellar bursitis

219

1424

1.61

9.18

2.3

2.2

7.25

10.42

ug/l

1.50

193

1303

Open wound of abdomen, lower back and pelvis

135

777

1.82

9.08

2.4

5.76

8.04

ug/l

1.25

115

710

Acne vulgaris

189

1176

1.63

9.06

2.3

2.1

8.03

7.12

ug/l

0.21

170

1019

Deep endometriosis

331

2334

1.46

9.06

2.4

2.2

6.13

5.99

ug/l

0.03

281

2013

Use of galantamine

482

3639

1.38

9.05

2.5

5.38

6.25

ug/l

0.45

383

3018

Fenamates

593

3091

1.33

9.03

2.2

2.4

6.99

9.64

ug/l

2.03

493

2719

Polyarthritis, unspecified

168

1030

1.71

9.00

2.4

4.35

7.05

ug/l

2.75

150

906

Chondropathies

582

4485

1.32

8.99

2.8

2.3

8.19

7.92

ug/l

0.07

498

4010

Disorders of purine and pyrimidine metabolism

161

3.08

8.98

2.8

2.6

3.03

7.12

ug/l

1.85

147

Other noninflammatory disorders of vagina

270

1834

1.51

8.96

2.2

4.47

7.12

ug/l

3.09

206

1595

malignant neoplasm of female genital organs

713

5526

1.29

8.94

2.4

4.37

5.89

ug/l

1.60

603

4655

Algoneurodystrophy

125

706

1.85

8.92

2.0

2.2

11.40

6.59

ug/l

0.58

105

644

Symptoms and signs involving emotional state

116

640

1.89

8.92

2.4

2.1

9.51

7.76

ug/l

0.19

572

Benign neoplasm: Skin of ear and external auricular canal

202

1302

1.63

8.91

2.6

2.5

5.60

7.06

ug/l

0.98

168

1144

Fall on and from stairs and steps

1172

9781

1.22

8.90

2.3

2.4

6.84

7.29

ug/l

0.21

975

8528

Drug-induced osteoporosis with pathological fracture

520

2.05

8.88

3.1

2.5

8.76

6.57

ug/l

0.36

454

Pneumothorax

342

2446

1.45

8.86

2.6

2.4

8.39

7.56

ug/l

0.37

301

2170

Traumatic ischaemia of muscle

367

2.25

8.86

3.1

2.4

12.36

7.33

ug/l

0.83

333

Burns and corrosions of multiple and unspecified body regions

107

580

1.96

8.85

2.9

2.4

6.59

8.25

ug/l

0.68

100

524

Leisure time condition

793

6367

1.27

8.83

2.4

6.29

7.33

ug/l

1.00

615

5581

Nontoxic multinodular goitre

859

6963

1.26

8.81

2.3

2.4

5.13

6.06

ug/l

0.99

745

5949

Abnormal spermatozoa

417

5571

0.73

8.79

2.3

2.5

6.15

8.76

ug/l

1.28

371

5003

Oligomenorrhoea

519

1.97

8.78

2.8

2.2

6.15

6.62

ug/l

0.12

453

Other and unspecified paralytic syndromes

361

2.25

8.78

2.3

6.68

7.39

ug/l

0.18

326

Persons encountering health services in circumstances related to reproduction

1614

12623

0.85

8.75

2.0

2.2

9.16

8.51

ug/l

0.34

1461

11341

Lichen sclerosus et atrophicus

473

3560

1.36

8.75

2.1

2.3

3.95

6.60

ug/l

7.07

412

3068

Postprocedural disorders of digestive system, not elsewhere classified

166

1025

1.71

8.74

2.6

2.4

6.91

7.42

ug/l

0.10

141

904

Colectomy operation

834

6755

1.26

8.74

2.4

6.14

7.36

ug/l

1.01

728

5870

Dislocation, sprain and strain of joints and ligaments of lumbar spine and pelvis

139

815

1.78

8.73

2.5

2.3

4.22

7.74

ug/l

3.72

123

735

Other retinal artery occlusion

137

809

1.81

8.70

3.2

2.6

5.08

7.02

ug/l

1.43

117

703

Asthma and opportunity respiratory infection

235

1575

1.56

8.69

3.2

2.4

6.94

7.22

ug/l

0.09

195

1379

Sicca syndrome [Sjögren]

351

2526

1.43

8.68

2.2

2.4

5.67

6.40

ug/l

0.34

292

2203

297

2070

1.48

8.66

3.2

2.4

5.34

6.57

ug/l

0.86

240

1698

Other diseases of stomach and duodenum

303

2129

1.47

8.65

2.3

2.2

6.05

7.90

ug/l

1.20

267

1896

Inflammatory diseases of prostate (prostatitis)

668

5284

1.30

8.65

2.8

2.3

8.06

9.43

ug/l

0.57

568

4787

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

1063

8799

1.22

8.65

2.5

2.3

7.45

7.82

ug/l

0.15

937

7826

Ectropion of eyelid

246

1671

1.55

8.60

2.4

5.34

6.95

ug/l

1.45

213

1412

Excessive vomiting in pregnancy

203

1306

1.59

8.60

2.2

2.3

5.37

5.39

ug/l

0.01

171

1145

Paranoid personality disorder

410

2.13

8.58

2.2

2.4

4.14

7.91

ug/l

2.71

373

Dislocation, sprain and strain of joints and ligaments of thorax

161

989

1.70

8.58

3.3

2.4

4.53

7.29

ug/l

2.28

149

887

Other blood glucose lowering drugs, excl. Insulins

795

6421

1.27

8.57

2.7

2.4

5.90

7.64

ug/l

2.19

702

5555

Uterine polyps

1007

4816

1.24

8.54

2.4

2.2

4.60

6.58

ug/l

3.77

841

4168

ILD, hospital admissions

804

6510

1.27

8.53

2.7

2.4

10.96

7.11

ug/l

4.26

707

5649

Open wound of thorax

392

2.16

8.52

2.6

2.2

9.80

9.27

ug/l

0.06

357

Other interstitial pulmonary diseases

816

6621

1.26

8.49

2.7

2.4

11.21

7.09

ug/l

4.61

719

5744

Rheumatic valve diseases

124

715

1.85

8.49

2.2

2.6

14.33

6.58

ug/l

1.25

107

606

Intentional self-harm by unspecified means

191

2.66

8.48

2.1

8.54

7.66

ug/l

0.10

172

Persistent delusional disorders

340

2446

1.43

8.48

2.8

2.4

5.92

7.70

ug/l

0.86

280

2154

Hyperosmolality and hypernatraemia

422

2.14

8.47

3.6

2.4

7.76

7.35

ug/l

0.08

367

Polyp of the female genital tract

1063

4956

1.23

8.44

2.4

2.2

5.15

6.50

ug/l

1.51

883

4268

Disorders in reading

191

2.63

8.42

1.8

1.9

7.97

6.87

ug/l

0.14

169

Pyoderma

505

2.01

8.41

2.6

2.3

4.14

8.49

ug/l

3.01

445

Burn and corrosion of trunk

139

827

1.77

8.41

2.4

5.50

7.88

ug/l

1.58

121

748

Sequelae of injuries of head

231

1548

1.55

8.40

1.9

2.4

7.50

7.45

ug/l

0.02

197

1407

Radial styloid tenosynovitis [de Quervain]

194

1247

1.60

8.38

2.4

2.1

6.00

7.39

ug/l

0.67

168

1106

Other female pelvic inflammatory diseases

537

4135

1.32

8.34

2.2

4.43

6.10

ug/l

1.61

423

3579

Other and unspecified injuries of lower leg

290

2028

1.47

8.34

2.5

2.3

7.09

7.32

ug/l

0.07

250

1812

Abnormal findings on diagnostic imaging of other body structures

650

5142

1.29

8.32

2.3

2.4

6.21

6.83

ug/l

0.44

563

4526

Interstitial lung disease

816

6637

1.26

8.31

2.7

2.4

11.21

7.09

ug/l

4.62

719

5757

Interstitial lung disease endpoints

816

6637

1.26

8.31

2.7

2.4

11.21

7.09

ug/l

4.62

719

5757

Contusion of other and unspecified parts of foot

183

1164

1.62

8.28

2.4

2.2

4.92

7.60

ug/l

2.18

166

1045

Plantar fascial fibromatosis

371

2712

1.40

8.26

2.6

2.1

5.22

8.39

ug/l

3.03

328

2406

Other diseases of blood and blood-forming organs, wide

977

8085

1.23

8.21

2.4

8.66

7.48

ug/l

0.57

832

7109

Acute bronchiolitis

153

836

1.69

8.21

3.2

2.0

6.77

6.33

ug/l

0.11

127

712

Disturbances of smell and taste

181

1157

1.63

8.19

2.5

2.2

6.21

7.76

ug/l

0.80

159

1046

Fracture at wrist and hand level

1427

12153

1.18

8.18

2.4

2.3

7.75

8.07

ug/l

0.16

1250

10779

Chalazion

460

3483

1.35

8.17

3.0

2.2

5.58

7.99

ug/l

2.76

394

3112

Other viral hepatitis

212

1399

1.56

8.16

2.4

2.2

10.39

8.30

ug/l

0.40

190

1272

Salpingitis and oophoritis

586

4578

1.30

8.16

2.5

2.2

5.45

6.23

ug/l

0.50

508

4009

Follicular cysts of skin and subcutaneous tissue

775

6266

1.26

8.14

2.4

2.3

6.12

7.63

ug/l

1.59

695

5548

Behavioural disorders

301

2.25

8.13

2.6

2.0

13.85

8.24

ug/l

0.34

269

Evidence of alcohol involvement determined by blood alcohol level

351

2.20

8.13

3.8

2.3

5.04

8.82

ug/l

2.31

322

Other disorders involving the immune mechanism, not elsewhere classified

141

850

1.74

8.13

2.3

2.4

6.57

8.05

ug/l

0.33

123

777

Weight loss

472

3600

1.35

8.09

2.4

6.81

7.15

ug/l

0.09

384

3165

Anomalies of dental arch relationship, including avohilmo

623

4426

1.29

8.08

2.1

2.3

6.41

7.41

ug/l

0.45

549

3941

Dissocial personality disorder

372

2.15

8.08

2.9

2.1

6.09

10.96

ug/l

1.27

349

Endometriosis of pelvic peritoneum

430

2921

1.36

8.04

2.0

2.2

3.65

7.16

ug/l

6.33

364

2578

Other inflammation of eyelid

618

4878

1.29

8.04

2.7

2.3

6.08

7.87

ug/l

2.00

520

4289

Total colectomy operation

181

1163

1.62

8.04

2.6

2.3

4.95

7.75

ug/l

1.90

158

1053

Total colectomy

181

1163

1.62

8.04

2.6

2.3

4.95

7.75

ug/l

1.90

158

1053

Gestational [pregnancy-induced] hypertension

618

4846

1.29

8.03

2.1

2.0

4.95

5.86

ug/l

0.72

568

4199

ILD, hospital admissions 1, main diag only

712

5733

1.27

8.00

2.7

2.4

11.73

7.11

ug/l

4.86

630

4997

Unspecified jaundice

235

1599

1.53

7.98

2.7

2.2

4.96

8.42

ug/l

3.14

206

1409

Postzoster neuralgia

539

1.97

7.98

3.4

2.5

5.27

6.51

ug/l

0.30

465

Congenital malformations and deformations of the musculoskeletal system

255

1742

1.49

7.97

2.0

2.2

9.38

6.93

ug/l

0.70

225

1538

Pneumonia due to Streptococcus pneumoniae

187

1212

1.60

7.97

3.3

2.2

5.60

7.96

ug/l

1.60

160

1077

Drug-induced cataract

113

646

1.86

7.96

2.9

2.4

11.37

7.34

ug/l

0.90

101

584

Dementia due to Parkinsons disease, excluding more controls

120

698

1.82

7.94

2.5

2.3

5.93

7.07

ug/l

0.43

627

Scabies, including avohilmo

475

3621

1.33

7.90

2.6

2.2

7.18

7.52

ug/l

0.10

424

3239

Other disorders of adrenal gland

188

1223

1.60

7.87

2.9

2.3

5.60

6.99

ug/l

0.65

163

1092

Medial epicondylitis

150

924

1.69

7.86

2.3

2.1

4.89

8.38

ug/l

3.26

137

830

Cluster headache, strict, including avohilmo

180

1157

1.61

7.86

2.6

2.1

4.95

7.80

ug/l

1.26

153

1047

Protozoal diseases

148

915

1.71

7.85

2.4

2.5

8.12

7.72

ug/l

0.09

133

830

Mixed disorders of conduct and emotions

216

2.43

7.79

1.9

3.74

6.77

ug/l

1.18

182

Ptosis of eyelid

544

4254

1.31

7.78

2.5

2.4

5.86

7.47

ug/l

1.43

463

3729

Other and unspecified disorders involving the immune mechanism, not elsewhere classified

131

784

1.76

7.78

2.3

4.28

8.13

ug/l

4.18

114

718

Assault by sharp object

370

2.12

7.75

2.4

2.1

10.15

9.61

ug/l

0.05

342

Polymyositis

216

2.57

7.73

3.1

2.2

17.25

6.95

ug/l

2.11

191

Infections of genitourinary tract in pregnancy

260

1805

1.47

7.72

2.1

2.3

4.36

5.77

ug/l

0.79

243

1559

Other keratitis

439

3329

1.35

7.72

2.5

2.3

7.85

7.79

ug/l

0.01

399

2974

Protozoal diseases, including avohilmo

151

942

1.69

7.72

2.4

2.5

8.15

7.62

ug/l

0.13

135

855

Disorders of conjunctiva

3614

25398

1.11

7.71

2.5

2.3

7.17

7.22

ug/l

0.04

3093

22317

Heterophoria

283

2000

1.45

7.71

2.4

2.2

5.78

7.28

ug/l

1.01

241

1789

Benign neoplasm: Skin of other and unspecified parts of face

489

3774

1.33

7.71

2.7

2.4

5.80

7.11

ug/l

0.60

399

3288

Other and unspecified injuries of abdomen, lower back and pelvis

372

2.12

7.69

2.9

2.4

7.33

7.79

ug/l

0.08

336

Psoriatic and enteropathic arthropathies

447

3400

1.34

7.69

2.3

2.2

4.86

8.48

ug/l

7.57

394

3048

Disorder of external ear, unspecified

162

1028

1.65

7.67

2.5

2.4

7.86

7.52

ug/l

0.07

146

934

Sequelae of injuries of neck and trunk

139

849

1.72

7.67

2.2

2.3

6.55

7.47

ug/l

0.32

121

777

Severe visual impairment, binocular

157

2.92

7.66

2.6

2.9

5.11

6.76

ug/l

0.38

139

Diabetic neuropathy

617

4899

1.29

7.63

2.9

2.6

5.56

7.96

ug/l

4.59

557

4324

Exposure to other and unspecified inanimate mechanical forces

299

2142

1.43

7.60

2.4

2.3

8.25

8.01

ug/l

0.04

246

1939

Other and unspecified coagulation defects

189

1239

1.58

7.60

1.9

2.3

10.65

7.30

ug/l

0.85

162

1110

Emotional disorders and disorders of social functioning with onset specific to childhood

489

1.90

7.59

1.7

2.4

5.39

6.82

ug/l

0.36

408

Other viral hepatitis, including avohilmo

221

1495

1.52

7.59

2.3

2.2

10.07

8.23

ug/l

0.36

198

1359

Volvulus

141

868

1.71

7.58

2.9

2.4

6.54

7.30

ug/l

0.19

123

774

Orchitis and epididymitis

465

3575

1.34

7.57

2.7

2.3

11.14

8.84

ug/l

0.53

412

3204

Personal history of certain other diseases

220

2.41

7.54

2.0

2.1

4.44

5.30

ug/l

0.33

195

Complications following myocardial infarction

168

2.71

7.50

3.6

1.9

11.51

3.88

ug/l

0.85

128

Prurigo nodularis

127

765

1.76

7.48

3.1

2.5

8.06

7.58

ug/l

0.06

118

684

Varicose veins of other sites

286

2044

1.44

7.48

2.6

2.4

7.00

8.59

ug/l

0.79

243

1839

Psoriatic arthropathies

392

2941

1.36

7.45

2.3

4.98

8.69

ug/l

7.07

342

2632

Lichen planus, including avohilmo

842

6940

1.24

7.45

2.3

5.73

7.41

ug/l

2.42

730

6081

Seronegative rheumatoid arthritis

488

3780

1.32

7.42

2.3

5.61

7.74

ug/l

1.87

408

3315

Injury of eye and orbit

532

4160

1.30

7.41

2.5

2.3

6.50

8.65

ug/l

1.87

469

3745

Scabies

184

1207

1.58

7.40

2.5

2.3

6.77

9.06

ug/l

1.06

163

1096

Entropion and trichiasis of eyelid

459

3541

1.34

7.38

2.7

2.4

5.20

7.06

ug/l

2.83

381

3043

Alzheimer’s disease (Late onset)

1428

10140

1.18

7.38

2.5

2.6

5.95

6.00

ug/l

0.03

1068

8544

Abnormal findings in nipple discharge synovial fluid wound secretions

365

2.11

7.37

2.2

2.4

12.36

7.83

ug/l

0.89

324

Chronic laryngitis and laryngotracheitis

597

4747

1.28

7.35

2.4

2.3

6.93

7.54

ug/l

0.32

473

4165

Hyperuricaemia without signs of inflammatory arthritis and tophaceous disease

137

3.03

7.35

3.0

2.6

3.08

7.24

ug/l

1.53

125

Fourth [trochlear] nerve palsy

118

702

1.79

7.33

2.6

2.5

10.10

7.17

ug/l

0.28

101

630

Cluster headache, wide,, including avohilmo

190

1257

1.56

7.32

2.6

2.2

4.89

8.03

ug/l

1.53

161

1136

Abnormal findings on diagnostic imaging of central nervous system

203

1365

1.54

7.30

2.3

4.72

7.48

ug/l

2.63

180

1225

Nonalcoholic fatty liver disease

393

2962

1.36

7.28

2.2

2.3

6.70

8.12

ug/l

0.74

349

2673

Respiratory disorders in diseases classified elsewhere

382

2.09

7.28

3.1

2.4

13.83

7.33

ug/l

0.99

338

Car occupant injured in noncollision transport accident

138

850

1.69

7.27

2.4

2.3

9.66

7.86

ug/l

0.25

125

769

Other and/or unspecified nontoxic goitre

340

2511

1.39

7.27

2.4

6.04

6.42

ug/l

0.14

310

2186

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

555

2720

1.29

7.26

1.7

1.9

5.12

5.13

ug/l

0.01

475

2370

Lesion of sciatic nerve

227

1570

1.51

7.26

3.0

2.5

8.19

6.96

ug/l

0.21

203

1345

Nontoxic goitre/thyroid nodule

1280

10972

1.18

7.24

2.3

5.11

6.29

ug/l

2.12

1121

9392

Dermatitis due to substances taken internally

225

1547

1.50

7.24

2.3

5.48

7.46

ug/l

1.41

193

1368

Neuromuscular dysfunction of bladder

405

3073

1.35

7.23

2.4

2.2

5.71

7.95

ug/l

2.05

332

2746

Congenital malformations of the urinary system

222

1522

1.50

7.23

2.2

2.3

6.81

7.78

ug/l

0.39

201

1363

Blepharochalasis

1394

12038

1.18

7.21

2.5

2.4

5.73

7.06

ug/l

1.84

1196

10501

Other juvenile arthritis

103

584

1.81

7.20

2.1

2.2

5.31

6.68

ug/l

0.57

506

Intentional self-harm by sharp object

406

1.99

7.19

2.6

2.1

3.11

9.05

ug/l

4.91

365

Impacted cerumen

565

4485

1.29

7.19

2.1

2.4

6.27

7.19

ug/l

0.75

333

3947

Non-allergic asthma

355

2641

1.38

7.18

2.7

2.4

5.40

7.19

ug/l

1.85

324

2354

Pyothorax

221

1524

1.51

7.18

2.7

2.5

7.37

7.62

ug/l

0.08

196

1368

Persons with potential health hazards related to communicable diseases

800

9622

0.82

7.14

2.3

2.2

11.33

7.49

ug/l

1.89

683

8560

Other obstetric conditions, not elsewhere classified

575

2844

1.28

7.11

1.7

1.9

5.14

5.15

ug/l

0.00

494

2488

Iridocyclitis

948

7934

1.21

7.09

2.5

2.3

5.38

7.55

ug/l

4.82

840

6952

Hidradenitis suppurativa

121

724

1.73

7.07

2.2

2.1

6.04

7.90

ug/l

0.59

105

657

Toxic effect of other and unspecified substances

235

2.35

7.06

3.4

2.2

15.51

9.13

ug/l

0.73

216

Schizoid personality disorder

434

1.98

7.06

3.3

2.2

12.03

8.87

ug/l

0.21

395

Other disorders of the genitourinary system

548

4341

1.29

7.05

2.5

2.4

6.13

6.26

ug/l

0.06

462

3736

Open wound of shoulder and upper arm

513

1.89

7.03

2.7

2.3

7.91

7.71

ug/l

0.03

455

Primary_lymphoid and hematopoietic malignant neoplasms

1192

10198

1.19

7.01

2.4

6.99

7.39

ug/l

0.21

1023

8881

Adrenocortical insufficiency

155

994

1.62

7.00

3.1

2.4

5.03

6.99

ug/l

0.98

133

892

Anorexia

323

2.14

6.98

2.2

2.5

2.73

5.25

ug/l

3.07

280

Hyperplasia of prostate

1943

9640

1.15

6.98

2.5

2.3

7.88

9.30

ug/l

1.75

1699

8727

Oral leukoplakia and other epithelial disorders of tongue and oral cavity , including avohilmo

399

3041

1.35

6.96

2.1

2.4

10.82

7.33

ug/l

0.65

342

2714

Congenital malformations of the urinary system, including avohilmo

235

1642

1.47

6.94

2.1

2.3

6.93

7.69

ug/l

0.30

214

1473

Chronic viral hepatitis

166

1080

1.58

6.89

2.4

2.2

11.33

8.69

ug/l

0.41

150

983

Reactive arthropathies

333

2469

1.38

6.89

2.6

2.3

6.10

8.25

ug/l

1.89

286

2204

Meralgia paraesthetica

152

976

1.63

6.86

2.6

2.4

4.41

7.74

ug/l

3.54

134

882

Mixed specific developmental disorders

193

2.37

6.85

1.6

2.1

12.00

8.38

ug/l

0.34

162

Injury of muscle and tendon at wrist and hand level

554

4409

1.28

6.80

2.1

2.3

7.03

8.53

ug/l

1.11

506

3977

Deviated nasal septum

1434

12439

1.17

6.79

2.4

2.3

9.41

8.79

ug/l

0.25

1265

11165

Molar incisor enamel hypoplasia, with caries

3.45

6.74

3.0

1.5

19.32

6.86

ug/l

1.10

Bicipital tendinitis

206

1415

1.51

6.73

2.0

2.1

8.82

9.79

ug/l

0.22

176

1285

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

1753

15459

0.87

6.73

2.0

2.3

5.54

7.10

ug/l

2.85

1540

13604

Diffuse brain injury

132

820

1.66

6.71

2.4

2.2

7.63

9.11

ug/l

0.44

108

757

Vestibular neuronitis

385

2935

1.35

6.71

2.4

5.02

7.61

ug/l

3.51

341

2627

Personal history of risk-factors, not elsewhere classified

234

2.29

6.66

2.7

2.2

4.11

6.38

ug/l

1.02

211

Chronic conjunctivitis

129

802

1.68

6.66

2.8

2.3

3.94

7.77

ug/l

4.80

110

716

Other maternal disorders predominantly related to pregnancy

1602

8728

1.16

6.66

2.2

2.1

5.41

6.24

ug/l

0.89

1436

7607

Generalized skin eruption due to drugs and medicaments

165

1086

1.58

6.65

2.4

2.5

5.64

7.23

ug/l

0.74

138

958

Open wound of hip and thigh

132

824

1.66

6.65

2.2

8.02

8.78

ug/l

0.12

114

747

Sequelae of injuries of lower limb

361

2726

1.35

6.65

2.4

2.3

8.32

7.81

ug/l

0.13

323

2452

Burn and corrosion of hip and lower limb, except ankle and foot

574

1.81

6.63

2.2

2.4

4.59

8.64

ug/l

3.43

522

Evidence of alcohol involvement determined by level of intoxication

197

2.44

6.62

2.8

2.3

4.31

7.20

ug/l

1.72

178

Chronic nephritic syndrome

176

1178

1.56

6.62

2.7

2.4

5.03

7.86

ug/l

1.89

159

1062

Other drug-induced secondary parkinsonism

299

2.20

6.62

3.0

2.5

5.70

7.29

ug/l

0.46

271

Autoimmune hepatitis, wide definition

185

1247

1.53

6.62

2.1

2.3

7.64

7.43

ug/l

0.07

165

1116

Benign neoplasm of meninges

460

3599

1.31

6.61

2.6

2.4

6.53

6.62

ug/l

0.04

386

3124

Alzheimer’s disease (Early onset), excluding more controls

179

1128

1.54

6.57

2.6

2.3

6.53

6.75

ug/l

0.04

122

971

Other peripheral vascular diseases

321

2387

1.38

6.57

2.4

2.3

6.03

6.56

ug/l

0.31

276

2107

Additional codes for the location of defect, injury or illness

246

1756

1.45

6.54

2.5

2.4

3.57

7.25

ug/l

11.12

231

1575

Ankylosing hyperostosis [Forestier]

390

2.01

6.53

3.0

2.3

5.35

7.18

ug/l

0.70

348

147

2.59

6.52

2.4

1.8

3.64

7.00

ug/l

0.99

125

Melanocytic naevi, other sites/unspecified

325

2424

1.37

6.52

2.4

2.3

8.42

7.50

ug/l

0.20

299

2182

Caries of enamel

4178

25141

1.09

6.52

2.2

2.3

7.54

7.58

ug/l

0.03

3707

22314

Seropositive rheumatoid arthritis, strict definition

621

5035

1.26

6.51

2.4

2.3

6.16

7.16

ug/l

0.98

559

4420

Haemorrhagic disorder due to circulating anticoagulants

502

1.90

6.49

3.0

2.5

6.59

6.40

ug/l

0.05

433

Crohn's disease of small intestine

246

1754

1.44

6.48

2.5

2.2

7.03

7.85

ug/l

0.23

221

1595

Hydrocele

598

4837

1.26

6.48

2.6

2.4

10.00

8.48

ug/l

0.51

535

4311

Unspecified nephritic syndrome

104

618

1.78

6.47

3.0

2.4

6.68

7.84

ug/l

0.24

555

Systemic sclerosis (FG)

101

594

1.78

6.47

2.6

2.4

15.81

6.83

ug/l

0.55

531

Dislocation, sprain and strain of joints and ligaments of head

135

851

1.63

6.46

2.3

2.2

4.25

7.91

ug/l

4.01

120

761

Chronic tubulo-interstitial nephritis

162

1069

1.57

6.46

2.4

2.3

5.49

6.86

ug/l

0.61

136

915

Necrosis of pulp, including avohilmo

2331

20666

1.12

6.46

2.3

2.2

7.05

7.94

ug/l

1.15

2061

18421

Coeliac disease

450

3514

1.31

6.45

2.2

2.3

5.86

7.02

ug/l

0.95

391

3104

Other abnormalities of plasma proteins

494

1.89

6.44

2.5

6.28

7.50

ug/l

0.28

437

Abscess of anal and rectal regions

322

2402

1.37

6.43

2.2

9.83

9.07

ug/l

0.13

278

2192

Other diseases of gallbladder

210

1465

1.49

6.41

2.5

2.3

6.62

6.90

ug/l

0.09

173

1277

Ankylosing spondylitis

312

2317

1.38

6.40

2.8

2.2

5.12

9.75

ug/l

4.56

268

2092

Drug-induced hypoglycaemia without coma

472

1.90

6.38

2.0

2.5

7.97

7.86

ug/l

0.01

420

Other and specified injuries of hip and thigh

116

714

1.71

6.33

2.8

2.6

8.73

6.65

ug/l

0.20

614

Viral hepatitis

248

1779

1.43

6.32

2.4

2.3

9.65

7.98

ug/l

0.36

216

1618

Mental and behavioural disorders due to cannabinoids

417

1.90

6.31

2.1

2.0

3.10

10.16

ug/l

7.18

376

Lichen ruber planus, wide definition including periferal and oral lichen planus

967

8203

1.20

6.30

2.2

2.3

5.83

7.29

ug/l

2.15

837

7219

Optic atrophy

466

1.89

6.30

2.4

4.12

7.21

ug/l

2.50

414

Anaphylactic shock due to adverse effect of correct drug or medication properly administered

268

2.19

6.29

3.2

2.4

5.55

6.31

ug/l

0.10

242

Unspecified event, undetermined intent

103

613

1.76

6.29

2.3

9.08

7.38

ug/l

0.17

557

Scar conditions and fibrosis of skin

145

937

1.60

6.29

2.2

8.43

7.26

ug/l

0.21

132

843

Conjunctivitis (acute, non atopic), including avohilmo

4679

26138

1.09

6.29

2.4

2.3

5.91

7.60

ug/l

8.14

4087

23050

Other disorders of veins

1784

15550

1.14

6.28

2.4

2.3

7.89

7.03

ug/l

0.50

1458

13636

Secondary and unspecified malignant neoplasm of lymph nodes, including Hilmo

763

6349

1.23

6.28

2.2

2.5

7.43

8.23

ug/l

0.33

687

5607

Other nonscarring hair loss

202

2.37

6.26

2.2

2.0

10.54

4.39

ug/l

0.51

177

Assault by unspecified means

399

1.93

6.25

2.0

2.1

7.16

9.40

ug/l

0.32

365

Dislocation, sprain and strain of joint and ligaments of hip

182

1243

1.53

6.24

2.6

2.5

5.59

7.08

ug/l

0.72

162

1079

Congenital iodine-deficiency syndrome/hypothyroidism

128

809

1.65

6.23

2.8

2.5

5.51

6.14

ug/l

0.25

101

688

Nonspecific lymphadenitis

211

1476

1.47

6.22

1.9

2.2

6.49

8.45

ug/l

0.71

186

1334

Burns and corrosions confined to eye and internal organs

106

638

1.73

6.21

2.0

2.2

4.71

8.68

ug/l

3.22

582

Malignant neoplasm of digestive organs, including Hilmo

2246

14816

1.13

6.19

2.3

2.5

5.58

7.91

ug/l

8.86

1916

12985

Isolated proteinuria

122

764

1.67

6.17

2.8

2.4

6.19

7.61

ug/l

0.23

109

691

Suggestive for eosinophilic asthma

391

3024

1.32

6.15

2.4

2.2

6.45

8.08

ug/l

1.33

353

2704

Other bursitis of hip

101

604

1.76

6.15

2.6

2.3

5.52

7.22

ug/l

0.58

530

Benign neoplasm of mouth and pharynx

466

3686

1.29

6.14

2.5

2.4

6.43

7.83

ug/l

0.93

393

3271

Bronchiectasis

380

2935

1.33

6.13

3.1

2.3

6.95

7.39

ug/l

0.17

311

2536

Other and unspecified disorders of skin and subcutaneous tissue

262

1913

1.41

6.11

2.4

6.23

7.10

ug/l

0.45

184

1701

Nasal polyp

838

7045

1.21

6.08

2.3

7.19

8.09

ug/l

0.52

750

6260

Other intracranial haemorrhages

173

1179

1.54

6.08

2.9

2.6

4.03

6.33

ug/l

4.10

151

1030

Complications of genitourinary prosthetic devices, implants and grafts

108

658

1.72

6.08

2.8

2.4

4.78

6.87

ug/l

1.03

573

ILD and respiratory illness in diseases classified elsewhere

151

2.69

6.07

3.0

2.4

9.38

8.69

ug/l

0.07

139

Alzheimer’s disease, strict definition

1508

10695

1.15

6.07

2.5

2.6

5.72

6.18

ug/l

0.46

1125

9051

Pleural plaque

518

4167

1.28

6.07

3.0

2.4

6.23

7.05

ug/l

0.61

440

3639

Toxic effect of alcohol

561

1.78

6.05

3.1

2.3

4.86

8.95

ug/l

3.54

513

Other and unspecified intracranial injuries

140

910

1.60

6.05

2.7

2.3

6.12

7.77

ug/l

0.79

124

813

Acute generalized exanthematous pustulosis

183

1257

1.51

6.03

2.3

2.5

5.94

7.20

ug/l

0.55

154

1106

Hypoparathyroidism

164

1105

1.55

6.03

2.5

2.4

7.99

6.57

ug/l

0.35

133

957

Other and unspecified trigeminal disorders

385

1.95

6.01

2.7

2.5

6.02

7.05

ug/l

0.20

344

Immunodeficiencies

182

1249

1.50

6.01

2.6

2.3

5.01

7.45

ug/l

2.31

157

1120

Viral hepatitis, including avohilmo

256

1863

1.40

6.00

2.4

2.3

9.40

8.22

ug/l

0.24

223

1687

Other salmonella infections

153

1015

1.56

6.00

3.0

2.2

6.68

7.91

ug/l

0.35

127

900

Perforation of tympanic membrane

400

3112

1.31

5.99

2.4

5.40

7.18

ug/l

1.77

334

2751

Emphysema

370

2857

1.33

5.98

3.1

2.3

9.27

7.97

ug/l

0.57

319

2495

Other and unspecified hypertrophic disorders of skin

138

2.68

5.98

1.9

2.1

7.62

6.11

ug/l

0.28

125

Acute and subacute iridocyclitis

772

6452

1.21

5.96

2.6

2.3

5.57

7.66

ug/l

3.63

691

5689

Idiopathic pulmonary fibrosis

410

3215

1.32

5.96

2.6

2.5

14.07

7.25

ug/l

6.31

364

2755

Acute nasopharyngitis (common cold)

425

3301

1.30

5.96

2.4

2.1

6.70

9.74

ug/l

3.32

382

3021

Herpesviral keratitis and keratoconjunctivitis

194

1353

1.49

5.96

2.3

2.4

6.28

7.39

ug/l

0.35

166

1211

Convalescence

205

1441

1.46

5.94

2.4

2.2

7.57

6.62

ug/l

0.15

167

1291

Abnormal weight loss

426

3351

1.30

5.92

2.5

2.4

7.27

7.23

ug/l

0.01

344

2943

Thyrotoxicosis with diffuse goitre

481

3827

1.28

5.91

2.2

8.27

6.40

ug/l

0.65

408

3340

Other renal tubulo-interstitial diseases

579

1.75

5.89

2.6

2.4

7.21

6.57

ug/l

0.13

505

Other and unspecified nail disorders

104

634

1.72

5.88

2.5

2.4

6.68

7.36

ug/l

0.13

565

Pediculosis, acariasis and other infestations, including avohilmo

563

4559

1.25

5.87

2.5

2.3

7.09

8.01

ug/l

0.35

501

4069

Other and unspecified injuries of wrist and hand

140

913

1.58

5.86

2.2

6.40

6.85

ug/l

0.15

123

809

Erectile dysfunction

422

3331

1.31

5.86

2.8

2.5

21.03

8.15

ug/l

4.76

386

2960

Adhesive middle ear disease

359

1.97

5.86

2.8

2.3

3.96

7.86

ug/l

1.92

322

Other congenital malformations, including avohilmo

399

3103

1.31

5.86

2.3

2.2

10.01

6.59

ug/l

1.53

360

2758

Epidural haemorrhage

202

2.33

5.86

2.7

2.3

5.38

8.56

ug/l

1.04

183

Campylobacter enteritis

121

767

1.65

5.85

2.6

2.3

5.31

7.66

ug/l

1.10

107

691

Drug-induced adrenocortical insufficiency

477

1.84

5.84

2.9

2.4

6.30

7.72

ug/l

0.29

428

Other specified/unspecified inflammatory spondylopathies

142

928

1.57

5.83

2.2

2.0

9.93

8.19

ug/l

0.12

125

829

Other crystal arthropathies

108

670

1.71

5.83

3.0

2.6

4.01

6.42

ug/l

2.06

586

Inflammatory disease of cervix uteri

235

1700

1.42

5.81

2.1

2.3

4.13

5.66

ug/l

1.45

186

1473

Disorders of optic nerve and visual pathways

348

2669

1.33

5.79

2.4

2.3

5.64

7.08

ug/l

1.25

301

2370

Pemphigoid

150

1005

1.57

5.79

2.3

2.5

5.14

6.35

ug/l

0.59

122

875

Monoclonal gammopathy of undetermined significance (MGUS), including Hilmo

254

1871

1.41

5.79

2.5

5.76

7.61

ug/l

1.20

223

1628

Eosinophilic disease (BM)

354

1.97

5.77

2.5

2.2

18.19

7.27

ug/l

0.46

322

Dental pulpitis, including avohilmo

3729

21980

1.09

5.77

2.2

6.04

8.07

ug/l

6.99

3293

19622

Superficial injury of neck

381

1.91

5.76

2.7

2.3

14.39

7.97

ug/l

0.27

348

Crohn disease (strict definition, require KELA, min 2 HDR)

210

1490

1.44

5.74

2.3

2.2

6.06

7.44

ug/l

0.43

180

1352

Sudden idiopathic hearing loss

446

3542

1.29

5.73

2.4

2.3

6.51

7.54

ug/l

0.69

368

3130

133

871

1.62

5.73

3.3

2.6

5.72

6.86

ug/l

0.51

107

761

Other fall from one level to another

894

7594

1.19

5.68

2.5

2.4

8.22

7.86

ug/l

0.15

795

6701

Iliotibial band syndrome

231

2.20

5.67

2.2

5.31

7.33

ug/l

0.37

215

Obstructive hydrocephalus

401

1.91

5.66

2.4

7.52

7.27

ug/l

0.03

356

Optic atrophy, wide definition

497

1.81

5.66

2.4

4.08

7.60

ug/l

3.22

441

Histrionic personality disorder

119

2.82

5.64

3.2

2.4

6.83

5.04

ug/l

0.16

106

Crohn disease (strict definition, require KELA)

213

1520

1.43

5.64

2.3

2.2

6.04

7.48

ug/l

0.46

183

1380

Congenital malformations and deformations of the musculoskeletal system, including avohilmo

319

2407

1.34

5.62

3.1

2.2

9.13

7.17

ug/l

0.64

272

2134

Thyroiditis

258

1904

1.39

5.61

2.4

2.2

6.66

6.67

ug/l

0.00

228

1674

Malignant neoplasm of vulva, including Hilmo

434

1.88

5.60

2.5

3.19

5.52

ug/l

1.93

373

Thyrotropin deficiency

233

2.19

5.58

2.2

3.16

7.64

ug/l

2.42

211

Oesophageal obstruction

174

1207

1.50

5.58

2.5

2.4

5.01

7.44

ug/l

2.43

152

1075

Bacterial, viral and other infectious agents, including avohilmo

333

2553

1.33

5.57

2.4

2.3

10.13

8.77

ug/l

0.37

295

2310

Other disorders of breast

435

3447

1.28

5.56

2.1

2.2

4.79

6.09

ug/l

0.78

366

2965

Dislocation, sprain and strain of joints and ligaments of knee

2335

19092

1.11

5.55

2.1

2.2

7.13

7.95

ug/l

0.74

2054

17057

IBD patients in KELA-register

801

6755

1.20

5.55

2.4

2.3

6.55

8.08

ug/l

1.45

712

6042

Pregnancy examination and test

293

1347

1.36

5.54

3.1

1.8

3.97

5.84

ug/l

1.36

261

1172

Scleritis

303

2.03

5.52

2.6

2.4

4.37

6.40

ug/l

1.30

275

146

2.64

5.50

3.0

2.3

9.91

7.97

ug/l

0.23

135

Divergent concomitant strabismus

273

2039

1.37

5.50

2.3

7.58

7.42

ug/l

0.03

234

1835

Vascular dementia (subcortical)

200

1430

1.46

5.50

2.6

4.60

5.93

ug/l

1.26

169

1226

Pneumonia derived septicemia

147

987

1.55

5.49

2.9

2.3

6.40

7.58

ug/l

0.48

121

874

Inguinal hernia, bilateral

527

4293

1.26

5.47

2.3

2.4

8.23

8.62

ug/l

0.11

473

3824

Perineal laceration during delivery

166

1942

0.68

5.46

1.6

1.9

4.22

5.36

ug/l

0.59

137

1684

Hypercalcemia

209

1507

1.44

5.42

2.6

4.81

7.17

ug/l

3.05

174

1322

Type 1 diabetes, strict (exclude DM2)

240

1750

1.39

5.41

2.0

7.52

8.13

ug/l

0.19

205

1565

Crystal arthropathies, rheuma endpoint

108

684

1.67

5.39

3.0

2.5

4.01

6.54

ug/l

2.15

597

Inguinal or femoral hernia, bilateral

534

4366

1.25

5.36

2.4

8.22

8.54

ug/l

0.09

479

3893

Other/unspecified enthesopathies, not elsewhere classified

347

2693

1.32

5.35

2.3

2.2

5.41

8.26

ug/l

3.70

299

2370

Bursitis of shoulder

108

681

1.65

5.35

2.5

2.2

6.49

7.69

ug/l

0.37

100

605

Type 1 diabetes, definitions combined

241

1762

1.38

5.34

2.0

7.49

8.02

ug/l

0.16

206

1573

Benign neoplasm: Cerebral meninges

409

3246

1.29

5.34

2.5

2.4

6.95

6.56

ug/l

0.16

338

2830

Intracranial and intraspinal abscess and granuloma

352

1.96

5.33

2.7

2.4

7.47

7.74

ug/l

0.04

313

Hypopituitarism

268

2006

1.37

5.33

2.5

2.3

6.33

8.44

ug/l

0.83

230

1818

Abnormal findings on examination of urine, without diagnosis

186

1316

1.46

5.31

2.6

2.4

5.90

7.37

ug/l

0.37

159

1173

269

3544

0.74

5.28

2.8

2.4

8.32

8.76

ug/l

0.13

239

3162

Muscle strain

127

832

1.58

5.28

2.3

2.2

7.54

7.94

ug/l

0.07

115

744

Residual foreign body in soft tissue

194

1381

1.44

5.28

2.4

2.2

4.83

9.72

ug/l

5.02

170

1253

Other superficial mycoses, including avohilmo

350

2719

1.31

5.27

2.4

2.2

9.82

7.47

ug/l

0.59

300

2431

Papilloedema, unspecified

529

1.73

5.24

2.1

2.5

3.49

6.97

ug/l

3.97

473

Tic and related disorders

145

2.43

5.24

2.2

2.0

5.92

8.83

ug/l

0.30

128

Anterior Iridocyclitis

814

6922

1.19

5.22

2.6

2.3

5.56

7.68

ug/l

3.95

723

6088

Pediculosis, acariasis and other infestations

227

1663

1.40

5.22

2.4

2.3

6.95

8.73

ug/l

0.83

202

1512

Thrombocytopenia, unspecified

318

2453

1.33

5.21

2.3

2.4

10.28

7.55

ug/l

0.90

277

2167

Collapsed vertebra, not elsewhere classified

249

2.15

5.20

2.3

2.4

5.65

6.53

ug/l

0.21

215

Crohn disease (strict definition, all UC cases excluded)

176

1234

1.46

5.20

2.1

2.3

5.40

7.58

ug/l

1.12

154

1116

Stenosis and insufficiency of lacrimal passages

393

3113

1.29

5.19

2.5

2.3

5.99

6.79

ug/l

0.35

336

2722

Other bullous disorders

121

791

1.60

5.18

2.4

2.5

6.49

7.18

ug/l

0.18

105

708

Type 1 diabetes, strict definition, subgroup 1

152

1030

1.49

5.16

1.9

6.93

7.91

ug/l

0.24

133

917

Biological medication for rheuma

563

4629

1.23

5.15

2.1

2.2

5.76

7.90

ug/l

2.50

497

4155

Post-traumatic wound infection, not elsewhere classified

124

816

1.58

5.15

3.6

2.4

8.97

8.13

ug/l

0.15

104

739

Oral lichen planus or lichen planus, and hypothyroidism or thyroxine medication

243

1809

1.38

5.12

2.4

2.3

4.93

6.38

ug/l

0.85

206

1582

Habit and impulse disorders

317

1.94

5.12

2.4

2.3

14.20

9.37

ug/l

0.24

293

Benign neoplasm of middle ear and respiratory system

345

2699

1.31

5.09

2.5

2.4

8.61

8.02

ug/l

0.10

310

2401

Other and unspecified noninflammatory disorders of ovary, fallopian tube and broad ligament

463

1.76

5.08

2.2

4.45

7.32

ug/l

1.64

411

Specific development disorders of speech and language

167

1120

1.47

5.05

2.6

2.4

5.51

7.17

ug/l

0.79

145

973

L02BG Aromatase inhibitors

927

10599

0.85

5.05

2.0

2.3

3.93

5.91

ug/l

8.99

773

9111

Inflammatory disorders of male genital organs, not elsewhere classified

417

1.84

5.04

2.2

2.3

6.28

9.62

ug/l

0.98

374

Primary biliary cholangitis, wide definition

590

1.68

5.04

2.1

2.3

12.49

6.80

ug/l

0.61

523

Rosacea

464

3753

1.26

5.04

2.4

2.3

7.32

6.82

ug/l

0.10

408

3334

ILD-related respiratory insufficiency

178

1269

1.47

5.03

2.8

2.5

15.59

6.91

ug/l

4.23

162

1116

Anxious personality disorder

311

1.93

5.02

2.7

2.2

4.28

8.19

ug/l

1.60

279

Other congenital malformations of skin

135

907

1.53

4.99

2.4

2.3

10.17

7.48

ug/l

0.32

124

812

Carbimazole or st.post thyroidectomy, condition for graves disease

755

6403

1.19

4.99

2.3

9.09

7.05

ug/l

0.93

645

5613

Somnolence

300

1.97

4.98

3.5

2.4

6.79

8.04

ug/l

0.25

268

Hordeolum and other deep inflammation of eyelid

226

1668

1.39

4.98

2.7

2.2

8.75

7.72

ug/l

0.27

198

1508

Carcinoma in situ of skin of ear and external auricular canal

614

1.69

4.97

2.4

2.7

5.36

6.70

ug/l

0.55

543

Crohn's disease patients in KELA-register (KELA code 209, or 208 with ICD K50)

223

1641

1.39

4.96

2.3

2.2

5.91

7.59

ug/l

0.59

190

1487

Schizotypal disorder

453

1.76

4.95

2.4

2.2

5.29

8.40

ug/l

1.65

418

Supervision of high-risk pregnancy

421

2005

1.27

4.94

1.8

1.9

4.47

6.33

ug/l

1.44

369

1771

Osteonecrosis

275

2098

1.35

4.93

2.4

2.3

8.83

7.18

ug/l

0.37

234

1888

Other lack of coordination

472

1.77

4.92

2.7

2.4

6.80

7.99

ug/l

0.17

416

Cauda equina syndrome

353

1.89

4.91

3.5

2.5

6.11

7.20

ug/l

0.21

323

Crohn's disease of large intestine

175

1240

1.45

4.91

2.2

5.83

7.86

ug/l

0.89

152

1131

Exposure to smoke, fire and flames

107

689

1.62

4.90

2.5

2.4

5.08

8.56

ug/l

3.19

624

Other peripheral vertigo

397

3174

1.28

4.90

2.6

2.4

6.67

7.06

ug/l

0.16

334

2797

Adenocarcinoma of pancreas

1118

0.57

4.89

2.3

2.6

3.78

7.57

ug/l

3.73

982

Other and unspecified bullous disorders

289

2.00

4.88

2.2

2.5

7.06

5.57

ug/l

0.22

258

Other inflammation of eyelid, including avohilmo

1628

14569

1.13

4.88

2.4

2.2

7.38

7.58

ug/l

0.10

1391

12862

Viral infections of the central nervous system, including avohilmo

285

2184

1.33

4.86

2.7

2.3

5.61

7.12

ug/l

1.09

240

1955

Disorders of speech understanding and production

137

909

1.52

4.86

2.8

2.6

5.33

7.19

ug/l

0.76

120

795

Achalasia of cardia

489

1.74

4.85

2.7

2.3

3.59

7.80

ug/l

3.94

432

Impacted teeth

429

2950

1.26

4.83

2.0

2.1

6.60

7.02

ug/l

0.13

386

2579

Systemic sclerosis, icd10

101

645

1.64

4.81

2.6

2.4

15.81

6.59

ug/l

0.57

571

Allergic rhinitis

918

7817

1.17

4.81

2.2

6.33

7.61

ug/l

1.09

795

6938

Bacterial, viral and other infectious agents

307

2380

1.32

4.80

2.4

2.3

9.84

8.51

ug/l

0.35

272

2161

Later onset COPD

1595

11478

1.13

4.78

2.8

2.5

5.57

7.01

ug/l

4.69

1305

9877

Fall on same level involving ice and snow

2567

23524

1.10

4.78

2.5

2.3

7.41

7.28

ug/l

0.09

2172

20663

Recurrent dislocation and subluxation of joint

201

1462

1.40

4.78

2.0

2.2

5.58

7.89

ug/l

1.03

169

1317

Dementia in other diseases classified elsewhere

227

1695

1.38

4.78

2.6

2.4

5.73

7.39

ug/l

1.00

131

1496

Paraplegia, diplegia of upper limbs

632

1.64

4.75

3.6

2.4

6.77

8.05

ug/l

0.36

562

Frostbite

277

2.00

4.75

2.2

5.53

9.00

ug/l

1.17

249

Implicit parasitic Sepsis, including avohilmo

155

2.40

4.75

2.6

2.4

9.48

6.49

ug/l

0.56

132

Emotional disorders starting during childhood or adolescence

503

1.68

4.75

1.7

1.9

6.70

7.00

ug/l

0.05

433

Benign neoplasm of other and unspecified endocrine glands

550

4564

1.23

4.74

2.5

2.3

5.48

7.86

ug/l

2.14

490

4058

Previous suicide attempt

193

2.18

4.73

2.4

2.3

3.12

8.72

ug/l

2.96

182

Other Crohn's disease

228

1698

1.37

4.72

2.3

2.2

6.76

7.71

ug/l

0.29

202

1546

Inflammatory bowel disease, strict (require KELA)

801

6857

1.18

4.72

2.4

2.3

6.55

7.95

ug/l

1.26

712

6122

Pathological/recurrent dislocation and subluxation of joint, not elsewhere classified

236

1765

1.36

4.71

2.0

2.2

6.21

8.20

ug/l

0.88

200

1590

Benign neoplasm: Larynx

144

998

1.50

4.70

3.0

2.6

5.52

7.27

ug/l

1.01

132

893

Other encephalitis

112

736

1.58

4.69

2.3

2.4

4.28

7.91

ug/l

3.58

652

Congenital deformities of feet

475

1.72

4.69

2.3

12.58

7.71

ug/l

0.44

433

Pleural plaque with presence of asbestos

390

3140

1.28

4.69

3.0

2.5

5.65

7.39

ug/l

1.89

329

2748

Drug-induced osteoporosis

382

1.84

4.67

2.2

2.6

10.05

6.34

ug/l

0.58

333

Autoimmune hyperthyroidism

210

1548

1.39

4.66

2.2

9.65

6.38

ug/l

0.56

171

1369

Colitis due to radiation

340

1.90

4.62

2.9

2.5

5.25

8.25

ug/l

1.18

301

Injury of urinary and pelvic organs

581

1.66

4.62

2.4

10.21

8.16

ug/l

0.28

525

IgA nephropathy (IgA glomerulonephritis)

636

1.62

4.61

2.4

2.3

3.82

8.99

ug/l

5.35

585

Contusion of toe(s) without damage to nail

539

1.66

4.61

2.3

2.1

7.45

7.48

ug/l

0.00

485

Other and unspecified rosacea

342

2704

1.29

4.61

2.5

2.3

8.51

7.05

ug/l

0.24

298

2413

Implicit parasitic Sepsis

145

2.45

4.60

2.7

2.3

8.66

6.63

ug/l

0.32

126

Progressive vascular leukoencephalopathy

224

1687

1.38

4.56

1.7

2.6

6.31

5.45

ug/l

0.34

184

1419

Toxic liver disease

414

1.78

4.55

2.9

2.5

6.93

7.31

ug/l

0.07

371

Other forms of systemic lupus erythematosus

177

2.23

4.54

1.9

2.4

7.98

5.33

ug/l

0.42

157

Hyphaema and other vascular disorders of iris and ciliary body

104

681

1.60

4.52

2.7

2.5

5.83

7.41

ug/l

0.81

609

Psoriasis vulgaris

753

6447

1.18

4.52

2.5

2.3

6.49

7.95

ug/l

1.68

660

5740

L04AC Interleukin inhibitors

218

1625

1.37

4.52

2.1

2.2

4.63

8.88

ug/l

4.48

190

1484

Hypertrophy of breast in women and men

610

5124

1.20

4.51

2.2

4.35

6.92

ug/l

3.95

533

4513

Oesophageal varices

193

1420

1.41

4.50

2.3

2.4

5.88

8.34

ug/l

1.30

170

1286

Idiopathic thrombocytopenic purpura

124

841

1.53

4.50

2.7

2.4

4.95

6.81

ug/l

1.30

114

750

Contact with heat and hot substances

199

1466

1.39

4.49

2.4

2.3

6.40

8.10

ug/l

1.03

180

1324

Viral infections of the central nervous system

264

2027

1.33

4.49

2.6

2.3

5.71

7.24

ug/l

1.01

223

1814

Systemic sclerosis

101

657

1.60

4.47

2.6

2.3

15.81

6.39

ug/l

0.58

580

Cerebral palsy

245

1.99

4.47

2.4

2.3

7.49

7.89

ug/l

0.06

225

Other deformities of toe(s)

144

1006

1.48

4.47

2.4

3.65

6.96

ug/l

5.69

115

878

Other misadventures during surgical and medical care

108

714

1.58

4.47

2.2

2.4

7.35

7.62

ug/l

0.05

640

Other specified disorders of kidney and ureter

143

1000

1.48

4.46

2.9

2.4

6.92

7.88

ug/l

0.28

131

886

Glaucoma suspect

1743

15760

1.12

4.46

2.5

2.4

6.15

6.98

ug/l

0.74

1527

13675

Third [oculomotor] nerve palsy

605

1.64

4.45

2.6

2.4

4.55

7.07

ug/l

1.72

533

Benign neoplasm: Skin of lip

388

1.81

4.44

2.1

2.5

4.97

7.15

ug/l

0.82

345

Atopic dermatitis, strict definition with reimbursement

847

7021

1.17

4.42

2.1

7.19

7.73

ug/l

0.24

746

6211

Encephalitis

117

788

1.54

4.39

2.3

2.4

4.18

7.75

ug/l

3.77

698

Contact with hot air and gases

167

2.27

4.39

1.7

2.8

10.54

8.74

ug/l

0.21

151

Pneumococcal septicemia

141

986

1.48

4.38

2.9

2.5

6.48

7.40

ug/l

0.33

115

882

Other diseases of peritoneum

176

1279

1.42

4.38

2.5

2.4

4.75

7.12

ug/l

1.25

145

1130

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified, including avohilmo

173

1224

1.41

4.37

1.9

2.1

8.98

7.31

ug/l

0.29

146

1078

Keratitis and keratoconjunctivitis in other diseases classified elsewhere

160

1146

1.44

4.37

2.7

2.5

4.93

7.16

ug/l

2.24

133

1021

Type 1 diabetes, strict definition

160

1134

1.43

4.35

2.0

1.9

7.13

7.78

ug/l

0.16

140

1006

Other bacterial agents as the cause of diseases classified to other chapters

294

1.93

4.34

2.4

2.3

16.27

7.33

ug/l

0.57

258

Other acute viral hepatitis

278

1.93

4.33

1.9

2.3

5.66

8.97

ug/l

1.13

255

Beningn neoplasm: Meninges, unspecified

460

1.72

4.31

2.5

2.6

4.30

6.06

ug/l

0.78

402

Myelodysplastic syndrome, including Hilmo

161

1162

1.44

4.29

2.8

2.6

8.20

7.28

ug/l

0.13

131

1011

Scleritis and episcleritis

216

1623

1.36

4.29

2.2

4.84

7.25

ug/l

2.12

201

1453

Drug-induced obesity

181

2.17

4.28

2.2

2.6

3.52

5.08

ug/l

0.82

162

All dysplastic lesions of the vulva

142

996

1.46

4.28

2.2

3.48

5.82

ug/l

2.46

125

869

Cutaneous lupus erythematosus

640

1.59

4.27

2.8

2.4

4.98

7.50

ug/l

1.54

564

Other disorders of iris and ciliary body

129

893

1.50

4.27

2.8

2.5

6.21

7.22

ug/l

0.46

111

792

Dystonia

202

1505

1.38

4.27

3.3

2.3

3.83

7.20

ug/l

7.39

177

1351

Abscess of external ear

316

1.86

4.27

3.7

2.3

4.75

7.23

ug/l

0.70

289

Hyperkinetic disorders (excl. ADHD)

210

2.02

4.27

2.1

1.8

6.83

8.99

ug/l

0.39

186

Inflammatory disorders of breast

163

1169

1.42

4.26

2.0

2.1

3.88

5.96

ug/l

2.03

137

1024

Rash and other nonspecific skin eruption

363

2921

1.26

4.24

2.2

2.3

7.04

7.12

ug/l

0.03

325

2563

Calcification and ossification of muscle

3.23

4.23

2.6

2.2

2.29

12.75

ug/l

1.59

Brain meningioma, including Hilmo

222

1683

1.36

4.23

2.0

2.5

5.05

6.99

ug/l

1.93

196

1472

Other meningitis

361

1.79

4.23

2.3

4.75

6.42

ug/l

0.68

324

Corneal scars and opacities

125

863

1.50

4.20

2.5

5.76

7.37

ug/l

0.96

105

770

Superficial frostbite

170

2.22

4.19

2.1

2.2

5.46

10.68

ug/l

1.30

153

Malignant neoplasm of vulva

321

1.87

4.18

2.9

2.4

3.24

5.40

ug/l

1.29

272

Tonsillectomy and adenotomy

1654

10373

1.11

4.17

2.2

2.1

6.35

7.87

ug/l

1.65

1457

9272

Osteonecrosis due to drugs

482

1.70

4.14

2.2

2.6

7.25

6.20

ug/l

0.17

430

Nephrotic syndrome

125

865

1.50

4.13

2.3

2.5

4.85

7.56

ug/l

1.84

110

773

Infective bursitis

129

900

1.49

4.11

2.6

2.3

11.67

8.91

ug/l

0.18

112

814

Severe visual impairment, monocular

292

1.90

4.11

3.2

2.6

7.45

7.66

ug/l

0.02

261

Other vitreous opacities

180

1329

1.40

4.11

2.5

2.4

4.97

7.34

ug/l

2.78

155

1175

Type1 diabetes, definitions combined, early onset

124

847

1.48

4.10

2.1

1.9

5.61

8.20

ug/l

1.17

105

751

HSIL lesion of the vulva

426

1.72

4.10

2.0

2.3

2.47

5.39

ug/l

3.65

377

Injury of muscle and tendon at hip and thigh level

393

3203

1.25

4.10

2.5

2.3

8.53

8.42

ug/l

0.02

353

2899

Asthma mixed form (mode), excluding more controls

162

1170

1.41

4.10

2.0

2.1

3.99

7.20

ug/l

4.49

146

1022

malignant neoplasm of male genital organs

1265

8530

0.88

4.09

2.4

2.5

7.14

9.42

ug/l

3.39

1104

7669

Fibrosis of liver

214

2.07

4.09

2.6

2.3

7.84

8.61

ug/l

0.09

193

Complications predominantly related to the puerperium

631

5361

1.19

4.09

2.1

5.10

5.86

ug/l

0.47

560

4694

Congenital malformations of the respiratory system, including avohilmo

457

1.69

4.07

2.6

2.4

4.86

6.34

ug/l

0.71

406

Other congenital malformations of circulatory system

105

704

1.55

4.07

1.9

2.4

5.56

7.40

ug/l

0.71

640

Melanocytic naevi

1161

10317

1.13

4.07

2.4

2.3

8.65

7.42

ug/l

0.62

1031

9065

Intermittent heterotropia

166

1204

1.40

4.05

2.3

9.29

7.19

ug/l

0.32

136

1071

Viral encephalitis, not elsewhere classified/unspecified

553

1.62

4.05

2.7

2.5

4.51

7.43

ug/l

1.85

495

Syphilis

110

746

1.53

4.05

2.9

2.4

5.11

8.45

ug/l

3.28

675

Syphilis, including avohilmo

110

746

1.53

4.05

2.9

2.4

5.11

8.45

ug/l

3.28

675

Exposure to sunlight

3.13

4.02

2.5

2.9

6.07

5.35

ug/l

0.08

Erythema multiforme

585

1.60

4.02

3.5

2.5

6.46

7.38

ug/l

0.22

521

Psoriasis

1166

10379

1.13

4.01

2.4

2.3

5.92

8.10

ug/l

5.56

1028

9210

Spondylopathies in diseases classified elsewhere

377

1.77

4.01

2.8

2.2

5.38

7.50

ug/l

0.51

331

Other facial nerve disorders

113

771

1.52

4.01

2.7

2.4

4.90

7.78

ug/l

1.50

687

Juvenile arthritis (FINNGEN)

111

750

1.51

4.01

2.2

2.1

5.13

6.82

ug/l

0.86

660

malignant neoplasm of male genital organs, including Hilmo

1290

8655

0.89

4.00

2.4

2.5

7.21

9.43

ug/l

3.37

1127

7784

Combined immunodeficiencies

273

1.91

3.97

3.2

2.3

3.20

6.44

ug/l

2.38

243

Abscess of mediastinum

3.44

3.95

2.7

2.6

6.39

6.29

ug/l

0.01

Benign neoplasm: Liver

555

1.60

3.95

2.1

2.3

8.05

6.38

ug/l

0.31

497

Cardiomyopathy due to drugs and other external agents

3.49

3.94

3.6

2.6

7.45

4.32

ug/l

0.26

Nonsuppurative otitis media

666

4939

1.18

3.94

2.2

2.3

6.12

6.80

ug/l

0.46

565

4342

Malignant neoplasm of ovary, including Hilmo

253

1972

1.31

3.94

2.5

3.45

6.34

ug/l

5.73

221

1688

Distal bite

548

1.59

3.93

1.6

2.1

5.00

8.15

ug/l

1.48

474

Aspergillosis

268

1.93

3.92

2.4

14.32

9.07

ug/l

0.71

238

Other autoimmune haemolytic anaemias

388

1.75

3.91

2.3

2.6

5.21

6.82

ug/l

0.62

348

Viral meningitis, including avohilmo

115

789

1.49

3.91

2.3

6.56

7.57

ug/l

0.30

715

Other otitis externa (chronic)

262

2052

1.30

3.91

2.4

5.56

7.34

ug/l

1.58

193

1856

Nonpyogenic thrombosis of intracranial venous system

209

2.02

3.90

1.4

2.3

6.66

7.78

ug/l

0.18

189

Brain meningioma

214

1635

1.34

3.90

2.0

2.5

5.15

6.99

ug/l

1.70

189

1429

Perichondritis of external ear

544

1.62

3.90

2.9

2.5

5.78

6.23

ug/l

0.13

487

Aspergillosis, including avohilmo

276

1.91

3.89

2.5

2.4

14.05

8.89

ug/l

0.71

245

Agranulocytosis

436

3614

1.23

3.89

2.3

7.23

7.26

ug/l

0.01

373

3205

Viral encephalitis, not elsewhere classified/unspecified, including avohilmo

567

1.60

3.88

2.9

2.5

4.50

7.35

ug/l

1.84

509

Other and unspecified injuries of ankle and foot

137

973

1.44

3.87

2.4

2.2

6.40

7.25

ug/l

0.28

121

868

Other disorders of bladder

554

4700

1.20

3.86

2.5

2.3

5.76

7.94

ug/l

3.12

459

4174

Benign neoplasm: Other and unspecified parts of mouth

141

1013

1.44

3.84

2.6

2.5

5.16

7.41

ug/l

1.85

118

918

Hypoplasia of dental enamel

2.56

3.84

3.2

1.9

21.08

7.44

ug/l

0.93

Endometriosis ASRM stages 1,2

443

3672

1.22

3.83

2.0

2.1

3.63

5.77

ug/l

3.76

375

3196

Acne, including avohilmo

462

3099

1.21

3.82

2.3

2.1

6.90

6.30

ug/l

0.21

403

2721

Malignant neoplasm of prostate, including Hilmo

1279

8411

0.89

3.82

2.4

2.5

7.02

9.38

ug/l

3.88

1116

7563

Right hemicolectomy

273

2162

1.30

3.81

2.5

7.55

7.03

ug/l

0.14

242

1883

Malignant neoplasm of oesophagus, including Hilmo

185

1393

1.38

3.81

2.0

2.4

5.30

8.20

ug/l

2.50

155

1239

Benign neoplasm of major salivary glands

410

3389

1.23

3.81

2.6

2.4

5.71

7.48

ug/l

1.90

366

2990

Exposure to unspecified smoke, fire and flames

255

1.92

3.80

2.8

2.3

5.06

9.35

ug/l

1.75

231

Other symptoms and signs involving the urinary system

462

3863

1.22

3.79

2.5

2.4

7.44

7.74

ug/l

0.12

419

3445

Vascular dementia (other)

265

1.93

3.78

2.6

2.7

3.81

5.92

ug/l

0.98

236

In situ neoplasms

1835

16788

1.10

3.77

2.4

6.88

6.63

ug/l

0.15

1601

14485

Vascular dementia (undefined)

223

1706

1.33

3.76

2.6

4.42

5.50

ug/l

0.87

155

1415

Mental retardation, excluding more controls

104

679

1.51

3.76

2.3

2.2

5.23

9.23

ug/l

1.74

610

Congenital malformations of the respiratory system

413

1.69

3.75

2.5

2.4

4.53

6.76

ug/l

1.42

366

Urethritis and urethral syndrome

555

1.59

3.73

3.2

2.2

5.42

7.62

ug/l

0.48

494

Vulvovaginal ulceration/inflammation in other diseases

168

1240

1.37

3.73

2.4

2.1

3.11

5.81

ug/l

4.31

142

1091

Abnormal findings on diagnostic imaging of breast

376

1.73

3.73

2.8

2.3

2.79

5.62

ug/l

2.50

334

Ulcer of vagina/vulva

594

1.56

3.73

2.2

2.3

6.14

6.65

ug/l

0.14

521

Sleep disorders, other/unspecified

107

731

1.50

3.72

2.5

2.2

4.92

7.19

ug/l

1.10

656

Acute alcohol intoxication ICD-9

149

1087

1.42

3.72

3.3

2.5

5.92

7.79

ug/l

0.60

135

977

Pilonidal cyst

254

1990

1.29

3.72

2.3

2.2

5.53

8.90

ug/l

3.00

222

1811

Long labour

344

3588

0.81

3.72

1.8

2.0

4.92

5.62

ug/l

0.30

300

3148

Other and unspecified injuries of thorax

493

1.63

3.71

2.9

2.5

4.30

7.71

ug/l

2.55

442

Blindness or visual impairment, binocular

125

2.35

3.69

2.8

2.6

9.11

6.06

ug/l

0.31

112

Lagophthalmos

410

1.71

3.69

2.6

2.5

5.55

6.39

ug/l

0.25

366

Chronic diseases of tonsils and adenoids

3041

17862

1.08

3.66

2.3

2.2

6.35

8.07

ug/l

3.86

2686

15913

Carcinoma in situ of breast, intraductal

187

2455

0.75

3.66

2.0

2.3

4.72

6.06

ug/l

0.65

155

2121

Palmar fascial fibromatosis [Dupuytren]

709

6159

1.17

3.65

2.6

2.3

6.44

8.22

ug/l

1.82

592

5371

Conjunctivitis

3042

22834

1.08

3.65

2.3

6.82

7.18

ug/l

0.31

2600

20033

Other lesions of median nerve

127

906

1.45

3.65

2.5

4.55

7.69

ug/l

3.26

783

Supervision of normal pregnancy

282

2029

0.79

3.65

1.5

1.8

4.88

6.55

ug/l

1.21

245

1791

Redundant prepuce, phimosis and paraphimosis

875

7579

1.15

3.65

2.4

2.3

8.82

9.42

ug/l

0.20

783

6868

Cholesteatoma of external ear

238

1.95

3.64

2.3

2.6

6.97

7.48

ug/l

0.06

213

Procedures for purposes other than remedying health state

558

1.57

3.64

2.1

2.2

4.03

6.73

ug/l

1.84

504

Malignant neoplasm of retroperitoneum and peritoneum, including Hilmo

538

1.60

3.63

2.6

2.5

7.61

6.66

ug/l

0.12

471

Intercostal neuropathy

216

1.98

3.62

2.4

2.6

3.57

6.03

ug/l

1.43

191

Ménière disease

393

3254

1.23

3.61

2.5

2.4

6.44

6.89

ug/l

0.18

339

2856

Other and unspecified mononeuropathies of upper limb

114

797

1.47

3.60

2.7

2.3

12.00

7.81

ug/l

0.40

102

720

Reactive arthropathies, FINNGEN

243

1905

1.30

3.60

2.4

2.3

6.55

8.32

ug/l

0.89

207

1707

Chronic hepatitis, not elsewhere classified

131

940

1.43

3.59

2.0

2.3

5.55

7.63

ug/l

1.20

118

842

Portal vein thrombosis

483

1.63

3.58

2.4

4.18

7.36

ug/l

2.53

430

Ectopic pregnancy

452

3783

1.21

3.57

2.0

2.1

4.44

5.93

ug/l

2.02

383

3356

Other salmonella infections, including avohilmo

160

1186

1.38

3.57

3.0

2.2

6.53

7.96

ug/l

0.46

133

1057

Viral meningitis

109

755

1.48

3.57

2.3

2.2

6.41

7.65

ug/l

0.37

685

Malignant neoplasm of prostate

1263

8299

0.89

3.56

2.4

2.5

6.96

9.37

ug/l

3.88

1099

7458

Other/unspecified disorders of vestibular function

181

1371

1.36

3.56

2.5

2.4

6.85

7.40

ug/l

0.11

149

1215

Lactose intolerance, other/unspecified

601

1.54

3.55

2.1

2.2

3.76

6.67

ug/l

2.79

530

Congenital malformations of trachea and bronchus

254

1.88

3.54

2.9

2.3

5.57

ug/l

0.00

227

Mixed connective tissue disease

460

1.63

3.53

2.4

2.3

6.83

7.23

ug/l

0.08

403

Sixth [abducent] nerve palsy

153

1133

1.40

3.52

2.7

2.5

6.54

7.37

ug/l

0.15

134

1018

Vascular dementia (multiple infarctions)

444

1.64

3.51

2.9

2.7

4.11

6.52

ug/l

1.82

382

Aphakia

397

1.67

3.51

2.8

2.3

7.14

7.13

ug/l

0.00

347

Disorders of optic nerve, not elsewhere classified

656

1.53

3.50

2.9

2.5

4.95

7.36

ug/l

1.66

589

Malignant neoplasm of liver and intrahepatic bile ducts, including Hilmo

245

1938

1.30

3.50

2.5

6.71

7.96

ug/l

0.45

211

1684

Unspecified chronic bronchitis

156

1158

1.38

3.49

3.3

2.4

7.84

7.41

ug/l

0.04

132

1004

Injury of blood vessels of thorax

2.54

3.49

2.6

2.8

13.50

4.32

ug/l

0.87

Memory loss

420

3517

1.22

3.48

2.3

2.5

6.24

7.12

ug/l

0.30

348

3083

Polycystic ovarian syndrome, broad definition

185

1399

1.33

3.48

1.9

1.8

3.00

4.46

ug/l

1.63

160

1224

Other and unspecified nerve root and plexus disorders, also in other diseases

786

6895

1.15

3.47

2.4

2.2

6.29

8.40

ug/l

2.10

671

6137

Hodgkin lymphoma, hilmo

109

762

1.48

3.47

2.2

2.3

6.88

7.92

ug/l

0.34

690

Systemic sclerosis,strict definition

204

1.97

3.47

2.7

2.4

28.14

7.68

ug/l

0.44

179

Other specified and unspecified disorders of eyelid

424

1.66

3.46

3.0

2.4

5.39

7.83

ug/l

0.87

381

Maternal care for known or suspected fetal abnormality and damage

164

1855

0.74

3.46

1.5

2.0

16.04

5.50

ug/l

1.29

134

1624

Wide developmental disorders, excluding more controls

296

1.74

3.45

1.7

1.8

3.36

8.26

ug/l

3.43

254

Toxic effect of corrosive substances

102

2.41

3.44

2.4

2.3

5.96

8.74

ug/l

0.59

Primary biliary cholangitis (PBC)

567

1.55

3.43

2.0

2.4

12.07

5.96

ug/l

0.60

499

Multifocal fibrosclerosis

185

2.05

3.43

2.1

2.6

6.73

4.81

ug/l

0.35

159

Disorders of myoneural junction and muscle in diseases classified elsewhere

213

1.96

3.43

2.3

2.4

3.89

6.28

ug/l

0.79

189

Monoplegia

433

1.64

3.42

2.9

2.5

6.53

7.18

ug/l

0.11

391

Torsion of ovary, ovarian pedicle and fallopian tube

321

1.72

3.41

2.4

2.2

1.61

7.74

ug/l

7.59

287

Primary open-angle glaucoma, strict

1348

12200

1.11

3.41

2.5

6.90

6.77

ug/l

0.06

1145

10412

Acquired absence of organs, not elsewhere classified

309

1.77

3.40

2.4

4.63

6.15

ug/l

0.61

275

Benign neoplasm of other and unspecified sites

133

968

1.42

3.39

2.3

2.5

6.58

7.34

ug/l

0.22

122

869

Labour and delivery complicated by intrapartum haemorrhage, not elsewhere classified

144

1059

1.39

3.37

2.5

2.1

3.75

5.70

ug/l

2.18

132

936

Other specified and unspecified disorders of eye and adnexa

150

1114

1.38

3.36

2.2

2.4

10.68

7.18

ug/l

0.48

124

983

Intentional self-harm by crashing of motor vehicle

5.51

3.35

1.8

2.5

3.46

5.14

ug/l

—

Lichen simplex chronicus

138

1013

1.40

3.34

2.4

2.3

4.75

7.84

ug/l

3.20

122

912

Vasculitis limited to skin, not elsewhere classified

108

761

1.47

3.33

2.6

2.5

5.62

7.10

ug/l

0.78

672

Congenital deformities of feet, including avohilmo

113

799

1.44

3.32

5.3

2.2

11.61

7.23

ug/l

0.55

720

Disorders of phosphorus metabolism and phosphatases

104

2.38

3.31

3.0

2.5

4.29

7.28

ug/l

1.26

Tic disorders

170

2.00

3.31

2.1

2.2

6.07

8.68

ug/l

0.25

145

Primary adrenocortical insufficiency

274

1.80

3.31

3.2

2.4

2.93

6.29

ug/l

2.43

246

Secondary uncertain malignant neoplasm

649

5651

1.17

3.30

2.2

2.5

7.25

7.70

ug/l

0.15

562

4918

Bullous pemphigoid

113

808

1.46

3.30

2.4

2.6

5.20

6.58

ug/l

0.50

708

Foreign body on external eye

552

4743

1.18

3.29

2.7

2.3

7.53

9.38

ug/l

1.00

508

4335

Arteriovenous malformation of cerebral vessels

290

1.78

3.29

1.8

2.4

6.45

7.20

ug/l

0.12

264

Benign neoplasm: Kidney

152

1137

1.38

3.29

2.6

2.5

4.69

7.19

ug/l

2.41

132

1014

Patent foramen ovale

483

1.58

3.29

2.5

2.3

14.81

8.13

ug/l

1.40

437

Lactose intolerance

669

1.49

3.28

2.1

2.2

3.75

6.95

ug/l

3.49

590

Benign neoplasm of urinary organs

203

1581

1.32

3.28

2.6

2.5

4.38

7.13

ug/l

4.08

170

1400

Benign neoplasm: salivary glands, exclude unknown (D119)

358

2969

1.23

3.28

2.6

2.4

5.74

7.67

ug/l

1.90

323

2630

Malignant neoplasm of corpus uteri

377

3146

1.22

3.26

2.5

5.08

6.03

ug/l

0.36

317

2636

Benign neoplasm: Liver/bile ducts

655

1.49

3.26

2.0

2.3

7.39

6.73

ug/l

0.12

580

Nosocomial condition (hospital)

167

2.07

3.25

1.9

2.4

3.00

9.26

ug/l

2.19

149

Degenerative conditions of globe

146

2.15

3.25

3.6

2.8

3.96

6.45

ug/l

0.83

123

Pedestrian injured in collision with car, pick-up truck or van

657

1.49

3.23

2.3

2.4

5.79

7.43

ug/l

0.55

584

Malignant neoplasm of corpus uteri, including Hilmo

407

3425

1.21

3.21

2.5

5.37

6.13

ug/l

0.29

342

2875

Hyperfunction of pituitary gland

144

1068

1.37

3.20

5.8

2.2

6.08

6.74

ug/l

0.17

123

956

Contracture of joint

338

1.70

3.20

2.4

2.5

7.21

7.87

ug/l

0.13

297

Other and unspecified injuries of shoulder and upper arm

125

910

1.41

3.18

3.7

2.3

8.78

7.86

ug/l

0.12

105

816

Medicines for HER+ breast cancer

1168

12028

0.90

3.17

2.1

2.3

3.73

5.91

ug/l

14.18

972

10322

Other bacterial agents as the cause of diseases classified to other chapters, including avohilmo

347

1.69

3.17

2.4

2.3

16.75

6.87

ug/l

0.71

306

Thyroiditis, unspecified

338

1.69

3.17

2.1

2.3

3.94

5.58

ug/l

1.02

300

Other benign neoplasms of connective and other soft tissue

367

3059

1.22

3.17

2.3

4.94

7.10

ug/l

3.21

320

2713

Abnormal serum enzyme levels

1513

13366

1.10

3.16

2.5

2.4

7.72

8.27

ug/l

0.50

1402

11906

Exposure to other and unspecified forces of nature

154

2.08

3.16

1.6

2.0

3.34

6.38

ug/l

2.88

137

Upper arm

2.97

3.15

2.7

2.3

1.76

5.83

ug/l

3.33

Senility

323

1.71

3.13

3.4

2.3

4.74

6.10

ug/l

0.54

261

Renal cell carcinoma of kidney

162

1235

1.35

3.13

2.9

2.6

4.45

7.46

ug/l

4.29

144

1083

Malignant neoplasm of urinary organs, including Hilmo

569

4936

1.17

3.10

2.5

4.99

7.90

ug/l

5.37

505

4330

therapeutic use

136

1012

1.39

3.08

2.2

2.5

5.95

6.65

ug/l

0.25

904

Tumor necrosis factor alpha inhibitors

471

4016

1.18

3.07

2.2

5.85

7.88

ug/l

1.89

417

3599

Endometriosis ASRM stages 3,4

685

6007

1.15

3.07

2.2

5.27

5.76

ug/l

0.23

575

5149

CR(E)ST syndrome

389

1.63

3.06

2.4

2.3

21.41

5.40

ug/l

0.59

345

Crushing injury of head

3.29

3.06

2.1

2.9

8.28

5.34

ug/l

0.43

Diastasis of muscle

169

1.98

3.06

2.6

2.1

3.91

8.59

ug/l

1.64

151

Oral leukoplakia, including avohilmo

117

851

1.42

3.05

2.3

2.5

5.12

7.53

ug/l

0.77

101

760

Malignant immunoproliferative diseases

345

1.70

3.05

2.7

2.8

12.11

6.94

ug/l

0.30

305

Other acute skin changes due to ultraviolet radiation

137

1021

1.38

3.05

2.2

2.4

6.62

6.79

ug/l

0.05

114

905

Other contact dermatitis

279

2271

1.25

3.05

2.4

2.3

5.00

7.04

ug/l

1.73

247

2013

Cachexia

157

2.06

3.03

2.1

2.3

4.27

7.48

ug/l

1.89

137

Polyhydramnios

587

1.49

3.03

2.1

2.0

2.07

5.25

ug/l

7.04

513

Actinomycosis

2.44

3.03

1.8

2.4

6.51

7.17

ug/l

0.05

Drug-induced interstitial lung disorders, unspecified

2.96

3.02

2.1

2.7

8.44

5.94

ug/l

0.24

Effects of heat and light

215

1.88

3.01

2.3

2.6

7.38

5.94

ug/l

0.23

194

Other maltreatment syndromes

640

1.47

3.01

2.1

2.2

7.51

8.64

ug/l

0.30

590

Conductive hearing loss, unspecified

302

2484

1.24

3.00

2.3

5.98

7.45

ug/l

1.48

251

2208

Pedestrian injured in transport accident

264

2142

1.25

3.00

2.7

2.4

7.44

7.32

ug/l

0.03

228

1894

Contact urticaria

2.90

3.00

1.9

2.8

5.42

6.47

ug/l

0.13

Enteropathic arthropathies

518

1.53

3.00

2.7

2.2

3.56

8.13

ug/l

4.00

462

Other/unspecified soft tissue disorders related to use, overuse and pressure

103

733

1.44

3.00

1.7

2.1

7.28

7.98

ug/l

0.13

660

Primary angle-closure glaucoma

203

1604

1.30

2.99

3.0

2.5

5.14

6.99

ug/l

1.54

168

1383

Non-follicular lymphoma

430

3662

1.20

2.99

2.3

2.4

7.15

7.32

ug/l

0.04

367

3229

Disorders of globe

112

812

1.43

2.99

2.5

2.4

6.04

6.96

ug/l

0.37

706

Tuberculosis, wide, including avohilmo

331

2754

1.22

2.98

2.6

2.5

6.67

6.89

ug/l

0.06

273

2345

Other abnormal findings of blood chemistry

187

1460

1.31

2.98

2.7

2.4

14.07

7.13

ug/l

1.53

169

1313

Malnutrition

628

1.48

2.97

3.0

2.6

6.28

6.57

ug/l

0.08

541

Other congenital malformations of female genitalia

2.39

2.96

3.1

1.8

1.97

4.84

ug/l

1.85

Disorders of refraction and accommodation

930

8297

1.12

2.95

2.1

2.3

7.75

7.61

ug/l

0.06

818

7332

Use of levodopa decarboxylase inhibitor

698

6166

1.15

2.94

2.4

2.5

6.07

7.00

ug/l

1.07

538

5355

Primary open-angle glaucoma

1641

14556

1.09

2.94

2.5

6.72

6.68

ug/l

0.02

1372

12442

Tuberculosis, IBD comorbidity

314

2604

1.23

2.93

2.6

2.5

5.44

6.92

ug/l

1.55

258

2226

Foreign body in respiratory tract

176

1365

1.32

2.93

2.8

2.5

5.25

7.66

ug/l

1.10

154

1219

Malignant neoplasm of oesophagus

137

1032

1.38

2.92

1.8

2.5

5.28

8.29

ug/l

2.25

119

919

Use of ropinirole

160

1232

1.34

2.91

2.9

2.5

6.15

7.55

ug/l

0.68

130

1108

HSIL lesion of the cervix uteri, vagina or vulva

434

3694

1.18

2.88

1.9

2.1

6.09

5.47

ug/l

0.13

381

3220

Autonomic disorders

631

1.47

2.88

2.5

2.4

4.90

7.46

ug/l

1.01

564

Contact with blunt object, undetermined intent

131

2.10

2.88

2.9

2.1

6.13

8.19

ug/l

0.33

117

Tuberculosis, wide

326

2719

1.22

2.88

2.6

2.5

6.64

6.92

ug/l

0.07

268

2315

Myelodysplastic syndrome

479

1.56

2.87

3.1

2.6

10.61

6.57

ug/l

0.25

410

Amblyopia ex anopsia

123

908

1.38

2.87

2.3

2.4

6.39

7.27

ug/l

0.32

804

Hypertrophy of breast

468

4014

1.18

2.86

2.1

3.46

6.48

ug/l

10.78

401

3499

Other and unspecified aplastic anaemias

302

1.70

2.86

2.3

2.5

9.74

6.98

ug/l

0.42

266

Urethral stricture

272

2233

1.25

2.85

2.3

7.12

8.10

ug/l

0.52

232

1995

Polyarteritis nodosa and related conditions

349

1.64

2.84

4.2

2.2

5.23

7.06

ug/l

0.56

317

Unspecified lump in breast

522

4524

1.17

2.83

2.3

3.67

6.17

ug/l

8.72

445

3878

Anogenital herpesviral [herpes simplex] infection, including avohilmo

268

2187

1.24

2.83

2.0

2.2

7.17

6.63

ug/l

0.13

214

1946

L01XE Protein kinase inhibitors

223

1795

1.27

2.82

2.2

2.5

9.00

7.48

ug/l

0.40

197

1612

Disorders of eyelid in diseases classified elsewhere

119

879

1.39

2.81

3.0

2.3

4.95

7.31

ug/l

1.13

103

780

Lesion of plantar nerve

224

1801

1.27

2.81

2.5

2.3

3.69

6.99

ug/l

9.70

191

1580

Benign neoplasm: Peripheral nerves and autonomic nervous system

463

1.55

2.81

2.2

2.6

7.29

7.88

ug/l

0.10

416

Episcleritis

172

1339

1.31

2.79

2.0

2.2

4.99

7.26

ug/l

1.49

164

1203

Generalized epilepsy

119

878

1.38

2.79

1.9

2.2

7.08

7.67

ug/l

0.07

790

Melanocytic naevi of trunk

437

3743

1.18

2.78

2.6

2.3

11.28

7.62

ug/l

1.03

399

3346

Symptoms and signs involving appearance and behaviour

168

1.93

2.78

3.0

2.4

2.75

6.28

ug/l

2.66

145

Congenital malformations of the nervous system

357

1.61

2.77

2.3

2.2

7.37

7.30

ug/l

0.01

316

Viral agents as the cause of diseases classified to other chapters, including avohilmo

636

1.46

2.77

2.6

2.4

11.10

7.92

ug/l

0.52

567

Unspecified dementia

576

4522

1.16

2.76

2.7

2.5

6.45

6.29

ug/l

0.06

432

3791

Vasomotor rhinitis (mode)

265

2174

1.24

2.75

2.0

2.4

4.87

7.11

ug/l

2.73

232

1948

Benign neoplasm: other/unspecified salivary gland

114

842

1.40

2.75

2.3

2.6

5.55

7.02

ug/l

0.65

102

744

Burn and corrosion confined to eye and adnexa

537

1.49

2.75

1.9

2.3

3.95

8.85

ug/l

4.54

492

Secondary and unspecified malignant neoplasm of lymph nodes

375

3182

1.20

2.75

2.2

2.5

8.83

8.11

ug/l

0.16

329

2798

Eosinophilia

449

1.55

2.75

2.5

2.4

18.09

6.77

ug/l

0.49

404

Malignant neoplasm of digestive organs

1998

14219

1.08

2.74

2.2

2.5

5.35

7.92

ug/l

10.21

1706

12435

Malignant neoplasm of kidney, except renal pelvis, including Hilmo

485

4202

1.17

2.74

2.5

5.18

7.72

ug/l

3.57

433

3691

Granulomatous disorders of skin and subcutaneous tissue

620

1.46

2.74

2.5

2.3

5.46

6.79

ug/l

0.57

551

Other nonthrombocytopenic purpura

291

1.71

2.74

3.3

2.8

6.02

7.13

ug/l

0.16

254

Other diseases of spinal cord

111

815

1.40

2.74

2.4

6.37

7.58

ug/l

0.37

735

Use of rivastigmine

874

7841

1.13

2.73

2.5

6.37

6.07

ug/l

0.17

679

6531

Single delivery by forceps and vacuum extractor

160

1238

0.77

2.73

1.7

2.1

4.76

7.46

ug/l

1.59

137

1069

Assault by blunt object

321

1.64

2.71

3.2

2.1

24.15

9.36

ug/l

0.56

294

Impotence

268

2211

1.24

2.70

2.6

2.4

10.44

9.42

ug/l

0.16

246

2028

Prolapse and hernia of ovary and fallopian tube

183

1434

1.30

2.70

2.9

2.6

5.87

6.10

ug/l

0.05

151

1178

Fistulae involving female genital tract

345

1.62

2.70

3.0

2.3

3.37

7.26

ug/l

3.18

305

Fitting and adjustment of external prosthetic device

2.43

2.69

2.5

2.7

6.99

7.44

ug/l

0.05

Malignant neoplasm of lip, including Hilmo

388

1.60

2.69

2.7

4.94

6.30

ug/l

0.73

338

Benign neoplasm: Middle ear, nasal cavity and accessory sinuses

164

1280

1.31

2.68

2.2

2.4

7.76

7.32

ug/l

0.09

147

1157

Congenital heart conduction disorder

4.49

2.68

1.5

2.0

10.45

3.47

ug/l

—

Dyshidrosis [pompholyx]

306

1.65

2.67

1.8

2.2

4.50

7.60

ug/l

1.11

274

Subacute thyroiditis

122

912

1.37

2.67

2.1

2.2

4.46

6.64

ug/l

1.57

109

811

Endometriosis of ovary

469

3810

1.17

2.66

2.1

2.2

4.00

6.74

ug/l

5.94

388

3335

Malignant neoplasm of bladder, including Hilmo

610

5311

1.15

2.66

2.5

5.74

7.83

ug/l

3.45

512

4625

Other and unspecified hydrocephalus

543

1.49

2.66

2.2

2.5

5.83

7.12

ug/l

0.17

480

Diseases of middle ear and mastoid

2092

15931

1.08

2.65

2.3

6.23

7.55

ug/l

1.69

1804

13999

Atlantoaxial subluxation

150

1.98

2.64

2.2

2.3

7.31

7.08

ug/l

0.03

140

Gestational diabetes (for exclusion)

686

4165

1.14

2.64

1.8

1.9

4.10

5.80

ug/l

1.61

609

3663

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

581

1.45

2.64

2.0

2.1

9.05

8.17

ug/l

0.14

520

Otitis media, unspecified

294

2246

1.22

2.63

2.1

2.3

5.99

6.87

ug/l

0.44

251

1995

Atopic dermatitis, strict definition

778

6792

1.13

2.62

2.1

2.2

7.52

7.46

ug/l

0.02

692

6006

Poisoning by and exposure to other and unspecified chemicals and noxious substances, undetermined intent

262

1.70

2.60

3.4

2.4

6.64

8.72

ug/l

0.50

246

Other psoriatic arthropathies

366

3112

1.19

2.59

2.3

4.92

8.28

ug/l

5.55

323

2808

Other and unspecified myoneural disorders

103

2.22

2.57

2.8

2.1

4.30

4.59

ug/l

0.09

Dermatitis herpetiformis

497

1.50

2.57

2.5

5.95

7.03

ug/l

0.31

451

Follow-up care involving plastic surgery

125

944

1.35

2.57

2.2

2.1

4.44

6.39

ug/l

1.17

841

Tic and related disorders

194

1.80

2.57

2.2

2.3

5.92

8.59

ug/l

0.28

169

Other degenerative diseases of the basal ganglia

676

1.44

2.56

2.1

2.7

8.53

7.11

ug/l

0.28

607

Morphin

724

1.41

2.55

3.1

2.3

4.19

7.21

ug/l

2.14

643

Other specified/unspecified bacterial intestinal infections

259

2140

1.23

2.55

2.4

6.45

7.28

ug/l

0.31

221

1900

Benign neoplasm: Brain, supratentorial

391

1.56

2.55

3.3

2.4

6.73

6.57

ug/l

0.03

352

Torticollis

302

1.63

2.55

2.9

2.2

6.78

8.97

ug/l

0.45

274

Sequelae of intentional self-harm, assault and events of undetermined intent

116

2.08

2.54

2.5

2.1

3.14

6.54

ug/l

1.45

106

Other and unspecified vasculitis limited to skin

682

1.42

2.54

2.6

2.5

5.57

7.30

ug/l

0.90

603

Sequelae of other and unspecified infectious and parasitic diseases

176

1393

1.29

2.54

2.3

2.2

9.30

8.16

ug/l

0.21

151

1261

Hypothyroidism due to medicaments and other exogenous substances

304

1.65

2.54

2.2

2.3

12.87

7.06

ug/l

0.49

266

Gingival hyperplasia

137

1052

1.33

2.54

2.3

8.71

7.62

ug/l

0.23

116

944

Psoriatic arthropathies, ICD10

372

3176

1.19

2.52

2.3

4.98

8.32

ug/l

5.51

327

2868

Drug-induced neutropenia

263

2180

1.23

2.51

2.3

2.4

7.22

7.46

ug/l

0.08

232

1962

Inflammation of lacrimal passages (chronic)

492

1.50

2.51

2.7

2.4

3.46

7.39

ug/l

3.66

428

Benign neoplasm: Adrenal gland

317

2675

1.21

2.51

2.5

2.4

5.86

7.39

ug/l

0.64

283

2399

Delivery

1198

6905

0.91

2.51

2.3

2.4

5.08

6.24

ug/l

2.03

1069

5782

Impacted maxillary molar

104

763

1.38

2.50

1.8

2.4

4.94

6.55

ug/l

0.75

662

Meningitis

174

1379

1.29

2.50

2.3

5.81

7.63

ug/l

0.93

148

1241

Prolonged pregnancy

169

1827

0.78

2.50

1.4

2.0

2.78

5.66

ug/l

4.13

137

1591

Carcinoma in situ of oral cavity, oesophagus and stomach

184

1.87

2.49

2.3

2.8

3.86

5.31

ug/l

0.69

163

Actinomycosis, including avohilmo

2.21

2.49

1.7

2.3

6.51

6.84

ug/l

0.03

Diffuse large B-cell lymphoma, including Hilmo

226

1852

1.25

2.48

2.4

2.5

10.73

7.95

ug/l

0.41

186

1627

Diffuse large B-cell lymphoma

226

1852

1.25

2.48

2.4

2.5

10.73

7.95

ug/l

0.41

186

1627

Diffuse large B-cell lymphoma, helper endpoint

226

1852

1.25

2.48

2.4

2.5

10.73

7.95

ug/l

0.41

186

1627

Sequelae of other and unspecified infectious and parasitic diseases, including avohilmo

177

1407

1.28

2.48

2.3

2.2

9.29

8.16

ug/l

0.21

152

1274

Allergic purpura

727

1.39

2.46

2.9

2.3

6.49

7.53

ug/l

0.20

648

Injury of nerves at shoulder and upper arm level

283

1.66

2.46

3.1

2.3

14.43

6.98

ug/l

0.59

255

Glaucoma, exfoliation

545

4804

1.15

2.45

2.4

2.5

4.85

6.61

ug/l

3.87

446

4002

Osteitis due to dental implant

238

1.74

2.45

2.9

2.6

6.28

5.88

ug/l

0.06

210

Pollen allergy

444

3788

1.16

2.45

2.0

2.1

6.60

7.12

ug/l

0.25

376

3363

Vascular dementia (mixed)

104

775

1.39

2.44

2.0

2.7

5.64

6.28

ug/l

0.16

676

Pneumoconiosis due to asbestos and other mineral fibres

106

792

1.39

2.44

3.1

2.5

6.88

6.50

ug/l

0.10

683

Abnormal findings on antenatal screening of mother

113

843

1.35

2.44

1.5

2.1

9.06

4.77

ug/l

0.30

104

724

Procreative management

836

7635

0.90

2.44

2.0

2.2

12.10

7.77

ug/l

2.33

734

6809

FESS (DNB20)

430

3722

1.17

2.44

2.1

2.3

7.00

8.07

ug/l

0.33

380

3374

Other disorders of prostate

168

1335

1.29

2.44

2.2

2.3

6.49

8.93

ug/l

1.69

160

1193

Other sexually transmitted chlamydial diseases, including avohilmo

105

1408

0.74

2.43

1.6

2.1

10.69

6.36

ug/l

0.70

1231

Melanocytic naevi of lower limb, including hip

151

1181

1.30

2.43

2.4

2.3

7.49

7.54

ug/l

0.01

131

1059

Alzheimer’s disease (undefined)

344

0.48

2.43

2.1

2.7

15.03

6.14

ug/l

—

273

Other surgical follow-up care

114

858

1.36

2.42

2.3

13.78

6.75

ug/l

0.75

767

Retinal detachment with retinal break

567

5014

1.14

2.40

2.5

2.4

8.38

7.73

ug/l

0.20

497

4413

Infections with a predominantly sexual mode of transmission

805

7228

1.12

2.40

2.1

8.23

7.26

ug/l

0.40

676

6405

Occupational exposure to risk-factors

136

1054

1.32

2.40

3.3

2.4

7.76

8.13

ug/l

0.09

117

968

Autism spe, excluding more controls

220

1.70

2.38

1.8

3.36

8.36

ug/l

2.43

191

Immunodeficiency with predominantly antibody defects

621

1.42

2.38

2.5

2.3

5.44

6.70

ug/l

0.57

557

Complications following abortion and ectopic and molar pregnancy

111

835

1.36

2.38

2.0

2.4

10.32

5.80

ug/l

0.58

745

Malignant neoplasm of kidney, except renal pelvis

427

3711

1.17

2.37

2.6

2.5

5.12

7.88

ug/l

3.57

381

3269

Benign neoplasm: Parotid gland

313

2654

1.20

2.36

2.7

2.4

5.95

7.46

ug/l

1.17

280

2359

Carcinoma in situ of vulva

201

1.77

2.35

1.5

2.3

3.15

4.67

ug/l

0.76

182

Malignant neoplasm of urinary organs

473

4143

1.16

2.35

2.6

2.5

5.00

7.76

ug/l

4.18

422

3635

Embedded and impacted teeth

593

4252

1.14

2.35

2.1

7.05

7.02

ug/l

0.01

534

3739

Other specified/unspecified disorders of bone/cartilage

105

786

1.37

2.35

2.5

2.3

6.08

8.16

ug/l

0.73

712

Other disorders of central nervous system

286

1.63

2.35

2.5

2.4

5.79

6.87

ug/l

0.26

259

Non-Hodgkin lymphoma, all, including Hilmo

612

5448

1.14

2.35

2.4

2.5

6.82

7.90

ug/l

0.45

531

4771

Mental disorders, not otherwise specified

218

1783

1.24

2.34

2.1

6.57

7.58

ug/l

0.44

195

1598

Motor neuron disease (with DMD)

489

1.47

2.34

2.6

2.3

12.94

7.29

ug/l

0.61

448

Other specified/unspecified necrotizing vasculopathies

417

1.52

2.34

2.5

2.4

5.28

7.49

ug/l

0.92

369

327

1.59

2.33

3.1

2.5

5.21

8.32

ug/l

1.16

296

Biomechanical lesions, not elsewhere classified

200

1628

1.25

2.33

2.4

2.5

9.99

7.43

ug/l

0.49

171

1459

Serous carcinoma of ovary, including Hilmo

130

1006

1.33

2.32

2.5

3.72

6.32

ug/l

2.38

114

881

Bilateral sagittal split ramus osteotomy operation

631

1.40

2.32

1.7

2.1

4.23

7.20

ug/l

2.11

574

Unspecified behavioural syndromes associated with physiological disturbances and physical factors +Physiological and behavioural factors associated with disorders of diseases classified elsewhere

294

1.61

2.32

2.7

2.1

11.04

7.74

ug/l

0.26

254

Female infertility, tubal origin

689

1.38

2.32

1.9

4.98

7.62

ug/l

0.72

625

Poisoning by medicine, drug-induced

295

1.62

2.32

2.2

4.22

7.85

ug/l

1.28

273

Malignant neoplasm of bronchus and lung

795

7347

0.90

2.30

2.3

2.5

6.54

7.81

ug/l

0.90

692

6376

Adalimumab

288

2425

1.20

2.30

2.1

2.2

6.30

7.98

ug/l

0.84

251

2187

Lymphoid leukaemia

236

1958

1.23

2.30

2.3

2.5

6.89

7.56

ug/l

0.17

195

1726

Malignant neoplasm of cervix uteri, including Hilmo

592

1.42

2.29

2.1

2.4

3.03

6.20

ug/l

3.82

521

Respiratory TBC, ICD-8 codes not specifying whether confirmed bacteriologically or histologically

128

992

1.33

2.28

2.7

2.6

4.11

6.39

ug/l

2.67

108

851

All dysplastic lesions of the cervix uteri, vagina or vulva

671

5849

1.12

2.27

2.0

2.1

5.75

5.67

ug/l

0.02

594

5093

Benign lipomatous neoplasm

1214

11192

1.09

2.27

2.4

6.57

7.56

ug/l

0.80

1075

9845

Other and unspecified acute skin changes due to ultraviolet radiation

106

801

1.36

2.27

2.4

2.5

6.42

7.38

ug/l

0.29

700

Anogenital herpesviral [herpes simplex] infection

154

1217

1.28

2.25

1.7

2.0

6.63

6.96

ug/l

0.06

116

1088

Oral lichen planus and hypothyroidism or thyroxine medication

494

1.46

2.25

2.2

7.24

6.98

ug/l

0.03

439

Other and unspecified mononeuropathies of lower limb

106

801

1.36

2.25

2.2

2.4

7.02

7.65

ug/l

0.08

714

Macular pucker

745

6727

1.12

2.24

2.8

2.4

7.03

7.18

ug/l

0.08

644

5898

Other disorders of white blood cells

205

1680

1.24

2.24

2.4

10.80

7.33

ug/l

0.41

178

1507

Acute myeloid leukaemia and myelodysplastic syndromes

114

873

1.35

2.24

2.8

2.6

7.98

6.86

ug/l

0.11

755

Acute lymphadenitis

170

1362

1.27

2.24

2.3

2.2

7.18

7.94

ug/l

0.20

153

1213

Femoral hernia

179

1447

1.26

2.24

3.6

2.4

7.09

7.01

ug/l

0.02

153

1274

Infection due to other mycobacteria, including avohilmo

495

1.46

2.24

3.1

2.5

8.31

7.50

ug/l

0.16

426

Corticotropin deficiency

220

1.72

2.24

2.7

2.5

3.21

6.35

ug/l

2.27

197

Mixed conductive and sensorineural hearing loss

521

4607

1.14

2.24

2.4

6.54

7.46

ug/l

0.49

417

4018

Ulcerative enterocolitis

101

757

1.36

2.24

2.5

2.3

3.80

8.22

ug/l

4.71

685

Hyperprolactinaemia

653

1.39

2.23

7.8

2.2

5.29

6.62

ug/l

0.29

590

Adenocarcinoma and ductal carcinoma of pancreas

105

1374

0.75

2.22

2.3

2.5

3.16

7.77

ug/l

9.34

1206

Barrett oesophagus

210

1729

1.24

2.22

2.0

2.3

7.08

8.51

ug/l

0.58

176

1558

Injury of nerves and spinal cord at neck level

709

1.38

2.22

2.3

10.52

7.61

ug/l

0.46

638

Other obstructed labour

176

1416

1.26

2.22

1.9

2.0

9.48

5.71

ug/l

0.38

154

1251

Female infertility

655

3497

1.13

2.21

1.9

2.1

4.90

7.17

ug/l

2.84

565

3081

Accidental poisoning by and exposure to other and unspecified chemicals and noxious substances

109

827

1.34

2.21

1.9

2.3

5.21

7.56

ug/l

1.47

743

Benign neoplasm of bone and articular cartilage

276

2327

1.20

2.21

2.3

6.36

7.52

ug/l

0.53

240

2096

Asthma mixed form (mode)

162

1293

1.27

2.21

2.0

2.1

3.99

7.81

ug/l

6.00

146

1138

Premature rupture of membranes

285

2404

0.84

2.21

2.0

5.02

5.67

ug/l

0.24

245

2100

Enteritis due to Yersinia enterocolitica

109

2.03

2.20

2.5

3.42

8.44

ug/l

2.17

100

Benign neoplasm: Other parts of oropharynx

229

1.69

2.19

1.9

2.5

4.79

5.90

ug/l

0.25

210

Female infertility, cervical, vaginal, other or unspecified origin

603

3423

1.13

2.19

1.9

2.1

4.85

7.20

ug/l

2.93

521

3021

Left hemicolectomy

103

781

1.36

2.19

2.3

2.5

8.36

6.78

ug/l

0.23

689

Atopic conjunctivitis

135

1056

1.30

2.18

2.4

2.2

6.47

7.32

ug/l

0.18

125

934

Special screening examination for infectious and parasitic diseases

495

3167

1.14

2.18

1.6

1.9

11.90

9.57

ug/l

0.59

386

2864

Injury of nerves at hip and thigh level

103

2.09

2.18

1.9

2.4

3.19

5.02

ug/l

0.57

Other and unspecified disorders of adult personality and behaviour

2.14

2.18

1.5

2.3

7.87

6.24

ug/l

0.21

Carcinoma in situ of skin, other sites/unspecified

585

1.43

2.18

2.1

2.6

11.91

6.19

ug/l

0.41

509

Lens-induced iridocyclitis

2.72

2.18

1.5

2.1

4.41

5.68

ug/l

0.28

Puerperal sepsis

352

3030

1.17

2.18

2.2

2.1

5.65

6.12

ug/l

0.15

318

2661

Hyperaldosteronism

116

894

1.33

2.17

2.5

2.4

14.66

6.78

ug/l

0.76

101

804

Fatigue fracture of vertebra

117

1.99

2.17

2.3

2.5

4.36

5.72

ug/l

0.72

103

Disorders of synovium and tendon in diseases classified elsewhere

608

1.40

2.16

2.9

2.2

8.22

8.10

ug/l

0.01

543

Abscess of lung

457

1.47

2.16

2.8

2.5

10.05

8.21

ug/l

0.34

411

Panniculitis, unspecified

261

1.63

2.16

3.0

2.2

4.27

7.35

ug/l

1.06

223

Benign neoplasm: Spinal cord

399

1.51

2.16

2.6

2.5

4.53

6.97

ug/l

0.89

358

Single spontaneous delivery

1201

6884

0.92

2.16

2.3

2.4

5.15

6.25

ug/l

1.84

1068

5766

Adenomyosis (Endometriosis of uterus)

411

3574

1.16

2.16

2.0

2.2

5.80

6.57

ug/l

0.35

346

3112

Personal history of malignant neoplasm

169

2090

0.80

2.16

2.1

6.30

5.58

ug/l

0.16

136

1816

conjunctival degenerations and deposits

653

1.39

2.14

1.9

2.4

3.33

7.27

ug/l

4.14

580

Parkinson's disease, strict definition

695

6273

1.12

2.13

2.3

2.5

6.34

7.02

ug/l

0.62

537

5460

Contusion of ankle

123

954

1.31

2.13

2.5

2.2

5.26

7.30

ug/l

1.06

116

852

Donors of organs and tissues

285

1.59

2.12

1.6

2.0

14.97

8.63

ug/l

0.40

260

Rare circulating lymphoid malignancy, including Hilmo

124

968

1.31

2.11

2.0

2.6

7.29

7.64

ug/l

0.05

104

853

Myeloid leukaemia

112

863

1.33

2.11

2.3

2.5

4.37

7.46

ug/l

2.61

771

Vitamin A deficiency

104

2.05

2.11

20.0

2.4

4.68

8.32

ug/l

0.51

Childhood allergy (age < 16)

191

1280

1.24

2.10

1.7

1.9

6.68

6.06

ug/l

0.17

160

1087

Injury of muscle and tendon at forearm level

501

1.44

2.10

2.1

2.4

14.52

8.58

ug/l

0.38

454

Acute nephritic syndrome

595

1.40

2.10

2.8

2.4

6.24

7.89

ug/l

0.29

540

Tibial collateral bursitis [Pellegrini-Stieda]

247

1.63

2.09

2.5

2.4

11.11

6.78

ug/l

0.37

224

Ovarian dysfunction

137

1077

1.28

2.09

2.1

1.9

6.15

4.67

ug/l

0.32

122

933

Vitiligo

247

1.63

2.09

2.1

2.3

4.79

7.96

ug/l

0.98

223

Burn and corrosion of head and neck

535

1.42

2.09

3.1

2.2

5.93

9.04

ug/l

1.31

489

Ulcerative proctitis

194

1592

1.24

2.08

2.1

2.2

4.55

7.93

ug/l

4.47

167

1447

Ulcerative rectosigmoiditis

269

2277

1.20

2.08

2.8

2.2

5.55

8.06

ug/l

1.80

242

2058

Use of rotigotine

338

1.55

2.07

2.6

2.4

7.66

6.41

ug/l

0.22

303

Spinal enthesopathy

119

923

1.31

2.07

3.0

2.3

5.09

6.41

ug/l

0.93

745

Cysts of oral region, not elsewhere classified

218

1815

1.22

2.06

2.2

2.4

6.82

8.38

ug/l

0.66

197

1645

Other disorders of amniotic fluid and membranes

229

1840

1.21

2.06

1.7

2.1

4.26

5.68

ug/l

0.46

208

1610

Other and unspecified iridocyclitis

168

1362

1.25

2.05

2.4

4.71

8.21

ug/l

4.41

151

1226

Cholesteatoma of middle ear

208

1727

1.23

2.05

2.4

5.94

7.72

ug/l

1.37

178

1534

Pituitary-dependent Cushing's disease

2.35

2.04

2.1

4.99

4.94

ug/l

0.01

Occlusion and stenosis of arteries, not leading to stroke

421

1.47

2.03

3.2

2.6

7.02

6.73

ug/l

0.04

364

Other melanin hyperpigmentation

685

1.37

2.03

2.0

2.5

8.34

7.15

ug/l

0.21

608

Livedoid vasculitis

106

2.03

2.0

2.4

7.89

6.71

ug/l

0.16

Erythema nodosum

745

1.34

2.01

3.5

2.3

4.75

6.59

ug/l

0.94

665

Flatulence and related conditions

234

1.64

2.01

2.3

3.42

8.22

ug/l

2.40

210

Other and unspecified pemphigoid

317

1.56

2.00

2.4

2.8

4.81

6.16

ug/l

0.43

275

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, including Hilmo

312

2691

1.18

1.99

2.5

6.12

7.78

ug/l

0.91

274

2341

Primary hyperparathyroidism

446

3941

1.15

1.98

2.3

2.4

5.41

6.68

ug/l

0.95

365

3423

Other congenital malformations of intestine, including avohilmo

267

1.59

1.98

2.2

7.21

6.37

ug/l

0.16

237

Human immunodeficiency virus [HIV] disease

483

0.60

1.98

1.8

2.1

8.15

9.70

ug/l

0.15

450

Other and unspecified psoriasis

260

2208

1.20

1.98

2.3

2.4

5.86

7.74

ug/l

1.74

230

1991

Malignant neoplasm of breast, ER-negative, including Hilmo

683

7052

0.90

1.97

2.2

2.4

4.96

5.82

ug/l

0.93

558

6017

Medical abortion

2115

10787

1.06

1.97

2.3

2.2

6.34

5.51

ug/l

0.97

1790

9270

Hirsutism in women

242

1.60

1.96

1.5

2.0

7.05

4.23

ug/l

0.36

215

Ethmoidectomy

443

3912

1.14

1.96

2.1

2.3

7.16

8.14

ug/l

0.30

392

3539

Other disorders of bone density and structure

627

1.37

1.95

2.4

2.3

6.58

7.45

ug/l

0.24

564

Other neurotic disorders

179

1471

1.24

1.95

2.2

2.3

5.89

7.64

ug/l

0.70

159

1317

HSIL lesion of the cervix uteri

356

3092

1.16

1.95

1.9

2.1

6.78

5.34

ug/l

0.28

317

2706

Contact with lifting and transmission devices, not elsewhere classified

518

1.41

1.94

2.3

2.2

7.11

9.04

ug/l

0.50

472

Juvenile osteochondrosis

609

1.37

1.94

2.3

2.2

5.07

8.43

ug/l

1.58

551

Chronic Coagulation defects

482

1.42

1.94

2.3

2.4

6.42

6.94

ug/l

0.10

431

Infection due to other mycobacteria

476

1.43

1.94

3.1

2.5

8.69

7.64

ug/l

0.21

410

Other mycoses, not elsewhere classified/unspecified, including avohilmo

484

1.42

1.93

2.4

2.3

11.42

7.61

ug/l

0.56

431

Protein-energy malnutrition of moderate and mild degree

278

1.58

1.93

2.7

4.24

8.23

ug/l

1.37

247

Benign neoplasm: Skin of scalp and neck

725

1.34

1.93

2.2

2.5

5.36

6.69

ug/l

0.47

657

Use of entacapone

275

0.49

1.92

2.3

2.6

3.79

6.67

ug/l

1.60

240

Benign neoplasm of ovary

588

5287

1.12

1.92

2.4

2.3

5.14

5.91

ug/l

0.55

508

4524

Injury of muscle and tendon at lower leg level

584

5251

1.12

1.92

2.5

2.3

10.82

8.66

ug/l

0.59

518

4751

Other acquired deformities of ankle and foot

206

1.67

1.92

2.8

2.6

7.73

7.14

ug/l

0.08

186

Pyogenic granuloma

417

1.45

1.91

2.2

2.4

4.08

8.41

ug/l

1.95

366

Sexual assault by bodily force

3.03

1.91

1.8

1.7

13.66

4.15

ug/l

—

Human immunodeficiency virus [HIV] disease, including avohilmo

490

0.62

1.91

1.8

2.2

8.15

9.60

ug/l

0.14

456

Vitamin B12 deficiency anaemia

452

4009

1.14

1.90

2.5

2.4

6.23

6.83

ug/l

0.26

369

3429

Isolated proteinuria with specified morphological lesion

311

1.54

1.90

2.6

14.40

6.64

ug/l

0.50

278

Nezelof syndrome

116

1.94

1.90

3.9

2.5

2.79

6.19

ug/l

2.40

104

Frontotemporal dementia, wide, incl. Pick's disease

216

1.67

1.89

3.3

2.5

6.91

8.41

ug/l

0.17

191

Simple and mucopurulent chronic bronchitis

168

1378

1.24

1.88

3.0

2.4

5.16

7.21

ug/l

1.44

136

1193

Antepartum haemorrhage, not elsewhere classified

145

1165

1.25

1.88

1.8

2.2

4.26

6.03

ug/l

0.70

126

1016

Sequelae of infectious and parasitic diseases

273

2339

1.18

1.88

2.5

2.4

9.30

7.52

ug/l

0.40

232

2042

Other specified disorders of external ear

163

1336

1.25

1.87

2.6

2.5

6.94

7.34

ug/l

0.14

130

1222

Other specified/unspecified deforming dorsopathies

385

1.46

1.87

2.3

2.2

34.09

7.53

ug/l

0.88

339

Sequelae of infectious and parasitic diseases, including avohilmo

281

2414

1.18

1.87

2.5

2.4

9.18

7.53

ug/l

0.37

237

2103

Fall on and from ladder

325

2827

1.17

1.87

2.6

2.4

7.75

8.44

ug/l

0.18

294

2557

Inflammation of lacrimal passages (acute and unspecified)

479

1.42

1.86

2.3

2.4

7.51

6.32

ug/l

0.25

420

Endocrine disorders, other/unspecified

475

0.62

1.86

1.6

2.4

6.37

6.69

ug/l

0.05

428

Secondary malignant neoplasm of respiratory and digestive organs, including Hilmo

873

8025

1.10

1.86

2.1

2.5

4.94

8.02

ug/l

5.88

766

7045

Maternal care for known or suspected abnormality of pelvic organs

376

2901

0.87

1.86

1.9

2.0

4.75

5.45

ug/l

0.36

326

2540

Disorders of male genital organs in diseases classified elsewhere

177

1.72

1.86

1.8

2.3

11.42

12.10

ug/l

0.05

164

Benign mammary dysplasia

495

4420

1.13

1.85

2.3

4.50

6.02

ug/l

2.05

417

3738

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

578

5202

1.12

1.85

2.5

2.3

6.91

7.88

ug/l

0.63

521

4671

Carcinoma in situ of skin of scalp and neck

139

1124

1.27

1.85

2.2

2.6

6.75

6.54

ug/l

0.06

121

976

Von Willebrand disease

231

1.60

1.85

2.4

2.2

4.05

5.55

ug/l

0.39

205

Erythema elevatum diutinum

4.74

1.83

2.8

1.5

7.84

3.77

ug/l

—

Carcinoma in situ of skin of trunk

162

1333

1.25

1.83

2.1

2.6

5.69

6.39

ug/l

0.26

137

1153

Medical treatment for female infertility

271

3128

0.85

1.82

1.7

1.9

3.93

5.36

ug/l

1.12

239

2744

LeFortI or BSSO operation

102

791

1.31

1.81

1.7

2.1

4.32

7.37

ug/l

2.82

716

Hypersplenism

103

1.96

1.81

3.2

2.3

17.28

9.39

ug/l

0.35

Benign neoplasm of brain and other parts of central nervous system

237

2016

1.19

1.81

2.7

2.4

5.44

7.20

ug/l

1.61

210

1806

Thyrotoxicosis with toxic multinodular goitre

238

2027

1.19

1.80

2.6

2.4

5.52

6.42

ug/l

0.35

210

1750

Dysplasia of cervi uteri

559

3526

1.12

1.79

2.0

2.2

6.77

7.00

ug/l

0.06

491

3090

Alcoholic liver disease

430

3821

1.14

1.79

2.6

2.4

6.74

8.63

ug/l

1.49

370

3451

Poor fetal growth

195

1625

1.21

1.79

1.7

2.0

4.33

4.81

ug/l

0.20

180

1414

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

514

4608

1.12

1.78

2.5

2.3

6.99

8.10

ug/l

0.66

463

4141

Other/unspecified crystal arthropathies

228

1.63

1.78

3.3

2.7

4.40

7.72

ug/l

0.93

197

Benign neoplasm: Lip

648

1.35

1.78

2.7

2.5

5.36

7.02

ug/l

0.58

574

Use of biperiden

187

1561

1.22

1.77

2.7

2.3

4.39

8.35

ug/l

6.17

157

1413

Benign neoplasm: Oesophagus

350

1.48

1.77

2.0

2.5

6.28

8.03

ug/l

0.36

310

Other and unspecified erythematous conditions

114

903

1.29

1.76

2.1

2.4

6.24

7.41

ug/l

0.39

800

Iron deficiency

465

1.39

1.75

2.7

2.2

10.73

6.24

ug/l

0.79

417

Malignant neoplasm of cervix uteri

374

1.45

1.75

2.1

2.2

3.10

5.87

ug/l

2.16

328

Other chondrocalcinosis

453

1.42

1.75

3.2

2.6

3.56

6.52

ug/l

2.19

402

Small cell lung cancer

944

0.74

1.75

2.4

2.5

4.00

6.88

ug/l

3.18

815

Small cell lung cancer, including Hilmo

944

0.74

1.75

2.4

2.5

4.00

6.88

ug/l

3.18

815

Nonsuppurative otitis media, including avohilmo

934

7447

1.09

1.74

2.3

2.2

5.92

7.31

ug/l

1.70

801

6556

Parkinson's disease

735

6733

1.10

1.73

2.4

2.5

6.30

6.96

ug/l

0.63

572

5858

LSIL lesion of the vulva

606

1.34

1.72

2.2

4.12

5.78

ug/l

0.76

535

Disorders of glycine metabolism

4.25

1.71

2.0

2.4

2.74

5.57

ug/l

—

L02BA Anti-estrogens

452

5054

0.89

1.71

2.1

2.3

3.17

6.09

ug/l

17.29

376

4344

Human immunodeficiency virus [HIV] disease resulting in other conditions, including avohilmo

428

0.62

1.71

1.7

2.1

8.65

9.92

ug/l

0.11

402

Injury of nerves at wrist and hand level

124

996

1.27

1.70

2.3

7.36

7.90

ug/l

0.15

116

909

Folate deficiency anaemia

345

1.48

1.70

4.0

2.5

9.87

8.20

ug/l

0.24

305

Drug-induced tremor

190

1.66

1.69

2.4

5.77

7.83

ug/l

0.33

175

Gluteal tendinitis

133

1077

1.25

1.69

2.6

2.2

3.45

7.72

ug/l

9.64

102

954

Non-Hodgkin lymphoma, all

208

1765

1.20

1.69

2.2

2.5

5.40

7.62

ug/l

1.36

176

1530

Other factor of the environment

311

1.49

1.69

2.4

5.42

6.52

ug/l

0.21

282

Cyst of Bartholin Gland

756

1.30

1.69

2.0

2.1

4.59

5.94

ug/l

0.59

679

Personality and behavioural disorders due to brain disease, damage and dysfunction

403

1.43

1.68

2.6

2.4

5.27

8.82

ug/l

1.17

363

Other bursitis, not elsewhere classified

254

1.55

1.68

2.3

2.4

2.69

8.94

ug/l

3.55

221

Postpartum hemorraghe, parous women as controls

400

3773

0.88

1.68

1.8

1.9

7.53

5.16

ug/l

0.56

361

3332

Dysplastic lesion of unknown severity of the cervix uteri

150

1.71

1.67

3.0

2.3

1.98

5.34

ug/l

1.97

133

Benign neoplasm: Scapula and long bones of upper limb

238

1.56

1.67

2.9

2.5

5.13

8.96

ug/l

1.45

214

Human immunodeficiency virus [HIV] disease resulting in other conditions

425

0.62

1.66

1.7

2.1

8.65

9.98

ug/l

0.11

399

Adult respiratory distress syndrome

397

1.43

1.66

3.0

2.5

7.93

7.69

ug/l

0.02

351

Other/unspecified reactive arthropathies

215

1829

1.19

1.65

2.5

2.3

6.50

7.55

ug/l

0.45

184

1654

Universal erythroderma, KELA reimbursement

380

1.44

1.65

2.6

7.73

8.36

ug/l

0.09

342

Benign lipomatous neoplasm of other sites/unspecified

348

3071

1.15

1.65

2.3

2.4

5.96

7.13

ug/l

0.74

299

2681

Carcinoma in situ of skin of other and unspecified parts of face

436

3907

1.13

1.64

2.4

2.5

8.74

6.58

ug/l

0.78

372

3301

Contact with other hot fluids

725

1.30

1.64

2.4

2.3

5.93

8.01

ug/l

1.02

653

Impetigo

122

982

1.26

1.63

2.9

2.3

8.28

8.14

ug/l

0.02

103

877

Motor neuron disease ALS

482

1.38

1.63

2.7

2.3

11.29

7.32

ug/l

0.36

442

Malignant neoplasm of ovary

177

1484

1.21

1.63

2.3

2.5

3.80

6.37

ug/l

3.09

154

1277

Other benign neoplasm of uterus: Other parts/unspecified

124

1521

0.80

1.63

2.1

2.5

9.60

5.50

ug/l

0.92

1252

Benign neoplasm: Floor of mouth

2.00

1.63

1.6

2.4

2.97

6.97

ug/l

2.19

Other and unspecified medical devices associated with adverse incidents

161

1.71

1.63

2.9

2.6

10.13

8.29

ug/l

0.21

145

Guillain-Barre syndrome

449

1.40

1.63

2.2

2.4

8.35

7.76

ug/l

0.07

407

Causalgia

355

1.44

1.62

2.0

2.4

3.09

8.15

ug/l

4.48

323

Abscess of Bartholin gland

447

1.39

1.62

1.9

2.1

3.73

5.13

ug/l

0.82

405

Golimumab

770

1.29

1.62

2.1

6.36

7.24

ug/l

0.23

699

Triptan medication for migraine, min. 3 purchases

1623

11431

1.06

1.62

2.1

6.57

7.36

ug/l

0.49

1435

10137

Drug-induced dystonia

2.10

1.61

2.9

2.3

6.71

5.95

ug/l

—

Ulcerative colitis (strict definition, require KELA)

531

4801

1.11

1.61

2.5

2.3

6.93

8.02

ug/l

0.67

480

4309

Striking against or struck by other objects

1213

11334

1.07

1.61

2.5

2.3

9.10

8.18

ug/l

0.57

1020

10096

Melanocytic naevi of other and unspecified parts of face

193

1632

1.20

1.60

2.0

2.3

4.76

6.94

ug/l

1.75

166

1444

Other disorders of male genital organs

148

1222

1.23

1.60

2.5

2.3

11.28

9.29

ug/l

0.23

135

1120

Infectious mononucleosis, including avohilmo

167

1390

1.21

1.60

2.1

2.2

4.15

7.34

ug/l

2.92

151

1237

Infectious mononucleosis

167

1390

1.21

1.60

2.1

2.2

4.15

7.34

ug/l

2.92

151

1237

Mental retardation

104

817

1.28

1.60

2.3

5.23

8.48

ug/l

1.33

724

Renal tubulo-interstitial disorders in diseases classified elsewhere

266

1.52

1.59

2.5

18.20

6.61

ug/l

0.47

231

Impaction of intestines

185

1.63

1.59

2.7

2.5

12.85

7.63

ug/l

0.25

164

Accidental poisoning by and exposure to alcohol

390

1.41

1.59

3.3

2.4

5.15

8.30

ug/l

1.17

349

Other disorders of pigmentation

164

1369

1.22

1.59

2.0

2.3

6.99

7.27

ug/l

0.07

149

1212

Nontoxic diffuse goitre

109

872

1.27

1.58

2.4

2.3

4.80

6.33

ug/l

0.60

749

Migraine, single triptan purchase ok & required. ICD-code if available is included

2636

17051

1.05

1.58

2.2

6.77

7.67

ug/l

0.93

2325

15144

Triptan medication for migraine, single purchase ok

2636

17051

1.05

1.58

2.2

6.77

7.67

ug/l

0.93

2325

15144

Malignant neoplasm of pancreas

255

2933

0.86

1.58

2.2

2.5

3.71

7.52

ug/l

12.34

220

2545

Nontoxic single thyroid nodule

240

2069

1.17

1.58

2.1

2.3

6.59

6.72

ug/l

0.04

205

1815

Atypical virus infections of central nervous system

242

1.54

1.57

2.4

2.3

5.71

7.67

ug/l

0.47

218

Small cell lung cancer, helper endpoint

927

0.75

1.56

2.4

2.6

4.00

6.58

ug/l

2.58

799

Other benign neoplasms of uterus

157

1875

0.82

1.56

2.0

2.5

8.43

5.51

ug/l

0.82

109

1569

Tuberculosis

263

2288

1.17

1.56

2.7

2.5

5.07

6.77

ug/l

1.83

213

1948

Carcinoma in situ of vagina

116

1.79

1.54

3.3

2.4

1.94

3.64

ug/l

1.91

103

Parkinson's disease, including avohilmo

762

7036

1.09

1.54

2.4

2.5

6.30

7.16

ug/l

0.91

594

6122

Periodontal disease, other/unspecified

751

1.29

1.53

2.1

2.3

4.38

7.53

ug/l

3.22

673

Other inflammation of vagina/vulva

634

1.31

1.53

2.1

4.41

5.34

ug/l

0.27

569

Delivery, wide proxy

1038

5913

0.93

1.53

2.3

2.4

5.02

5.80

ug/l

0.97

909

4899

Malignant neoplasm of breast, HER-negative

646

6764

0.91

1.52

2.2

2.4

5.00

5.87

ug/l

0.88

528

5761

Hypertrophy of tongue papillae

369

1.42

1.52

2.4

2.6

3.52

6.65

ug/l

2.36

334

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

493

4461

1.11

1.52

2.5

2.3

6.66

7.68

ug/l

0.39

437

3978

Other acquired deformities of musculoskeletal system and connective tissue

161

1349

1.21

1.51

2.1

2.4

10.36

7.88

ug/l

0.35

140

1202

Cerebral arteritis

2.11

1.51

3.2

2.8

3.55

4.72

ug/l

0.42

Hypertrichosis

292

1.46

1.51

1.5

2.0

6.63

4.49

ug/l

0.29

257

Frontotemporal dementia

189

1.62

1.50

3.0

2.5

7.82

8.81

ug/l

0.09

168

Carcinoma in situ, bladder

173

1465

1.21

1.50

2.9

2.5

6.82

7.79

ug/l

0.33

157

1316

Certain conditions originating in the perinatal period

144

1055

1.22

1.49

2.1

2.3

10.61

6.44

ug/l

0.75

125

906

L02BB Anti-androgens

376

4198

0.88

1.49

2.5

6.79

7.21

ug/l

0.14

334

3656

Drug- and heavy-metal-induced tubulo-interstitial and tubular conditions

1.98

1.48

4.5

2.9

8.69

7.48

ug/l

0.08

Ankylosing spondylitis, ICD10

288

2529

1.15

1.48

2.8

2.3

5.13

8.24

ug/l

2.40

247

2293

Fluid overload

1.97

1.48

3.7

2.1

34.04

5.27

ug/l

0.46

Other hyperalimentation

1.97

1.48

2.0

3.1

29.89

4.68

ug/l

—

Mental retardation, wide definition

112

898

1.25

1.47

2.3

2.4

5.55

8.55

ug/l

1.22

100

800

Polycystic ovarian syndrome

637

1.30

1.47

2.3

1.9

4.63

4.17

ug/l

0.11

544

Raynaud syndrome

279

2446

1.15

1.47

2.1

2.3

6.79

6.95

ug/l

0.05

237

2187

Other sexually transmitted chlamydial diseases

856

0.75

1.47

1.6

2.3

12.45

7.30

ug/l

0.53

754

Idiopathic hypoparathyroidism

2.02

1.47

3.1

2.9

5.18

4.25

ug/l

0.16

Alcohol induced polyneuropathy

331

1.44

1.46

2.2

2.4

5.03

9.21

ug/l

1.47

297

Open bite

106

853

1.25

1.44

1.8

2.0

5.03

6.74

ug/l

0.77

761

Malignant neoplasm of lip

290

1.47

1.44

2.6

2.7

4.48

6.61

ug/l

1.29

248

Haemangioma and lymphangioma, any site

309

2733

1.14

1.43

2.3

4.70

7.11

ug/l

2.76

265

2440

Retained placenta and membranes, without haemorrhage

292

2570

1.14

1.43

2.1

2.0

4.82

5.98

ug/l

0.63

260

2234

Prominent ears

1.85

1.43

1.9

2.0

1.75

5.10

ug/l

2.28

Other disorders of penis

408

3667

1.12

1.43

2.8

2.3

7.30

9.38

ug/l

0.75

355

3308

Malignant neoplasm of head and neck

361

3227

1.13

1.43

2.3

2.4

6.93

8.07

ug/l

0.67

313

2860

Polyarteritis nodosa

191

1.58

1.42

6.2

2.3

6.43

5.25

ug/l

0.21

172

Other noninflammatory disorders of cervix uteri

153

1284

1.21

1.42

2.0

2.3

5.28

7.62

ug/l

1.57

130

1118

Atypical virus infections of central nervous system, including avohilmo

248

1.50

1.42

2.4

2.3

5.71

7.57

ug/l

0.44

223

Malignant neoplasm of bronchus and lung, including Hilmo

928

8287

0.93

1.42

2.3

2.5

6.41

7.94

ug/l

1.40

811

7205

Embedded teeth, including avohilmo

186

1584

1.18

1.42

2.1

2.3

7.72

6.93

ug/l

0.23

171

1394

Dyslexia and other symbolic dysfunctions, not elsewhere classified

1.92

1.41

2.5

2.3

2.59

4.71

ug/l

1.12

Hepatocellular carcinoma, including Hilmo

135

1124

1.23

1.41

2.6

2.5

6.21

8.20

ug/l

0.74

113

990

Macular hole

238

2076

1.16

1.40

2.4

5.84

7.34

ug/l

1.29

211

1836

Disorders of orbit

142

1186

1.21

1.40

2.2

2.3

6.05

7.51

ug/l

0.78

119

1070

Multiple myeloma, including Hilmo

200

1724

1.18

1.39

2.9

2.5

5.85

7.82

ug/l

0.99

174

1504

Dysplastic lesion of unknown severity in the cervix uteri, vagina or vulva

215

1.52

1.39

4.1

2.4

2.38

5.24

ug/l

2.24

191

Failure in dosage during surgical and medical care

2.32

1.39

4.7

2.8

3.19

4.58

ug/l

—

Molar incisor enamel hypoplasia

397

1.36

1.39

2.2

2.1

17.64

6.54

ug/l

1.67

349

Other erythematous conditions

125

1033

1.23

1.38

2.1

2.4

6.25

7.75

ug/l

0.56

103

920

Burn and corrosion of shoulder and upper limb, except wrist and hand

559

1.31

1.37

2.9

2.2

8.07

7.95

ug/l

0.02

507

Benign neoplasm: Connective and other soft tissue of lower limb, including hip

657

1.29

1.37

2.6

2.5

4.31

8.02

ug/l

2.48

585

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder

237

2072

1.16

1.36

2.4

2.5

5.38

7.49

ug/l

1.67

210

1800

Injury of nerves and lumbar spinal cord at abdomen, lower back and pelvis level

129

1.70

1.36

2.1

2.4

5.69

6.61

ug/l

0.18

120

Arthropathic psoriasis

389

3501

1.12

1.36

2.3

5.20

8.06

ug/l

4.58

339

3158

Inguinal of femoral hernia, unilateral

105

855

1.25

1.36

2.9

2.4

8.94

6.98

ug/l

0.32

749

Femoral hernia, unilateral

105

855

1.25

1.36

2.9

2.4

8.94

6.98

ug/l

0.32

749

Inguinal hernia, unilateral

105

855

1.25

1.36

2.9

2.4

8.94

6.98

ug/l

0.32

749

Purulent endophthalmitis

210

1.54

1.36

2.6

2.5

8.98

5.15

ug/l

0.76

182

Whooping cough, including avohilmo

274

1.45

1.36

1.9

2.1

25.97

7.86

ug/l

0.42

247

Respiratory tuberculosis, confirmed and not-confirmed

220

1913

1.17

1.35

2.7

2.6

5.08

6.74

ug/l

1.65

180

1643

Tuberculosis of other organs, strict, including avohilmo

100

811

1.26

1.35

2.6

10.22

5.77

ug/l

0.52

688

Bacterial meningitis

114

936

1.24

1.35

2.3

2.4

6.19

7.75

ug/l

0.47

849

Other congenital malformations of ear

128

1.67

1.35

1.7

2.0

10.26

5.45

ug/l

0.24

118

Secondary polycythaemia

748

1.27

1.35

2.7

2.3

10.39

7.93

ug/l

0.28

672

Hypoplasia of dental enamel , including avohilmo

385

1.36

1.35

2.2

2.0

17.29

6.84

ug/l

1.46

337

Respiratory tuberculosis

220

1914

1.16

1.35

2.7

2.6

5.08

6.73

ug/l

1.64

180

1644

Malignant neoplasm of head and neck, including Hilmo

442

4010

1.11

1.34

2.4

2.5

7.01

8.19

ug/l

0.74

383

3552

Tuberculosis of other organs, strict

803

1.26

1.34

2.6

10.11

5.72

ug/l

0.50

681

Other disorders of cornea

359

3221

1.12

1.34

2.4

2.3

8.58

7.51

ug/l

0.30

306

2844

Leukaemia of unspecified cell type

277

1.46

1.34

2.4

3.84

7.73

ug/l

1.60

242

Use of selegiline

190

1638

1.18

1.33

2.3

2.5

5.17

7.34

ug/l

1.78

134

1446

Acute appendicitis, with complications

739

6857

1.08

1.33

2.2

2.4

7.00

7.71

ug/l

0.56

655

6064

Peroneal tendinitis

352

1.39

1.33

2.1

2.2

14.38

7.29

ug/l

0.33

324

Pregnancy with abortive outcome

2200

10949

1.05

1.33

2.3

2.2

6.08

5.49

ug/l

0.64

1860

9379

Thrombotic microangiopathy

154

1.62

1.32

3.4

2.4

3.11

8.20

ug/l

1.97

135

Toxic effect of contact with venomous animals

133

1112

1.21

1.31

2.5

2.4

5.84

7.60

ug/l

1.03

120

1002

Leiomyosarcoma, including Hilmo

304

1.43

1.31

1.8

2.5

9.73

6.89

ug/l

0.17

261

Chorioretinal inflammation

786

1.26

1.31

2.7

2.3

7.99

7.37

ug/l

0.12

704

Caught, crushed, jammed or pinched in or between objects

162

1378

1.19

1.31

2.1

2.3

5.68

7.58

ug/l

1.66

141

1246

Other localized connective tissue disorders

484

1.33

1.31

2.4

2.2

24.10

7.43

ug/l

0.58

428

Postpartum haemorrhage due to anatomy

109

1327

0.82

1.30

1.6

1.7

5.28

4.42

ug/l

0.19

1168

Other infective otitis externa

211

1835

1.16

1.30

2.1

2.3

5.88

7.50

ug/l

0.98

171

1666

Viral agents as the cause of diseases classified to other chapters

564

1.30

1.29

2.8

2.5

11.63

7.95

ug/l

0.53

503

Horner syndrome

321

1.41

1.29

1.8

2.3

5.13

8.28

ug/l

0.68

296

Malignant neoplasm of floor of mouth, including Hilmo

297

1.44

1.29

2.9

2.7

7.74

7.44

ug/l

0.04

257

Malignant neoplasm of oral cavity, including Hilmo

185

1596

1.18

1.29

2.3

2.4

7.60

8.21

ug/l

0.19

165

1414

Retinoschisis and retinal cysts

790

1.26

1.28

2.5

5.81

7.01

ug/l

0.33

703

Injury of nerves at ankle and foot level

163

1.59

1.28

2.4

2.1

16.64

7.93

ug/l

0.54

148

Lyme disease, including avohilmo

1171

12403

0.94

1.28

2.1

2.3

7.68

7.62

ug/l

0.03

994

11019

Lyme disease

1171

12403

0.94

1.28

2.1

2.3

7.68

7.62

ug/l

0.03

994

11019

Congenital malformations of eye, ear, face and neck

163

1389

1.18

1.28

2.1

2.3

7.03

7.49

ug/l

0.10

135

1247

Family history of certain disabilities and chronic diseases leading to disablement

103

840

1.24

1.28

2.3

1.9

10.84

6.16

ug/l

0.56

746

Juvenile rheumatoid arthirtis

337

1.38

1.28

2.0

2.1

6.07

6.59

ug/l

0.10

300

Disorder of pancreatic internal secretion, other and/or unspecified

188

1.54

1.27

2.7

2.5

2.75

8.04

ug/l

2.67

169

Deaf mutism, not elsewhere classified

132

1.66

1.27

2.5

2.6

3.86

6.31

ug/l

0.56

117

Alopecia areata

575

1.29

1.25

2.3

2.2

6.92

8.04

ug/l

0.29

513

Crossbite

159

1246

1.18

1.25

2.2

2.1

11.89

7.52

ug/l

0.60

137

1112

Bitten or stung by nonvenomous insect and other nonvenomous arthropods

108

891

1.23

1.24

2.4

2.3

5.04

7.48

ug/l

1.48

803

All dysplastic lesions of the cervix uteri

523

4719

1.09

1.24

1.9

2.0

6.20

5.53

ug/l

0.18

468

4125

Benign neoplasm: Rectosigmoid junction

170

1464

1.18

1.24

2.4

2.5

6.35

7.16

ug/l

0.42

145

1309

Haemangioma, any site

287

2558

1.13

1.22

2.3

2.4

4.86

7.05

ug/l

2.13

246

2284

Other and unspecified injuries of neck

173

1.54

1.22

1.7

2.3

2.26

6.85

ug/l

3.96

159

Need for other prophylactic measures

200

1743

1.16

1.22

1.8

2.4

12.57

7.66

ug/l

0.92

171

1571

Other, unspecified and serous retinal detachments

125

1050

1.21

1.22

2.5

2.4

6.40

7.51

ug/l

0.37

107

934

Other spirochaetal diseases

1183

12503

0.94

1.22

2.1

2.3

7.79

7.64

ug/l

0.07

1005

11108

Other hearing loss

1348

12394

1.06

1.21

2.2

2.4

6.31

7.24

ug/l

1.04

1111

10684

Crushed, pushed or stepped on by crowd or human stampede

192

1666

1.16

1.21

2.0

2.2

7.67

7.93

ug/l

0.07

168

1505

Rubella [German measles], including avohilmo

122

1023

1.21

2.3

2.4

8.63

11.95

ug/l

1.03

111

950

Lifestyle-related condition

291

1.41

1.20

2.1

2.3

5.85

6.63

ug/l

0.13

264

Cyst of kidney

302

2707

1.13

1.20

2.3

2.4

6.32

7.59

ug/l

0.75

265

2402

Personal history of allergy to drugs, medicaments and biological substances

223

1.47

1.20

1.9

2.1

4.37

7.72

ug/l

1.07

202

Erosion of teeth , including avohilmo

816

7631

1.07

1.19

2.2

2.3

7.63

7.68

ug/l

0.02

709

6789

Melanoma in situ of other and unspecified parts of face

470

0.70

1.19

2.0

2.6

7.50

7.32

ug/l

0.02

409

Multiple myeloma and malignant plasma cell neoplasms

208

1824

1.16

1.19

2.9

2.5

5.73

7.55

ug/l

0.92

182

1607

Atypical mycobacterium lung infection

370

1.36

1.19

2.2

2.4

8.00

7.41

ug/l

0.09

320

Myeloproliferative diseases

336

3031

1.12

1.19

2.3

2.4

5.31

7.23

ug/l

2.20

271

2664

Melanoma in situ

142

1661

0.84

1.18

1.9

2.5

7.49

6.85

ug/l

0.19

122

1469

Other predominantly sexually transmitted diseases, not elsewhere classified, including avohilmo

457

4176

1.10

1.18

1.9

2.2

9.90

6.58

ug/l

1.16

394

3703

Profound mental retardation

2.68

1.18

3.4

3.0

2.78

4.68

ug/l

—

Secondary malignant neoplasm of other and unspecified sites

691

1.26

1.18

2.4

2.6

4.07

7.84

ug/l

3.42

610

Leiomyoma of uterus

2208

11878

1.05

1.18

2.1

2.3

5.58

5.72

ug/l

0.13

1822

10249

Burn and corrosion of ankle and foot

370

1.36

1.18

3.0

2.4

5.80

8.47

ug/l

0.76

337

Orthopaedic devices associated with adverse incidents

601

1.28

1.17

2.1

2.5

5.30

6.52

ug/l

0.30

531

Spirochaetal infections, other/unspecified, including avohilmo

1182

12477

0.94

1.17

2.0

2.3

7.66

7.61

ug/l

0.02

1004

11083

Spirochaetal infections, other/unspecified

325

2929

1.12

1.16

2.0

2.4

6.98

7.37

ug/l

0.20

269

2634

Abrasion of teeth

1331

12650

1.06

1.16

2.2

2.3

7.11

7.42

ug/l

0.13

1178

11254

Deficiency of other B group vitamins

628

1.27

1.16

2.9

2.5

4.00

7.26

ug/l

2.71

547

Leiomyosarcoma

235

1.46

1.15

1.6

2.7

11.70

7.79

ug/l

0.19

202

Glaucoma secondary to eye trauma

193

1.51

1.15

3.9

2.7

4.97

6.17

ug/l

0.42

172

Fasciculation

285

1.40

1.15

2.2

2.3

4.41

6.58

ug/l

0.94

256

Acute epiglottitis

380

1.34

1.15

4.3

2.2

3.59

8.69

ug/l

3.80

341

Etanercept

185

1610

1.16

1.15

2.2

6.59

7.70

ug/l

0.41

164

1449

Unspecified abortion

114

953

1.21

1.14

2.1

2.2

4.92

5.44

ug/l

0.09

100

869

Spasmodic torticollis

818

1.23

1.14

2.6

2.4

3.25

6.75

ug/l

6.37

732

Malignant neoplasm of other and unspecified parts of tongue, including Hilmo

757

1.24

1.14

2.3

2.6

6.91

7.53

ug/l

0.16

677

Mantle cell lymphoma, including Hilmo

533

1.29

1.14

1.9

2.6

6.50

7.58

ug/l

0.20

471

Other appendicitis

274

2449

1.13

2.3

8.17

7.80

ug/l

0.07

244

2201

Malignant neoplasm of oral cavity

145

1243

1.19

1.13

2.3

2.5

8.62

8.11

ug/l

0.12

128

1112

Other conjunctival vascular disorders and cysts

684

1.25

1.13

2.6

2.3

12.65

7.36

ug/l

0.45

604

Traumatic amputation of ankle and foot

1.88

1.13

1.9

2.2

9.38

12.82

ug/l

0.23

Defect, injury or illness of face

2.08

1.13

3.4

2.2

3.33

4.09

ug/l

—

Loose body in joint

693

1.25

1.13

2.4

5.36

8.93

ug/l

2.09

629

Parapsoriasis

487

1.30

1.12

2.3

2.5

6.46

7.20

ug/l

0.13

438

Malignant neoplasm of bladder

328

2965

1.12

2.3

2.5

5.13

7.43

ug/l

3.22

273

2553

Presbycusis

620

6578

0.92

1.12

2.2

2.5

5.61

6.59

ug/l

1.18

492

5529

Benign neoplasm: Appendix

322

1.37

1.11

2.2

2.8

14.26

7.80

ug/l

0.34

285

Injury of blood vessels at neck level

113

1.67

1.11

2.1

2.2

15.01

6.00

ug/l

0.37

107

Calculus of lower urinary tract

231

2051

1.14

1.11

2.8

2.4

6.36

7.45

ug/l

0.48

183

1821

Melanocytic naevi of upper limb, including shoulder

622

1.26

1.11

2.8

2.4

10.30

6.20

ug/l

0.33

558

Wegener granulomatosis

418

1.32

1.11

2.1

2.4

4.75

6.84

ug/l

0.67

376

Gastrointestinal stromal tumor and sarcoma

429

1.32

1.09

2.3

2.6

4.49

7.01

ug/l

1.15

377

Tuberculosis of other organs

688

1.25

1.09

2.6

6.47

6.14

ug/l

0.08

587

Oral lichen planus, including avohilmo , including avohilmo

234

2079

1.14

1.09

2.0

2.4

6.87

6.98

ug/l

0.03

199

1850

Mucosal proctocolitis

381

3474

1.10

1.08

2.6

2.2

8.29

8.33

ug/l

0.01

340

3143

Malignant neoplasm of heart, mediastinum and pleura, including Hilmo

653

1.25

1.08

2.3

2.6

9.78

7.47

ug/l

0.33

567

Rubella [German measles]

120

1018

1.20

1.07

2.3

8.69

11.99

ug/l

1.01

110

945

Cervical polyps

264

2364

1.12

1.06

2.3

2.2

7.96

7.45

ug/l

0.09

224

2079

Myasthenia gravis

528

1.28

1.06

3.2

2.5

4.39

6.77

ug/l

1.29

480

Malignant neoplasm of pancreas, including Hilmo

330

3630

0.90

1.06

2.3

2.5

4.02

7.23

ug/l

10.19

284

3154

Benign neoplasm: Carotid body

1.86

1.05

2.1

4.52

5.50

ug/l

0.31

Other injuries of upper limb, level unspecified

334

1.35

1.04

3.0

2.5

3.56

8.11

ug/l

2.81

294

Congenital lens malformations

1.74

1.04

2.1

3.1

23.10

7.56

ug/l

—

Cerebral atherosclerosis

457

1.30

1.04

2.4

2.6

4.45

6.72

ug/l

1.10

396

Carcinoma in situ of skin of upper limb, including shoulder

120

1024

1.20

1.04

2.1

2.7

5.84

6.31

ug/l

0.20

101

884

Vertigo of central origin

485

1.29

1.04

2.0

2.4

5.79

6.44

ug/l

0.13

429

Occupant of railway train or railway vehicle injured in transport accident

0.00

1.04

0.0

2.2

—

4.30

—

Bitten or struck by other mammals

321

2910

1.11

1.04

2.2

6.64

6.78

ug/l

0.05

283

2593

Helminthiases

431

1.30

1.03

2.3

2.4

10.21

7.27

ug/l

0.42

383

Infections with a predominantly sexual mode of transmission, including avohilmo

1029

8909

1.06

1.03

2.1

7.66

7.38

ug/l

0.12

872

7881

Hypermetropia

220

1953

1.13

1.03

2.3

6.45

7.62

ug/l

0.29

195

1734

Foreign body in ear

458

1.29

1.02

2.9

2.3

4.58

7.84

ug/l

2.00

416

Anisometropia and aniseikonia

850

0.80

1.02

2.1

2.4

6.68

7.14

ug/l

0.11

762

Malignant neoplasm of respiratory system and intrathoracic organs

941

8244

0.94

1.02

2.3

2.5

6.67

8.06

ug/l

1.13

821

7180

Oral lichen planus

803

1.22

1.02

1.7

2.4

6.66

7.64

ug/l

0.27

714

Congenital retinoschisis

1.98

1.02

2.2

2.4

4.63

7.19

ug/l

—

Allergic contact dermatitis due to drugs in contact with skin

576

1.25

1.01

1.9

2.4

5.21

6.27

ug/l

0.35

507

Malignant neoplasm of heart, mediastinum and pleura

461

1.29

1.01

2.3

2.7

7.80

7.55

ug/l

0.05

402

Osteopathy in diseases classified elsewhere

216

1.44

1.00

2.1

2.3

4.33

7.69

ug/l

1.33

196

Other and unspecified types of non-Hodgkin lymphoma, hilmo

164

1436

1.16

1.00

2.4

2.5

10.74

7.20

ug/l

0.53

146

1272

Dementia due to Parkinson's disease

120

1028

1.19

1.00

2.5

2.7

5.93

6.36

ug/l

0.13

903

Respiratory tuberculosis, not confirmed, including avohilmo

162

1417

1.16

1.00

2.7

2.6

4.47

6.42

ug/l

2.31

136

1213

Congenital deformities of hip

257

1.38

0.99

2.2

2.3

14.45

5.37

ug/l

0.61

225

Malignant neoplasm of liver and intrahepatic bile ducts

139

1204

1.17

0.99

2.5

6.48

8.16

ug/l

0.60

118

1052

Malignant neoplasm of tonsil and base of tongue

745

0.79

0.99

2.6

2.5

9.76

8.92

ug/l

0.10

669

Postpartum haemorrhage

400

3595

0.92

0.99

1.8

1.9

7.53

5.62

ug/l

0.42

361

3154

Contusion of toe(s) with damage to nail

250

1.39

0.99

1.8

2.3

6.79

7.77

ug/l

0.10

226

Chronic suppurative otitis media, including avohilmo

257

2312

1.12

0.99

2.3

2.4

6.18

7.35

ug/l

0.51

224

2050

Burn and corrosion of wrist and hand

106

896

1.20

0.99

2.3

5.19

8.52

ug/l

1.84

815

Nystagmus and other irregular eye movements

337

1.33

0.99

2.4

2.2

4.99

8.12

ug/l

1.20

301

Injury of muscle and tendon at ankle and foot level

623

1.24

0.98

2.1

2.3

10.21

7.78

ug/l

0.24

560

Chronic suppurative otitis media

219

1953

1.13

0.98

2.2

2.4

6.64

7.07

ug/l

0.13

189

1737

Malignant neoplasm of colon, including Hilmo

892

8405

1.06

0.98

2.3

2.5

5.26

7.71

ug/l

4.82

752

7259

Anomalies of pupillary function

479

1.27

0.98

2.7

2.2

10.04

7.28

ug/l

0.25

431

Use of interferon beta-1a

376

0.71

0.97

1.7

2.1

6.12

6.99

ug/l

0.13

349

Chromosomal abnormalities, not elsewhere classified

301

1.34

0.97

1.9

2.2

9.15

8.58

ug/l

0.09

270

Benign neoplasm: Connective and other soft tissue of upper limb, including shoulder

147

1279

1.16

0.97

2.3

4.78

7.91

ug/l

2.50

138

1152

Diabetes insipidus

217

1.42

0.97

2.9

2.5

3.41

6.21

ug/l

1.91

195

Hepatocellular carcinoma

102

864

1.20

0.97

2.4

2.5

7.03

7.91

ug/l

0.19

756

Other disorders affecting eyelid function

280

0.66

0.97

4.0

2.5

4.87

6.48

ug/l

0.23

260

Malignant neoplasm of other and unspecified parts of tongue

527

1.26

0.97

2.2

2.7

6.89

7.70

ug/l

0.18

462

Other disorders of Eustachian tube

798

1.21

0.96

1.9

2.4

5.53

7.02

ug/l

0.56

717

Other disorders of binocular movement

435

1.28

0.96

2.4

2.2

4.74

7.30

ug/l

1.23

390

Other spirochaetal diseases, including avohilmo

1204

12619

0.95

0.96

2.0

2.3

7.84

7.64

ug/l

0.10

1023

11207

Colorectal cancer, including Hilmo

1305

11625

1.05

0.96

2.2

2.5

5.83

7.60

ug/l

3.23

1105

10094

Alcoholic cardiomyopathy

176

1.48

0.96

4.6

2.7

7.97

8.41

ug/l

0.04

159

Other menopausal disorders

805

4223

1.07

0.95

2.0

2.2

4.79

6.85

ug/l

2.91

713

3716

Separation of retinal layers (serosa)

151

1319

1.16

0.95

2.2

2.3

7.66

8.38

ug/l

0.18

129

1200

Benign neoplasm: Prostate

245

1.40

0.95

2.0

2.5

4.81

7.15

ug/l

0.74

216

Malignant neoplasm, without specification of site

144

1255

1.16

0.95

2.1

2.5

6.10

7.12

ug/l

0.23

124

1077

Noise effects on inner ear

121

1403

0.85

0.95

2.0

2.4

6.11

8.76

ug/l

1.61

100

1294

Ankylosing spondylitis, strict definition

120

1030

1.18

0.94

3.3

2.2

6.94

8.26

ug/l

0.26

107

938

Ulcerative ileocolitis

962

0.82

0.94

2.2

2.1

9.74

7.97

ug/l

0.34

875

Guttate psoriasis

349

1.31

0.94

2.5

2.4

5.55

7.58

ug/l

0.72

313

LSIL lesion of the cervix uteri, vagina or vulva

295

2679

1.11

0.94

2.0

2.1

4.96

5.33

ug/l

0.23

260

2347

Benign neoplasm: Skin of trunk

142

1237

1.16

0.93

2.6

2.4

10.03

7.00

ug/l

0.39

116

1105

Other puerperal infections

117

1001

1.17

0.93

1.7

2.2

3.23

4.62

ug/l

1.11

101

874

Shigellosis, including avohilmo

143

1.51

0.93

3.4

2.2

9.13

7.91

ug/l

0.10

123

Other and unspecified immunodeficiencies with predominantly antibody defects

262

1.36

0.93

2.3

2.2

6.02

5.78

ug/l

0.04

232

Malignant neoplasm of other and unspecified male genital organs, including Hilmo

1.86

0.92

3.7

3.5

17.14

8.57

ug/l

0.31

Malignant neoplasm of other and ill-defined sites, including Hilmo

557

1.25

0.92

2.2

2.5

3.51

6.88

ug/l

2.54

483

Benign neoplasm: Choroid

199

2227

0.89

0.92

2.5

2.4

6.31

6.89

ug/l

0.23

164

1995

Malignant neoplasm of penis, including Hilmo

228

0.63

0.91

1.9

2.9

9.46

9.19

ug/l

—

198

Other and unspecified corneal deformities and disorders

106

905

1.19

0.91

2.3

2.4

9.46

8.04

ug/l

0.16

813

Other complications of labour and delivery, not elsewhere classified

120

1234

0.86

0.90

1.7

2.0

3.12

5.03

ug/l

1.26

104

1063

Presbyopia

250

2260

1.11

0.90

1.8

2.2

8.97

8.08

ug/l

0.19

228

2054

Malignant neoplasm of bone and articular cartilage, including Hilmo

604

1.23

0.90

2.3

2.5

4.62

7.35

ug/l

2.06

536

Laparoscopic right hemicolectomy

243

2198

1.12

0.90

2.1

2.5

4.64

7.28

ug/l

2.39

207

1942

Carrier of infectious disease

603

1.23

0.90

4.3

2.5

6.05

6.40

ug/l

0.06

536

Ovarian dysfunction, other/unspecified

1.65

0.90

1.4

2.0

2.70

4.30

ug/l

0.81

Exposure to other and unspecified animate mechanical forces

648

1.22

0.89

2.2

5.57

7.05

ug/l

0.62

587

Benign neoplasm: Other and unspecified parts of small intestine

505

1.25

0.89

1.7

2.5

4.33

7.12

ug/l

1.72

443

Other specific arthropathies, wide

549

1.24

0.89

2.3

3.88

7.63

ug/l

2.66

494

Contact with other sharp object(s)

144

1643

0.87

0.89

2.4

2.3

5.34

8.19

ug/l

2.09

127

1492

Circumscribed brain atrophy

724

1.21

0.89

3.2

2.6

7.84

6.85

ug/l

0.15

641

Contraceptive management

1132

8292

0.95

0.89

2.1

7.28

8.70

ug/l

1.08

1021

7504

Melanoma in situ of lip

0.00

0.88

0.0

1.9

—

3.60

—

Acute poliomyelitis

380

1.29

0.88

3.1

2.5

5.55

7.44

ug/l

0.55

334

Undescended testis, unilateral

128

1.51

0.88

3.4

2.3

10.90

8.82

ug/l

0.13

112

Ulcerative colitis (strict definition, all Crohn cases excluded)

441

4096

1.08

0.87

2.4

2.3

6.88

8.05

ug/l

0.66

400

3682

Other and unspecified disorders of white blood cells

138

1208

1.16

0.87

2.3

2.4

7.09

7.34

ug/l

0.07

116

1086

Other predominantly sexually transmitted diseases, not elsewhere classified

382

3526

1.09

0.87

1.9

2.1

10.73

6.51

ug/l

1.31

328

3128

Perioral dermatitis

442

1.26

0.86

2.3

2.2

3.77

5.86

ug/l

1.16

392

Carcinoma in situ of other and unspecified sites

179

1597

1.14

0.86

3.0

2.5

6.68

7.58

ug/l

0.31

163

1428

Respiratory tuberculosis, confirmed

552

1.23

0.86

2.6

6.64

7.08

ug/l

0.09

482

Motorcycle rider injured in other and unspecified transport accidents

156

1376

1.14

0.86

2.2

6.14

9.13

ug/l

2.05

140

1246

Other congenital malformations of skin, including avohilmo

228

2057

1.12

0.86

2.5

2.2

8.87

7.00

ug/l

0.37

203

1833

Maternal care related to the fetus and amniotic cavity and possible delivery problems

915

5650

0.95

0.86

1.9

2.1

4.21

6.24

ug/l

3.48

817

4986

Other abnormal products of conception

614

3776

1.07

0.86

1.7

1.9

4.01

5.57

ug/l

1.84

538

3375

Clear cell adenocarcinoma of kidney

202

1815

1.13

0.86

2.2

2.4

5.66

7.97

ug/l

1.03

183

1623

Congenital ichthyosis

1.77

0.86

2.5

2.1

17.15

4.48

ug/l

0.43

Acute poliomyelitis, including avohilmo

382

1.28

0.85

3.1

2.5

5.55

7.44

ug/l

0.56

336

Osteomyelitis of vertebra

1.68

0.85

3.2

2.5

6.34

9.79

ug/l

0.45

Generalized epilepsy, mode (most common among epilepsy diagnosis)

634

1.21

0.85

1.8

2.2

3.67

8.40

ug/l

5.31

568

Wide developmental disorders

414

1.26

0.84

1.7

2.0

3.36

7.97

ug/l

3.38

360

Other congenital malformations of peripheral vascular system

267

1.33

0.83

1.7

2.2

2.64

6.26

ug/l

3.05

240

Obstructed labour due to maternal pelvic abnormality

391

3623

1.08

0.83

2.2

2.1

7.33

6.46

ug/l

0.30

343

3175

Alzheimer’s disease (undefined), excluding more controls

239

0.68

0.82

2.1

2.5

15.03

4.93

ug/l

—

199

Other specified and unspecified disorders of lens

260

1.34

0.82

2.2

2.3

16.35

7.53

ug/l

0.41

217

Astigmatism

186

1663

1.13

0.82

2.0

2.3

8.22

7.40

ug/l

0.24

159

1487

Respiratory tuberculosis, not confirmed

158

1404

1.14

0.81

2.7

2.6

4.44

6.40

ug/l

2.27

132

1203

Inhalation and ingestion of food causing obstruction of respiratory tract

278

1.33

0.81

2.4

2.6

5.22

8.13

ug/l

0.72

247

Myeloproliferative diseases (CML excluded)

298

2739

1.10

0.80

2.3

2.4

5.25

7.20

ug/l

2.00

235

2409

All dysplastic lesions of the vagina

584

1.21

0.80

2.7

2.1

5.11

6.55

ug/l

0.40

525

Other infestations, including avohilmo

538

0.79

1.7

2.4

7.51

7.23

ug/l

0.04

478

Rheumatic fever without mention of heart involvement

1.63

0.78

2.3

2.2

3.53

7.15

ug/l

1.56

Other specified diseases with participation of lymphoreticular and reticulohistiocytic tissue

1.63

0.78

1.8

2.5

5.98

5.56

ug/l

0.07

Malignant neoplasm of other and ill-defined digestive organs, including Hilmo

624

1.21

0.78

2.3

2.6

6.67

7.12

ug/l

0.05

543

Accidental poisoning by and exposure to organic solvents and halogenated hydrocarbons and their vapours

1.77

0.78

1.8

2.8

7.82

5.62

ug/l

—

Frostbite with tissue necrosis

1.67

0.78

1.5

2.2

6.52

12.15

ug/l

0.57

Malignant neoplasm of eye, brain and central nervous system, including Hilmo

262

2397

1.10

0.78

2.2

2.4

5.28

8.07

ug/l

3.04

226

2121

Pedal cyclist injured in noncollision transport accidents

309

3352

0.92

0.78

2.3

9.94

7.98

ug/l

0.41

267

3013

Vertical strabismus

108

938

1.16

0.78

2.1

2.4

10.51

7.29

ug/l

0.44

839

Multiple myeloma

124

1090

1.15

0.78

2.5

5.32

7.40

ug/l

0.69

105

943

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS)

124

1090

1.15

0.78

2.5

5.32

7.40

ug/l

0.69

105

943

Other infiltrative disorders of skin and subcutaneous tissue

116

1.52

0.77

2.6

2.3

4.17

6.65

ug/l

1.07

103

Juvenile cataract

1.62

0.77

1.6

2.4

17.11

6.77

ug/l

0.30

Kissing spine

1.73

0.77

3.8

2.7

4.86

7.37

ug/l

—

Benign neoplasm: Spinal meninges

316

1.30

0.77

3.1

2.6

3.29

4.93

ug/l

1.57

280

Malignant neoplasm of rectosigmoid junction, including Hilmo

122

1072

1.15

0.77

2.0

2.6

8.90

7.56

ug/l

0.22

106

945

Other specified and unspecified strabismus

271

1.31

0.77

2.0

2.3

13.32

7.36

ug/l

0.40

246

Erosion and ectropion of cervix uteri

661

1.19

0.76

1.8

2.3

5.23

7.20

ug/l

0.91

577

Foreign body in genitourinary tract

219

1.35

0.76

3.4

2.4

7.07

4.93

ug/l

0.33

194

Polycythaemia vera

141

1253

1.14

0.75

2.1

2.5

4.67

7.84

ug/l

2.65

106

1110

Accidental poisoning by and exposure to pesticides

1.68

0.75

1.8

2.3

2.20

5.33

ug/l

—

Other secondary coxarthrosis

119

1045

1.15

0.75

2.5

2.4

8.17

7.75

ug/l

0.05

100

931

Other endocrine disorders

1011

0.86

0.75

2.2

2.3

5.72

7.65

ug/l

0.88

896

Cerebral amyloid angiopathy

195

1.39

0.74

1.7

2.4

8.80

6.29

ug/l

0.47

174

Psoriasis (vulgaris), strict definition

111

971

1.16

0.74

2.4

2.3

5.10

8.06

ug/l

2.46

886

Nutritional marasmus

1.83

0.74

1.0

2.3

2.49

4.14

ug/l

—

Malignant neoplasm of brain, including Hilmo

174

1566

1.12

0.73

2.1

2.4

4.50

8.04

ug/l

5.07

155

1392

Allergic contact dermatitis

380

3539

1.08

0.73

2.3

2.2

5.87

6.80

ug/l

0.61

323

3132

Phantom limb syndrome with pain

1.63

0.73

1.3

2.6

2.89

7.11

ug/l

—

Subclinical iodine-deficiency hypothyroidism

1.81

0.73

1.9

2.6

31.04

6.66

ug/l

—

Melanocytic naevi of scalp and neck

609

1.20

0.73

2.8

2.5

9.28

6.75

ug/l

0.32

552

Benign neoplasm: Conjunctiva

109

954

1.16

0.73

2.2

2.4

5.78

7.68

ug/l

0.92

850

Other degenerative disorders of eyelid and periocular area

1.60

0.72

4.8

2.6

3.30

5.86

ug/l

1.40

Migraine, unspecified, drug-induced

143

1.43

0.72

3.0

2.0

10.63

4.21

ug/l

0.80

127

Use of antiglaucoma preparations and miotics

346

3219

1.08

0.72

2.4

2.5

7.65

6.71

ug/l

0.24

281

2714

Respiratory tuberculosis, confirmed, including avohilmo

574

1.20

0.72

2.6

6.57

6.90

ug/l

0.07

501

Respiratory tuberculosis, bacteriologically and histologically confirmed

574

1.20

0.72

2.6

6.58

6.97

ug/l

0.08

499

Malignant neoplasm of gallbladder

180

0.64

0.72

2.7

2.4

1.52

7.65

ug/l

2.95

156

Benign lipomatous neoplasm of skin and subcutaneous tissue of head, face and neck

237

2171

1.10

0.71

2.4

2.3

8.96

7.90

ug/l

0.23

215

1954

Traumatic cerebral oedema

1.59

0.71

1.9

2.9

7.33

8.54

ug/l

—

HSIL lesion of the vagina

310

1.28

0.71

2.7

2.3

4.67

5.03

ug/l

0.05

279

Malignant neoplasm of colon

728

6931

1.06

0.71

2.3

2.5

5.32

7.80

ug/l

3.83

619

5989

Colour vision deficiencies

1.57

0.71

2.8

1.8

3.08

7.59

ug/l

2.03

Acute myeloid leukaemia, helper endpoint

429

1.24

0.70

2.3

2.6

3.96

7.56

ug/l

1.92

369

Acute myeloid leukaemia, including Hilmo

429

1.24

0.70

2.3

2.6

3.96

7.56

ug/l

1.92

369

Acute myeloid leukaemia

429

1.24

0.70

2.3

2.6

3.96

7.56

ug/l

1.92

369

Epiphora

668

1.18

0.70

2.7

2.3

8.20

8.15

ug/l

0.01

590

Panhypopituitarism

502

1.21

0.70

3.7

2.5

3.94

7.06

ug/l

2.48

454

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum

409

4360

0.93

0.70

2.0

2.5

6.56

7.93

ug/l

0.75

351

3854

Congenital deformities of hip, including avohilmo

301

1.27

0.69

2.1

2.2

13.63

6.22

ug/l

0.51

264

Hereditary ataxia

375

1.25

0.69

2.7

2.3

3.66

7.71

ug/l

2.87

331

Obstructed labour due to malposition and malpresentation of fetus

399

3452

1.07

0.69

1.9

5.83

5.54

ug/l

0.09

354

3048

Sequelae of other and unspecified effects of external causes

136

1.43

0.69

2.5

2.6

19.20

5.62

ug/l

0.40

121

Cervical root disorders

188

1.36

0.69

1.8

2.7

3.51

7.83

ug/l

1.97

170

L02BX Other hormone antagonists and related agents

229

2493

0.91

0.69

2.6

2.4

5.11

8.25

ug/l

4.93

204

2217

Postpolio syndrome

1.71

0.69

3.2

2.5

3.21

4.75

ug/l

—

Syndrome of inappropriate secretion of antidiuretic hormone

180

1.38

0.69

2.9

2.6

5.14

5.33

ug/l

0.05

160

Respiratory tuberculosis, clinically confirmed

383

0.77

0.68

2.4

2.7

5.84

7.28

ug/l

0.30

330

Malignant neoplasm of tongue, including Hilmo

105

924

1.15

0.67

2.3

2.5

8.43

7.63

ug/l

0.16

830

Sunburn

1.65

0.67

1.6

2.0

1.79

6.37

ug/l

—

Turner's syndrome

1.83

0.67

1.8

14.12

4.58

ug/l

—

Intrahepatic Cholestasis of Pregnancy (ICP) , excluding more controls

1035

0.87

0.67

1.6

1.8

10.69

4.66

ug/l

0.86

914

Malignant neoplasm of anus and anal canal, including Hilmo

423

1.23

0.67

1.6

2.5

4.96

7.39

ug/l

1.04

361

Suppurative otitis media, unspecified

587

1.19

0.66

1.9

2.4

9.08

6.68

ug/l

0.37

519

Malignant neoplasm of mesothelium and soft tissue

162

1465

1.12

0.66

2.6

2.5

7.36

7.97

ug/l

0.14

148

1292

Graves disease, strict definition

276

2554

1.09

0.66

2.0

2.2

5.50

6.55

ug/l

0.68

233

2269

Malignant neoplasm of brain

120

1066

1.14

0.66

1.8

2.4

3.51

8.68

ug/l

11.14

106

958

Deep bite

289

2350

1.08

0.66

2.1

2.2

5.63

7.58

ug/l

1.71

249

2091

Malignant neoplasm of eye, brain and central nervous system

157

1417

1.12

0.66

2.0

2.4

3.78

8.27

ug/l

9.98

134

1264

Generalized pustular psoriasis

101

0.58

0.65

5.2

2.7

5.25

6.23

ug/l

—

Otosclerosis

223

2425

0.91

0.65

2.4

2.3

8.21

7.38

ug/l

0.19

189

2163

Infections of breast associated with childbirth

505

1.20

0.65

2.0

4.06

4.90

ug/l

0.29

458

Mandibular retrognathia

115

1292

0.88

0.64

2.0

2.1

5.04

7.23

ug/l

1.71

107

1154

Disorders of other and unspecified cranial nerves

147

1.40

0.64

4.0

2.6

4.05

7.58

ug/l

0.92

129

Non-small cell lung cancer, including Hilmo

654

6436

0.95

0.64

2.3

2.5

5.52

7.73

ug/l

3.45

579

5581

Autism

305

1.25

0.64

1.8

3.54

7.60

ug/l

2.02

260

Malignant neoplasm of rectum

396

4209

0.93

0.64

2.0

2.5

6.05

7.86

ug/l

1.49

341

3711

Other nutritional anaemias

307

1.26

0.63

2.4

2.6

6.00

5.11

ug/l

0.18

266

Generalized epilepsy, strict definition

425

1.21

0.62

2.0

2.2

11.32

7.94

ug/l

0.17

386

Benign neoplasm: Pancreas

106

940

1.14

0.62

2.4

2.5

5.15

6.76

ug/l

0.87

832

Carcinoma in situ of skin

374

3515

1.07

0.62

2.4

2.5

8.89

7.10

ug/l

0.52

323

3046

Other ulcerative colitis

167

1518

1.11

0.61

2.6

2.2

5.63

7.82

ug/l

1.18

156

1385

Other endophthalmitis

175

1.35

0.61

1.6

2.5

5.97

5.30

ug/l

0.14

152

Other and unspecified disorders of lacrimal system

1.57

0.61

3.1

2.8

13.10

3.39

ug/l

—

Waldenstrom macroglobulinemia, lymphoplasmacytic lymphoma, including Hilmo

292

1.27

0.60

2.7

2.8

6.21

8.41

ug/l

0.26

255

Benign neoplasm: Vagina

318

1.25

0.60

2.1

2.4

3.50

4.91

ug/l

0.75

282

Colorectal cancer

1156

10710

1.04

0.60

2.2

2.5

5.86

7.73

ug/l

3.08

986

9291

Other bursitis of knee

391

1.22

0.60

2.3

2.2

16.34

9.91

ug/l

0.59

349

Other articular cartilage disorders

697

1.16

0.60

2.1

2.4

6.28

8.18

ug/l

0.40

620

Polyglandular dysfunction

1.56

0.60

4.3

2.4

10.12

6.97

ug/l

—

Injury of nerves at lower leg level

255

1.28

0.60

1.6

2.4

7.09

6.08

ug/l

0.16

231

Bullous keratopathy

283

1.27

0.60

2.0

2.7

5.60

6.70

ug/l

0.27

251

Gonococcal infection

800

1.15

0.60

2.3

5.79

7.80

ug/l

1.18

726

Other corneal oedema

274

1.27

0.60

3.9

2.5

4.15

7.09

ug/l

1.32

245

Other bursitis of elbow

265

1.27

0.59

2.6

2.4

35.33

9.79

ug/l

0.49

235

Frostbite involving multiple body regions and unspecified frostbite

1.53

0.59

3.4

2.4

8.61

7.37

ug/l

—

Non-small cell lung cancer

442

4615

0.94

0.59

2.1

2.5

5.55

7.37

ug/l

2.01

391

4002

Malignant neoplasm of other and unspecified female genital organs, including Hilmo

868

1.14

0.59

2.1

2.5

3.94

6.38

ug/l

1.74

757

Other and unspecified disease of Bartholin gland

698

1.16

0.59

2.0

2.4

4.66

6.83

ug/l

1.13

614

Benign neoplasm: Tongue

849

1.14

0.59

2.3

2.5

8.30

7.28

ug/l

0.18

757

Congenital retinoschisis

1.57

0.59

2.1

2.6

4.39

7.72

ug/l

1.02

Mild mental retardation

530

1.18

0.59

2.0

2.3

6.02

7.92

ug/l

0.36

468

Amoebiasis

141

1.38

0.59

1.6

2.3

5.59

5.78

ug/l

0.03

125

Ulcerative colitis (strict) with PSC

161

0.67

0.58

1.4

2.2

1.81

7.93

ug/l

2.78

149

Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue

293

1.26

0.58

2.0

2.6

2.74

6.41

ug/l

3.13

261

Congenital malformations of breast, including avohilmo

219

0.72

0.58

1.8

2.1

12.87

4.79

ug/l

0.40

191

Pedestrian injured in collision with pedal cycle

878

1.14

0.58

3.3

2.4

11.46

7.76

ug/l

0.67

792

Benign neoplasm: Bladder

293

1.25

0.58

2.6

2.5

5.25

8.15

ug/l

0.83

257

Benign neoplasm: Connective and other soft tissue of trunk, unspecified

159

1.35

0.58

1.7

2.8

4.12

9.07

ug/l

1.22

141

Torsion of testis

356

1.22

0.57

1.9

2.1

6.44

10.31

ug/l

1.02

322

Rapidly progressive nephritic syndrome

1.59

0.57

2.3

3.63

5.99

ug/l

—

Carcinoma in situ of rectum

441

1.20

0.57

2.2

2.6

6.60

7.85

ug/l

0.37

402

Malignant neoplasm of mesothelium and soft tissue, including Hilmo

264

2463

1.08

0.56

2.4

8.58

7.57

ug/l

0.28

241

2158

Primary Sclerosing Cholangitis, IBD and UDCA required

468

1.19

0.56

8.7

2.3

2.72

7.81

ug/l

6.98

428

Degeneration of the brain due to alcohol

741

1.15

0.55

3.0

2.5

6.21

8.14

ug/l

0.84

666

Malignant melanoma of skin, including Hilmo

630

6029

1.05

0.55

2.3

2.5

7.69

7.89

ug/l

0.07

546

5282

Injury of blood vessels at lower leg level

143

1.37

0.55

3.2

2.1

11.67

5.55

ug/l

0.40

123

Adenocarcinoma and papilloma adenocarcinoma of rectum

395

4172

0.94

0.55

2.0

2.5

6.74

7.60

ug/l

0.40

338

3686

Drug-induced polyneuropathy

241

1.27

0.55

2.3

2.7

11.03

8.17

ug/l

0.20

216

Autism spe

303

1.23

0.55

1.8

1.9

3.36

7.84

ug/l

2.28

264

Benign leiomyoma with endometriosis

459

4832

0.95

0.54

2.0

2.3

6.44

5.81

ug/l

0.22

368

4151

Colon adenocarcinoma, helper endpoint

576

5507

1.05

0.54

2.4

5.34

7.03

ug/l

1.71

496

4759

Contact with nonpowered hand tool

140

1274

1.11

0.53

2.1

2.3

11.49

8.74

ug/l

0.72

125

1173

Abnormal findings in secretions and smears from cervix uteri vagina vulva

1234

9366

0.97

0.53

1.9

2.1

4.91

5.97

ug/l

1.63

1078

8148

Benign neoplasm: Connective and other soft tissue of abdomen

1.44

0.53

3.6

2.3

5.07

4.87

ug/l

—

Benign neoplasm: Skin, unspecified

133

1208

1.11

0.53

2.0

2.3

6.63

7.54

ug/l

0.28

107

1085

Benign neoplasm: Long bones of lower limb

799

1.14

0.53

1.9

2.3

5.77

7.53

ug/l

0.71

725

Exposure to ignition of highly flammable material

109

1.41

0.53

2.5

2.1

3.89

6.16

ug/l

0.80

Acrodermatitis continua

1.54

0.53

2.0

2.5

1.97

5.81

ug/l

—

Malignant neoplasm of breast, HER-positive

1075

8271

0.97

0.53

2.1

2.3

3.84

5.94

ug/l

10.62

893

7135

Other protozoal intestinal diseases

324

1.22

0.52

2.9

2.2

4.63

7.25

ug/l

0.74

294

Other abnormal findings in urine

510

1.17

0.52

2.2

2.6

4.38

7.44

ug/l

1.95

449

Other and unspecified glaucoma

304

2860

1.07

0.52

2.5

5.74

6.96

ug/l

1.05

247

2448

Carcinoma in situ of other and unspecified digestive organs

174

1604

1.09

0.52

2.3

2.5

7.12

7.63

ug/l

0.17

157

1445

Labour and delivery complicated by fetal stress [distress]

314

2174

0.94

0.52

1.6

1.9

4.92

5.35

ug/l

0.12

274

1893

Malignant neoplasm of ureter

106

0.64

0.51

2.6

2.2

1.66

6.03

ug/l

—

Benign neoplasm of breast

320

3396

0.94

0.51

2.1

2.3

6.02

5.77

ug/l

0.11

264

2892

Iridocyclitis in diseases classified elsewhere

529

1.17

0.51

1.9

2.4

4.20

7.93

ug/l

2.49

479

Retinal breaks without detachment

562

5873

0.95

0.51

2.3

6.49

7.77

ug/l

1.29

494

5206

Malignant neoplasm of breast, ER-positive, including Hilmo

1078

8277

0.97

0.51

2.1

2.3

3.86

5.94

ug/l

10.48

896

7140

Malignant neoplasm of tonsil and base of tongue, including Hilmo

859

0.87

0.51

2.6

2.5

9.96

9.12

ug/l

0.11

773

Malignant neoplasm of pyriform sinus, including Hilmo

1.60

0.51

1.4

2.8

5.81

11.69

ug/l

—

Benign neoplasm: Pituitary gland, craniopharyngeal duct

163

1499

1.09

0.50

2.2

2.4

6.21

7.21

ug/l

0.31

138

1351

Maternal care for known or suspected malpresentation of fetus

241

1843

0.93

0.50

1.6

2.0

3.50

5.29

ug/l

1.31

207

1601

Congenital malformations of nose, including avohilmo

1.60

0.50

1.7

3.1

8.74

5.38

ug/l

—

Malignant neoplasm of other and unspecified female genital organs

531

1.17

0.50

2.3

2.4

4.06

6.44

ug/l

0.99

465

Benign neoplasm: Skin of lower limb, including hip

766

1.13

0.49

2.5

2.4

7.20

7.37

ug/l

0.03

685

Colon adenocarcinoma

576

5521

1.05

0.49

2.4

2.5

5.34

7.29

ug/l

2.12

496

4768

Other congenital malformations of urinary system

1.42

0.49

1.8

2.3

11.89

5.60

ug/l

0.37

Gonococcal infection, including avohilmo

851

1.12

0.49

2.4

2.2

5.91

7.71

ug/l

1.04

772

Adenocarcinoma and papillary adenocarcinoma of stomach

1077

0.89

0.49

2.4

2.5

4.42

7.52

ug/l

2.06

943

Malignant neoplasm of other and unspecified parts of biliary tract, including Hilmo

778

1.13

0.48

2.2

2.6

3.97

7.53

ug/l

3.24

684

Benign neoplasm of other and unspecified female genital organs

125

1140

1.10

0.47

2.4

2.3

6.26

5.77

ug/l

0.11

101

989

Other specified and unspecified disorders of iris and ciliary body

1.42

0.47

2.8

2.4

5.74

5.60

ug/l

0.02

Degeneration of nervous system due to alcohol

751

1.13

0.47

3.0

2.5

6.21

8.17

ug/l

0.86

679

Neuroendocrine tumor and carcinoma of pancreas

201

1.27

0.47

2.1

2.4

5.62

8.90

ug/l

0.67

177

Foreign body entering into or through eye or natural orifice

252

2366

1.07

0.47

2.4

8.16

8.53

ug/l

0.07

218

2144

Carcinoma in situ of cervix uteri

183

1697

1.08

0.46

1.8

2.2

8.73

5.22

ug/l

0.40

168

1478

Complications of the puerperium, not elsewhere classified

561

1.15

0.46

1.9

4.32

4.91

ug/l

0.19

506

Bicornuate uterus

0.60

0.46

1.8

2.1

1.92

3.74

ug/l

—

Benign neoplasm: Thymus

1.47

0.46

1.3

2.7

24.56

8.81

ug/l

0.33

Maxillary retrognathism

274

1.21

0.45

1.6

2.3

3.62

9.02

ug/l

2.87

244

Benign neoplasm: Testis

127

0.69

0.45

2.2

2.3

6.90

10.60

ug/l

—

112

Postpartum hemorraghe, all women as controls

400

4097

0.95

0.45

1.8

1.9

7.53

5.38

ug/l

0.49

361

3607

Maternal care for other known or suspected fetal problems

355

2109

1.06

0.45

1.7

1.9

3.91

5.42

ug/l

1.30

318

1830

Malignant melanoma of skin

513

4920

1.05

0.45

2.4

2.5

7.96

7.78

ug/l

0.05

444

4311

Use of cabergoline

307

0.81

0.45

2.1

2.4

12.58

8.11

ug/l

0.27

280

Postpartum care and examination

170

1151

0.92

0.43

1.8

3.63

5.87

ug/l

1.56

148

995

Hydrocephalus in other diseases

149

1.30

0.43

1.5

2.3

6.99

4.96

ug/l

0.19

129

Severe combined immunodeficiency [SCID] with low T- and B-cell numbers

0.00

0.43

0.0

2.1

—

4.41

—

Intrahepatic Cholestasis of Pregnancy (ICP)

997

0.90

0.43

1.6

1.8

10.69

5.00

ug/l

0.79

879

Malignant neoplasm of stomach, including Hilmo

247

2328

1.07

0.43

2.6

2.5

5.52

7.64

ug/l

1.79

198

2018

Pedal cyclist injured in other and unspecified transport accidents

358

3409

1.05

0.42

2.3

11.60

7.66

ug/l

0.72

298

3044

Disease of thymus, other/unspecified

1.56

0.42

1.4

2.1

3.10

6.17

ug/l

—

Pedestrian injured in other and unspecified transport accidents

315

1.19

0.41

2.9

2.5

2.43

7.26

ug/l

3.31

284

Sequelae of tuberculosis

616

1.13

0.41

3.1

2.7

10.92

6.18

ug/l

0.35

514

Pleural plaque without asbestos

157

1461

1.08

0.41

2.8

2.6

7.57

6.68

ug/l

0.24

133

1275

Congenital malformations of breast

205

0.78

0.40

1.7

2.1

12.87

4.90

ug/l

0.39

180

Family history of malignant neoplasm

261

2467

1.06

0.40

1.6

2.0

4.18

5.27

ug/l

0.93

220

2174

Crowding of teeth, including avohilmo

151

1158

1.08

0.40

1.9

2.2

7.53

7.24

ug/l

0.03

138

1011

Premenstrual syndrome

150

1.27

0.40

1.8

4.13

5.68

ug/l

0.28

132

Radiodermatitis

1.43

0.40

3.1

2.2

11.37

5.30

ug/l

—

Familial benign pemphigus (Hailey-Hailey disease)

1.41

0.40

1.3

2.8

9.09

4.86

ug/l

—

Malignant neoplasm of larynx, including Hilmo

732

1.12

0.40

2.5

2.6

7.10

7.98

ug/l

0.13

640

Benign neoplasm: Short bones of upper limb

372

1.17

0.40

1.8

2.3

3.46

7.86

ug/l

3.26

339

Failed induction of labour

687

0.89

0.40

1.6

2.3

3.54

4.76

ug/l

0.45

591

Malignant neoplasm of renal pelvis, including Hilmo

439

1.16

0.39

2.8

3.29

7.70

ug/l

4.77

381

Mandibular prognathia

298

1.18

0.39

1.6

2.1

7.38

9.04

ug/l

0.20

267

Graves ophthalmopathy, strict

547

0.87

0.39

2.3

2.4

6.77

5.80

ug/l

0.19

488

Other diseases of blood and blood-forming organs

244

2309

1.06

0.38

2.5

2.4

8.14

7.58

ug/l

0.14

204

2067

Malignant neoplasm of breast, including Hilmo

1368

8967

0.98

0.38

2.1

2.3

4.44

6.12

ug/l

5.04

1131

7730

Malignant neoplasm of breast, HER2-negative, including Hilmo

1368

8967

0.98

0.38

2.1

2.3

4.44

6.12

ug/l

5.04

1131

7730

Undefined dementia

588

5239

1.04

0.38

2.7

2.6

6.40

6.06

ug/l

0.14

441

4229

Congenital malformations of ovaries, fallopian tubes and broad ligaments

936

0.90

0.38

1.6

2.0

3.02

5.80

ug/l

3.38

832

Disorders of adrenal gland, other and/or unspecified

125

1.30

0.38

2.2

2.3

10.44

4.88

ug/l

0.49

113

Myotonic dystrophy (Steinert)

1.33

0.38

1.3

2.2

4.46

5.11

ug/l

—

Endometriosis diagnosis and infertility diagnosis occurring together

193

1812

1.07

0.38

1.8

2.0

3.68

5.17

ug/l

1.05

162

1611

Non-small cell lung cancer, adenocarcinoma, helper endpoint

242

2553

0.94

0.37

2.2

2.5

4.41

7.64

ug/l

5.23

212

2226

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8, excluding more controls

141

1514

0.93

0.36

2.1

2.0

11.21

5.01

ug/l

1.14

123

1346

Calcaneal spur

310

1.17

0.36

2.1

2.2

14.48

6.40

ug/l

0.43

277

Sequelae of tuberculosis, including avohilmo

632

1.12

0.36

3.1

2.6

10.92

6.20

ug/l

0.35

526

Mumps, including avohilmo

701

0.89

0.36

2.4

2.2

5.65

7.52

ug/l

0.71

636

Multiple delivery

148

1585

0.93

0.36

1.9

2.1

4.52

7.50

ug/l

1.89

136

1365

Carcinoma in situ of colon

113

1046

1.09

0.35

2.4

7.86

7.69

ug/l

0.03

107

944

Traumatic amputation of shoulder and upper arm

1.38

0.35

6.7

2.3

2.70

4.48

ug/l

—

Amputation of ankle

1.38

0.35

2.5

3.95

5.04

ug/l

—

Follicular adenocarcinoma of thyroid gland, including Hilmo

302

1.17

0.35

2.1

2.5

4.91

6.38

ug/l

0.36

262

Diseases caused by chlamydiae

172

1.23

0.35

2.4

2.2

2.73

4.54

ug/l

1.00

152

Tooth eruption problems

255

2339

1.05

0.35

2.1

8.17

7.00

ug/l

0.32

232

2038

Sequelae of other accidents

453

1.14

0.35

3.2

2.5

4.99

7.54

ug/l

1.15

400

Foreign body or object entering through skin

183

1725

1.07

0.34

2.1

2.4

6.53

7.68

ug/l

0.62

156

1561

Malignant neoplasm, without specification of site, including Hilmo

194

1832

1.06

0.34

2.1

2.5

5.47

7.13

ug/l

0.60

167

1573

Hereditary corneal dystrophies

122

1135

1.08

0.34

2.0

2.5

9.68

7.62

ug/l

0.31

102

1006

Benign neoplasm: Vertebral column

1.39

0.34

2.3

3.04

4.75

ug/l

—

Carcinoma in situ of skin of lower limb, including hip

828

1.10

0.33

2.2

2.6

9.75

6.57

ug/l

0.73

714

Accessory breast

0.68

0.33

1.3

2.1

3.10

4.01

ug/l

—

Benign neoplasm: Anus and anal canal

914

1.09

0.33

2.2

2.5

7.16

7.06

ug/l

0.02

806

Postpartum haemorrhage due to retained placenta

178

1888

0.94

0.33

1.8

9.89

4.76

ug/l

0.57

158

1672

Malignant neoplasm of respiratory system and intrathoracic organs, including Hilmo

1086

9130

0.98

0.32

2.3

2.5

6.53

7.90

ug/l

1.32

950

7958

Pedal cyclist injured in transport accident

701

7208

0.97

0.32

2.2

2.3

9.11

7.66

ug/l

0.44

593

6379

Convergent concomitant strabismus

132

1234

1.07

0.32

2.4

2.2

7.22

7.81

ug/l

0.14

116

1112

Malignant neoplasm of small intestine, including Hilmo

116

1081

1.08

0.32

2.5

6.50

7.97

ug/l

0.45

103

963

Malignant neoplasm of eye and adnexa, including Hilmo

552

1.12

0.32

2.4

2.5

5.01

7.18

ug/l

1.02

480

Corneal degeneration

504

1.12

0.32

1.5

2.2

8.73

7.36

ug/l

0.16

447

Exophthalmic conditions

296

1.16

0.31

1.9

2.3

6.60

6.30

ug/l

0.07

272

Haemophilus septicemia

1.33

0.31

2.1

2.7

4.54

5.50

ug/l

—

Malignant neoplasm of other connective and soft tissue

851

1.09

0.31

2.4

2.5

5.83

7.47

ug/l

0.64

751

Malignant neoplasm of other endocrine glands and related structures, including Hilmo

152

0.77

0.31

1.9

2.5

3.52

7.50

ug/l

0.89

137

Malignant neoplasm of rectum, including Hilmo

505

5209

0.97

0.30

2.0

2.5

6.68

7.94

ug/l

0.77

434

4574

Malignant neoplasm of eye and adnexa

288

1.16

0.30

1.8

2.5

5.01

7.24

ug/l

0.57

252

Benign neoplasm: Cranial nerves

899

0.92

0.30

2.7

2.4

6.26

7.34

ug/l

0.49

805

Chronic myeloproliferative disease

492

0.88

0.30

2.3

2.5

9.19

6.97

ug/l

0.38

436

Brain glioblastoma, helper endpoint

459

1.12

0.30

1.4

2.4

2.48

7.49

ug/l

7.65

420

Benign neoplasm of thyroid gland

102

949

1.08

0.30

2.4

4.59

7.32

ug/l

1.21

838

Disorder of the sleep-wake schedule

373

1.13

0.29

2.7

2.3

2.55

7.88

ug/l

6.08

336

Chondromalacia

732

0.91

0.29

1.8

2.3

6.71

7.22

ug/l

0.09

665

Non-small cell lung cancer, adenocarcinoma

242

2529

0.95

0.29

2.2

2.5

4.41

7.59

ug/l

5.39

212

2208

Overexertion and strenuous or repetitive movements

308

2961

1.04

0.29

2.3

2.4

11.41

8.21

ug/l

0.54

267

2656

Carcinoma in situ of penis

1.26

0.28

2.5

2.6

11.19

9.58

ug/l

—

Spontaneous abortion

1168

7976

0.98

0.28

2.1

4.60

5.85

ug/l

1.96

1026

6979

Certolizumab pegol

308

1.14

0.28

1.6

2.1

8.25

7.05

ug/l

0.16

278

Cholangitis (primary sclerosing, PSC), with reimbursement 202

451

1.12

0.28

2.1

2.3

1.81

8.06

ug/l

8.70

409

Congenital ovarian cysts

679

0.91

0.28

1.6

2.0

3.28

5.34

ug/l

1.57

607

Early syphilis

311

0.86

0.28

1.9

2.3

6.94

9.33

ug/l

0.60

283

Essential (haemorrhagic) thrombocythaemia

138

1302

1.07

0.28

2.6

2.5

4.79

7.58

ug/l

2.20

122

1152

Contact with venomous snakes and lizards

271

1.16

0.28

1.9

2.3

6.40

6.21

ug/l

0.03

234

Malignant melanoma, including Hilmo

757

7393

1.03

0.28

2.3

2.5

7.79

7.74

ug/l

0.02

651

6453

Other and unspecified skin changes due to chronic exposure to nonionizing radiation

452

1.12

0.28

2.9

2.6

4.36

6.42

ug/l

0.61

391

Other and unspecified degenerative diseases of nervous system

111

1041

1.07

0.27

2.4

2.6

6.44

6.32

ug/l

0.03

909

Pterygium

1028

0.93

0.27

3.9

2.5

8.63

7.08

ug/l

0.34

921

Congenital obstructive defects of renal pelvis and congenital malformations of ureter

366

1.13

0.27

2.2

2.4

12.71

5.78

ug/l

0.81

324

Mumps

687

0.91

0.27

2.4

2.3

5.65

7.46

ug/l

0.68

623

Malignant neoplasm of oropharynx

582

0.90

0.27

2.4

2.6

6.70

8.84

ug/l

0.48

527

Graves ophthalmopathy

614

0.91

0.27

2.1

2.3

6.06

6.10

ug/l

0.01

548

Malignant neoplasm of small intestine

819

1.08

0.27

2.5

4.46

8.15

ug/l

3.06

726

Atopic dermatitis

1927

15113

1.02

0.27

2.4

2.1

6.72

7.84

ug/l

1.25

1673

13355

Chronic iridocyclitis

145

1373

1.06

0.26

2.7

2.4

4.60

8.01

ug/l

4.70

123

1226

Infliximab

358

1.12

0.26

2.2

2.1

3.37

8.72

ug/l

2.89

328

Pseudopolyposis of colon

1.22

0.25

5.3

2.0

16.50

5.54

ug/l

—

Hypospadias

1.21

0.25

4.3

2.3

5.84

7.16

ug/l

—

Unspecified multiple injuries

1.20

0.25

1.7

2.3

7.99

4.45

ug/l

—

Unspecified renal colic

161

1.20

0.25

1.9

2.6

13.93

7.66

ug/l

0.31

146

Other protozoal intestinal diseases, including avohilmo

474

1.10

0.25

2.7

2.1

6.78

7.50

ug/l

0.10

427

Open bite that required surgery (Lefort1 or BSSO)

133

1.21

0.24

1.2

1.9

3.18

6.62

ug/l

1.19

121

Varicella [chickenpox]

124

1172

1.06

0.24

2.4

2.3

12.67

10.18

ug/l

0.29

115

1069

Malignant neoplasm of tongue

707

1.08

0.24

2.3

2.6

8.88

8.16

ug/l

0.11

631

Eustachian salpingitis and obstruction

160

1680

0.95

0.24

1.9

2.2

6.47

6.92

ug/l

0.13

136

1508

Alzheimer’s disease (Early onset)

182

1741

1.05

0.24

2.6

2.5

6.49

6.83

ug/l

0.07

123

1449

Chronic myeloid leukaemia

153

1.20

0.23

2.4

5.27

10.77

ug/l

1.55

135

Glaucoma-related operations

209

2175

0.96

0.23

2.3

2.5

4.76

6.46

ug/l

2.42

179

1884

Optic neuritis

902

1.07

0.23

2.3

2.2

7.49

7.37

ug/l

0.02

810

Defect, injury or illness of neck

125

1.21

0.23

1.7

2.4

3.83

5.23

ug/l

0.70

115

Melanoma in situ of trunk

555

0.91

0.23

1.8

2.6

9.65

7.73

ug/l

0.35

502

Pedestrian injured in collision with other nonmotor vehicle

1.24

0.22

3.8

2.3

4.30

3.38

ug/l

—

Other diseases of appendix

324

1.12

0.22

2.2

2.4

10.31

6.89

ug/l

0.47

291

Testicular dysfunction

131

1245

1.06

0.22

2.7

2.3

8.80

10.06

ug/l

0.26

119

1142

Crushing injury of shoulder and upper arm

0.00

0.22

0.0

4.2

—

9.02

—

MS-disease / Multiple Sclerosis

151

1583

0.95

0.22

2.1

6.15

7.32

ug/l

0.54

128

1411

Refsum disease

0.00

0.22

0.0

3.8

—

6.62

—

Antenatal screening

389

2112

1.03

0.22

1.7

1.8

3.96

6.59

ug/l

3.55

357

1862

Other fluke infections

0.00

0.22

0.0

2.1

—

5.23

—

Spermatocele

305

3148

0.97

0.22

2.5

2.4

6.99

8.61

ug/l

1.35

269

2824

Short stature starting before birth

1.23

0.22

2.0

2.2

25.34

10.64

ug/l

—

Colorectal adenocarcinoma

958

9291

1.02

0.22

2.2

2.5

5.93

7.85

ug/l

2.63

823

8056

Follicular lymphoma, hilmo

151

1442

1.05

0.22

2.2

2.5

5.35

7.23

ug/l

0.43

132

1281

6-mercaptopurine

679

0.92

0.22

2.1

6.27

7.09

ug/l

0.08

618

Other birth injuries

0.00

0.22

0.0

2.6

—

7.92

—

Desensitization to allergens

884

0.94

0.21

1.8

2.0

3.97

7.22

ug/l

2.50

794

Defect, injury or illness of skull

0.00

0.21

0.0

2.2

—

5.27

—

Benign neoplasm: Vulva

532

0.92

0.21

2.1

2.3

4.13

6.75

ug/l

1.55

464

Thoracic root disorders

1.27

0.21

1.5

2.1

3.53

6.19

ug/l

—

Pregnancy, childbirth and the puerperium

1008

5351

0.98

0.21

2.4

5.25

5.51

ug/l

0.22

853

4360

Pulmonary eosinophilia, not elsewhere classified

355

1.11

0.20

2.8

2.5

6.66

7.00

ug/l

0.06

314

Hereditary lymphedema, including avohilmo

1.24

0.20

2.0

2.3

13.07

3.69

ug/l

—

Maxillary hypoplasia

1.26

0.20

2.7

2.1

10.27

10.66

ug/l

—

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8

141

1476

0.95

0.20

2.1

2.0

11.21

5.40

ug/l

1.03

123

1313

Chronic mastoiditis

830

1.07

0.20

2.1

2.6

4.61

6.74

ug/l

1.31

742

Diseases of thymus

1.24

0.20

1.3

2.6

3.12

5.15

ug/l

—

Knuckle pads

1.22

0.20

2.0

2.5

4.68

10.29

ug/l

—

Other osteochondrodysplasias, including avohilmo

271

0.88

0.20

2.9

2.4

6.29

5.83

ug/l

0.05

247

Malignant neoplasm of uterus, part unspecified, including Hilmo

165

1.17

0.20

1.8

2.6

2.72

4.54

ug/l

0.93

143

Pustulosis palmaris et plantaris

120

1143

1.05

0.20

2.5

2.3

3.40

7.15

ug/l

7.48

101

1026

Other disorders of choroid

433

1.09

0.20

2.6

2.4

11.94

6.85

ug/l

0.42

382

Benign neoplasm: Connective and other soft tissue, unspecified

312

0.89

0.20

1.4

2.5

12.05

7.21

ug/l

0.45

276

Progressive supranuclear ophthalmoplegia (Steele-Richardson-Olszewski)

217

0.86

0.19

2.0

2.6

7.81

7.84

ug/l

0.00

192

Malignant neoplasm of tonsil

529

0.92

0.19

2.4

2.6

7.05

8.76

ug/l

0.32

480

Intentional self-harm by hanging, strangulation and suffocation

175

0.85

0.19

1.9

2.4

6.42

9.79

ug/l

—

158

Use of donepezil

1053

10186

0.98

0.19

2.3

2.6

6.62

6.05

ug/l

0.33

761

8545

Malignant neoplasm of breast, HER2-negative

1363

8903

0.99

0.18

2.1

2.3

4.44

6.08

ug/l

4.86

1125

7679

Crushing injury of wrist and hand

464

1.08

0.18

2.1

2.3

5.51

7.42

ug/l

0.75

417

Single delivery by caesarean section

281

1652

0.97

0.18

1.7

2.0

2.87

7.84

ug/l

8.93

249

1429

Early syphilis, including avohilmo

331

0.90

0.18

1.9

2.2

7.00

9.18

ug/l

0.58

301

Benign lipomatous neoplasm of skin and subcutaneous tissue of other and unspecified sites

195

1.14

0.18

1.5

2.4

2.22

7.76

ug/l

3.28

177

Hypogonadotropic hypogonadism

825

1.06

0.17

1.9

2.2

5.20

10.09

ug/l

3.43

758

Other congenital malformations of face and neck

620

1.07

0.17

2.1

2.3

5.31

7.56

ug/l

0.62

560

Malignant neoplasm of breast

1365

8909

0.99

0.17

2.1

2.3

4.46

6.08

ug/l

4.78

1127

7685

Placenta praevia

581

1.07

0.17

1.8

2.0

7.71

5.44

ug/l

0.27

510

Other congenital malformations of digestive system

0.71

0.17

1.6

3.1

2.40

5.41

ug/l

—

Other and unspecified syphilis

0.73

0.17

1.4

2.3

6.92

6.07

ug/l

—

Maternal care for cervical incompetence

814

0.94

0.17

2.5

2.2

7.34

6.05

ug/l

0.16

723

Meningococcal infection, including avohilmo

148

1.16

0.17

1.8

2.4

5.69

8.48

ug/l

0.36

133

Peripheral retinal degeneration

885

1.05

0.17

2.6

2.3

6.18

7.52

ug/l

0.35

785

UC patients in KELA-register (code 208), prior to 1994

143

1376

1.04

0.17

3.0

2.3

8.77

7.67

ug/l

0.25

133

1250

Other specified/unspecified hearing loss

336

3280

1.03

0.17

2.1

2.3

7.12

7.40

ug/l

0.07

301

2853

Varicella [chickenpox], including avohilmo

135

1296

1.04

0.17

2.6

2.3

12.37

9.90

ug/l

0.31

125

1182

Myopia

312

3042

1.03

0.16

2.1

2.2

8.45

7.22

ug/l

0.43

279

2716

Certain zoonotic bacterial diseases, including avohilmo

847

1.05

0.16

2.6

2.4

7.77

7.05

ug/l

0.15

761

Carcinoma in situ of breast

0.77

0.16

1.0

2.4

3.45

3.90

ug/l

—

Neuroendocrine tumor and carcinoma of stomach

178

1.14

0.16

2.1

2.5

2.46

7.94

ug/l

2.68

152

Other or unspecified immunodeficiency

0.75

0.16

2.5

15.60

5.31

ug/l

—

Brain astrocytoma, helper endpoint

1.13

0.15

1.7

2.1

8.77

6.25

ug/l

—

Phantom limb syndrome

1.11

0.15

1.3

2.4

2.89

6.12

ug/l

—

Villonodular synovitis (pigmented)

188

1.13

0.15

2.7

2.6

3.21

7.36

ug/l

1.97

167

Other demyelinating diseases of the central nervous system

738

0.95

0.15

1.9

2.1

6.79

6.80

ug/l

0.00

670

Use of amantadine

471

0.93

0.15

2.1

2.4

4.42

6.96

ug/l

1.27

415

Mandibular prognathia AND surgery (LeFortI or BSSO)

0.81

0.15

1.1

2.0

2.80

10.25

ug/l

—

Disorders of lacrimal system and orbit in diseases classified elsewhere

614

0.94

0.14

2.1

2.4

6.08

6.53

ug/l

0.09

549

Malignant neoplasm of nasal cavity and middle ear, including Hilmo

237

1.11

0.14

2.0

2.7

7.34

8.48

ug/l

0.13

207

Laparoscopic left hemicolectomy

562

0.94

0.14

2.4

2.6

4.16

8.25

ug/l

3.12

500

Unequal limb length (acquired)

122

1.15

0.14

2.4

2.5

5.01

7.10

ug/l

0.33

101

Helminthiases, including avohilmo

868

0.95

0.14

2.3

8.56

7.17

ug/l

0.27

775

Disorders of tooth development and eruption

447

3571

1.02

0.14

2.0

2.1

7.51

8.48

ug/l

0.40

391

3140

Qualitative platelet defects

1.18

0.13

3.8

2.7

6.36

4.82

ug/l

0.14

Viral conjunctivitis, including avohilmo

902

1.04

0.13

2.2

6.98

6.91

ug/l

0.01

805

Sequelae of poliomyelitis, including avohilmo

316

1.08

0.13

2.2

2.5

5.25

7.64

ug/l

0.63

281

Malignant melanoma

662

6540

1.01

0.11

2.3

2.5

8.00

7.87

ug/l

0.05

572

5720

Benign neoplasm of male genital organs

730

0.95

0.11

2.0

2.5

9.49

8.49

ug/l

0.14

661

Viral conjunctivitis

455

1.06

0.11

2.2

2.3

10.30

6.61

ug/l

0.35

411

Malignant neoplasm of rectosigmoid junction

623

1.05

0.11

2.2

2.6

12.04

7.37

ug/l

0.47

541

Malignant neoplasm of stomach

209

2045

1.02

0.10

2.5

5.27

7.71

ug/l

1.88

163

1781

Secondary malignant neoplasm of respiratory and digestive organs

667

0.96

0.10

2.3

2.6

2.92

7.19

ug/l

4.59

583

Hereditary lymphedema

1.18

0.10

2.0

2.1

15.28

3.94

ug/l

—

Disorders of acoustic nerve

809

0.96

0.10

2.6

2.4

5.83

7.71

ug/l

1.02

727

Food allergy

1.17

0.10

1.2

1.7

1.40

2.58

ug/l

—

Diseases caused by chlamydiae, including avohilmo

222

1.08

0.10

2.2

2.1

2.66

4.66

ug/l

1.52

198

L01XX Other antineoplastic agents

212

2163

0.98

0.10

2.3

2.5

4.71

7.50

ug/l

3.13

175

1910

Diffuse (eosinophilic) fasciitis

1.07

0.10

4.0

2.4

4.56

5.04

ug/l

—

Other osteochondropathies

194

1901

1.02

0.09

2.7

2.3

13.47

8.44

ug/l

0.67

171

1724

Plasmodium falciparum malaria

1.14

0.09

1.0

2.7

2.45

5.98

ug/l

—

Keratoconus

614

0.96

0.09

2.1

2.3

6.82

8.45

ug/l

0.41

559

Plasmodium falciparum malaria, including avohilmo

1.10

0.09

1.0

2.7

2.45

5.90

ug/l

—

Congenital malformations of lung, including avohilmo

1.10

0.09

3.2

2.2

1.43

4.96

ug/l

—

Bacterial sepsis of newborn

1.11

0.09

4.3

3.1

17.08

8.73

ug/l

—

Effects of other deprivation

1.08

0.09

1.3

1.8

1.43

4.97

ug/l

—

Disorders of parathyroid gland, other and/or unspecified

214

1.08

0.09

3.4

2.5

2.72

5.05

ug/l

3.32

190

LSIL lesion of the vagina

302

1.06

0.08

2.4

2.2

5.32

5.56

ug/l

0.05

267

Malignant neoplasm of bone and articular cartilage of other and unspecified sites

185

1.09

0.08

1.8

2.7

6.01

7.54

ug/l

0.30

164

Use of rasagiline

884

1.03

0.08

2.7

2.6

7.34

7.31

ug/l

0.01

795

Contact with sharp glass

854

1.03

0.08

1.7

2.1

7.66

8.12

ug/l

0.11

777

Non-small cell lung cancer, squamous, helper endpoint

192

1955

0.98

0.08

2.2

2.5

6.70

7.25

ug/l

0.16

172

1685

Fibrothorax

0.83

0.08

5.0

2.5

3.68

6.44

ug/l

—

Benign neoplasm: Lymph nodes

1.03

0.08

1.9

2.4

5.71

4.91

ug/l

—

Dislocation, sprain and strain of joints and ligaments of elbow

153

1561

0.98

0.08

2.1

2.2

6.15

7.22

ug/l

0.56

134

1406

Abnormalities of forces of labour

171

1678

1.02

0.07

1.8

1.9

5.98

5.72

ug/l

0.04

150

1488

Tooth agenesis EXCLUDE clefts and syndromes

489

0.96

0.07

1.9

8.43

6.92

ug/l

0.29

422

Use of levodopa decarbox-comt-inhibitor

117

1197

0.98

0.07

2.7

2.6

6.95

6.88

ug/l

0.02

1064

Other specified/unspecified diseases of inner ear

143

0.90

0.07

3.5

2.1

2.78

5.20

ug/l

1.23

127

Chorioretinal scars

112

0.88

0.07

3.1

2.6

4.29

7.99

ug/l

—

Meningococcal infection

147

1.09

0.07

1.9

2.4

2.76

8.51

ug/l

—

132

Hereditary hypogammaglobulinemia

1.09

0.07

2.2

2.4

7.62

5.10

ug/l

—

Malignant neoplasm of other and ill-defined digestive organs

294

1.06

0.07

2.0

2.7

2.71

7.10

ug/l

3.02

257

Brain astrocytoma, including Hilmo

1.06

0.07

1.7

2.3

8.77

9.75

ug/l

—

Brain astrocytoma

1.06

0.07

1.7

2.3

8.77

9.75

ug/l

—

Acute hepatitis B

1.06

0.07

5.1

2.6

5.60

6.02

ug/l

—

Acute hepatitis B, including avohilmo

1.04

0.07

5.1

2.6

5.60

5.92

ug/l

—

Osteosarcoma, including Hilmo

1.02

0.07

2.1

3.1

3.03

6.42

ug/l

—

Bus occupant injured in other and unspecified transport accidents

167

1.08

0.07

2.7

2.2

4.00

6.69

ug/l

0.73

148

Localized scleroderma [morphea]

354

1.05

0.06

2.0

2.2

39.96

7.31

ug/l

0.63

308

Benign neoplasm: Bronchus and lung

384

1.05

0.06

2.4

2.7

7.64

8.19

ug/l

0.09

341

Allergic conjunctivitis

1899

18335

1.00

0.06

2.2

7.66

6.82

ug/l

0.58

1600

16058

LSIL lesion of the cervix uteri

201

1982

1.01

0.06

1.9

2.0

5.11

5.26

ug/l

0.07

178

1739

Chronic lymphocytic leukaemia and small lyphocytis leukaemia, including Hilmo

118

1158

1.02

0.06

2.2

2.6

5.14

8.35

ug/l

1.94

1016

Chronic lymphocytic leukaemia

118

1158

1.02

0.06

2.2

2.6

5.14

8.35

ug/l

1.94

1016

Chronic lymphocytic leukaemia, helper endpoint

118

1158

1.02

0.06

2.2

2.6

5.14

8.35

ug/l

1.94

1016

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

1803

17327

1.00

0.06

2.2

7.69

6.86

ug/l

0.55

1510

15183

Malignant neoplasm of endocrine gland

216

2133

1.01

0.05

2.0

2.3

6.11

7.30

ug/l

0.38

185

1881

Other and unspecified diseases of blood and blood-forming organs

808

0.98

0.05

2.1

2.4

8.17

7.25

ug/l

0.22

722

Malignant neoplasm of thyroid gland, including Hilmo

221

2184

1.01

0.05

2.1

2.3

6.15

7.18

ug/l

0.33

188

1928

Demyelinating diseases of the central nervous system

198

1955

1.01

0.05

2.0

2.2

6.44

7.16

ug/l

0.30

169

1747

Systemic atrophies primarily affecting the central nervous system

146

1439

1.02

0.05

2.6

2.4

7.21

7.06

ug/l

0.02

131

1267

Malignant neoplasm of thyroid gland

195

1972

0.99

0.04

2.0

2.3

6.42

7.25

ug/l

0.21

165

1749

Other and unspecified papulosquamous disorders

170

1.06

0.04

2.8

2.4

8.45

5.91

ug/l

0.22

150

Congenital malformations of genital organs

163

1638

0.99

0.04

2.2

2.0

5.81

6.15

ug/l

0.10

136

1443

Contact with machinery

392

3945

0.99

0.04

2.7

2.4

8.28

8.91

ug/l

0.27

356

3572

Traumatic amputation of wrist and hand

141

1393

1.01

0.03

2.4

8.37

8.68

ug/l

0.07

131

1273

Polypectomy (DHB20)

223

2250

0.99

0.03

2.2

2.4

6.38

8.87

ug/l

1.71

210

2042

Benign neoplasm of eye and adnexa

368

3704

0.99

0.03

2.4

7.19

7.14

ug/l

0.02

305

3269

Malignant neoplasm of other connective and soft tissue, including Hilmo

143

1446

0.99

0.03

2.3

2.5

7.70

7.80

ug/l

0.02

128

1273

Maternal care for known or suspected disproportion

592

0.98

0.03

1.4

1.9

3.44

5.81

ug/l

1.39

521

Complications of labour and delivery

1699

9456

1.00

0.03

2.1

5.23

6.06

ug/l

1.08

1512

8197

Pedal cyclist injured in collision with motor vehicle

778

1.02

0.03

2.0

2.4

4.66

8.04

ug/l

3.23

700

Twin gestation

128

1293

0.99

0.02

1.9

5.71

6.10

ug/l

0.09

119

1131

Sequelae of injuries of upper limb

291

2925

0.99

0.02

2.1

2.3

9.42

7.99

ug/l

0.25

247

2643

Adenocarcinoma and Papillary adenocarcinoma of kidney

441

1.02

0.02

2.6

5.56

8.20

ug/l

1.15

393

Malignant neoplasm of oropharynx, including Hilmo

740

0.99

0.02

2.5

6.16

8.64

ug/l

0.83

665

Testicular hypofunction

109

1101

0.99

0.02

2.6

2.2

9.53

10.26

ug/l

0.11

1010

Other obstetric trauma

720

0.99

0.02

1.7

1.8

4.34

5.44

ug/l

0.44

626

Pustular psoriasis

129

1301

0.99

0.02

2.6

2.3

3.47

7.12

ug/l

8.02

110

1161

Adenocarcinoma of small intestine

103

1.08

0.02

1.7

2.6

5.40

6.15

ug/l

0.15

Brain glioblastoma

502

1.02

0.01

1.4

2.5

2.48

7.84

ug/l

8.27

448

Normotensive glaucoma

353

3519

1.00

0.01

2.4

2.5

6.47

6.80

ug/l

0.17

300

3027

Papillary adenocarcinoma of thyroid gland

147

1461

1.01

0.01

2.1

2.4

6.48

7.10

ug/l

0.13

125

1307

113

1122

1.01

0.01

1.5

1.7

8.86

4.34

ug/l

1.56

978

Malignant neoplasm of larynx

583

1.01

0.01

2.1

2.7

5.82

8.05

ug/l

0.55

511

Carcinoma in situ of skin of lip

106

0.94

0.01

3.1

2.7

12.13

6.15

ug/l

—

Cleft palate

136

0.95

0.00

2.0

7.37

6.08

ug/l

0.17

124

Follicular adenocarcinoma of thyroid gland

206

0.97

0.00

1.9

2.5

4.74

6.02

ug/l

0.18

176

Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs

251

2503

1.00

0.00

2.2

2.3

6.05

7.15

ug/l

0.60

222

2246

Non-small cell lung cancer, squamous

192

1926

1.00

0.00

2.2

2.5

6.70

7.49

ug/l

0.25

172

1641

Struck by thrown, projected or falling objec

146

1455

1.00

0.00

2.5

2.3

7.88

8.03

ug/l

0.03

132

1314

Malignant neoplasm of tonsil, including Hilmo

595

1.01

0.00

2.6

2.5

6.54

8.43

ug/l

0.46

540

Colorectal neuroendocrine tumor and carcinoma

426

1.01

0.00

2.7

2.4

7.94

7.05

ug/l

0.11

372

Multiple gestation

134

1344

1.00

0.00

1.9

5.59

6.07

ug/l

0.11

124

1179

Malaria

114

0.96

0.00

1.5

2.4

11.11

9.03

ug/l

0.15

104

Macular cyst

111

1114

1.00

0.00

2.4

2.5

6.19

7.24

ug/l

0.38

979

Chromomycosis and phaeomycotic abscess, including avohilmo

1.01

0.00

1.6

2.5

11.26

5.46

ug/l

—

Vitamin B12 deficiency anemia due to intrinsic factor deficiency

628

1.00

0.00

2.3

2.5

7.20

6.33

ug/l

0.17

541

Malignant neoplasm of endocrine gland, including Hilmo

251

2509

1.00

0.00

2.2

2.4

5.76

7.31

ug/l

0.66

217

2209

Malignant neoplasm of nasal cavity and sinuses, including Hilmo

329

1.00

0.00

1.9

2.7

6.02

8.15

ug/l

0.38

288

Marginal zone B-cell lymphoma, including Hilmo

571

1.00

0.00

1.9

2.4

3.97

8.09

ug/l

3.03

499

Brain glioblastoma and astrocytoma

599

1.00

0.00

1.5

2.4

3.57

8.07

ug/l

5.09

538

Intussusception

567

1.01

0.00

2.7

2.3

5.29

7.95

ug/l

0.77

516

Other secondary gonarthrosis

173

1733

1.00

0.00

2.6

2.4

5.34

7.72

ug/l

2.34

154

1543

Crystalline deposits in vitreous body

315

1.02

0.00

3.2

2.5

4.89

8.08

ug/l

1.02

278

Carcinoma in situ of rectosigmoid junction

0.00

0.0

2.0

—

2.62

—

Major histocompatibility complex class I deficiency

0.00

0.0

2.2

—

8.12

—

Epiphyseal arrest

0.00

0.0

3.3

—

6.53

—

Unspecified early complication of trauma

0.00

0.0

1.6

—

6.80

—

Drug-induced folate deficiency anaemia

0.00

0.0

3.8

—

10.69

—

Medullary carcinoma of thyroid gland, including Hilmo

1.00

0.00

3.0

23.02

4.84

ug/l

—

Gastric ulcer - Acute with haemorrhage, drug-induced

1.02

-0.00

2.2

2.1

5.97

4.85

ug/l

—

Other parasitologically confirmed or unspecified malaria

0.94

-0.00

2.2

21.50

8.23

ug/l

—

Malignant neoplasm of oropharyng

0.90

-0.00

2.0

3.1

3.64

12.01

ug/l

—

Smallpox

0.00

-0.00

0.0

3.1

—

8.21

—

Meningitis, viral

0.92

-0.00

1.5

1.9

5.72

3.05

ug/l

—

Carcinoma in situ of larynx

0.92

-0.00

1.0

2.5

5.48

5.00

ug/l

—

Osteosarcoma

1.02

-0.00

2.6

2.1

3.18

8.22

ug/l

—

Congenital hydrocephalus

0.98

-0.00

2.7

1.8

8.73

4.08

ug/l

—

Lichen planopilaris

0.90

-0.00

1.6

2.6

4.39

4.77

ug/l

—

Acquired keratosis follicularis

0.00

-0.00

0.0

2.1

—

6.40

—

Toxic liver disease with cholestasis, drug-induced

0.00

-0.00

0.0

3.2

—

9.98

—

Other disorders originating in the perinatal period

1.01

-0.00

2.0

2.6

7.72

8.22

ug/l

—

Other specific arthropathies

1.02

-0.00

1.2

2.6

2.94

5.54

ug/l

—

Relapsing panniculitis [Weber-Christian]

0.00

-0.00

0.0

1.5

—

4.15

—

Microcephaly

0.00

-0.00

0.0

5.4

—

4.60

—

Other disorders of intestinal carbohydrate absorption

0.00

-0.00

0.0

3.2

—

8.27

—

Yellow fever

0.00

-0.00

0.0

2.8

—

12.40

—

Use of metixene

0.00

-0.00

0.0

2.7

—

3.20

—

Anthrax, including avohilmo

0.00

-0.00

0.0

2.9

—

3.28

—

Poikiloderma of Civatte

0.98

-0.00

3.2

2.5

3.16

7.57

ug/l

—

Common variable immunodeficiency with predominant abnormalities of B-cell numbers and function

1.02

-0.00

1.6

2.6

3.72

4.48

ug/l

—

Maple-syrup-urine disease

0.00

-0.00

0.0

4.0

—

6.36

—

Polyglandular hyperfunction

0.00

-0.00

0.0

2.0

—

2.98

—

Anthrax

0.00

-0.00

0.0

2.9

—

3.27

—

Yellow fever, including avohilmo

0.00

-0.00

0.0

2.8

—

12.40

—

Disorders of glycosaminoglycan metabolism, other/unspecified

0.00

-0.00

0.0

1.2

—

4.70

—

Duodenal ulcer - Acute with haemorrhage, drug-induced

0.95

-0.00

4.2

2.6

7.96

9.11

ug/l

—

Peutz-Jeghers syndrome

0.00

-0.00

0.0

1.0

—

2.24

—

Pinta [carate]

0.00

-0.00

0.0

3.4

—

16.82

—

Benign neoplasm: Extrahepatic bile ducts

0.93

-0.00

1.7

2.1

1.87

5.62

ug/l

—

Disorders of sexual preference

0.98

-0.00

2.2

2.5

4.57

7.87

ug/l

—

Other and unspecified syphilis, including avohilmo

0.92

-0.00

1.3

2.2

6.16

6.21

ug/l

—

Obstetric and gynaecological devices associated with adverse incidents

0.00

-0.00

0.0

2.0

—

1.32

—

Pseudomembranous colitis, drug-induced

0.00

-0.00

0.0

2.9

—

9.24

—

Smallpox, including avohilmo

0.00

-0.00

0.0

3.1

—

8.21

—

Glaucoma secondary to drugs

0.95

-0.00

2.0

2.3

9.43

5.58

ug/l

—

Other disorders of middle ear and mastoid in diseases classified elsewhere

0.00

-0.00

0.0

3.2

—

3.27

—

Birth injury to scalp

0.00

-0.00

0.0

4.1

—

6.25

—

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Creatine kinase.MB [Mass/volume] in Serum or Plasma

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS